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ABSTRACT 
E. coli primarily resides as a commensal in the colon of humans and warm-blooded animals. 
There is ample evidence to indicate that human commensal strains can infect anatomical sites 
outside the colon, particularly the urinary tract. This is further complicated by the fact that the 
commensal E. coli population represents a large reservoir of antibiotic resistance genes. Many 
studies have examined the properties of strains that cause urinary tract infections but studies 
on which commensal E. coli strains are likely to cause non-intestinal infections are somewhat 
limited. The work presented in this thesis tested the hypothesis that the strains which can 
persist in the human colon for a long time, are more likely than other strains, to have similar 
properties to the E. coli that cause extraintestinal infections. To address this, a collection of 
persistent and other commensal E. coli strains from 11 healthy Australian adults without any 
recent antibiotic treatment was assembled and analysed. 
Seventy-three strains were collected from 11 subjects, and 8 of these adults each 
carried 1 or 2 strains that were detected in multiple faecal samples over a period of months to 
years. These were persistent strains and a total of 13 were found of which 7 were from 
phylogenetic group B2 and 3 each were from groups A1 and D. Of the 19 virulence and 
siderophore receptor genes screened for, the group II capsule [kpsMT II] and the 
yersiniabactin receptor [fyuA] correlated with strain persistence. The 13 persistent strains each 
contained kpsMT II and 12 carried fyuA. Nine of the 13 strains belonged to ST95, ST69, 
ST405 or ST131, the clones that are often found in UTI and other non-intestinal infections. In 
contrast, a group of 36 strains found here that were not detected in multiple samples included 
only 12 with kpsMT II and 14 with fyuA, and a single ST95 and one ST131 strain. 
The 73 strains and few additional commensal strains were characterised for their 
resistance to 11 antibiotics and 46 resistant strains were found. Seven of the persistent strains 
were resistant to at least one antibiotic, showing that resistant strains can persist in the 
	   VI	  
absence of antibiotic selection. One of the resistant strains was found to carry a 6.8 kb 
plasmid that had a dfrA14 gene cassette, which confers resistance to trimethoprim, in the strA 
streptomycin resistance gene. This plasmid, named pCERC1, was completely sequenced and 
its replication region was identified. Four other very closely related plasmids were found 
among the 46 resistant strains. A large plasmid carrying a large resistance island that 
contained a class 1 integron, appeared to be present in 3 ST69 strains that were found here. 
Variants of this island were present in 2 further ST69. Hence, plasmids appeared to be the 
main agent in the dissemination of antibiotic resistance genes amongst the commensal strains.  
The resemblance shared between persistent strains and those that cause extraintesintal 
infections indicated that persistent strains, which are successful commensals, are the subset of 
commensal strains that are most likely to cause non-intestinal infections. Moreover, the 
acquisition and accumulation of resistance genes by persistent strains could explain the 
emergence of multiply antibiotic resistant clones like ST131 and ST69.  
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1.1 General Overview 
1.1.1 Escherichia coli 
Since it was first isolated in 1885 by Theodor Escherich, E. coli has become one of the most 
studied bacterial organisms on the planet. It is well known for its utility in genetic 
experiments and in protein expression systems, thus is commonly found in laboratories across 
the world. E. coli reside primarily in the large intestine of humans and warm-blooded animals 
(11, 105, 139, 178, 256, 288), where their presence is not considered to be detrimental to the 
well being of the host organism, thus allowing both organisms to stably co-exist. Hence, they 
are called commensal E. coli. They can also be found in other niches such as soil and aquatic 
environments (297, 302).  
E. coli however have a darker side. Extraintestinal or enteropathogenic E. coli can 
cause infections. The enteropathogens cause intestinal diseases and historically, they have 
been studied in greater detail because lower hygiene and food-handling standards resulted in 
high incidences of intestinal disease. Enteropathogenic E. coli are distinct from commensal 
and E. coli that cause infections at other sites, and there are 6 known pathotypes (196). They 
will not be discussed in this thesis. 
The E. coli that cause infections outside the gastrointestinal tract can infect several 
anatomical sites, causing significant morbidity and mortality (251). E. coli are believed to be 
the most common cause of these non-intestinal infections (105, 127, 139, 229, 314), 
particularly urinary tract infections [UTI], neonatal meningitis (229) and bacteraemia (314). 
In the developed world, these E. coli are estimated to have a far larger economic and medical 
impact than enteric infections (105, 251). Consequently, they have been largely studied from 
a clinical perspective. Collectively, these E. coli are called Extraintestinal Pathogenic E. coli 
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[ExPEC]. However, since the 1960’s (294) evidence has been mounting of a relationship 
between UTI strains and ones found in the commensal flora [reviewed in (46, 127, 277)].  
 
1.1.1.1 Commensal E. coli 
Commensal bacteria asymptomatically colonize the skin, oral cavity, nasal cavity, 
gastrointestinal system and other surfaces in the human body that come into contact with the 
external environment (10, 288). The commensals reap the benefits provided by the host 
environment, such as nutrition, and in return, some are able to assist the host organism in 
biochemical process such as digestion. This implies a symbiotic relationship. It has been 
proposed that this mutually-beneficial commensal lifestyle of E. coli may be induced by the 
unique environmental and nutritional cues that E. coli encounter once in the gastrointestinal 
niche (11). The colon is the primary habitat of E. coli (287) but they are a minority constituent 
of the microbial flora and occasionally individuals are found without E. coli (20, 150, 288). 
The total bacterial population contained within the colon has been estimated to be 
approximately 1012 bacterial cells per gram of colonic contents (79, 94, 186), and the E. coli 
population of the adult colon has been shown to be between 105 to 109 colony forming units 
[CFU] per gram of faeces (14, 20, 56, 106, 108, 109, 158, 178). Hence, E. coli represent at 
most 0.1% of the intestinal commensal bacterial population.  
 
1.1.1.2 Antibiotic resistant commensal E. coli 
It has been known for a while that the human commensal E. coli population harbours 
antibiotic resistant members (110), and it has been claimed that it is almost impossible to find 
subjects who have not been exposed to antibiotics or antibiotic resistant bacteria from other 
humans or the environment (110). Though E. coli is a minority inhabitant of the colon and 
represents less than 0.1% of the microbial flora, it is considered to be a major reservoir for 
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antibiotic resistance genes (20, 71, 159, 160, 168, 175), and this reservoir is linked to another 
reservoir of resistant strains, the food supply (173, 215, 247). There are many reports of the 
carriage of antibiotic resistant commensal E. coli by healthy humans (8, 20, 22, 34, 35, 73, 
143, 152, 159, 225, 270, 275) but most of these studies do not report the combinations of 
antibiotic resistance phenotypes or resistance genes that were found. Other studies 
characterise isolates only for the presence of integrons (267, 268, 275). Isolates can carry 
many different antibiotic resistance genes and these can be in gene cassettes in integrons or in 
other contexts (20), and hence, detailed analysis is required to adequately track the 
epidemiology of resistance. Several studies have now shown that more that 60 to 90% of 
healthy community members with no recent history of antibiotic use carry a resistant 
commensal strain (20, 22, 35, 73, 159). Hence, human commensal E. coli are considered to be 
a major reservoir for antibiotic resistant genes (20, 159, 160, 175), and they could be the most 
important reservoir.  
 
1.1.1.3 Commensal E. coli can cause infections 
In 2002 in the USA alone, extraintestinal infections were conservatively estimated to cost 
over a billion dollars per annum in direct health care costs (251). This cost is likely to be 
higher today. The primary reservoir of E. coli strains that cause infections is believed to be the 
infected host’s own commensal flora (311), and this is especially so in women with recurrent 
UTI infections (190).  
UTI, especially uncomplicated cystitis in women, where the infection is confined to 
the bladder, accounts for most non-intestinal E. coli infections and these infections are 
believed to have the highest economic burden and they cause significant morbidity (105, 139, 
229, 251, 311). A UTI is defined as symptoms with the presence of significant numbers of 
pathogenic bacteria in the urinary tract (105, 139, 311). However, there are individuals, 
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particularly amongst the elderly population, who have asymptomatic bacteriuria (105). From 
a clinical perspective, the pathology of E. coli infections is quite well understood, particularly 
in the case of urinary tract infections (105, 229, 311), which have been studied since the 
1960s. UTI can be divided into several categories [Table 1.1], and the severity of infection 
increases as the infection ascends from the bladder to the bloodstream. Bacteriuria is the 
presence of bacteria in the urine but the symptoms usually associated with cystitis, such as 
pain, are absent (105). Cystitis and bacteriuria are defined as uncomplicated UTI of the lower 
urinary tract (105) but in some cases, E. coli can ascend the urinary tract and infect the 
kidney, causing pyelonephritis, a more serious form of UTI (105). Severe kidney infections 
can result in urosepsis, which is defined as a bloodstream infection that is caused by bacteria 
originating from the urinary tract (105). Another major infection caused by E. coli strains is 
neonatal meningitis, where infection of the cerebrospinal fluid of newborns occurs (139, 229), 
and it has a greater risk of mortality than uncomplicated UTI. Once E. coli strains enter a 
sterile anatomical site such as the urinary tract, their ability to cause an infection varies. Those 
that cause infections usually express traits that are called virulence factors [VF].  
 
Table 1.1: Types of UTI 
Type of infection Site of infection 
Bacteriuria Bacteria in urine only 
Cystitis Bladder 
Pyelonephritis Kidney 
Urosepsis Kidney to bloodstream 
 
Attempts to establish which commensal E. coli strain may have caused a UTI are 
difficult. This is because faecal sampling in prior studies often begins post-infection, once 
symptoms have emerged, which is normally days after the onset of infection. At this point, 
the strain composition in the colon could have changed.  
Two theories that attempt to describe which commensal strains can cause UTI have 
emerged. These are the special pathogenicity and the prevalence theories (310). The 
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prevalence theory states that the numerically dominant strain in the faeces at the time of 
infection was likely to be the cause as it had a greater opportunity to cause infection. The 
alternate special pathogenicity theory postulates that E. coli with specific virulence factors, 
regardless of their abundance in the faeces, cause infections (310). 
 
1.2 The population structure of E. coli 
Population structure is defined by the balance between genetic changes derived from 
recombination and mutation, where clonally structured populations exhibit a low level of 
recombination whereas panmictic populations display high levels of recombination (43, 287). 
Early studies examined the diversity of the E. coli population collected from multiple niches, 
including strains from the faecal flora and non-intestinal infections, by looking at the 
electrophoretic mobility of up to 20 enzymes extracted from each strain (43, 184, 210, 211, 
265, 266, 308, 309), termed multilocus enzyme electrophoresis [MLEE]. The enzymes 
examined are housekeeping enzymes that are required by the cell to survive. It was found that 
the E. coli population had evolved in a clonal manner, and recombination had played a limited 
role in this process (210, 211, 308, 309). A diverse group of 72 E. coli strains that were 
collected from the faeces and UTIs of humans and 16 other mammalian species was 
assembled and named the E. coli reference [ECOR] collection (212). MLEE analysis of the 
ECOR collection using 38 enzyme loci grouped the 72 strains into 4 major phylogenetic 
groups, which were A, B1, B2 and D, and a further small accessory group, E (112). Groups 
A, B1, B2 and D are the main E. coli phylogenetic groups (46, 287); most E. coli fall into one 
of these 4 lineages. It has been proposed that group E and the newly discovered group F are 
accessory groups that contain a far smaller percentage of E. coli (287). Enteropathogenic 
O157:H7 strains are reported to belong to group E (92). 
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MLEE has now been replaced by multilocus sequence typing [MLST] as the preferred 
tool for population structure analysis (46). This approach examines variation in approximately 
500 bp nucleotide sequences from 6 to 8 housekeeping genes, and each unique combination 
of alleles is assigned a sequence type [ST] (46). There are 3 typing schemes (77, 239, 312), 
which examine different housekeeping genes. According to Wirth and associates (312), 
isolates can be grouped into clonal complexes [CCs] that are comprised of the main ST, 
which has the most isolates, and those that differ by 1 allele [single locus variant [SLV]] or 2 
alleles [double locus variant [DLV]]. 
Tenaillon and co-workers (287) concatenated the MLST sequences of 8 genes from 
each of the 72 ECOR strains and analysed them using ClonalFrame, and they projected that 
group B2 is the basal taxa of E. coli and group D was the earliest lineage to diverge followed 
by B1 and A (46, 287) [Figure 1.1]. 
 
Figure 1.1: The phylogenetic history of E. coli using ClonalFrame analysis. The tree was constructed using 
the sequences of 8 housekeeping genes from each isolate and is rooted on Escherichia fergusonii. The small 
outermost circles represent the 72 ECOR strains and the triangles represent publicly available E. coli genomes. 
Solid circles and triangles represent isolates from infections whereas open symbols represent commensal strains. 
Group A is blue, B1 is green, E is purple, D is yellow, B2 is red and F is orange. Dots on the nodes indicate that 
the clade defined by the node is monophyletic with more than 80% support. Taken with permission from 
Tenaillon et al. (287), licence number 2944611124624. 
CHAPTER 1      General Introduction 8 
MLST analysis of group A isolates has found this group to be quite homogenous as most of 
them belong to ST10 (92, 312), and this high ST homogeneity is consistent with it being the 
latest lineage to diverge.  
MLEE analysis concluded that groups B2 and B1 were sister taxa, hence the 
commonality in their nomenclature (112), though recent data suggests that groups A and B1 
are more likely to be sister taxa (46, 287). 
 
1.2.1 Identifcation of E. coli phylogenetic groups 
A phylogenetic group PCR was developed to rapidly assign most E. coli to 1 of 7 genotypes 
that represent the 4 main phylogenetic groups (48, 50). This assignment is based on all 
possible combinations of the presence or absence of 2 genes [chuA and yjaA] and an 
anonymous DNA fragment [TSPE4.C2] (48, 50). The 7 possible genotypes are A0, A1, B1, 
B22, B23, D1 and D2 (78) [Figure 1.2], and this multiplex PCR is now used routinely in E. coli 
population-level studies (92).  
 
Figure 1.2: The Clermont phylogenetic group PCR. A hypothetical gel image of the phylogenetic group PCR, 
and assignment is based on the presence or absence of any combination of the genetic fragments chuA, yjaA and 
TSPE4.C2 that are listed on the side. The 7 possible genotypes are listed below. The dash indicates an 
unassigned genotype. 
 
MLST analysis has shown that 80-85% of E. coli strains are assigned to the correct 
phylogenetic group based on this PCR (50, 92). Strains that do not contain any of the DNA 
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pieces are assigned to A0, but these isolates could be missing phylogenetic bands because they 
could be members of one of the cryptic clades of E. coli (50). Cryptic clades include novel 
members of the genus Escherichia but their species assignment requires extra characterisation 
(50). However, most studies do not differentiate between A0 and A1 isolates, using group A 
instead to represent them both. Recently, Clermont and associates have devised a new set of 
PCRs that can separate E. coli into 8 phylogenetic groups, including groups C, E and F, and 
further distinguish A0 and A1 isolates (51). 
 
1.3 Commensal E. coli population in adult humans  
There are very few studies that examine the E. coli population within the colon of adults. 
Most analyses usually characterise a single isolate from each adult and this is insufficient to 
draw conclusions about the population structure. There are some that have examined the 
human commensal E. coli population structure (43, 108, 132, 182, 244, 262, 263, 272) but 
most of this was done prior to the advent of molecular tools such as PCR. Early work in this 
field had shown that E. coli colonisation of the gastrointestinal tract began at infancy (99) but 
it was not known if adult humans carried quantitatively complex E. coli strain populations, 
which they had accumulated since infancy, or populations that were composed of 3 or 4 
strains that were constantly replaced (262, 263). Due to the limited strain typing methods 
available at the time, strain persistence was largely investigated using O-antigen profiles to 
distinguish E. coli strains, and it was thought that each strain expressed a unique O-antigen 
(262, 263). Most adults were found to carry between 1 to 4 different O-types in each faecal 
sample (108, 244, 262, 263, 272) but certain O-types were present in the colon for long 
periods of time, indicating that E. coli strains could persist in the colon. Strains were defined 
as a ‘resident’ if their O antigen was detected over a period of months to years, while a 
‘transient’ strain was one that did not persist or was observed to persist for a few days and 
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occasionally a few weeks (262-264). A ‘dominant’ strain was the numerically most abundant 
strain (262-264). Sears and associates conducted the earliest studies on strain persistence and 
their work forms the foundation of what is known about the E. coli population structure in the 
adult colon. This work is routinely cited by other commensal E. coli studies as the earliest 
evidence of strain persistence in the colon.  
Studies on children have not been considered here because their microbial flora are 
reported to be less stable than adult microflora (21, 169). The few studies that examined the 
number of E. coli strains carried and turnover in the adult colon are discussed below. 
Summaries of the studies discussed are in Tables 1.2 and 1.3. 
 
Table 1.2: A summary of methods used on some studies of E. coli in the human colon 
Year Strain typing methods Isolates/ samplea 
Duration 
[years]b 
Adult 
subjects Reference 
1950 O-type NS 2.5 2 Sears, (262)  
1951c O-type NS 4 3d Sears, (263) 
1962 O-type, biochemical assays 10 0.5 6 Robinet, (244) 
1976 O- and H-type, biochemical assays 10 0.5-3.5e 9 Shooter, (272) 
1977 O-type, antibiotic resistance type, 
biochemical assays 
10 0.2-0.8e 9 Hartley, (108) 
1981 MLEE 11-74 0.9 1 Caugant, (43) 
1999 Ribotyping, antibiotic resistance 
type, biochemical assays 
10-15 1 1 McBurney, 
(182) 
2008 PFGE, MLST, biochemical assays 5 4 5 Johnson, (132) 
aIsolates analysed per faecal sample and NS is not stated 
bLength subjects were followed and samples collected 
cStudy a continuation of from previous study in 1950 
d1 additional subject. Two subjects were followed from the previous study (262) 
eSubjects participated at varying lengths 
 
1.3.1 Early studies on commensal E. coli colonisation of humans 
Sears and colleagues were interested in determining the total number of strains that are 
present in the adult colon at any one time, and examining if any of these strains could persist 
(262, 263). To examine the E. coli strain population in adults, they studied 115 and 111 faecal 
specimens that were collected from two adults over a 2.5 year period (262). Both subjects 
contained between 1 to 4 O-types in every faecal sample that was examined. In the first 
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subject, isolates that were typed as O7 were found for 271 days and they were replaced by 
O28 isolates after the subject was ill and admitted to the hospital (262). The second adult 
carried O2 and O75 isolates that were present concurrently for 485 days. After 2 months of 
travel, they were both replaced by O28 and O7 isolates (262). Hence, the 2 subjects carried 1 
or 2 O-types that were present for 6 months to over a year, and hospitalisation or travel 
appears to have displaced those strains, resulting in acquisition of new resident strains. The 
other O-types that were found were not observed to be dominant and some were present in 
multiple samples but for less than 1 month (262). Similar findings were made when the study 
was expanded to include a third subject (263).  
Robinet sampled 6 individuals monthly for 6 months and 10 isolates per sample were 
O-typed and characterised using 8 biochemical assays (244). Again, every faecal sample 
contained between 1 to 4 O-types (244) but some isolates could not be typed accurately, 
highlighting a limitation of this method. Four subjects appeared to have strains that were 
detected in multiple samples, and the abundances of these strains fluctuated. Hartley and co-
workers made similar findings when they characterised 10 E. coli isolates per sample from 9 
adults for up to 9 months (108).  
The reliability of the conclusions drawn by the studies based on a single feature, 
namely the O-type, were called into question when an additional typing method was 
incorporated. Faecal E. coli isolates from 9 people over a period of 5 months were examined 
by Shooter and associates (272). Strains that had the same O-type were found to have 
multiple H-types (272). The high strain diversity that was observed by Shooter and co-
workers, in contrast to some of the previous studies (262, 263), lead them to conclude that 
strain turn over was the cause of E. coli strain diversity in the gastrointestinal tract (272). 
From the work by Shooter and colleagues, it is clear that increasing the discrimatory powers 
improved the ability to distinguish individual strains. In light of this, the strains of a single O-
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type in the Sears (262, 263), Robinet (244) and Hartley (108) studies that were detected in 
multiple samples could have represented multiple strains that shared an O-type. Moreover, the 
replacement of one strain by another sharing the same O-type but with different O:H 
serotypes would have remained undetected.  
 
1.3.2 MLEE analysis of strains 
The advent of MLEE provided a tool that had a better capacity to distinguish E. coli strains. 
Only one study has used MLEE to examine the long-term commensal E. coli population 
structure (43), and this was done on 22 faecal samples that were collected from an adult over 
an 11-month period. The subject had not consumed antibiotics 5 years prior to or during the 
study. Fifty-three MLEE types were found over the study duration and most samples had 1 to 
5 types, though 3 samples had over 10 types. Only 2 types were detected for more than 6 
months, and these 2 types were described as residents. The abundance of these 2 strains 
fluctuated throughout the study duration and they were both not detected in 4 samples in the 
middle of their tenure in the colon. Like Shooter and associates (272), the authors concluded 
that the acquisition of new strains from the environment was a major factor affecting colonic 
diversity and changes in the clonal composition of the E. coli population (43).  
 
1.3.3 Recent studies on strain persistence  
An examination of the commensal flora of adults using modern tools such as PCR and MLST 
can provide a clearer picture of the commensal E. coli population. A study on an adult that 
examined 14 samples taken over a 12-month period and characterised 10 colonies per faecal 
sample by ribotyping [nucleotide characterisation of bacterial rRNA] (182) identified a strain 
that was present in every sample, and it was usually the most abundant strain found. In the 
second sample, only 4 isolates of this strain were detected and only 1 isolate was detected in 
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the tenth sample. Because ribotyping is not often used in the characterisation of commensal or 
disease causing E. coli, the findings of this study cannot be compared to other studies. 
The faecal E. coli population has been examined using MLST and this has provided 
some insight into the relationship between strains that have adapted to the colonic niche, to 
those that can cause extraintestinal infections. In a study on a family of 5 over a 4-year period, 
5 E. coli colonies from each of the 6 faecal samples provided by each person were typed using 
MLST and pulsed field gel electrophoresis [PFGE] (132). A ST73 strain was detected in one 
faecal sample from one person in 2005, and in two people in 2007. In 2008, ST73 isolates 
were recovered from the faeces of 4 people (132). Thus, the ST73 isolates were present in 4 
of the 5 household members for over 4 years. These 4 household members also carried ST95 
isolates, but they were only detected in the samples collected in 2005 (132). Only 2 people 
carried ST95 isolates in multiple samples [2 of the 3 samples] (132). Notably, ST95 [see 
Section 1.6.1.2] and ST73 are members of globally disseminated virulent E. coli that are often 
isolated from UTI and other infections (142). None of the isolates that were seen only in a 
single sample were from these STs. Hence, cohabiting individuals tended to share E. coli 
isolates and some were from STs associated with UTIs. The sequencing of multiple 
chronologically distinct ST73 isolates from this family found some evidence of the repeated 
entry of different lineages rather than persistence of one strain (238).  
Though this study (132) provided compelling evidence for the carriage of commensal 
strains by individuals for an extended period of time, only 5 isolates per sample were 
examined. Fluctuations in the strain population might have resulted in some strains remaining 
undetected. Hence, increasing the number of isolates examined could provide greater insight 
into the changes that the commensal E. coli strain population of a person can undergo. The 
findings of these studies on commensal E. coli are summarised below [Table 1.3]. 
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Table 1.3: Summary of findings on studies of E. coli in the human colon 
Year Subjects Duration [years] 
# of strains/ 
faecal sample PS
a  # of subjects without resident[s] Reference 
1950 2 2.5 1-4 6 0 Sears, (262) 
1951 3 4 1-4 3b 0 Sears, (263) 
1962 6 0.5 1-5 4 2 Robinet, (244) 
1976 9 0.5-3.5 NA ?c ?c Shooter, (272) 
1977 9 0.2-0.8 1-4 7 2 Hartley, (108) 
1981 1 0.9 1-13 2 0 Caugant, (43) 
1999 1 1 1-5 1 0 McBurney, (182) 
2008 5 4 1-3 4 0 Johnson, (132) 
aTotal number of strain present in multiple faecal samples detected in study 
bResident strains detected in previous Sears et al. study (262) not included 
cStudy claimed that resident strains were detected but did not explicitly state which strains they were 
 
1.4 Virulence factors  
As the tools used to examine E. coli improved, many of the traits that are used by E. coli to 
cause infections were identified. These traits are called virulence factors, and a trait is only 
considered to be VF after the role that it plays in pathogenesis has been experimentally 
proven (137, 142). Strains that are able to colonise the urinary tract usually contain many 
more VFs than those that cannot do so (137, 142). Some of the proven virulence factors 
include P fimbriae, group II capsular polysaccharide and the aerobactin iron uptake system 
(139, 142). Molecular based approaches now allow strains to be rapidly screened for many 
genes, and those that correlate well to E. coli recovered from infections are thought to be 
involved in the infection process (298). However, the lack of experimental evidence 
supporting a role as a VF has lead these genes to be considered as putative VF (139) or 
virulence-associated genes [VAGs]. Studies on the prevalence of virulence genes often do not 
examine the clonaility of isolates, and vice versa. Thus, the VAGs that are commonly found 
could be due to a close association of these genes with members of a specific clone.   
There are many different classes of VFs that E. coli can use to cause an infection 
[Figure 1.3]. For example, when infecting the urinary tract, E. coli deploy fimbriae and 
adhesins to adhere to epithelial cells and resist the flushing effect of urine (105, 142, 311). 
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Other VFs are involved in scavenging for nutrients and protecting the bacterium from an 
immune response (105, 142, 311). Toxins are another class of VFs and they can be highly 
damaging to the cell, this includes causing red blood cell lysis (120, 142, 311). E. coli can use 
various combinations of VFs to cause infections, and it is because of this that virulence in E. 
coli is believed to be a multifactorial process (11, 142, 298).   
The carriage of VFs by commensal strains has been examined in several studies (91, 
130, 165, 190, 209, 254), and in some (5, 67, 148, 204, 205, 207), certain virulence factors 
were proposed to have evolved as intestinal colonisation factors because they were detected 
more frequently in E. coli that could colonise human intestine for long periods of time or 
resist predation by protozoan species found in the gut. However, direct evidence to support 
VFs functioning as colonisation factors is limited, and this section predominantly discusses 
the roles that VFs play in pathogenesis. The VFs and certain VAGs that are examined by the 
bulk of the studies on isolates from infections are discussed here.  
 
Figure 1.3: E. coli virulence factors. The figure shows some of the common VFs expressed by E. coli. 
Examples of VFs are listed under each VF class.  
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1.4.1 P fimbriae 
P fimbriae are mannose-resistant adhesins, and their name is derived from their specificity 
towards P blood group antigen receptors (13, 120). Thus, they bind or agglutinate the P 
antigen on human uroepithelial cells and erythrocytes, and at a higher frequency to renal cells, 
which are reported to have a higher concentration of P antigen receptors (120, 139). Between 
60 to 85% of pyelonephritis isolates have been found to express P fimbriae (295, 296). P 
fimbriae were shown to bind human colonic cells, and this was suggested to be important for 
the maintenance of E. coli within the colonic environment (313). The genes that are required 
for the expression of P fimbriae are the papC, papE, papF and papG genes (13, 120). The 
papG gene, which has 3 known alleles, papGI, papGII and papGIII, encodes the adhesin tip 
of the fimbria conferring specificity and mediating attachment to receptors located on the 
surface of target cells (13, 120). 
 
1.4.2 Type 1 fimbriae 
Type 1 fimbriae are mannose-sensitive adhesins because adherence can be inhibited by the 
addition of D-mannose, α-methylmannoside or concanavalin A (120, 139). Receptors for type 
1 fimbriae are found on human buccal epithelial cells, intestinal cells, blood vessel walls, 
muscular layers, urothelium and vaginal cells (120, 139), thus it is likely to be involved in the 
colonisation of many different anatomical sites. Type 1 fimbriae were shown to be important 
for the attachment of E. coli to mice bladder cells (53, 98) but they did not play a role in 
attachment to kidney cells, which do not contain appropriate receptors (120). These fimbriae 
have also been shown to mediate the attachment of E. coli to human colonic cells (9). There 
are conflicting reports on the prevalence of type 1 fimbriae with claims of them being in 50 to 
70% of all E. coli (13), 80 to 90% of all E. coli (139) or in most E. coli (311).  
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1.4.3 Other fimbriae and adhesins 
Other fimbriae and adhesins that play a role in the adherence of E. coli during infections 
include the Dr family of afimbrial adhesins, S fimbriae and F1C fimbriae (13, 120). The 
structures and genetic constitution of these organelles vary considerably but they provide 
cellular attachment to different surfaces, such as the bladder and intestinal sites (13, 120).  
The S fimbriae genetic determinant [sfa] is closely related to the F1C fimbriae [foc] 
with the difference in the two lying in their receptor specificities (13). The prevalence of S 
and F1C fimbriae are often reported together as sfa/foc. S fimbriae are claimed to be 
important in the pathogenesis of strains that cause meningitis (32).  
 
1.4.4 Group II capsular polysaccharide 
The group II capsular polysaccharide, more commonly known as the K antigen is an 
exopolysaccharide that encapsulates the entire bacterial cell, shielding and promoting evasion 
from host immune response mechanisms, acids and other constituents of the cell’s external 
environment (120, 243, 307). The capsule is also thought to play a role in the promotion of 
bacterial adherence to surfaces, and to one another, thus facilitating biofilm formation (243). 
There are 4 main groups of capsules but group II has been suggested to be the most important 
in extraintestinal infections (307). Within the group II family of capsules, numerous antigenic 
types exists but K1 and K5 are the best characterised types and they are claimed to be more 
frequently associated with extraintestinal infections that the other group II capsule types (243, 
307). Group II encapsulated isolates have been demonstrated to be more lethal than non-
encapsulated wild-type isolates in a mouse model (36) but when non-encapsulated isolates 
were provided with the group II capsule genes (273), increased lethality was not observed. 
Thus, the capacity to cause infections probably depends on the presence of capsule and other 
VFs.  
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1.4.5 The ibeA invasin 
Neonatal meningitis causes significant morbidity and mortality (85), and one of the VFs 
thought to play an important role is the ibeA invasin. The ST95 E. coli strain RS218 was 
isolated from a newborn with meningitis, and it was shown to invade human brain 
microvascular endothelial cells [BMEC] (115). This strain has been shown to cause 
bacteremia in 90% of rats, and it was assumed that meningitis was induced in these rats 
because it was thought that high levels of bacteremia resulted in meningitis (115). However, 
mutant 10A-23, which had an insertion in a gene named later as invasion of brain endothelial 
cells [ibe10], was non-BMEC-invasive and only infected 3 of 21 mice [14%] (115). Thus, 
ibe10 was suggested to be important in meningitis infections (115). The protein encoded by 
this gene is thought to confer on E. coli the ability to cross the human blood-brain barrier 
(116). The ibe10 gene was detected in 32% of 67 isolates from the cerebrospinal fluid [CSF] 
but in only 17% of 47 bloodstream and 3.5% of 58 faecal isolates (29). In more recent studies, 
ibe10 is also known as ibeA.  
 
1.4.6 Iron-uptake systems 
Iron is an important cofactor in all living organisms and as such, it is needed in trace to 
moderate amounts for survival (139). In humans, the free unbound iron concentration is 
approximately 103 atoms/ml bodily fluid, and this is reduced further during an infection but 
bacteria tend to contain 105 to 106 iron atoms per cell (120, 139). Clearly, there is a need for 
bacteria to be able to extract iron from the host during colonization. To sequester iron, 
bacteria can synthesize and extrude siderophores, which are protein chelator molecules that 
complex free iron and are then taken back up by the cell (87). Enterobactin [also called 
enterochelin] is a catecholate siderophore that has been claimed to be present in almost all E. 
coli (87), and this could explain why it is rarely assayed for.  
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Salmochelin is a modified form of enterobactin that can evade the immunoprotein, 
siderocalin, which is expressed by the mammalian immune system to sequester enterobactin 
(81, 193). Salmochelin that is complexed to iron can be recognised and thus taken up by both 
the salmochelin and the enterobactin siderophore uptake receptors (193).  
Yersiniabactin is an iron-uptake system found in E. coli and the genes encoding it are 
contained within 35 kb island named the high-pathogenicity island [HPI] (260). Originally 
detected in Yersinia spp., this island appears to have been horizontally acquired by E. coli 
because the E. coli HPI contains several deletions relative to Yersinia spp. HPI (260). In 
mouse lethality experiments, 16 of 30 mice infected with a strain carrying the HPI were killed 
whereas none were killed when the same strain containing mutations in the HPI was used 
(259). The HPI has been reported in several studies to be more common in strains from 
phylogenetic groups B2 and D than groups A and B1 (260). Yersiniabactin has also been 
reported to be more common in isolates from infections than aerobactin, and this might be 
due to the higher affinity yersiniabactin has for iron, compared to aerobactin (259). 
Aerobactin is another siderophore found in E. coli and its genetic locus can be found 
on the chromosome or on a plasmid (120). Aerobactin has been reported to enhance the 
virulence potential of strains in animal infection assays (63), and it has occasionally been 
found to be linked to other VFs like hemolysin (17, 120).  
The iron-responsive element [ireA] has not been found to be associated with a 
siderophore but ireA expression was repressed by iron and IreA showed some similarity to 
other siderophore receptors (250). Thus, it is believed to be involved in iron-uptake (250). 
Because ireA expression was found to increase 3.6-fold in human urine, 6.6-fold in blood, 
16.2-fold in human ascites and contributed significantly to mouse bladder colonization, it is 
considered to be a virulence factor (250). 
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1.4.7 Hemolysin and colibactin toxins 
Hemolysin or α-hemolysin [HlyA] is a protein toxin secreted by E. coli that forms 2 nm pores 
in the erythrocytes leading to cellular lysis, and it is additionally thought to contribute to 
inflammation and other non-specific cellular damage (65, 120, 311). The damage caused by 
this toxin is thought to enhance the availability of key nutrients that are required by E. coli, 
such as iron (311). Due to its specificity towards red blood cells, this toxin is unlikely to have 
a functional role in the colon.  
The other toxin examined in this study was colibactin, which has only been found 
exclusively among B2 E. coli (133, 201). Colibactin is a polyketide and it is encoded by a 54 
kb polyketide synthase [pks] chromosomal island (133, 201), and this toxin has been found to 
induce DNA double-strand breaks in eukaryotic cells, which lead to cell death (201). 
Colibactin may function like hemolysin, wherein cellular death leads to the liberation of 
necessary nutrients essential for the survival of E. coli. However, in studies where isolates 
were recovered from healthy members of the community (133, 201), no mention was made of 
any observed ill effects in those individuals. Thus, colibactin production may not be 
damaging to intestinal epithelial cells.  
 
1.5 The colon as a reservoir for harmful E. coli 
Despite there being over 150 E. coli O-types, those like O1, O2, O4, O6 and O75 were 
common [more than 50% of all isolates examined] among UTI isolates (54, 140, 234, 242, 
294, 301), and these O-types were also detected as the numerically dominant O-types in the 
faeces of up to 80% of patients from whom these isolates were recovered from (54, 140, 234, 
242, 294, 301). Thus, it was concluded that the infections were caused by strains that resided 
in the gastrointestinal tract. A larger number of O-types [more than 5] were often found in the 
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colon whereas the urinary tract was usually colonised by a single O-type (140, 242, 301). 
Hence, it was proposed that the ‘fittest’ intestinal strains infected the urinary tract (140). In a 
recent study on 42 women, 38 women each carried a strain in their faeces that was 
indistinguishable, using modern molecular tools, from a strain that caused cystitis (190). 
Though each woman only carried 1 urinary strain, most of them had 2 to 3 faecal strains in 
addition to the one that was indistinguishable from the urinary strain (190). The faecal strains 
that were believed to have caused the infections carried more VF than the other faecal strains. 
Hence, the authors concluded that the commensal strain with the properties to cause an 
infection was the one that had been selected from the faecal flora because of its more 
extensive VF carriage.  
To explain which faecal strains these so-called ‘fittest’ strains were, the prevalence 
and the special pathogenicity theories were proposed (310). The prevalence theory states that 
UTI is caused by the numerically dominant clone in the colon (310), and this theory arose 
from the observation that UTI serogroups were also abundant in the faeces of patients with 
UTIs. However, faecal isolates are usually examined after patients display symptoms of an 
infection, when the faecal strain population could have changed. The special pathogenicity 
theory posits that an infection is caused by a strain possessing the necessary VFs (310), and 
this gained prominence because VFs were increasingly characterized in the 1970s and 80s. 
These theories attempt to explain UTI in females, where transmission of E. coli has been 
shown to occur through the faecal-perineal-urethal route (317). They were not thought to be 
applicable in non-catheterized males due to the physiological differences of the male urethra. 
In males, it was believed to largely occur due to sexual activity with infected females (83). 
However, 30 out of 65 non-catheterized men with UTI (130) had indistinguishable  urinary 
and faecal isolates using VF genotyping, phylogenetic grouping, serogrouping, PFGE and 
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random amplification of polymorphic DNA [RAPD] analysis. Thus, UTI in males could also 
arise from faecal-urethal transmission.  
 
1.5.1 Special pathogenicity versus prevalence theory 
The prevalence theory gained early support because the O-types detected in urinary tract were 
often found in the faeces (54, 140, 234, 242, 294, 301). However, O-typing alone is 
insufficient in identifying individual strains as multiple strains can have the same O-type (3). 
As molecular based approaches became more common, the characteristics of pathogenic 
isolates were examined in more detail and VFs were identified, and they were usually more 
common in isolates recovered from infections than other E. coli (120). Hence, the special 
pathogenicity theory was proposed and it gained more prominence over time (310). In some 
studies however (130, 190, 242, 317), it appears that neither theory is sufficient on its own to 
explain which faecal strains are more likely to cause infections outside the colon.  
  One study found that in 20 of 26 symptomatic female patients, the predominant faecal 
strain had the same O-type as the UTI isolate (242). However, the comparisons were between 
a single urinary isolate and 10 faecal isolates per subject, using pre-molecular techniques. In 
another study (317), using PFGE on 100 faecal and urinary isolates from 9 women with 
cystitis, the urinary strain was the most abundant faecal strain in 6 women, supporting the 
prevalence theory but the strains found in both the faeces and the urinary tract contained more 
VFs than the strains that were found only in the faeces (317). The latter finding was consistent 
with the special pathogenicity theory. 
Among 65 men with UTI, 36 [56%] had urinary and faecal isolates that were 
indistinguishable using VF genotyping, phylogenetic grouping, serotyping, PFGE and RAPD 
analysis but the urinary isolates were not the predominant faecal isolate (130). However, in 16 
of the 65 men [25%], the urinary isolates were the predominant faecal isolates (130). More of 
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the urinary than the faecal isolates had VFs, and the urinary isolates were also more likely to 
be B2 strains [Table 1.4] (130). Hence, there was evidence to support both theories.  
Using the same typing methods on 1241 faecal and urinary isolates from 42 women, 
14 women carried the urinary strain as the only faecal strain and 4 carried it as a minority 
strain but 24 women did not carry the urinary strain in the faeces (190). More of the urinary 
strains that were also found in the faeces had VFs [especially yersiniabactin and group II 
capsule] whereas most of the faecal only strains did not (190). 
Despite the variation in methodology, the findings of these studies (130, 190, 242, 
317) show that these two theories are not mutually exclusive. The faecal strain population can 
fluctuate [see Section 1.3.3], and thus, the infecting strain, which carries more VFs than other 
faecal strains, could be a minority strain after the onset of infection, when the faeces is 
usually sampled.  
 
Table 1.4: Phylogenetic group distribution and VF carriage of UTI and commensal isolatesa 
Characteristicb Prevalence of trait, no. [%]  
 UTI [n = 65] Commensal [n=67] 
Phylogenetic group   
A 2   [  3] 26 [39] 
B1 3   [  5] 6   [  9] 
B2 59 [91] 23 [34] 
D 1   [  2] 12 [18] 
VFs   
Type 1 fimbriae [fimH] 64 [98] 65 [97] 
P fimbriae [papC] 47 [72] 22 [33] 
papGII 26 [40] 11 [16] 
papGIII 26 [40] 9   [13] 
S fimbriae [sfaS] 12 [18] 5   [  7] 
Dr adhesin [draBC] 0 3   [  4] 
Hemolysin [hlyD] 49 [75] 14 [21] 
Yersiniabactin [fyuA] 61 [94] 41 [61] 
Aerobactin [iutA] 28 [43] 27 [40] 
Salmochelin [iroN] 46 [71] 19 [28] 
Group II capsule [kpsMT II] 56 [86] 39 [58] 
K1 capsule 14 [22] 18 [27] 
aTaken from Johnson et al., 2005 (130) 
bOver 25 genes examined but only selected VFs shown here 
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1.5.2 VF carriage by commensals and isolates from infections 
The prevalence of VFs among disease causing isolates is well documented but studies on 
commensal isolates are somewhat limited. Studies of isolates from infections are often biased 
because those isolates are selected based on their resistance to antibiotics or membership of 
particular phylogroups. Hence, these isolates may have preponderance for particular VF. The 
abundance of VFs from 19 studies where E. coli were randomly collected from infections 
[Table 1.5], and from a comprehensive list of unbiased studies on commensal isolates [Table 
1.6] are summarised below. 
 
Table 1.5: The prevalence of VFs in isolates from infections 
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UTI 25 76 32 - - - 48 0 20 - 44 - 56 - - - 48 - (303) 
 42 98 41 - 29 10 41 2 19 81 - - 62 - 88 - 36 - (190) 
 65 98 72 - 40 40 18 0 9 86 22 - 43 71 94 - 75 - (130) 
 70 86 - - 23 6 7 14 - - - - - - - - - - (231) 
 88 100 45 - - - 20 6 32 - 44 - 35 - - - 22 - (209) 
 93 100 47 - - - 28 - - 82 - - 49 - - - 33 - (323) 
 100 100 74 - 62 21 42 3 11 75 - - 73 - 87 - 41 - (189) 
AFc 27 96 37 - - - 30 4 11 - 63 - 48 - - - 44 - (303) 
BSI 17 100 0 - - - 59 0 18 - 59 - 76 - - - 65 - (303) 
 50 92 48 - 24 28 42 2 22 70 - - 64 - 78 - 38 - (189) 
 62 - 69 - 48 - 39 - - - 81 - 55 45 82 32 45 58 (133) 
 63 97 68 - 48 21 38 5 11 79 25 - 54 44 81 32 44 - (254) 
 67 100 82 - 73 7 4 6 6 84 28 33 77 - 94 - 43 - (124) 
 75 100 79 - 71 7 4 9 5 63 28 33 80 - 93 - 41 - (125) 
 110 93 50 - - - 21 - 10 60 - - 45 44 71 30 21 - (25) 
 123 - - - - - 11 - - - - - 46 57 78 - 41 - (18) 
 161 - 49 - 29 17 29 - - - - - 66 58 78 - 32 - (119) 
CSF 12 67 0 - - - 33 8 42 - 83  92 - - - 17 - (303) 
 85 95 37 57 25 5 50 27 60 87 72  80 66 69 18 3 - (165) 
aNumber of isolates examined in study 
bPercentage of corresponding isolates where VF gene was detected. The “-” symbol represents not reported %. 
Numbers in bold indicate the highest and lowest proportions detected 
cAmniotic fluid 
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Though the prevalence of individual VFs can be established, an inherent limiration of 
VF studies is that the VF combinations contained within each isolated examined is rarely 
presented. Thus, it is difficult to establish which VF combinations are common.  
Data on the prevalence papGI in isolates from infections was also not readily found 
[Table 1.5], and it has been suggested to be rarely found allele (13). Data on colibactin was 
rare [Table 1.5] but this is probably because it is a newly discovered VF. Type 1 fimbriae was 
the only VF detected in more than 60% of isolates in both groups, and in most cases, it was in 
90 to 100% of isolates whereas the Dr adhesin was the least common VF [Table 1.5].  
The ibeA gene was more common in isolates from the CSF than isolates from other 
infections [Table 1.5], thus further supporting claims of its importance in meningitis 
infections (32, 115). The K1 antigen was up to 3 times more common among CSF isolates 
than other isolates [Table 1.5], and this is in agreement with previous reports of up to 90% of 
meningitis isolates expressing the K1 antigen (31, 32, 255). Hence, the distribution of some 
VFs appears to be influenced by the type of infection. Because the clonality of the isolates are 
often not examined, it is not known if the abundance of VFs are biased by the 
overrepresentation of particular clones that are more commonly found in infections [see 
Section 1.6.1].  
Like the studies on isolates from infections, only a few studies included data on the 
prevalence of K5 capsule, the papGI allele and colibactin [Table 1.6]. Type 1 fimbriae was 
the most common VF, and it was detected in up to 99% of isolates whereas Dr adhesin was 
the least common [Table 1.6], similar to the prevalence of these VFs in isolates from 
infections [Table 1.5]. Yersiniabactin was consistently the most common siderophore 
detected amongst isolates [Table 1.6].  
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Table 1.6: Prevalence of VFs among commensal E. coli isolates 
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NS 24 58 17 - - - 4 4 4 - 42 - 33 - - - 4 - (303) 
NS 41 73 - - 5 - 0 0 - - - - - - - - - - (231) 
106 61 98 18 - - - 11 7 26 - 21 - 30 - - - 5 - (209) 
13 63 81 28 0 18 6 19 0 - - 17 8 35 - 46 - 21 - (203, 206) 
65 67 97 33 - 16 13 7 4 9 58 27 - 40 28 61 - 21 - (130) 
42 67 96 15 - 10 0 9 0 6 24 - - 30 - 34 - 9 - (190) 
NS 69 - 30 - 17 - 16 - - 49 - - 20 26 56 7 16 32 (133) 
71 71 92 30 - 18 8 15 6 15 48 25 - 20 25 55 7 14 - (254) 
85 85 - - - - - 6 - - - - - 41 39 58 - 12 - (18) 
88 88 99 33 - - - 13 - - 70 - - 40 - - - 11 - (323) 
39 120 86 21 - 16 3 12 3 10 37 - - 42 - 45 - 8 - (191) 
22 146 49 10 0 8 0 0 1 - - 2 4 47 - - - 8 - (204) 
70 149 71 32 0 14 11 26 0 - - 27 7 29 - - - 23 - (205) 
168 168 - 11 - - - 4 1 3 - - - 16 - - - 7 - (72) 
NS 204 92 32 14 19 13 7 5 17 59 27 - 30 23 58 19 13 - (165) 
266 266 95 25 - - - 17 5 17 60 28 - 43 35 74 11 17 - (91) 
aNS is not stated 
bPercentage of isolates VF gene detected. The – represents not reported. Highest and lowest % in bold  
 
To facilitate further comparisons between the prevalence of VFs in commensal 
isolates and those from infections, the percentage distribution range of each VF from the 
commensal [Tables 1.5] and the extraintestinala disease causing isolates [Table 1.6] were 
compared [Table 1.7].  
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Table 1.7: Prevalence of VFs in studies on commensal and isolates from infections 
VF type  VFs Prevalencea [%]  
  Cb Pb 
Fimbriae / adhesin Type 1 fimbriae 49-99 67-100 
 P fimbriae 10-33 0-82 
 papG allele I 0-14 57c 
 papG allele II 5-19 23-73 
 papG allele III 0-13 5-40 
 S fimbriae  0-26 4-59 
 Dr adhesin  0-7 0-27 
Invasin ibeA  3-26 5-60 
Capsule Group II capsule  24-70 60-87 
 K1 capsule  2-42 22-83 
 K5 capsule 4-8e 33d 
Iron uptake Aerobactin  16-47 35-92 
 Salmochelin  23-39 44-71 
 Yersiniabactin  34-74 69-94 
 ireA 7-19 18-32 
Toxins Hemolysin  4-23 3-75 
 Colibactin  32c 58c 
a% prevalence range from Table 1.3 and 1.5  
bC represents commensal isolates and P represents pathogenic isolates 
cBased on prevalence results of a single study 
dBased on prevalence results of 2 studies 
eBased on prevalence results of 3 studies 
 
The prevalence of VFs was generally higher in the isolates that caused infections than 
in the commensal isolates except type for 1 fimbriae [Table 1.7]. Hence, type 1 fimbriae are 
common in E. coli and they cannot be used to distinguish commensals from E. coli that are 
recovered from infections. The Dr adhesin was the only VF that was not common in either 
commensal or the isolates from infections [Table 1.7]. The scarcity of the Dr adhesion 
indicates that it may not be very important in pathogenesis or colonisation of the colon.  
 Traits like iron scavenging and epithelial cell adherence are also required for survival 
in the gastrointestinal tract but the lower prevalence of these VFs among the intestinal isolates 
[Table 1.7] suggests that many commensal isolates do not them or other VFs. This was 
confirmed by the findings of a study that examined the VF carriage [PCRs to detect ibeA, 
hemolysin, S and P fimbriae, Dr adhesin and aerobactin genes] of 168 commensal isolates 
and found that 125 isolates [74%] did not carry any of the 6 genes assayed (72). If the colon is 
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a reservoir for isolates that cause infections, only the minority that carry VFs are likely to 
cause infections, and this is consistent with a claim made in the 1960s that only a few ‘fit’ 
intestinal strains that reside among a highly diverse colonic environment can infect the 
urinary tract (140). These ‘fittest’ strains are likely to be those that carry VFs and the 
extraintestinal virulence that results is a by-product of intestinal ‘fitness’, and this claim has 
also been made elsewhere (203, 206). Therefore, successful intestinal colonisers, which are 
those that can survive in the colon for an extended period of time, could also be adept at 
causing extraintestinal infections.  
 
1.5.3 VF carriage of long and short-term intestinal colonisers  
Except in the study by Johnson (132), persistent strains from adults have not been 
characterised for the presence of VF. The 14 strains found were examined for the presence of 
29 VFs and VAGs (132), and VF carriage was strongly associated with particular clones. The 
persistent ST73 strain carried 17 VFs and the persistent ST95 strain contained 13 VFs (132). 
However, many of the strains that were not detected in multiple samples also contained many 
VFs (132), and this is may be due to the limited number of isolates that were detected. A 
more thorough analysis might have yielded more transient strains, and these could have 
contained fewer VFs.  
 Because VF carriage has been examined in several longitudinal commensal E. coli 
studies that analysed strains recovered from the faeces of children and infants, their findings 
are discussed here. Seventy-seven strains collected from 70 Swedish infants were examined 
for the presence of 8 VFs. The infants were sampled 7 times over 12 months and 58 of the 
strains recovered were defined as ‘residents’ because they were detected for 3 weeks or more 
and the 19 remaining strains were ‘transient’ (207). Aerobactin and P fimbriae genes were 4 
to 6 times more likely to be detected in resident than transient strains, and hemolysin was 
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found only in resident strains (207). Thus, these VF appeared to be strongly associated with 
strains that could colonise infants. The same authors conducted another study that defined 
‘resident’ as a strain found in more than one sample from the same host, and 25 resident and 
38 transient E. coli isolated from 13 Swedish schoolgirls were examined for 8 VFs (203). Of 
the 25 resident strains, 44% carried a combination of aerobactin, P fimbriae, and K1 or K5 
capsule whereas this was true for only 3% of transient strains (203). Hemolysin did not show 
a correlation to strain persistence. Using the same criteria on 23 residents and 123 transient 
strains from Pakistani infants (204), Nowrouzian and associates found P fimbriae in a quarter 
of the resident strains and aerobactin was detected in 16 of these strains. However, these VFs 
were each detected in 8 of the 123 transient strains, and they were found together in only 6 of 
those strains.  
Based on their findings, Nowrouzian and co-workers proposed that virulence in E. coli 
might be “a coincidental product of adaptation to the colonic niche” (203, 206). This 
hypothesis could be related to the special pathogenicity and prevalence theories (310) but the 
lack of resident strain abundance data and limited VF characterisation makes it difficult to 
discern how these theories might be related. Additionally, the examination of another 
collection of 100 commensal strains from infants found that colibactin was in 53% of 32 long-
term colonisers but in only 14% of 21 transient strains (208), indicating that there could be 
more VFs that are associated with long-term intestinal colonisation.   
Intestinal colonisation and long-term survival of E. coli has also been linked to the 
presence of pathogenicity-associated islands [PAIs] (67). PAIs are large genomic islands [10 
to 200 kb] believed to be shared horizontally by E. coli that contain VF, and their carriage has 
been shown to be important to pathogenicity (305).  Strain 536 that was recovered from a UTI 
contains 7 PAIs, and the deletion of certain combination of PAIs from 536 was shown to 
reduce murine intestinal colonisation duration by the 536 mutants compared to 536 itself (67).  
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1.5.4 Phylogenetic group distribution among commensal isolates 
Group B2 E. coli cause most extraintestinal E. coli infections (142, 229, 277, 311). Hence, if 
the colon is a reservoir for strains that cause diseases outside the colon, then B2 strains should 
be common in the colon. However, it is often claimed that the human colon contains more 
group A and B1 E. coli. This claim is usually attributed to a study (227) that examined only 
15 commensal and 67 strains from infections and found that 7 commensal strains were from 
group A and 8 were B1 whereas 13 strains that had caused infections were group A, 15 were 
B1, 2 were D and 37 were B2. The authors concluded that B2 was more likely to be found in 
infections whereas A and B1 isolates were more likely to be in the commensal flora (227).  
Groups A and B1 have been found to be predominant phylogenetic groups of 
commensal isolates in 4 studies (72, 76, 190, 206), thus supporting the findings of Picard 
(227). However, this is contradictory to the findings of other studies. Eight found groups A 
and B2 to be more common (20, 48, 183, 207, 209, 254, 303, 323), 2 found groups B2 and D 
(91, 131), 2 found groups A and D (167, 191), and in one study, B1 and D E. coli were the 
most common (252). Hence, phylogenetic group membership of commensal isolates appears 
to be quite variable but in some adults, B2 E. coli can be the predominant strain, supporting 
the role that the colon plays as a reservoir for non-intestinal disease causing E. coli.  
A study conducted by Nowrouzian and co-workers that classified strains from the 
faeces of children as resident or transient found that 9 of the 24 resident strains were B2 
whereas only 2 of the 37 transient strains were B2 (206). Most of the transient strains were 
from group A. In another study by the same authors, 60% of 58 resident strains belonged to 
B2 compared to only 21% of 19 transient strains (207). Many studies have shown that B2 E. 
coli usually carry more VF than E. coli from the other phylogenetic groups (72, 91, 189, 206, 
227, 254, 323), and B2 strains from the faeces have been shown to be no different from the 
B2 strains recovered from infections, especially when examined for their ability to cause 
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lethality in mice (148). Hence, B2 strains could be better suited for long-term colonisation, 
and this could be due to their increased carriage of VF that are used as intestinal colonisation 
factors.   
 
1.6 E. coli that cause non-intestinal infections 
Early studies on E. coli from infections found isolates were usually from a limited number of 
serogroups or MLEE types (3, 216, 310). For example, of 150 UTI, septicaemia and 
meningitis isolates, 104 belonged to 6 serogroups (3). Amongst 267 pyelonephritis and 
cystitis isolates, 126 belonged to 8 serogroups (216). Ninety-one UTI isolates were analysed 
by MLEE using 16 enzymes, and 51 isolates were found to belong to only 4 types (310). 
Hence, isolates that cause infections are clonal in nature (3, 310).  
Unfortunately, the cost and skill required to perform these typing methods meant that 
not all isolates could be readily typed, and the data from both methods was not directly 
comparable. Furthermore, different strains could belong to the same serogroup (3, 272), and 
electrophoretic typing was not sensitive to certain changes in the amino acid sequences that 
had no net effect on the overall charge of an enzyme (184), thus limiting its utility. MLST has 
largely replaced both of these methods and it is the current preferred strain-typing tool 
because it utilises a higher resolution molecular approach to distinguish strains, and ST data 
from different laboratories can be easily compared. 
 
1.6.1 The clonality of isolates that cause infections 
After it was determined that E. coli usually belong to 1 of 4 main phylogenetic groups (112), 
and a PCR to screen for these groups was developed (48), subsequent studies showed that 
isolates from infections are often from B2 but other groups can also be common too (119, 
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165, 183, 189, 190, 209, 227, 232, 254, 303, 323). However, an examination of the strains 
using one of the MLST schemes (312) revealed that most of the B2 isolates that caused 
infections belonged to a few CCs, and this was similar to the findings made using 
serogrouping (3) and MLEE (310). In one study, 20 of 30 group B2 strains that expressed the 
K1 capsule, and caused neonatal meningitis, were from CC95 (312), whereas of 12 blood and 
27 UTI isolates that were antibiotic resistant, 23 were CC69 (285). Thus, isolates from 
infections were often comprised of a limited number of clones [Table 1.8].  
Though MLST analysis is routinely used to characterise E. coli that cause non-
intestinal infections, studies on unbiased collections of isolates are limited. Only antibiotic 
resistant isolates, particularly those resistant to fluoroquinolones and third generation 
cephalosporins, are often analysed, and this provides an incomplete representation of the 
clonal distribution of E. coli. A few studies have examined unbiased collection of isolates 
from infections [Table 1.8], and about half the isolates [50%] were associated with CC131, 
CC73, CC69 and CC95 [Table 1.8]. Thus, these STs represent the predominant clones 
recovered from human extraintestinal infections. Due to their relevance to this work, CCs 
131, 69, 95 and 405 are discussed further. 
 
Table 1.8: CCs identified amongst unselected E. coli isolates from infections 
Infection Isolatesa Number of isolates from the major CCsb   Ref 
  73 131 69 95 10 127 14 88 405 23 # STsc  
UTI 300 50 37 27 19 13 9 8 6 5 - 102 (89) 
UTI 70 - 13 9 4 7 - - - 8 - 26 (231) 
UTI 121 18 27 11 4 2 6 8 - 1 - 52 (59) 
UTI 68 4 43 1 4 0 1 1 1 0 1 22 (146) 
UTI 83 6 37 1 2 6 0 0 0 4 5 37 (90) 
Sepsis 46 0 26 2 0 4 0 0 0 0 6 
BSId 20 2 9 1 2 0 0 0 0 0 0 22 (146) 
BSId 220 20 51 19 40 9 3 3 - 4 3 41 (4) 
Total 928 100 243 71 75 41 19 20 7 22 15 280  
%e  11 26 8 8 4 2 2 1 2 2   
aTotal pathogenic isolates typed in the study 
bCommonly detected CCs reported in the study. A – indicates the data was not presented 
cTotal number of STs identified 
dBlood stream infections 
e% of isolates as a proportion of a total of 954 isolates 
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1.6.1.1 CC131 
CC131 is a highly pathogenic member of the B2 phylogenetic group (246), whose importance 
was established when it was found that 36 of 41 extended spectrum β-lactamase [ESBL]-
producing E. coli collected from Europe, Asia and North America belonged to ST131 (199). 
It is now reported to be the predominant CC detected in extraintestinal infections around the 
world suggesting that it is a globally disseminated clone (246, 314). In a recent study on 579 
CC131 isolates (134), the 3 earliest isolates were found, and they were from 1967, 1982 and 
1983. Hence, CC131 has been present in the clinical context for decades. Isolates are often 
resistant to 3 or more classes of antibiotics, including fluoroquinolones and third generation 
cephalosporins, and thus, they are considered to be multiply antibiotic resistant (4, 202, 246, 
314). One isolate was reported to carry an ESBL-production gene and 11 other antibiotic 
resistance genes on a plasmid (292). Surprisingly, only one representative CC131 strain, 
NA114, has been completely sequenced (15). Antibiotic resistant and susceptible isolates 
belonging to this CC have been found in the faeces of healthy Parisian adults (149).  
 
1.6.1.2 CC95 
A study of meningitis isolates in the 1970s reported that up to 77% of newborns were infected 
by E. coli expressing a K1 group II capsule (2, 255). Of 45 meningitis causing strains that 
expressed the K1 capsule, collected from Finland, the USA and England, 36 belonged to 2 
serogroups, O18:K1:H7 [23 strains] and O7:K1:H- [13 strains] (2). Five of the 23 O18:K1:H7 
strains were examined using the Whittam MLST scheme (239), and were found to be ST29 
(27). A further 12 French NMEC isolates, 4 pyelonephritis isolates including ECOR strain 62, 
and 3 faecal isolates from neonates were all found to be ST29 (27). However, ST29 was later 
redesignated as ST95 when these isolates were typed using the Achtman MLST scheme 
(187). CC95 isolates are also members of phylogenetic group B2. Isolates expressing the K1 
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group II capsule are often recovered from neonatal meningitis cases and from the faeces of 
adults, and a large proportion of these K1 isolates are members of CC95 (187, 188). Eighty of 
183 [44%] E. coli that expressed the K1 capsule were found to be members of CC95 (188), 
and 17 of these CC95 isolates were collected from the faeces of healthy adults. CC95 
represents another globally disseminated virulent clone of E. coli found to be responsible for 
infections around the world (187, 188). Unlike CC131 isolates, there are no published reports 
of multiply antibiotic resistant CC95 isolates.  
 
1.6.1.3 CC69 
A study on 337 E. coli UTI isolates from women in California and Michigan (172) found 73 
[22%] trimethoprim-sulfamethoxazole resistant [SuTpR] isolates, which was not unexpected 
because these antibiotics are regularly used to treat UTI (105). Using rep-PCR (123), 35 
[48%] of the 73 isolates were reported to have very closely related 4-band patterns, and this 
group was named clonal group A [CGA] (172). Seventy antibiotic susceptible isolates were 
assessed with rep-PCR and 3 [4%] were CGA (172). When another 67 SuTpR urinary isolates 
from Michigan were examined, 11 [16%] were CGA (172). Of a further 925 faecal isolates 
from 41 healthy Californian adults, 26 isolates from 15 of subjects were CGA, and 13 of these 
were SuTpR (172). A selection of 38 resistant and susceptible CGA isolates were typed using 
PFGE and 11 had indistinguishable profiles and only 1 isolate differed by more than 6 bands 
(172). Twenty-five CGA isolates were examined for carriage of 31 VFs and VAGs, and more 
than 60% had the same virulence profiles, leading the authors to conclude these isolates were 
closely related members of the same clone (172). Twenty-three of these CGA isolates were 
examined using the Wirth and colleagues MLST scheme (312) and 21 were identified as 
ST69 (285). CC69 isolates belong to phylogenetic group D, and they have been detected in 
infections around the world, particularly in UTIs (89, 314). They have been reported to be 
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associated with resistance to ampicillin [Ap], chloramphenicol [Cm], streptomycin [Sm], Su 
and Tp (126), and genes conferring these resistances were contained on a resistance island in 
the genome of a sequenced isolate (151).  
 
1.6.1.4 CC405 
Isolates belonging to CC405 are members of phylogenetic group D, and they are often 
associated with resistance to third generation cephalosporins (314). Recently, 3 of 18 isolates 
producing NDM-1 carbapenemase were reported to be ST405 (194). Among collections of E. 
coli isolates recovered from infections, approximately 2% of the isolates are CC405 [Table 
1.2]. However, when 581 clinical ESBL-producing E. coli isolates were analysed, 41 [7%] 
isolates were CC405 (180), thus making them the third largest ESBL-producing clone. They 
are increasingly detected around the world (314) but reports of their detection in human 
faeces were not found. 
 
1.6.2 VF carriage is variable  
In a study of 32 CC131 isolates from 10 countries [recovered from faeces, UTIs, wounds and 
water], 13 combinations of the fimH, fyuA, iutA, kpsMT II, neuB [K1], kfiC [K5], papC, the 3 
papG alleles, ibeA and iroN genes were observed (202). The most common VF genotype was 
the fimH, fyuA, iutA, kpsMT II and kfiC [16 isolates] however PFGE profiling indicated that 
these isolates belonged to 3 closely related groups (202). A study on 159 UTI isolates 
detected 10 CC131 isolates using a CC131-specific PCR (1). Only 2 of the 10 isolates had the 
same VF combination [fimH, fyuA, iutA, kpsMT II and K1] whereas the 8 remaining isolates 
had unique VF combinations (1). VFs such as iutA and iroN have been found on a plasmid 
that was recovered from a CC131 isolate (325). Thus, the heterogeneity of their VF profiles 
could be attributed to variation in plasmid carriage.  
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Isolates from CC69 (25, 151, 172), CC95 (25, 187) and CC73 (25) have also been 
reported to exhibit variation in their VF profiles. Aerobactin, hemolysin, P fimbriae, capsule, 
S fimbriae and yersiniabactin have also been found on PAIs (97, 120). PAIs are believed to be 
shared horizontally by E. coli because in the well characterised urinary strain, E. coli strain 
536, 5 of the 7 known PAIs have 16 to 48 bp direct repeats [DRs] next to them (174). Because 
PAIs can form mosaic structures (97), the same VFs can be carried by different PAIs. For 
example, hemolysin can be found on 3 different PAIs and 1 of those PAIs also carries P 
fimbriae (97). Hence, particular VF combinations could indicate the presence of specific 
PAIs. Some PAIs are unstable and are deleted from the chromosome at frequencies of 10-4 to 
10-6 (96, 97). Thus, VF variation could be due to the gain or loss of PAIs, and this variability 
has led VFs to be considered as part of the accessory genome (235).  
 
1.6.3 Using VF carriage to identify potential ExPEC isolates 
A classification for E. coli that uses the presence of at least 2 out of 5 different VFs to assign 
isolates as being operationally ExPEC was proposed (128, 249). Because it is not known if 
the isolates recovered from infections caused the infection, those isolates that contained at 
least 2 of the 5 proposed VFs were considered to be the most likely cause of infection until 
this assignment could be confirmed using and animal infection assay (249). These 5 VFs are 
S fimbriae, aerobactin, group II capsule, P fimbriae and the Dr adhesin (128). They were 
chosen because isolates carrying various combinations of at least 2 of these VFs were found 
to be more likely to infect and kill mice (128). Therefore, E. coli strains that possess any 2 of 
these 5 VFs, regardless of phylogenetic group membership and epidemiological source, can 
be considered operationally ExPEC or ‘ExPEC’ until they are proven to be ExPEC through 
assays in an appropriate animal model (249). However, the variable nature of VF carriage, 
even by members of the same CC, could complicate this ‘ExPEC’ assignment.  
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1.7 Antibiotic resistance 
1.7.1 Commensal E. coli and antibiotic resistance 
Commensal E. coli are considered to be a major reservoir for antibiotic resistant genes (20, 
71, 159, 160, 168, 175). Among 289 healthy adults living in the greater Boston area with no 
recent history of antibiotic use, 60% of the subjects carried isolates that were resistant to at 
least 1 of the 7 antibiotics tested (159). Even in regions where antibiotics are not readily 
accessible, such as in a remote Amazonian community (22), 82 of the 89 individuals 
examined carried E. coli that were resistant to at least one of the 11 antibiotics tested. Other 
studies have reported that between 60% to 90% of healthy Dutch, American, French, 
Australian, Swedish, Indian and South African adults examined carried at least one resistant 
E. coli (20, 34, 35, 143, 159, 225, 270, 275). A study conducted on children from rural 
Vietnam (73) found that only 46 [6%] out of 818 children did not carry a resistant strain, and 
a study on 20 healthy Mexican children found that over a 13-week period, at least one 
resistant strain was detected in each child at some point (41). It is believed that the carriage of 
multiply antibiotic resistance strains in the human population is increasing, and this will 
create a serious public health problem (175). 
As antibiotic susceptible E. coli move through this reservoir they can acquire 
resistance genes via horizontal gene transfer from resistant isolates, thus transforming 
susceptible isolates into resistant organisms. One study showed that a susceptible E. coli 
strain residing in the colon of an infant managed to acquire an ampicillin resistance 
determinant on a plasmid from a co-resident ampicillin resistant strain once the infant was 
treated with ampicillin (138). The fitness cost associated with a naturally acquired antibiotic 
resistance gene is usually offset by compensatory mutations in the genome that allow the 
resistance gene to be retained even in the absence of selection (30, 177). Hence, resistant 
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strains could persist in the colon, and, the continuous acquisition of resistance genes could 
make these strains multiply antibiotic resistant.  
 
1.7.1.1 Persistence of antibiotic resistant strains  
It was believed that antibiotic resistant strains could not persist in the colon without antibiotic 
selection because of a fitness cost associated with resistance gene carriage. However, Hartley 
and Richmond examined 99 faecal samples collected over 256 days, after antibiotic treatment 
was stopped, from a single adult using O- and antibiotic resistance typing on 10 colonies per 
sample, and they found that resistant strains can persist long after treatment has ceased (107). 
The isolates found were individually or collectively resistant to tetracycline, streptomycin, 
ampicillin, chloramphenicol and sulfamethoxazole, and they persisted for up to 10 days 
except for an O18 strain that was resistant to tetracycline, sulfamethoxazole and streptomycin. 
It was repeatedly detected for over 223 days after antibiotic treatment was ceased (107).  
A study on a subject with 12 samples taken over a 12-month period analysed 15 
colonies per faecal sample, and strains were distinguished by ribotyping (182). Two 
susceptible strains were repeatedly detected in the first four samples. After the fourth sample, 
the subject required amoxicillin treatment for an infection and when sampling resumed, 2 
strains that were both resistant to ampicillin, doxycycline and trimethoprim, were found in 5 
samples collected over 16 weeks. The last two samples [4 weeks apart] contained only an 
antibiotic susceptible E. coli strain (182). Hence, antibiotic treatment can displace susceptible 
resident strains, replacing them with antibiotic resistant strains that can persist.  
Work by Hartley and colleagues (108) found that in an adult who had not consumed 
antibiotics during and for at least a year prior to the commencement of the study carried a 
strain resistant to streptomycin, sulfamethoxazole and tetracycline, and it was detected in the 
15 samples that were examined (108). Hence, antibiotic resistant strains can persist in healthy 
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adults without any recent history of antibiotic use. However, as discussed earlier, the 
identification of strains using their O-type has inherent limitations.   
 
1.7.2 Antibiotic resistance in isolates from infections 
Antibiotic resistant isolates that cause infections can complicate treatment regimes, and the 
severity of this problem has increased markedly since the 1990s (229). E. coli infections were 
reported to be relatively susceptible to first line antibiotics until the mid to late 1990s when 
large surveillance studies across Europe, North and South America found that between 20 to 
45% of isolates from infections were resistant to antibiotics that were used for treatment, like 
cephalosporins, fluoroquinolones and trimethoprim-sulfamethoxazole (229). Resistance to 
multiple antibiotics is a key indicator of problematic bacterial strains because effective 
treatment is delayed until a suitable antibiotic can be administered and it reduces the options 
available for treatment (314). ESBL-producing E. coli are now commonly found among 
hospital-acquired and community-onset infections (229, 277). ESBL-producing E. coli have 
the ability to hydrolyse and therefore negate the antimicrobial effects of penicillins, 
cephalosporins and monobactams, which are the antibiotics that are mainly used to treat 
Gram-negative infections (229). Because disease causing E. coli emerge from the commensal 
population, and the commensal population is a large reservoir for antibiotic resistant strains, 
resistance is likely to have been acquired from other commensal E. coli.  
Though many CC131 isolates are antibiotic susceptible (135, 149), they are amongst 
the most well known ESBL-producing E. coli, and the successful global dissemination of this 
clone has been attributed to its acquisition of multiple antibiotic resistance determinants by a 
highly virulent clone (229). Globally, CC131 isolates have been reported to represent 
anywhere from 60 to 80% of the antibiotic resistant isolates recovered from UTI and 
bacteraemia (246). CC69 is another global clone, and 50% of cotrimoxazole-resistant isolates 
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recovered in the United States belong to CC69 (314). The genome of a representative CC69 
isolate, UMN026, has been sequenced (151), and a 22 kb resistance island was found within 
its genome. This island contained chloramphenicol, ampicillin, sulfamethoxazole, 
trimethoprim, erythromycin, streptomycin and spectinomycin resistance genes, and these 
genes were linked to multiple IS1 and IS26 insertion sequences (151).  
 
1.7.3 Horizontal dissemination of resistance genes 
There are many mobile genetic elements, chief among them are transposable elements, such 
as transposons, insertion sequences and gene cassettes. Mobile genetic elements are believed 
to be the most important means of dissemination of antibiotic resistance genes (224). 
 
1.7.3.1 Insertion Sequences 
An insertion sequence [IS] is a short simple transposable element, which is capable of 
insertion at multiple sites in a target molecule, and its ends are defined by inverted repeats 
[IR] (171). There are a large number of IS elements, all of which can be grouped into various 
families, based on their similarities or differences. Multiple copies of this IS can be found in 
the E. coli genome or on plasmids carried by E. coli and IS26 [Figure 1.4] is frequently 
associated with the movement of antibiotic resistance genes (224). IS26 is known to play an 
active role in the generation and rearrangement of resistance regions carrying multiple 
resistance genes (224). Antibiotic resistance genes bound by IS26 can be mobilised to other 
regions of a chromosome or a plasmid and can also be transferred between a chromosome and 
a plasmid. 
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Figure 1.4: IS26. The box represents the IS26 element. The inverted repeats [IR] that define the ends of the IS 
element are represented by IRl for the left inverted repeat and IRr for the right inverted repeat, relative to the 
orientation of the reading frame. The black arrow represents the reading frame of the IS26 transposase [tnp] 
gene. The red line represents either the chromosome or plasmid backbone. 
 
1.7.3.2 Transposons 
A transposon is a mobile sequence of DNA that serves as an agent of genetic change. Two 
classes of antibiotic resistance transposons are found in Gram-negative bacteria. The first, 
class I transposons [Figure 1.5], are compound transposons that are flanked by IS, and the 
transposase gene of the IS elements is responsible for the transposition of the transposon 
(286). These transposons can contain resistance genes, like in Tn10, Tn9 [Figure 1.5].  
The second, class II transposons [Figure 1.5], are those flanked by terminal IR, and 
they carry their own tranposase [tnpA] and resolvase [tnpR] genes (286). Class II transposons 
are a highly diverse group and are commonly found to carry many different antibiotic 
resistance genes within their structure. Tn1, Tn2 and Tn3 all contain the blaTEM gene, which 
confers ampicillin resistance, and these transposons are more than 97% identical to each other 
(223). The difference is largely confined to the transposon resolution site, res, located 
between the tnpA and tnpR genes (223). Hence, these 3 transposons can be readily 
distinguished by amplifying a 1.5 kb region that contains the res site and digesting it with 
MslI (19). Tn2 appears to be the most widely distributed of the group (19). 
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Figure 1.5: Class I and class II transposons. The black arrows represent the reading frames and the thick 
horizontal lines are IR. IS10 and IS1 are insertion sequences. The tetR and tetA[B] genes are tetracycline 
resistance genes. The catA1 gene confers chloramphenicol resistance. The tnpA and tnpR genes are transposase 
genes involved in the transposition or movement of the transposon. The blaTEM gene confers resistance to 
ampicillin. The merE, merD, merA, merP, merT and merR genes are involved in the mercuric ion resistance 
pathway. 
 
 Some class I transposons can contain more than 2 copies of the IS elements that are 
responsible for its transposition. For example, Tn6029 contains 3 copies of IS26 [Figure 1.6]. 
It contains segments derived from Tn1, Tn2 or Tn3, which contain the blaTEM gene, and a 
portion of plasmid pSRC15 [or RSF1010, which is almost identical to pSRC15] that contains 
the plasmid replication genes [repA and repC] and sul2 and strAB resistance genes, which 
confer resistance to sulfamethoxazole and streptomycin respectively (39). It has been 
suggested that transposons like Tn6029 do not move using the standard transposition 
mechanism as used by class I and II transposons (39).  
 
 
Figure 1.6: Tn6029. The arrows indicate the orientation and extent of the reading frames. The open green boxes 
represent IS26, the thick purple line is the region derived from Tn1, Tn2 or Tn3, and the thick red line is the 
region derived from pSRC15 or RSF1010. Sequence available at GenBank [accession number GQ150541] 
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1.7.3.3 Gene cassettes and integrons 
A gene cassette is a small mobile genetic element [MGE].  A gene cassette normally encodes 
a single gene with very little non-coding sequence in addition to the gene (237). A cassette 
also has a recombination site known as the 59-be or attC site [Figure 1.7], located 
downstream from the gene (237). Gene cassettes carry genes that express a variety of genes, 
including antibiotic resistance genes. Gene cassettes are normally found integrated at a 
specific site in an integron. An integron is a genetic module that contains all the components 
necessary to capture gene cassettes via a site-specific recombination system and express that 
gene by providing a promoter (100). There are many classes of integrons but class 1 and class 
2 integrons seem to be more frequently associated with antibiotic resistance. A class 1 
integron contains 5`-conserved segment [5`-CS], a variable region that contains the gene 
cassette[s] and a 3`-conserved segment [3`-CS] [Figure 1.8]. The intI1 integrase gene is 
carried within the 5`-CS [Figure 1.8], and it is a site-specific recombinase with an attI site 
next to it [Figure 1.7] that is used as a recognition site by the recombinase, and as a receptor 
site for gene cassette integration (100). The 5`-CS also contains a promoter, Pc [Figure 1.8] 
that allows for the expression of the cassette[s] (100). The 3`-CS carries a sul1 gene [Figure 
1.8] that confers sulfamethoxazole resistance (100). The integron is a defective transposon 
that is no longer mobile (100). However, its plays a crucial role in the capture and release of 
gene cassettes. Gene cassettes can also integrate at a secondary, non-specific site, and will 
still be expressed as long as there is a suitably orientated promoter present (237). An example 
is the dfrA14 gene cassette, which confers resistance to trimethoprim, and it has been found 
integrated in the strA gene, which confers streptomycin resistance (214).  
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Figure 1.7: An integron and the integration of a gene cassette. The thick black arrows indicate the direction 
of the reading frames. The intI1 gene encodes the integrase protein that captures and integrates gene cassettes. 
The cassette is in a linear form when integrated. The integrase protein also can excise and remove the gene 
cassette as a circular intermediate. 
 
 
 
Figure 1.8: A class 1 integron. The thick black arrows indicate the direction of the reading frames. The thick 
red line represents the 5`-CS and the thick orange line represents the 3`-CS. The Pc represents the promoter, the 
open green boxes are the gene cassettes and the solid green boxes represent the attC or 59-be. 
 
1.7.3.4 Complex transposons 
Complex or unit transposons are defined as elements that are larger than IS and carry 
antibiotic resistance and/or other genes, plus the genes that encode their transposition 
functions (224). Tn21 is an example of a complex transposon [Figure 1.9], which is part of 
the Tn3 family, and it has a class 1 integron designated In2, a mercury resistance region and 
its own tranposition genes. In2 has a 5`-conserved segment that contains the intI gene, 
promoter and the attI site, while the 3`-conserved segment contains the sul1 gene that confers 
sulfamethoxazole resistance, insertion sequences, and the truncated tni transposition gene 
module, which is used to confer mobility to the integron (100). The gene cassettes encoded 
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for by this integron are contained in between the 5`- and 3`- conserved segments. In In2, only 
tniA and a truncated tniB are present in the 3`-conserved segment. All the other tni genes 
necessary for integron transposition are not found in In2, rendering it immobile (163). 
Terminal IR also flank the integron, like the transposon. The Tn21 mercury resistance region 
contains two regulatory genes, merR and merD, and four structural genes, merC, merA, merP, 
and merT, all of which are involved in the transfer, chelation, detoxification and removal of 
mercury ions (163). Tn21 can be found within Tn9 [see Figure 1.6] and this transposon is 
known as Tn2670 (222). 
 
Figure 1.9: Tn21. The black arrows represent the reading frames. The IR are the inverted repeats that define the 
end of the transposon. IS326 and IS1353 are insertion sequences. The tnp and tni genes are involved in 
transposition. The res represents the resolution site. The mer genes are involved in the mercuric ion resistance 
pathway. In2 is the integron. The aadA1 gene confers spectinomycin and streptomycin resistance. The sul1 gene 
confers sulfamethoxazole resistance. 
 
1.7.3.5 Multiple antibiotic resistance islands 
IS elements like IS26, class I and II transposons and complex transposons like Tn21, can form 
complex resistance islands that confer resistance to multiple antibiotics. For example, most of 
the resistance genes carried by the CC69 strain UMN026 are found within a 23kb resistance 
island [Figure 1.5] (151).  
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Figure 1.10: Map of the resistance island in UMN026. The thick black line represents the chromosomal 
backbone. The horizontal arrows show the extent and orientation of the genes. Insertion sequences are shown as 
open boxes with their numbers inside. TF shown above the navy blue box indicates the unknown transposon 
fragment. Vertical bars are IRs and the lower case letters indicate the type of IRs. The thick red line represents 
the region derived from Tn21, the thick orange line represents the 3`-CS derived from a class 1 integron and the 
thick blue line represents the region derived from Tn2. The cat gene conferes chloramphenicol resistance, 
dhfrVII confers resistance to trimethoprim, aadA to streptomycin and spectinomycin, sul1 to sulfamethoxazole, 
the mph genes to erythromycin and blaTEM to ampicilin. Sequence available at GenBank [accession number 
CU928163] 
 
This island contains 4 copies of IS26 and 3 copies of IS1, a Tn9-like structure that is 
next to a piece of Tn21 that contains the transposase genes and the class 1 integron but with 
an inverted 3`-CS, and a fragment of Tn2 [Figure 1.5]. This structure also contains the mph 
cluster, which confers resistance to macrolides like erythromycin (230). These complex 
structures can have several levels of mobility and they can undergo extensive changes. The 
movement of gene cassettes can be mediated by intI1 or homologous recombination, and IS26 
and IS1 can mediate transposition, deletion or rearrangement events (40, 224). The 
transposase genes belonging to any associated transposons can also play a role in the 
evolution of these regions (40, 224) but in the UMN026 island, the IR of Tn21 are not 
present, and hence, the Tn21 transposase genes are not likely to be involved in future 
transposition events but they could have played a role in the evolution of this island. 
However, as IR belonging to other transposons are still present [Figure 1.10], the appropriate 
transposase genes could act in trans and be involved in future mobilisation events. Hence, 
mobile elements play an important role in the evolution of these structures.  
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1.7.3.6 Plasmids 
Plasmids are circular pieces of double-stranded extra chromosomal DNA that are capable of 
autonomous replication in a host bacterial cell. Their sizes vary from several hundred base 
pairs to several hundred kilobase pairs. They carry all the genetic traits necessary for their 
own replication and maintenance but more importantly, they are also known to carry genetic 
traits VF (24, 325), and they are frequently found to carry transposons, integrons and 
antibiotic resistance genes (33, 40, 74, 113, 214, 228, 293, 304, 325). The carriage of 
resistance genes is of particular importance because resistance plasmids can be transferred 
from a resistant to susceptible isolate in the colon (138), and the carriage of plasmids carrying 
multiple resistance genes or the accumulation of multiple resistance plasmids will lead to 
multiply antibiotic resistant strains.  
An example is the sul2-strAB cluster, as seen in the centre of Tn6029 [Figure 1.6], 
which can also be found on its own on small (58, 75, 318, 321) or on big (40, 324) plasmids. 
In some plasmids, this cluster is linked to other resistance genes like the tetracycline 
resistance determinant tetA[A] (324). Thus, the carriage of these plasmids can confer 
resistance to multiple antibiotics. Complex resistance island, like the island carried by 
UMN026 [Figure 1.10] can also be found on large plasmids (40, 324), thus enabling the 
propagation of these structures. The success of the CC131 in disseminating around the world 
has been attributed to its acquisition of multiple antibiotic resistance determinants by a highly 
virulent clone (229), and CC131 members often carry these resistance genes on plasmids (33, 
202, 292). Hence, plasmids play a major role in the horizontal dissemination of antibiotic 
resistance genes and the complex structures that these genes can be found in.  
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1.8 Aims  
Given the large contribution of E. coli to the public health burden and the evidence that non-
intestinal infections are caused by commensal strains, examining the properties of commensal 
E. coli in healthy Australian adults using current molecular tools should enhance our 
understanding of the relationship between successful commensalism and the ability cause UTI 
and other extraintestinal infections. However, a collection of persistent strains, representing 
successful commensal strains was not available for examination. In addition, commensal E. 
coli represent a potentially huge reservoir of antibiotic resistance genes and the 
characterisation of resistant strains recovered from the colon of Australian adults with no 
recent history of antibiotic use should provide insights into how antibiotic resistance in the 
commensal E. coli population is related to resistance in clinical isolates. The specific aims to 
address both these aspects were as follows: 
1. To assemble a collection of persistent commensal E. coli. 
2. To examine if the persistence properties of commensal strains and the infection 
causing properties of E. coli are the same.   
3. To examine the incidence of antibiotic resistance, resistance gene carriage and the 
context of these genes in commensal E. coli. 
4. To determine if antibiotic resistant strains can persist. 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER TWO 
 
Materials and methods 
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2.1 Materials 
2.1.1 Chemicals and reagents 
Basic chemicals were purchased from Sigma-Aldrich [St. Louis, MO, USA], Ajax Chemicals 
[Auburn, NSW, Australia], Bio-Rad [Hercules, CA, USA], VWR International [Radnor, PA, 
USA] or Promega [Madison, MI, USA] and were of molecular biology grade. 
 
2.1.2 Buffers and solutions 
Buffers and solutions were made up using H2O treated by reverse osmosis, according to 
protocols in Sambrook et al. (253). 
 
0.5 X TBE buffer   45 mM Tris 
     45 mM boric acid 
     1 mM EDTA 
 
TE buffer    10 mM Tris-HCl, pH 7.5 
     1 mM EDTA, pH 8 
 
EB buffer    1 mM EDTA, pH 8 
 
Loading dye    0.1% [w/v] bromophenol blue 
     0.2% [w/v] xylene 
     20 mg/ml ficoll 
 
Saline     0.9% [w/v] NaCl 
 
2.1.3 Bacterial growth media 
BactoTM Yeast extract, BactoTM tryptone and BactoTM agar were purchased from Becton 
Dickinson [Franklin Lakes, NJ, USA]. Sensitest Agar, Mueller-Hinton Agar, MacConkey 
CHAPTER	  2	   Materials	  and	  methods	   51	  
Agar and Simmons’ Citrate Agar were obtained from Oxoid [Basingstoke, Hampshire, UK]. 
Bacterial growth media was prepared according to the instructions supplied by the 
manufacturer.  
 
Luria-Bertani Browth [LB]   1% [w/v] tryptone 
      0.5% [w/v] yeast extract 
      1% [w/v] NaCl 
 
Luria-Bertani Agar [LA]   LB containing 1.5% [w/v] agar 
 
 
Mueller-Hinton Agar [MHA]  3.8% [w/v] Mueller-Hinton Agar in H2O 
 
MacConkey Agar    5.2% [w/v] MacConkey Agar in H2O 
 
 
Simmons’ Citrate Agar   2.3% [w/v] Simmons’ Citrate Agar in H2O  
 
Sensitest Agar    2.3% [w/v] Simmons’ Citrate Agar in H2O  
 
2.1.4 Sterilisation 
All appropriate media, buffers and solutions were autoclaved at 121°C at 103.4 kPa for 20 
minutes. Antibiotics were prepared in sterile tubes and diluted with sterile solvents but were 
not further sterilised.   
 
2.1.5 Enzymes 
Taq Polymerase, PhusionTM Polymerase, T4 DNA Quick Ligase, T4 DNA Polymerase, all 
restriction endonucleases, bovine serum albumin [BSA] and their appropriate buffers were 
obtained from New England Biolabs [Ipswich, MA, USA]. Pre-heat treated RNase A, 
lysozyme and Proteinase K were purchased from Sigma-Aldrich [St. Louis, MO, USA]. 
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2.1.6 Antibiotics 
All antibiotics were obtained from Sigma-Aldrich [St. Louis, MO, USA]. Antibiotic stock 
solutions were made up under the specifications given in Table 2.1 and stored at 4°C. These 
antibitotics, with the exception of fluroquinolones, represent the anitbiotics that are used to 
treat E. coli infections.  
 
Table 2.1: Stock antibiotic solutions 
Antibiotic Abbreviation Stock concentration 
[mg/ml] 
Diluent  
Ampicillin Ap 100 MQ H2O 
Cefotaxime CTX 10 MQ H2O 
Ceftazidime CAZ 10 MQ H2O 
Chloramphenicol Cm 25 100% Ethanol 
Kanamycin Km 50 MQ H2O 
Nalidixic acid Nx 25 0.5M NaOH 
Streptomycin Sm 25 MQ H2O 
Spectinomycin Sp 25 MQ H2O 
Sulfamethoxazole Su 100 MQ H2O and NaOH dropsa 
Tetracyclineb Tc 10 50% Ethanol 
Trimethoprim Tp 2.5 100% Methanol 
aNaOH drops added until dissolved. Heat gently applied whilst adding NaOH 
bLight sensitive; stored in light-proof container to prevent degradation 
 
2.2 Isolation and identification of E. coli strains 
2.2.1 Isolation of E. coli 
Isolation of commensal E. coli from the faeces of human subjects was conducted with 
informed consent and was approved by the University of Sydney Human Research Ethics 
Committee [04-2008/10778]. During 2008-2012, 11 healthy adult members of the community 
aged 20 to 45 years [8 male and 3 female] who had not taken antibiotics or travelled abroad 
within the previous 6 months provided freshly voided faecal sample. The subjects provided 
faecal samples at roughly 3-month intervals, where possible.  
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The subjects were provided with 20 ml sterile plastic sample jar obtained from 
Thermo Fisher Scientific [Waltham, MA, USA] and the faecal sample was processed 
immediately. The entire faecal sample was suspended to a 10% [w/v] solution in sterile 0.9% 
[w/v] saline and serially diluted and plated in duplicate onto MacConkey Agar plates without 
antibiotics. After overnight growth at 37°C, the plates were examined. The 10-1 dilutions 
proved to have a large amount of faecal matter and debris that may have potentially interfered 
with the results by allowing for the growth of susceptible E. coli on antibiotic supplemented 
MacConkey Agar and therefore were not used. One hundred microliters of the 10-2 and 10-3 
serial dilutions were routinely plated. As a result of this, the detection limit of this study was 
103 colony forming units [CFU]/g of faeces. Rare antibiotic resistant isolates were recovered 
by plating 10-2 dilutions directly onto MacConkey Agar or MHA containing antibiotics [final 
concentrations used are listed in Section 2.4]. 
 Colonies that were flat and deep-red were considered to be E. coli and examined 
further. Non-lactose fermenting E. coli form white colonies on MacConkey Agar (82), thus, 
white and flat colonies were examined further to determine if they were E. coli. Pink 
mucoidal colonies were considered to be Klebsiella pneumoniae. Other colony morphologies 
observed were also examined to identify the species. Species assignment based on the 
morphologies observed on MacConkey Agar was confirmed using API20E assays 
[bioMérieux, France, see Section 2.2.3.1]. The abundance of E. coli and other identifiable 
Enterobacteriaceae in the subjects was calculated. A 1 g sample was diluted to a 10% [w/v] 
solution, thus making a 10 ml faecal suspension. To calculate the abundance of 
Enterobacteriaceae in a 10 ml faecal suspension, the formula  
   ρ = [N/Vs] x [1/D] x 10 
was used, where  ρ: Concentration of cells in a 10 ml sample 
   N: Average number of colonies from duplicate plates 
   Vs: Volume pipette on to petri plate in ml 
   D: Dilution factor that was used    
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The 10% [w/v] faecal suspension was diluted to a 1% [v/v] suspension in LB and 
grown overnight at 37°C with constant shaking at 200 rpm. This overnight culture was frozen 
and stored at -81°C. This was done in case a sample needed to be re-examined after the faecal 
sample had been discarded.  
 
2.2.2 Grouping of E. coli isolates by antibiotic susceptibilities 
One hundred putative E. coli colonies from the MacConkey Agar plates, per subject, without 
antibiotics, were selected at random and screened for resistance to antibiotics by picking and 
patching [see Section 2.4.2]. Where white putative E. coli colonies were observed, the plates 
were divided into sections and isolates from each section were picked and patched until a total 
of 100 colonies were screened. This was done to prevent screening bias due to the appearance 
of the distinct white colonies. Colonies were also patched onto Simmons’ Citrate Agar 
[Oxoid, Basingstoke, UK] to further assist with species identification, assuming no growth for 
E. coli on this medium. 
After overnight growth at 37°C, these 100 colonies were grouped according to their 
susceptibility profiles. When colonies were observed on an antibiotic supplemented plate 
without a corresponding isolates with the same resistance phenotype amongst the 100 isolates 
screened [e.g. faecal suspension plated onto MacConkey Agar plates containing Tc and 
colonies were observed to grow but none of the 100 isolates screened were TcR], up to 10 
colonies from the MacConkey Agar plate containing antibiotics were screened to determine 
the resistance phenotype of these colonies. These were rare resistant colonies and they were 
screened using the same procedures. The resistance phenotype was confirmed for up to 10 
isolates from each phenotypic group disc diffusion assays [see Section 2.4.3]. 
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2.2.3 Identification of E. coli 
From each sample, up to 10 representative isolates from each resistance phenotypic group 
were examined to identify strains. Colonies were purified by streaking and selecting on LA or 
MHA containing antibiotics whereas susceptible colonies were purified on LA without any 
antibiotics. After overnight growth at 37°C, single colonies were selected and the species 
assignment was confirmed by analysing up to 3 purified isolates from each resistance group 
using the API20E assays [bioMérieux, France, Section 2.2.3.1].  
Purified colonies were grown overnight at 37°C in LB with constant shaking at 200 
rpm and DNA was extracted from these cultures [see Section 2.5.1.1]. The DNA from up to 
10 isolates was examined seperately using PCR with published primers (302) designed to 
target the E. coli specific β-D-glucuronidase [uidA] gene [see Primer Table A2.1 in Appendix 
II for details on primers and general PCR conditions are listed in Section 2.5.2]. These 
isolates were also screened using a multiple PCR (48) that assigns E. coli into 1 of the 7 
phylogenetic genotypes [A0, A1, B1, B22, B23, D1 and D2]. The detection of the E. coli 
specific uidA gene, which encodes the β-D-glucuronidase enzyme (302), assists in 
establishing if A0 isolates are E. coli and serves to additionally ensure that the DNA being 
amplified is of the appropriate quality. The API20E, uidA and phylogenetic data, and lactose-
fermentation [except for E. coli that formed white colonies on MacConkey Agar] were used 
to distinguish E. coli. 
 
2.2.3.1 API20E biotyping 
The API20E strip [bioMérieux, France] was used to confirm that the flat deep-red or white 
colonies or the pink and mucoidal colonies were E. coli or K. pneumoniae respectively. 
Briefly, the strip is made up of panels of cupules, each containing a different dehydrated 
coloured metabolic compound. A purified colony was suspended in 4 ml of sterile 0.9% [w/v] 
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saline and equal volumes were dispensed into the cupules of the API20E assay, according to 
the manufacturer’s instructions. The container was sealed and after overnight incubation at 
37°C, the isolate was scored based on its ability to metabolise each biochemical in the 
API20E kit. The colour changes due to positive or negative fermentation correlated to a code 
in the API20E codebook [bioMérieux, France], which identifies the Enterobacteriaceae 
species. The code can also be used as an extra measure of similarity or difference as isolates 
belonging to the same strain would have the same API20E metabolic profile. 
 
2.2.4 Strain identification 
Purified colonies were grown overnight in LB and DNA was extracted from up to 10 purified 
isolates per resistance group and screened by PCR using Random Amplification of 
Polymorphic DNA [RAPD] primers to identify different strains [see Section 2.5.2.4 for 
RAPD conditions]. Isolates that produced indistinguishable profiles after visualisation on an 
agarose gel by electrophoresis of the amplicons [see Section 2.5.3] were considered to be 
representatives of the same strain. Products were run on a 1% agarose gel and profiles were 
interpreted visually according to the presence or absence of bands compared to other strains. 	  
Where a sample containing only antibiotic susceptible isolates was detected, up to 20 
isolates had their DNA extracted using a boiled preparation [procedure described in Section 
2.5.1.2] and isolates were screened to detect the presence of multiple antibiotic susceptible 
strains. A strain was defined as isolates that produced indistinguishable phylogenetic group, 
uidA, lactose fermenting, API20E and RAPD profiles. Up to 10 isolates of each strain were 
frozen and stored at -81°C. 
 
 
 
CHAPTER	  2	   Materials	  and	  methods	   57	  
2.2.4.1 Identifying persistent strains  
A persistent strain was defined as a strain that was detected in multiple faecal samples. A 
persistent strain that was present in a subject for 6 months or longer was considered to be a 
long-term persistent strain whereas a short-term persistent strain was one that was present for 
less than six months. The presence of a strain in the faeces for at least 6 months was believed 
to be sufficient long for it to be a long-term persistent strain. Because the detection limit of 
this study was 103 colony forming units [CFU]/g [see Section 2.2.1], some persistent or other 
strains might not have been detected if they were present at abundances below 103 CFU/g. 
 
2.3 Genetic analysis 
2.3.1 Resistance gene analysis 
To identify which antibiotic resistance genes accounte for the resistance phenotypes observed, 
the resistance genes that usually confer resistance in Gram-negative bacteria were screened. 
Two isolates from each resistant strain were examined by PCR [see Section 2.5.2] for the 
presence of 21 genes, which included 18 resistance genes, the mercuric-ion reductase gene, 
merA, and the class 1 integron [intI1] and class 2 integron [intI2] genes. The primer details are 
listed in Table A2.2 of Appendix II. The merA gene was screened to determine if a mercuric-
ion resistance operon was present because mercuric-ion resistance regions carried by 
transposons are frequently associated with class 1 integrons (220). Gene cassettes were also 
screened using primers that amplify the variable regions of class 1 and class 2 integrons. 
Isolates were screened for the presence of all genes, regardless of whether they displayed the 
appropriate resistance phenotype. Amplicons were examined by visualising them on an 
agarose gel by electrophoresis [see Section 2.5.3] to determine if a resistance gene was 
present. The DNA from the susceptible strains was pooled into groups of 5 strains [2 isolates 
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per strain] and each group was screened for the presence resistance genes, class 1 and 2 
integrons and the merA gene. If a band corresponding to a resistance gene was observed from 
a pool of susceptible strains, screening was repeated on all isolates individually to determine 
which strain carried the resistance gene. Controls strains carrying the resistance genes assayed 
for were available, and hence, none of the genes detected were sequenced to confirm their 
identities. Sequencing [see Section 2.7] was done only to identify gene cassettes.  
 
2.3.2 VF analysis 
To ensure this study was comparable to other studies, PCRs were performed to detect the 
genes encoding VFs that were screened in the majority of previous studies. Three multiplex 
PCRs from a published study (203) have been designed to detect 11 genes [Table 2.3], and 
the primer pairs to detect 4 of the 5 genes that are used in the ‘ExPEC’ definition of strains 
[iutA, sfaDE, papC and draA] are contained within these 3 multiplexes (203). The fifth 
‘ExPEC’ gene primer pair, group II capsule [kpsMT II], was detected using a simplex PCR 
reaction [see Section 2.5.2]. All VF primers pairs used were from previously published 
studies [see Primer Table A2.8 in Appendix II for details on primers]. Strains were screened 
using duplicate isolates to reduce the chances of a band not appearing due to amplification 
failure or other issues. In instances where a faint amplicon was observed or when an expected 
band was not observed, the PCR was repeated as a simplex.  
The genetic region encoding group II capsule contains 2 conserved regions [Region 1 
and 3] that flank a variable region [Region 2] (243, 307). To detect the presence of group II 
capsules, Region 3 [kpsMT II] was probed with standard primers, and additionally probing 
was done on Region 2 with type specific primers [e.g. neuB [K1] and kfiC [K5]] to determine 
the specific capsular antigen (125). To detect and map the genomic island containing 
colibactin, primers that probe for the presence of 4 genes [clbB, clbN, clbP and clbQ] (133, 
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201) were used. However, one gene, clbB, has been shown to be sufficient in the detection of 
this trait (133).  
As positive controls were not available at the beginning of this work, control strains 
were identified during the course of the analysis by sequencing the first amplicon [see Section 
2.7] of the expected size detected. The isolates that produced the correct amplicons were then 
used as the positive controls in all subsequent PCR assays.  
 
2.3.3 MLST analysis 
Three MLST schemes are available to type E. coli (77, 239, 312) but only 1 scheme was used 
to characterise the isolates in this study, and this was the Achtman MLST scheme (312), 
which is used by the majority of published studies. This scheme was chosen to make the 
findings of this study comparable to other studies. The Achtman scheme distinguishes isolates 
based on the sequences of 7 E. coli housekeeping genes. The 7 housekeeping genes screened 
for are adenylate kinase [adk], fumarase C [fumC], DNA gyrase, subunit B [gyrB], isocitrate 
dehydrogenase [icd], malate dehydrogenase [mdh], adenylosuccinate synthase [purA] and 
recombinase [recA] (312).  
Each unique combination of 7 alleles represents a sequence type [ST], and according 
to Wirth and co-workers, isolates can be grouped into clonal complexes [CCs] that are 
comprised of the main ST, which is the most abundant ST, and those that differ by 1 [single 
locus variant [SLV]] or 2 alleles [double locus variant [DLV]] (312). Due to variation in the 
primer-binding sites in some strains, 6 of the 7 genes have additional primers that can be used 
to amplify the housekeeping gene when the original primer pair fails to produce an amplicon 
[see Table A2.9 in Appendix II for details on primers]. Only icd does not have additional 
primers.  
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 After the genes were amplified by PCR, the products were visualised on a gel, then gel 
purified [see Section 2.5.4] and sequenced [see Section 2.7]. Assembly and analysis of each 
target gene fragment was performed using SequencherTM v.5.0.1 software [Gene Codes 
Corporation, Ann Arbor, MI, USA]. The sequenced fragments were trimmed to a uniform 
length that corresponded with the region used to identify the target, by reference to allele 
sequences recovered from the Achtman MLST protocol published on the 
http://mlst.ucc.ie/mlst/dbs/Ecoli website. The sequences of target genes fragments were then 
assigned distinct allele numbers by submitting them to the MLST E. coli data base website 
[http://mlst.ucc.ie/mlst/dbs/Ecoli]. Finally, a ST and its associated CC were assigned for each 
isolate by comparing its allelic profile with that available in the MLST database. In the case 
of new alleles being identified, the curator of the database issued a unique allele number and, 
subsequently, a new ST, following examination of the DNA sequence trace files of the 
respective isolate.  
 
2.3.3.1 Clone specific PCRs 
Due to the importance of ST131, ST69 and ST95 in clinical infections, PCRs have been 
designed to rapidly detect members of these 3 clones (27, 49, 129). To detect isolates 
belonging to CC131, primers that target the CC131-specific pabB [ρ-Aminobenzoate 
synthesis] allele (49) were used. However, amplification of this allele is dependent on SNPs 
that are present in the 3`-ends of both primers. Hence, as acknowledged by the authors (49), 
primer end-base degradation can result in non-specific pabB amplification. To determine if 
CC95 isolates are present, primers targeting a gene [svg] present only in CC95 isolates (27) 
were used. To examine if CC69 members were present, a simplex PCR, whose forward 
primer contains 3 SNPs that are specific to the CC69 fumC allele (129), was used to rapidly 
detect CC69 isolates [see Primer Table A2.9 in Appendix II for details on primers] 
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2.4 Bacterial manipulation  
2.4.1 Bacterial growth conditions 
Bacterial cultures were routinely set up with 3 ml LB, which was inoculated with a single 
bacterial colony, and incubated overnight 37°C with constant shaking at 200 rpm to ensure 
aeration. LB was used for all broth cultures containing antibiotics. MHA [Oxoid, 
Basingstoke, UK] was used for plates containing the antibiotics Su and Tp, while LA or 
MacConkey Agar was used for all other antibiotics. Antibiotics, if any, were added after 
cooling the medium to 60°C at the final concentrations provided in Table 2.2. 
 
2.4.2 Picking and patching 
To determine which antibiotics an isolate was resistant to, single colonies from dilution or 
streak plates were patched, using a sterile toothpick, onto different antibiotic plates [some or 
all of those in Table 2.2] and lastly an LA or MacConkey Agar plate, to ensure the colony 
transferred to all the plates in the series. After overnight growth at 37°C, each colony was 
qualitatively scored for antibiotic resistance and sensitivity in relation to suitable positive and 
negative controls.  
 
Table 2.2: Working concentrations of antibiotics and media used 
Antibiotic Working Concentration   [µg/mL] Media used 
Ampicillin  100 MacConkey 
Cefotaxime 1 MacConkey 
Ceftazidime 1 MacConkey 
Chloramphenicol 25 MacConkey 
Kanamycin  20 MacConkey 
Spectinomycin  25 MacConkey 
Streptomycin 25 MacConkey 
Sulphamethoxazole 100 MHA 
Tetracycline  10 MacConkey 
Trimethoprim 25 MHA 
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2.4.3 Disc diffusion 
The Calibrated Dichotomous Sensitivity [CDS] disc diffusion assay was used to confirm the 
phenotype assigned to an isolate from picking and patching. A single bacterial colony was 
resuspended in 4 ml of sterile 0.9% saline [w/v] which was used to flood a Sensitest Agar 
[Oxoid, Basingstoke, UK] plate to form an even lawn of growth and the excess fluid was 
collected. This bacterial suspension could be used on multiple plates if desired. Six antibiotic 
discs were stamped onto each plate, which was incubated for 16 hours at 37°C. The antibiotic 
discs contained ampicillin [25 µg], cefotaxime [30 µg], ceftazidime [30 µg], chloramphenicol 
[30 µg], gentamicin [10 µg], kanamycin [50 µg], neomycin [30 µg], streptomycin [25 µg], 
spectinomycin [25 µg], compounds sulfonamide [300 µg], tetracycline [30 µg] or 
trimethoprim [5 µg] [Oxoid, New Hampshire, England]. The annular radius of the inhibition 
zone was measured from the edge of each antibiotic disc. A radius of 6 mm or greater was 
defined as sensitive to that antibiotic, and a radius of less than 6 mm as resistant, as per CDS 
guidelines. See http://web.med.unsw.edu.au/cdstest/ for guidelines. 
 
2.4.4 Bacterial storage 
Colonies were purified by streaking out onto a LA plate containing antibiotics or LA alone for 
susceptible isolates. Each colony was grown overnight at 37°C in LB containing antibiotics or 
LB alone with constant shaking at 200 rpm. The overnight cultures were stored by preparing 
them in 50% sterile glycerol in a Nalgene® Cryovial [Thermo Fisher Scientific, Waltham, 
MA, USA]. The cryovials were snap frozen in liquid nitrogen and then stored at -81°C. 
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2.4.5 Iron uptake assay 
Strains were tested for their ability to take up iron using a procedure that was adapted from 
the universal chemical assay for the detection and determination of siderophores method 
(261). All glassware used soaked overnight in 3 M Nitric acid and washed in MQ H2O to 
remove any residual traces of iron. Chrome Azurol S [CAS] [Sigma-Aldrich, St. Louis, MO, 
USA] was dissolved in MQ H2O, resulting in a 0.12% [w/v] yellow coloured solution. A 
solution of 0.18% [w/v] hexadecyltrimethylammonium bromide [HDTMA] [Sigma-Aldrich, 
St. Louis, MO, USA] was slowly added to the CAS solution under continuous stirring. A 0.17 
mM FeCl3.6H2O [dissolved in 10 mM HCl] [Sigma, St. Louis, MO, USA] solution was added 
to the CAS-HDTMA mixture under continuous stirring, resulting in the formation of a dark 
blue liquid. The FeCl3.6H2O solution must be added slowly and addition stopped as soon as 
the CAS-HDTMA mixture turns blue. If there is any excess FeCl3.6H2O solution, this can be 
discarded. The final volume of this mixture was approximately 100 ml.  
Separately, a 100 ml solution of 10 X MM9 salts [minimal media 9] [3% KH2PO4, 5% 
NaCl, 10% NH4Cl] was made up. This solution was made up to 850 ml with MQ H2O and 15 
g of Bacto agar [Becton Dickinson, Franklin Lakes, NJ, USA], 30.24 g of PIPES [piperazine-
N,N`-bis[2-ethanesulfonic acid] [Sigma-Aldrich, St. Louis, MO, USA] and 12 g of a 50% 
[w/v] NaOH solution were added. The NaOH was used to raise the pKa of PIPES [6.8]. This 
media was autoclaved [see Section 2.1.4], cooled to 50°C and then 30 ml of sterile 10% [w/v] 
Casamino acid solution was added. To prevent contamination, antibiotics may be added. An 
E. coli specific carbon source, which was a 10 ml sterile solution of 20% [w/v] glucose, was 
added. Additionally, a 1 ml sterile solution of 0.2% thiamine.HCl and a 3 ml sterile solution 
of a 1% L-tryptophan were added. Finally, the 100 ml dark blue CAS-iron [III] solution was 
added to this medium along the container’s glass wall with enough agitation to ensure proper 
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mixing but without the generation of foam. Once mixed, 20 to 30 ml of this blue medium was 
poured onto agar plates.  
A fresh colony of each strain was picked from an LA plate and patched on the iron-
limited medium and onto another LA or MacConkey Agar plate, to ensure the colony 
transferred to the iron-limited medium. Each plate was gridded and contained 30 to 40 
colonies. After overnight growth at 37°C, the plates were scored. Those that grew and formed 
yellow halos around the colony were considered to express siderophores.  
 
2.5 DNA preparation and manipulation 
2.5.1 DNA extraction 
2.5.1.1 Whole cell DNA extraction 
Chromosomal DNA was extracted from an overnight culture using the CTAB [Cetyltrimethyl 
ammonium bromide] genomic DNA Purification Method (279). A 1.5 ml of overnight culture 
was harvested by centrifugation, and the pellet was resuspended in TE containing 200 µg of 
lysozyme, 200 µg of RNase A, 50 µg of Proteinase K and 0.6% SDS [Sodium Dodecyl 
Sulfate]. The samples were incubated for 1 hour at 37°C, and then 1 hour at 50°C. After 
incubation, 1 M NaCl and 1% CTAB were added to the samples and then incubated at 65°C 
for 10 minutes. Chloroform/isoamyl alcohol [24:1] was added [half the total volume] and the 
samples were mixed thoroughly by shaking so that the aqueous and organic phases combined. 
The mixture was incubated on ice for 30 mins [important to separate cell debris from DNA] 
and then samples were centrifuged at max speed for 10 minutes. The aqueous phase was 
transferred to a fresh tube before adding an equal volume of phenol/chloroform/isoamyl 
alcohol  [25:24:1] and then mixing thoroughly. After centrifuging at max speed for 10 
minutes, the aqueous phase was transferred again to a fresh tube. DNA was precipitated by 
CHAPTER	  2	   Materials	  and	  methods	   65	  
the addition of 1 volume isopropanol followed by 2 washes with 70% ethanol. The isolated 
DNA was reconstituted in TE [10 mM Tris-HCl, 1 mM EDTA, pH 8] and stored at 4ºC. DNA 
was then diluted 1 in 100 in sterile Milli-Q [MQ] water before use for PCR. The quality and 
concentration of the extracted DNA was determined by agarose gel electrophoresis [see 
Section 2.5.3] and spectrophotometry on a NanodropTM ND-1000 spectrophotometer [see 
Section 2.5.5]. 
 
2.5.1.2 Boiled preparation 
Crudely obtained whole cell DNA was performed using a boiling lysis technique. A single 
bacterial colony was resuspended in 200 µl MQ water and incubated at 100°C for 5 mins and 
then centrifuged for 10 mins at 20,000 rpm. The resulting supernatant was used as a template 
for PCR [see Section 2.5.2; 2 - 5 µl supernatant used per PCR reaction]. 
 
2.5.1.3 Plasmid DNA  
Plasmid DNA was extracted using an alkaline lysis method (253). A 1.5 ml overnight culture 
was pelleted by centrifugation at 12 000 rpm for 30 seconds. The pellet was resuspended in 1 
volume of ice-cold buffer [Solution 1: 50 mM glucose, 25 mM Tris-HCl and 10 mM EDTA, 
pH 8] and 2 volumes of freshly prepared lysis solution [Solution 2: 0.2 M NaOH, 1% SDS] 
was mixed in by gentle inversion. The tube was kept on ice for 5 minutes and then 1.5 
volumes of ice-cold precipitation solution [Solution 3: potassium acetate; 5 M with respect to 
K and 3 M with respect to acetate] was added, the tube inverted and then held on ice for a 
further 5 mins. After centrifugation at 12 000 rpm for 5 minutes the supernatant was 
transferred to a new tube. An equal volume of phenol:chloroform:isoamyl alcohol [of 
proportions 25:24:1] was added, mixed by inversion, then centrifuged for 2 minutes at 12 000 
rpm. Double-stranded DNA was precipitated from the supernatant using 2 volumes of 100% 
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ethanol and mixed by inversion. This was allowed to stand for 2 minutes at room temperature, 
then centrifuged for 5 minutes at 12 000 rpm. The supernatant was removed and the pellet 
washed with in ice-cold 70% [w/v] ethanol, spun and centrifuged. The pellet was redissolved 
in TE buffer containing 200 µg RNAase A and stored at 4°C. For more concentrated plasmid 
DNA samples, for example those used for restriction endonuclease digestion [see Section 
2.6.2], up to 12 samples from the same culture were extracted separately, resuspended in 8.5 
µl and then combined.  
 
2.5.2 PCR 
2.5.2.1 Primers  
Oligonucleotides were synthesised by Integrated DNA Technologies [Coralville, IA, USA], 
received in lyophilised form, resuspended in TE at a concentration of 500 µM and stored at –
20°C. These were diluted in MQ H2O to a working concentration of 50 µM. All primers made 
during the course of this study, were designed using the program NetPrimer [Premier Biosoft 
International], specifically, each had an estimated annealing temperature of 60°C ± 2°C and a 
1 bp GC clamp. Characteristics of the primers used in PCR are available in Appendix 2. 
 
2.5.2.2 General PCR  
PCR amplification reactions contained 160 µM dNTP mix, 1 U Taq Polymerase [New 
England BioLabs, Ipswich, MA, USA] and 50 pmol of each primer and made up to a total 
volume of 12.5 to 25 µl in 1 X PCR reaction buffer [supplied with Taq polymerase; New 
England BioLabs, Ipswich, MA, USA]. Reactions were run in an Eppendorf Thermocycler 
[Eppendorf, Hamburg, Germany] with an initial incubation of 95°C for 5 min, followed by 35 
cycles of 95°C for 30 sec, 60°C for 30 sec, and 72°C for 0.5-3 mins [where 1 min was 
allowed for each kb of sequence expected], then a final incubation at 72°C for 5 min. DNA 
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was diluted to approximately 10 ng/µl and used as a template for PCR. Amplicons were 
separated and visualised using agarose gel electrophoresis [see Section 2.5.3] and products 
were identified using comparisons to standards. Identities were confirmed by either digestion 
with restriction enzymes [see Section 2.6.2] or by DNA sequencing [see Section 2.7]. 
 
2.5.2.3 Long-range PCR 
For PCR products greater than 3 kb in size, a high fidelity enzyme was used. PCR reactions 
were carried out in a total volume of 20 µl, in 1 x High Fidelity Buffer [supplied with 
PhusionTM Polymerase; New England BioLabs, Ipswich, MA, USA] and contained 200 µM 
dNTP mix, 0.4 U PhusionTM Polymerase and 20 pmol of each primer. Reactions were run in 
an Eppendorf Thermocycler [Eppendorf, Hamburg, Germany] with an initial incubation of 
98°C for 30 secs, followed by 35 cycles of 98°C for 10 sec, 60°C for 30 sec, and 72°C for 2- 
5 mins [where 15- 30 secs was allowed for each kb of sequence expected] and a final 
incubation at 72°C for 5 min. Products were analysed after resolution and visualisation using 
agarose gel electrophoresis [see Section 2.5.3]. 
 
2.5.2.4 RAPD 
RAPD PCR was performed according to the reaction conditions described in 2.5.2.2, but with 
the addition of only 1 primer [the volume of the other primer was made up with MQ H2O]. 
Three different primers were used for RAPD PCR and these were primers 1290, 1254 and 
1252 [in Table A2.1 in Appendix 2]. Primers were used individually to screen each isolate. 
RAPD cycling conditions are below [Table 2.3] and the PCR was performed in an Eppendorf 
Thermocycler [Eppendorf, Hamburg, Germany]. Products were run on an agarose gel and 
profiles were interpreted according to the presence or absence of bands, compared to control 
strains. RAPD PCR was performed on each sample at least twice, to ensure reproducibility.   
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Table 2.3: RAPD PCR conditions  
Step Temperature [°C] Cycling time [minutes] 
First denaturation 1. 94 5 
First annealing 2. 37 5 
First extension 3. 72 5 
 4 cycles of steps 1 to 3 
Second denaturation 4. 94 1 
Second annealing 5. 37 1 
Second extension 6. 72  2 
 30 cycles of steps 4 to 6 
Final extension 7. 72 10 
 
2.5.3 Agarose gel electrophoresis 
Agarose gels with a concentration of 0.8% to 1.5 % [w/v] were used for electrophoresis to 
visualise DNA fragments. Gels were made by boiling analytical grade agarose [Promega, 
Fitchburg, WI, USA] in 0.5 X TBE for 1 minute. The proportion of agarose in each gel, was 
dependant on the size of the DNA to be separated: for <0.5 kb, 1.2 to 1.5% [w/v] agarose was 
used; between 0.5 to 2 kb, 1% [w/v] agarose was used; >2 kb, 0.8% [w/v] agarose was used. 
Gels were stained using 0.5 µg/ml Ethidium Bromide [EtBr], which was added to liquid 
agarose, which had been cooled to room temperature. Once set, the gel was loaded with 
sample [approximately 5 µl for PCR sample, 10 to 20 µl for restriction digests and 4 µl for 
raw DNA extraction] that was mixed with loading dye. Molecular weight markers that were 
contained fragments that 1 kb or 100 bp apart [New England BioLabs, Ipswich, MA, USA] 
were used to estimate the size and concentration of DNA. Agarose gels were run in 0.5 X 
TBE, in electrophoresis boxes [BioRad, Hercules, CA, USA], at 150 V for 45 minutes. DNA 
bands on agarose gels were visualized with a UV transilluminator [at 280 nm] and imaged 
using a GelDoc1000 image analysis station [BioRad, Hercules, CA, USA]. 
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2.5.4 DNA purification techniques 
DNA was routinely purified using ethanol precipitation where 2 volumes of 100% ethanol 
and 1/10 volume of sodium acetate were added to the DNA, which was incubated at 4°C for 
at least 1 hour, and then spun at 12 000 rpm for 20 minutes. The pellet was then washed with 
1 mL ice-cold 70% ethanol and resuspended in TE or EB, depending on future manipulation. 
If multiple bands were observed in a PCR product, the products were run on an agarose gel 
and the desired band was excised using visualisation under long range UV [to prevent damage 
of the DNA]. The extracted band was then purified using Qiaquick Gel Extraction Kit 
[QIAGEN Inc, Valencia, CA, USA] and the spin column protocol was followed according to 
the manufacturer’s instructions and resuspended in a final volume of 30 µl EB.  
 
2.5.5 Estimation of DNA concentration 
Concentration of DNA was estimated using a Thermo Scientific NanodropTM ND-1000 
Spectrophotometer [Thermo Fisher Scientific, Waltham, MA, USA] using OD at 260 nm. 
DNA was also estimated for purity using the absorbance ratio of 260/280 nm, where DNA 
was considered pure if the ratio was ≥1.8.  
 
2.6 Construction and analysis of plasmid deletions 
2.6.1 Preparation of CaCl2 competent cells  
Chemically competent cells were prepared [adapted from Morrison, 1979 (192)] by 
inoculating 1 L LB [in a 5 L flask] with 1 ml of E. coli DH5α [resistant to Nalidixic acid] 
starter culture. The flask was shaken at 37°C, and spectrophotometric readings of the culture 
were taken until an optical density [OD] OD600 of 0.5 was reached. The cells were cooled on 
ice and then pelleted at 8,000 rpm for 8 mins at 4°C. Cells were resuspended in 0.1 M MgCl2 
CHAPTER	  2	   Materials	  and	  methods	   70	  
and pelleted as above. Cells were then resuspended in ice-cold 0.1 M CaCl2 and re-pelleted. 
The final pellet was resuspended in a solution containing 14% glycerol and 86mM CaCl2. 
Cell aliquots of 0.5 ml were snap frozen in liquid nitrogen and stored at –81°C. These cells 
were tested for competency using the cloning vector plasmid pUC19 that contained the blaTEM 
[ampicillin resistance] gene and yielded at least 105 transformants per µg DNA. 
 
2.6.2 Restriction endonuclease digestion 
Between 200 ng and 20 µg of template DNA [PCR products or plasmid DNA] was digested 
with 5-10 U of restriction endonuclease in 1 X buffer, and 1 X BSA as recommended and 
supplied by the manufacturer [New England Biolabs, Ipswich, MA, USA] in a total volume of 
between 20 and 50 µl. The digestion mix was incubated in a water-bath at 37°C for all 
enzymes used here. The digestion time varied depending on the DNA type, for example PCR 
products were digested for 1-2 hours, but concentrated plasmid DNA was digested for up to 
16 hours [with the possibility of re-addition of more enzyme, depending on the enzyme half 
life]. The digestion reaction was separated and visualised on conventional agarose gel 
electrophoresis [see Section 2.5.3]. 
 
2.6.3 Ligation 
Ligation reactions were set up on ice and carried out using the Quick Ligation Kit according 
to the manufacturer’s instructions [New England BioLabs, Ipswich, USA]. 1 µl of Quick 
DNA ligase was incubated for 5 to 30 mins at room temperature with the digested plasmid 
fragments [~5 µg]. Reactions were set up in 1 X Quick ligase buffer to a total volume of 10 µl 
and were used immediately or stored at -20OC. Deletions were selection on LA containing 
antibiotics [see Section 2.4.2]. 
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2.6.4 Transformation 
Transformation was performed by thawing 100 µl of CaCl2 chemically competent E. coli 
DH5α [resistant to Nalidixic acid] cells on ice and adding 1-10 µl of ligation mix [~1 µg 
DNA], then incubating this mixture on ice for 30 minutes. After heat shocking the cells at 
42°C for 40 secs, the cells were incubated on ice for a further 2 mins. The cells were diluted 1 
in 10 with LB and incubated with shaking at 37°C for 1 hour. Dilutions of the culture were 
made, if necessary, and were plated [100 µl/ plate] in duplicate on LA containing Ap 
[selection for vector; to determine transformation frequency] and LA containing an 
appropriate antibiotic [selection for plasmid deletions]. After overnight growth at 37°C, 
colonies were screened to identify the appropriate deletion. 
 
2.6.5 Sequencing plasmids 
A transformant carrying the desired plasmid was extracted [see Section 2.5.1.3] and purified 
[see Section 2.5.4]. PCR products of the resistance region were sequenced [see Section 2.7] 
and this sequence was used as a template to design primers [see Section 2.5.2.1] that were 
used to ‘primer walk’ and sequence the remaining regions of the plasmid. The sequencing 
primers were also used to map plasmids from the same family. 
 
2.6.6 Extended growth experiments 
To investigate the stability of antibiotic resistance[s] conferred by plasmid[s], bacterial 
cultures containing the plasmid[s] were continued for more than one night, without antibiotic 
selection, using serial dilution. A 2 ml starter culture was inoculated with a single colony and 
grown overnight with appropriate antibiotics to ensure the presence of the plasmid/s to be 
studied. The starter culture was diluted in saline and 0.1 ml of a 10-5 dilution [~1000 cells] 
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was added to 2 ml of fresh LB without antibiotics and incubated overnight at 37°C with 
constant shaking at 200 rpm. The resulting culture constituted the “Day 1” culture, which was 
diluted and ~1000 cells were added to fresh LB and grown overnight to yield the “Day 2” 
culture and so on. At certain intervals, cultures were diluted [dilutions used were 
approximated to give between 30 and 300 colonies per plate] and spread in duplicate onto 
plates with and without antibiotics to determine the proportion of antibiotic resistant cells [if 
the loss was greater than 10 fold]. Plates were incubated at 37°C overnight and counted the 
next day. Also, for more subtle detection of antibiotic resistance loss, individual colonies 
were taken off dilution plates without antibiotics and picked and patched onto plates 
containing single antibiotics to determine their antibiotic resistance phenotype. Serially 
diluted cultures with antibiotics were run in parallel and tested in the same way as above, to 
act as a positive control. 
 
2.7 DNA sequencing and analysis 
2.7.1 Preparation of DNA for sequencing 
Thirty to 90 ng of purified PCR sample or 500-1,500 ng of plasmid DNA purified by ethanol 
precipitation [see Section 2.5.6] was sequenced with 3-10 pmol of suitable primer in a final 
volume of 12 µl.  
 
2.7.2 Sequencing reaction  
Automated sequencing was performed at the Sydney Node of the Australian Genome 
Research Facility [AGRF] [Sydney, Australia] on an Applied Biosystem 3730, 7900 Genetic 
Analyser and Transgenomic WAVE-dHLC [Applied Biosystems, Carlsbad, CA, USA], using 
the Big Dye system.  
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2.7.3 Sequencing analysis 
Sequences were visualized and assembled using Sequencher version 5.1 [Gene Codes 
Corporation, Ann Arbor, MI, USA]. Sequenced regions were identified using BLAST 
[http://blast.ncbi.nlm.nih.gov] or in pair-wise comparisons using the BLAST paired alignment 
facility. Antibiotic resistance regions were delineated by detecting a series of common 
features, such as 3’-CS, 5’-CS, IS1, IS26, IS6100, using BLAST pair-wise analysis. This 
approach allowed resistance region boundaries to be defined and then analysis of the 
sequence in between and flanking regions [including detection of direct repeats] to be 
undertaken. Gene Construction Kit version 2.5 [Textco, West Lebanon, NH, USA] was used 
to create figures to scale. Single nucleotide differences between the expected sequence based 
on published sequences and the generated sequence were confirmed using more than one PCR 
product as sequencing template. 
 
 
  
 
 
 
 
 
 
 
 
 
CHAPTER THREE 
 
Isolation and characterisation of commensal E. coli  
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3.1 Introduction 
E. coli strains were found to be carried for a period of months to years but these studies 
examined the faecal flora of children or infants (203-205, 207). Only a few studies have 
documented the long-term commensal E. coli population structure of adults and most of these 
studies were conducted before the 1990s, prior to the availability of molecular analysis. There 
has only been one recent study that analysed the E. coli isolates from multiple faecal samples, 
and this study examined the commensal flora of only 2 adults (132). 
Studies that characterised strains using molecular methods to determine if antibiotic 
resistant commensal E. coli strains can reside over an extended period of time in the colon 
without any obvious antibiotic selection were not found. To examine this, a preliminary 
analysis of strain persistence and resistance was conducted through use of both biochemical 
and molecular based methods, on 4 faecal samples provided by a single human subject in 
2008 (12). Isolates were first differentiated by their antibiotic resistance profiles because this 
approach allowed for a large number of isolates to be rapidly segregated into groups. Ten 
representative isolates from each group were analysed to identify strains. Isolates of a 
multiply resistant E. coli strain, named 1-R1, which was resistant to ampicillin, streptomycin, 
sulfamethoxazole, tetracycline and trimethoprim were found in all 4 faecal samples that were 
collected over a 164-day period [approximately 5 months] [Table A1.1 in Appendix I]. Strain 
1-R1 carried the blaTEM [ApR], strA and strB [SmR], sul1 and sul2 [SuR], dfrA7 [TpR] and tetA 
[A] [TcR] resistance genes, accounting for its resistance phenotype. In the first sample, 1-R1 
was the only strain found but the 3 remaining samples, between 2 to 7 other E. coli strains 
were identified but none of these other strains were detected in multiple faecal samples. Thus, 
this preliminary study established that multiply antibiotic resistant E. coli strains can persist in 
the human colon in the absence of antibiotic selection (12).  
CHAPTER 3      Isolation and characterisation of commensal Escherichia coli 76	  
This chapter describes a study on a larger group of adult human subjects [11 adults]. 
The aim was to isolate and characterise more persistent and other commensal E. coli strains. 
Analysis conducted by Dr Jannine Bailey and Mr Jeremy Pinyon on 6 other subjects 
identified 5 further strains that were detected in multiple faecal samples, 3 of which were 
resistant to multiple antibiotics. Hence, a second aim was to track these 5 strains for as long as 
possible. Two approaches were taken, and the first entailed the analysis of more faecal 
samples from volunteers who had each already contributed a single faecal sample to a 
previous study (20). New volunteers willing to contribute multiple faecal samples were also 
recruited.  
 
3.2 Strain isolation 
This study was conducted with informed consent and was approved by the University of 
Sydney Human Research Ethics Committee [04-2008/10778]. All E. coli isolates were 
recovered between 2008 and 2012 from healthy adults. Eight male and 3 female subjects 
between 21 and 45 years of age provided multiple faecal samples. Dr Jannine Bailey and Mr 
Jeremy Pinyon provided assistance with the analysis of some of the faecal samples. The 
faecal samples were serially diluted and plated onto MacConkey agar, and the dilutions were 
also plated onto MacConkey agar or MHA plates containing antibiotics [see below for details 
on the antibiotics] to detect rare resistant isolates. The colonies that grew after overnight 
incubation at 37°C on the 10-2 and 10-3 dilution plates were counted to determine the 
abundance of Enterobacteriaceae. E. coli usually grow as flat, deep-red colonies on 
MacConkey agar, and 100 of these colonies per faecal sample were grown on Simmons’ 
citrate agar to identify putative E. coli isolates. E. coli are unable to grow on this medium 
whereas other Enterobacteriaceae, like Klebsiella pneumoniae [pink colonies on MacConkey 
agar] grow and change the green colour of the Simmons’ citrate agar to blue. White colonies 
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on the MacConkey Agar were considered to be other Enterobacteriaceae unless they did not 
grow on the Simmons’ citrate medium, and produced a uidA PCR amplicon [see below]. 
These white colonies were non-lactose fermenting E. coli. The unselected 100 isolates were 
also screened for their resistance profiles by patching colonies onto MacConkey agar 
containing either ampicillin [Ap; 100 µg/ml], ceftazidime [CAZ; 1 µg/ml], cefotaxime [CTX; 
1 µg/ml], chloramphenicol [Cm; 25 µg/ml], kanamycin [Km; 20 µg/ml], spectinomycin [Sp; 
25 µg/ml], streptomycin [Sm; 25 µg/ml] or tetracycline [Tc; 10 µg/ml] and MHA containing 
sulfamethoxazole [Su; 100 µg/ml] or trimethoprim [Tp; 25 µg/ml].  
Isolates were grouped by their resistance phenotype and 2 isolates from each group 
were examined using the API20E assay to confirm that they were E. coli. The biochemical 
tests in this assay also served as an additional tool to differentiate strains because not all 
strains produced the same API profile. DNA was extracted from up to 10 isolates per group, 
and these isolates were screened by PCR for the presence of the E. coli β-D-glucuronidase 
gene [uidA] (302) and their phylogenetic group membership (48). Random amplification of 
polymorphic DNA [RAPD] was performed on up to 10 isolates of each resistance phenotype 
detected to determine if the isolates within each phenotypic group represented a single strain. 
The RAPD data, the E. coli specific markers, API20E profiles, antibiotic resistance/ 
susceptibility profiles and the resistance gene content of isolates were used in combination to 
distinguish individual E. coli strains    
 
3.2.1 Extended sampling 
3.2.1.1 Subject 1 
3.2.1.1.1 E. coli strain 1-R1 
One hundred isolates each from 4 further samples were screened for susceptibility to the 10 
antibiotics listed above, and isolates with the ApR SmR SuR TcR TpR resistance phenotype of 
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strain 1-R1 were detected [Table 3.1]. Due to the low abundance of E. coli in the ninth sample 
[2.5 x 105 CFU/g], only 50 isolates were recovered and 31 of those had a resistance 
phenotype matching 1-R1 [Table 3.1].  
 
Table 3.1. Strain typing of E. coli in subject 1 
Sample Day E. coli strains 
Resistance 
phenotypea 
% Total 
E. colib 
API20E 
code 
Phylo 
groupc  uidA 
RAPD 
typed 
1-1 to 
1-4  
1, 29, 
99, 164 1-R1
e ApSmSuTcTp  1044552 A1 + 1 
         
 1-5 311 1-S9 Susceptible 41 5144572 B2  + 13 
  1-R1 ApSmSuTcTp 59 1044552 A1 + 1 
 1-6 366 1-S9 Susceptible 83 5144572 B2  + 13 
  1-R1 ApSmSuTcTp 17 1044552 A1  + 1 
 1-7 367 1-S9 Susceptible 52 5144572 B2  + 13 
  1-R1 ApSmSuTcTp 48 1044552 A1  + 1 
1-8 368 1-R1 ApSmSuTcTp 100 1044552 A1  + 1 
 1-9f 472 1.9-R6 ApCmSpSmSuTcTpg 36 5144532 B2 + 14 
  1.9-R7 ApTc 2 1044552 A1  + 15 
  1-R1 ApSmSuTcTp 62 1044552 A1  + 1 
aIsolates resistant to ampicillin [Ap], chloramphenicol [Cm], streptomycin [Sm], sulfamethoxazole [Su], 
tetracycline [Tc] and trimethoprim [Tp] 
bCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
cPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
dRAPD type is a combination of RAPD data collected with primers 1252, 1254 and 1290 
eData on strain 1-R1 collected during Honours Project 
f50 isolates screened for resistance phenotyping due to low E. coli abundance 
gNon-lactose fermenting E. coli. Formed white colonies on MacConkey agar  
 
Ten ApR SmR SuR TcR TpR isolates each from samples 5 to 8 and 5 isolates from 
sample 9 were purified. The resistance phenotype was confirmed for 5 of these isolates each 
from samples 5 to 8 and 3 isolates from sample 9 using the CDS disc diffusion assay with 12 
antibiotics [the 10 listed above, and to gentamicin and neomycin]. The API20E assay was 
performed on 3 isolates from samples 5 to 8 and 2 from sample 9, and all 14 isolates produced 
the API20E code 5144552, identical to that of 1-R1 [Table 3.1].   
DNA was extracted from all the purified isolates and the E. coli uidA gene PCR was 
performed on all 45 of these isolates to provide further evidence that these isolates were E. 
coli. An amplicon corresponding to the predicted size for the uidA PCR product [658 bp] was 
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detected in all cases. To identify the E. coli phylogenetic group membership of these 45 
isolates, the Clermont phylogenetic group PCR (48) was performed. An amplicon 
corresponding to the yjaA gene was seen in all isolates indicating that they were members of 
group A1. Using RAPD primer 1290, these 45 isolates had RAPD profiles indistinguishable 
from 1-R1 [Figure 3.1]. The profiles of these isolates were also indistinguishable using 
primers 1254 and 1252 respectively. The RAPD patterns of isolates from 1-R1 had previously 
been shown to be unique when compared to other strains from subject 1 [see Figure A1.1 in 
Appendix I].  
 
Figure 3.1. RAPD profile of 1-R1. The RAPD profiles of isolates of strain 1-R1 from days 1 to 1372. The 
strain name is above while the days of isolation are below. The image is of a 1% agarose gel run at 150 V in 
TBE for 45 minutes.  
 
All 45 isolates were examined for the presence of sul1 and sul2 [SuR], blaTEM and 
blaSHV [ApR], strA and strB [SmR], tetA [A], [B], [C], [D], [E] and [G] [TcR], intI1 of class 1 
integrons and its gene cassettes, to account for its resistance phenotype. All isolates had the 
blaTEM [ApR], strA and strB [SmR], sul1 and sul2 [SuR], the tetA [A] [TcR] resistance genes, 
and a class 1 integron with a gene cassette. Sequencing the gene cassette PCR amplicon from 
1 representative ApR SmR SuR TcR TpR isolate identified the cassette as dfrA7 [TpR]. The 
cassette amplicon of 2 further isolates from each sample was digested with DraI, and the 
digestion pattern produced was indistinguishable to the pattern of the sequenced dfrA7 
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cassette amplicon. Thus, the resistance phenotype of all these isolates was accounted for and 
their resistance gene content was the same as 1-R1. Hence, 1-R1 was detected in subject 1 for 
at least 472 days.  
 
3.2.1.1.2 Other resistant E. coli strains 
In sample 9, a single ApR TcR isolate was found, and it had the yjaA gene, thus was a group 
A1 member. It produced an API20E profile that was the same as 1-R1 [Table 3.1], and it also 
carried the blaTEM [ApR] and the tetA [A][TcR] resistance genes. However, when the RAPD 
PCR with primers 1252 [data not shown], 1254 and 1290 [Figure 3.2] was performed on this 
isolate, a RAPD profile that was different from 1-R1 was observed. Thus, this ApR TcR isolate 
was another strain and not a resistance variant of 1-R1, and this strain was named 1.9-R7.  
 
 
Figure 3.2: RAPD of the strains from sample 9.  The figure shows the RAPD profiles of strains 1-R1, 1.9-R6 
and 1.9-R7 using RAPD primers 1254 and 1290. The primer name is above while strain names are below. The 
image is of a 1% agarose gel run at 150 V in TBE for 45 minutes.  
 
Eighteen isolates that were resistant to Ap, Cm, Sm, Sp, Su, Tc and Tp were also 
found in the ninth sample [Table 3.1]. This was the first group of isolates with a CmR 
phenotype detected in subject 1. All isolates examined were members of the B2 phylogenetic 
group [Table 3.1], and produced different RAPD [Figure 3.2] and API20E profiles [Table 3.1] 
from 1-R1 and 1.9-R7. Hence, these isolates represented another strain named 1.9-R6. 
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3.2.1.1.3 Susceptible strains 
Samples 6 through 8 were taken at one-day intervals to find transient strains. No resistant 
strains besides 1-R1 were detected, and susceptible isolates were found only in samples 6 and 
7. DNA was extracted using the boiled preparation method from 20 susceptible isolates per 
sample and RAPD analysis with primers 1252, 1254 and 1290 produced indistinguishable 
bands for the 40 isolates. Thus, these isolates represented a single strain. Two isolates of the 
susceptible strain detected in sample 5, 1-S9, and 2 susceptible isolates each from samples 6 
and 7 were examined together with primer 1252, and the bands produced by these 6 isolates 
were indistinguishable [Figure 3.3]. Analysis with primers 1254 and 1290 also produced 
indistinguishable RAPD profiles for these 6 isolates. Hence, strain 1-S9 was also detected in 
samples 6 and 7, and persisted in subject 1 for at least 57 days.  
Approximately 41% of the E. coli in the fifth sample were strain 1-S9. Forty-five days 
later, this became 83% of isolates in the sixth sample, and decreased to 52% of the isolates in 
the seventh sample but then suddenly disappeared the next day [sample 8] [Table 3.1]. Strain 
1-S9 was not detected in sample 4 but there was a gap of 147 days between samples 4 and 5 
[approximately 5 months]. Hence, subject 1 could have carried 1-S9 for longer than 57 days.  
 
Figure 3.3: RAPD profile of 1-S9. The RAPD profiles of isolates of strain 1-S9 taken from days 311, 366 and 
372. The strain names are above each image while the days of isolation are below. The image is of a 1% agarose 
gel run at 150 V in TBE for 45 minutes.  
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3.2.1.1.4 1-R1 is present 2 years later 
By sample 9, 1-R1 had persisted for over 472 days. To determine if 1-R1 was still present 
over 2 years later, a tenth sample was collected, and the 100 putative E. coli isolates screened 
were resistant to only Ap. However, all isolates grew on Simmons’ citrate agar and were 
identified as K. pneumoniae [see Section 3.2.1.1.6]. To determine if 1-R1 was present, the 
MacConkey agar or MHA plates containing antibiotics were examined and 5 isolates growing 
on the MHA plate containing Su did not grow on Simmons’ citrate agar. Hence, these isolates 
were likely to be E. coli. They were purified and DNA was extracted, and all produced the 
expected amplicon for the uidA gene. Thus, these 5 isolates were the only E. coli detected in 
sample 10. E. coli were rare in this sample and the population was calculated to be at its 
lowest, which was 1.5 x 105 CFU/g [see Section 3.2.1.1.5]. Resistance screening of these 5 
isolates identified 2 phenotypes, of which 3 were ApR SmR SuR TcR TpR and the 2 remaining 
isolates were SuR TcR TpR. To increase the number of E. coli isolates analysed, more dilutions 
were plated out onto MacConkey agar containing either Ap, Sm, Su, Tc or Tp and 15 further 
isolates were recovered. Five of the 15 isolates were SuR TcR TpR, and they were from group 
B2, and they produced different API20E and RAPD profiles from 1-R1, 1.9-R6 and 1.9-R7. 
Hence, these isolates represented another strain and it was named 1.10-R8.  
The 10 remaining isolates were ApR SmR SuR TcR TpR and when 5 were analysed, 
they were members of group A1, had API20E and RAPD profiles that were indistinguishable 
from 1-R1 [Figure 3.2]. These isolates also carried the same resistance genes as 1-R1. 
Therefore, strain 1-R1 was still present 1372 days or almost 4 years after it was first detected.    
 
3.2.1.1.5 The abundance of E. coli  
E. coli was detected in every sample but it was usually less abundant than K. pneumoniae 
except in the seventh sample [Figure 3.4]. The number of E. coli fluctuated from as high as 
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1.9 x 107 CFU/g faeces in sample 4 to as low as 1.5 x 105 CFU/g faeces in sample 10 [see 
Table A1.2 in Appendix 1]. Samples 6 to 8 were taken at one-day intervals. During this time, 
the number of E. coli decreased 20 fold from 1.0 x 107 to 5.0 x 105 CFU/g [Figure 3.4 and 
Table A1.2 in Appendix 1].  
 
 
Figure 3.4: Abundance of Enterobacteriaceae in subject 1. The abundance of commensal E. coli and K. 
pneumoniae [CFU/g]. The blue line indicates the abundance of E. coli in and the red line represents K. 
pneumoniae.  
 
The number of 1-R1 and 1-S9 isolates detected fluctuated throughout the samples in 
which they were found [Table 3.1 and Figure 3.5]. In the 3 samples [sample 5, 6 and 7] where 
isolates of 1-S9 were found, their incidence was inversely proportional to that of 1-R1. The 
population of 1-S9 increased from 41% to 83% between the fifth and sixth samples whereas 
1-R1 decreased from 59% to 17% [Figure 3.5]. As the incidence of 1-R1 increased from the 
sixth to seventh samples, the abundance of strain 1-S9 decreased from 83% to 52% before 
suddenly disappearing in the eighth sample [Table 3.1]. Hence, the E. coli population is 
dynamic and strain populations can fluctuate greatly. 
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Figure 3.5: Fraction of strain 1-R1 among all E. coli. The figure shows the proportion of isolates that had the 
1-R1 resistance phenotype [ApR SmR SuR TcR TpR] of the 100 colonies examined in each of the 10 samples taken 
over 1372 days. The green line represents strain 1-R1. 
 
3.2.1.1.6 K. pneumoniae in subject 1 
Two distinct types of colony morphologies were observed in every sample. Colonies with a 
flat and deep-red appearance were E. coli whereas those that were pink and had a 
viscous/mucoid appearance were K. pneumoniae. K. pneumoniae, like E. coli, were detected 
in every faecal sample [see Figure 3.4 and Table A1.2 in Appendix I]. The K. pneumoniae 
population declined from the sixth to seventh samples from 6.9 x 106 to 7.5 x 104 CFU/g but 
then increased 60 fold in the eighth sample to 4.5 x 106 CFU/g [Figure 3.4 and Table A1.2 in 
Appendix I]. Thus, the abundance of these 2 species can fluctuate greatly on a daily basis. 
Fifty K. pneumoniae isolates from each time point were screened for their 
susceptibility to the 10 antibiotics listed above and they were only resistant to ampicillin. To 
confirm this phenotypic assignment, 3 K. pneumoniae isolates from each of the 5 samples 
were purified and assayed for their resistance to 12 antibiotics using the CDS disc diffusion 
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assay. All isolates were only ApR. Two K. pneumoniae isolates from each sample were 
screened for the blaTEM and blaSHV genes, and blaSHV was detected in all isolates. K. 
pneumoniae are naturally resistant to Ap because they carry the blaSHV gene in their 
chromosome (38). 
In the preliminary study, a single K. pneumoniae strain was detected in the 4 faecal 
samples examined (12). To determine if this strain was still present, 2 putative K. pneumoniae 
isolates each from the 6 additional samples were examined using API20E assays and these 
isolates were confirmed to be K. pneumoniae, producing the API20E code 5215773. The 
same code produced by the K. pneumoniae strain detected in the first 4 samples (12). Five K. 
pneumoniae isolates from each of these 6 further samples were examined using RAPD primer 
1290, and the profiles of these isolates were indistinguishable from the profile of the K. 
pneumoniae strain detected in the first 4 samples [data not shown]. These isolates also 
produced indistinguishable profiles with primers 1254 and 1252 respectively. Thus, isolates 
of a K. pneumoniae strain was found in the 10 samples and this strain was present for as long 
as 1-R1 was in subject 1.   
 In the tenth sample, another K. pneumoniae strain was detected because it did not have 
the typical viscous/mucoid K. pneumoniae appearance but API analysis identified it as K. 
pneumoniae [5205773]. This API20E profile was different to the profile of the other K. 
pneumoniae strain [5215773], and this difference was due to the ability of the strain that 
persisted to metabolise urea. The new K. pneumoniae strain had a different RAPD profile 
from the other strain, confirming that a new K. pneumonia strain was present in sample 10. 
 
3.2.1.2 Subject 2 
Two samples were collected from subject 2 and characterised by Dr Jannine Bailey, and strain 
2-S1 was seen in both samples [Table A1.3 in Appendix I and in line 1 of Table 3.2]. Strain 
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2-S1 formed white colonies on MacConkey agar, making it easy to identify. It persisted for 
over 99 days. Four further samples were collected over a period of close to 2 years. Dr 
Jannine Bailey assisted with the analysis of the first of these samples, sample 2-3.  
 
3.2.1.2.1 Strain 2-S1 is still present in subject 2 
In sample 2-3, over 10000 colonies were examined but white colonies were not observed. 
Hence, 2-S1 was not detected in the third sample.  
 
Table 3.2: Strain typing of E. coli in subject 2 
Sample Day E. coli strains 
Resistance 
phenotype 
% Total 
E. colia 
API20E 
code 
Phylo 
groupb  uidA 
RAPD 
type 
2-1, 2-2 1 and 99c 2-S1d Susceptible  5144532 B2  + 1 
2-2 99 2-S2 Susceptible  5144512 B2  + 3 
         
 2-3c 233 2-S2 Susceptible 9 5144512 B2 + 3 
  2.3-R3 SmSuTpe 1 5044572 D  + 5 
  2.3-R4 SuTcTp 1 5044552 D + 6 
  2.3-R5 SmSuTcTpe 89 5044572 D  + 5 
2-4 486 2-S1d Susceptible 58 5144532 B2  + 1 
  2-S2 Susceptible 42 5144512 B2 + 3 
2-5 597 2-S1d Susceptible 6 5144532 B2 + 1 
  2-S2 Susceptible 94 5144512 B2 + 3 
2-6 745 2-S1d Susceptible 0.4f 5144532 B2 + 1 
  2-S2 Susceptible 50 5144512 B2 + 3 
  2.6-S3 Susceptible 50 5144572 A0  + 7 
aCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
bPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
cExperimental support for the characterisation of these isolates was provided by Dr Jannine Bailey and Mr 
Jeremy Pinyon 
dNon-lactose fermenting E. coli. Formed white colonies on MacConkey agar. Abundance calculated as a 
proportion of the total E. coli [red and white colonies] population 
eResistance variants of the same strain 
fTotal of 3 white colonies detected amongst 208 E. coli colonies 
 
In the fourth, fifth and sixth samples, white colonies were again seen [Table 3.2]. The 
abundance of white colonies was calculated as a proportion of the total E. coli [red and white 
colonies]. It was the numerically dominant strain in the fourth sample but rare in sample 6 
where only 8 white colonies were seen amongst a total of 2166 colonies on MacConkey plates 
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[Table 3.2]. Isolates from each of these 3 time points produced RAPD, phylogenetic group, 
and API20E profiles that were indistinguishable from 2-S1 [Table 3.2]. Hence, 2-S1 persisted 
for over 2 years but was not found in sample 2-3. 
 
3.2.1.2.2 A second persistent susceptible strain in subject 2 
In sample 2-3, one susceptible and 3 resistant strains were detected. Twenty susceptible 
isolates were analysed using RAPD primer 1290, and their RAPD profiles were 
indistinguishable from strain 2-S2 [in line 2 of Table 3.2]. The API20E profile of 3 of these 
susceptible isolates and the phylogenetic group membership of 10 of these isolates was 
identical to 2-S2. Hence, isolates of strain 2-S2 were detected in the third sample 134 days 
after the second sample but not in the first sample. All deep-red colonies examined in samples 
2-4 and 2-5 were susceptible to the 10 antibiotics. Twenty susceptible colonies from each of 
these samples were examined using RAPD primer 1290, 1254 and 1252 but all isolates 
produced RAPD profiles indistinguishable from strain 2-S2 [Figure 3.6]. Thus, only strains 2-
S1 and 2-S2 were detected in samples 2-4 and 2-5 [Table 3.2].  
 
 
Figure 3.6: RAPD profiles of isolates in samples 2-4 and 2-5. RAPD profiles using primer 1254 of isolates of 
strains 2-S1 and 2-S2 from days 486 and 597. The sample numbers are above and the strain names are below. 
The image is of a 1% agarose gel run at 150 V in TBE for 45 minutes.  
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In the sixth sample, 10 of the 20 susceptible isolates examined had a different RAPD 
profile from strain 2-S2 and 2-S1 [Figure 3.7], and the API20E profile of these other 
susceptible isolates was also different from 2-S2 and 2-S1 [Table 3.2].  
 
 
Figure 3.7: RAPD profiles of isolates in sample 2-6. The RAPD profiles using primer 1290 of isolates of 
strains 2-S1, 2.6-S3 and 2-S2 taken from day 745. The strain names are below. The image is of a 1% agarose gel 
run at 150 V in TBE for 45 minutes.  
 
Phylogenetic analysis of these new susceptible isolates did not produce any bands, 
indicating that these isolates were A0 [Figure 3.8]. API20E data [Table 3.2] and the presence 
of a uidA amplicon confirmed that they were E. coli, and that absence of phylogenetic bands 
was not due to low DNA quality. Hence, a third susceptible strain, 2.6-S3 was detected in 
sample 6. Because 10 of the 20 susceptible isolates examined with RAPDs produced the 2.6-
S3 profile, 50% of the susceptible isolates in sample 2-6 were considered to represent 2.6-S3.  
 
 
Figure 3.8: Phylogenetic group profiles. The phylogenetic profiles of 2.6-S3, 2-S1, 2-S2 and 1-R1 isolates, 
included as a group A1 comparison. M represents the 100 bp ladder and relevant sizes are shown on the side. 
Strain names are shown below and phylogenetic groups are shown above. The identity of each phylogenetic 
band is shown on the right. The image is of a 1% agarose gel run at 150 V in TBE for 45 minutes.  
CHAPTER 3      Isolation and characterisation of commensal Escherichia coli 89	  
3.2.1.2.3 Resistant isolates 
In sample 2-3, isolates with 3 different resistance phenotypes were detected but these isolates 
produced the same API20E code and were from phylogenetic group D [Table 3.2]. The 
RAPD profile of the single isolate of strain 2.3-R3 [SmR SuR TpR] was indistinguishable from 
the RAPD profiles of 10 isolates of strain 2.3-R5 [SmR SuR TcR TpR] but the single isolate of 
2.3-R4 [SuR TcR TpR] produced a different RAPD profile [Figure 3.9]. Hence, 2.3-R3 was a 
resistance variant of 2.3-R5 but 2.3-R4 was another resistant strain that was rare. The 
resistance gene carriage of these strains is examined in Chapter 6. 
 
 
Figure 3.9: RAPD profiles of the resistant strains from sample 2-3. The RAPD profiles using primers 1252, 
1254 and 1290 on isolates of strains 2.3-R3, 2.3-R4 and 2.3-R5 from day 233. The primer names are above and 
the strain names are below. The image is of a 1% agarose gel run at 150 V in TBE for 45 minutes.  
 
To find more isolates of 2.3-R3 and 2.3-R4, 10 isolates were picked from each of the 
MacConkey agar plates containing the antibiotics Sm, Su or Tp and screened, and the 30 
isolates had SmR SuR TcR TpR resistance phenotype. Hence, these isolates were representatives 
of 2.3-R5 and further isolates of 2.3-R3 or 2.3-R4 were not found. This is consistent with the 
conclusion that 2.3-R3 is a 2.3-R5 variant, and 2.3-R4 was another rare resistant strain.  
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3.2.1.2.4 Other Enterobacteriaceae detected 
From the first to the fifth samples, colonies that were pink with a viscous/mucoid appearance 
were observed on the MacConkey agar plates. Two isolates from each sample were examined 
using the API20E assay and in all cases, these isolates were identified as K. pneumonia and 
they produced the same API20E code, 5215773. Hence, these isolates could represent a K. 
pneumoniae strain that persisted but RAPDs were not performed to investigate this further. At 
least 5 isolates from each time point were frozen and stored at -81°C for future analysis. 
Unlike subject 1, there was more diversity in terms of other Enterobacteriaceae species that 
were detected. Isolates that were flat and pink or red in colour, or those that were white and 
had flat spider-web like structures emanating from the centre of the colony, were also 
observed. Three isolates each of these new types of bacterial colonies were examined using 
API20E, and they were identified as being Kluyvera spp. in the second sample and 
Enterobacter cloacae in the third sample [Table 3.3]. Five isolates of each species were 
frozen and stored at -81°C 
 
Table 3.3: The abundance of Enterobacteriaceae in subject 2 
Sample Date Day Abundance CFU/g faecesa Others 
   E. coli K. pneumoniae  
2-1b, c 8/7/08 1 9.5 x 104 2.8 x 106  - 
2-2c 14/10/08 
99 1.0 x 107 1.0 x 105 Kluyvera spp. 
2-3c 25/2/09  233 3.5 x 106 3.0 x 105 Enterobacter cloacae 
2-4 5/11/09 486 4.1 x 106 8.3 x 106 - 
2-5b 24/2/10 597 1.2 x 106 5.5 x 105 - 
2-6 22/7/10 745 1.1 x 107 - - 
aCalculation done based on the number of CFU detected on 10-3 dilution plates of faecal sample 
bK. pneumoniae calculated from 10-2 dilution plates due to low abundance 
cDr Jannine Bailey assisted in data collection  
 
3.2.1.3 Subject 3 
Two samples from subject 3 were previously analysed and strains 3-S1 and 3-R1 were 
detected in both samples [Table A1.4 in Appendix I and Line 1 and 2 in Table 3.4]. In sample 
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3-2, Dr Jannine Bailey found evidence indicating that 3-S1 had acquired an Inc B/O plasmid 
carrying the blaTEM gene [ApR] from 3-R1, resulting in the 3-S1 ApR variant strain, 3-S1R 
[Line 3 of Table 3.4] [Bailey and Hall, unpublished observations]. Four additional samples 
were analysed to determine how long 3-S1 and 3-R1 could persist, and to determine if 3-S1R 
could persist. Subject 3 was unavailable between October 2009 and July 2010 due to overseas 
travel, hence the large sampling gap between 3-5 and 3-6 [Table 3.5]. 
 
3.2.1.3.1 Can 3-R1 and 3-S1 persist? 
Samples 3-3 and 3-4 were jointly analysed with Dr Jannine Bailey and Mr Jeremy Pinyon. 
None of strains in any of the 4 further samples analysed had the resistance or RAPD profiles 
of 3-R1, nor were any of the other strains from phylogenetic group D [Table 3.4]. Hence, 3-
R1 was only detected in the samples 3-1 and 3-2.  
 
Table 3.4: Strain typing of E. coli in subject 3 
Sample Day E. coli strains Resistance phenotype 
% Total 
E. colia 
API20E 
code 
Phylo 
groupb uidA 
RAPD 
type 
3-1, 3-2 1, 141 3-S1 Susceptible  5144552 B2 + 1 
3-1, 3-2 1, 141 3-R1 ApTc  5144552 D1 + 2 
3-2 141 3-S1Rd Ap  5144552	   B2 + 1 
         
 3-3c 226 3.3-S2 Susceptible 15 5144552 B2  + 3 
  3.3-R2 Ap 85 5144572 B2  + 4 
 3-4c 343 3-S1Rd Ap 100 5144552 B2  + 1 
3-5 416 3.5-S3 Susceptible 34 5044552 A0  + 5 
  3-S1Rd Ap 2 5144552 B2  + 1 
  3.5-R3 SmSpTp 64 1144572 A0  + 6 
3-6 793 3-S1 Susceptible 24 5144552 B2  + 1 
  3-S1Rd Ap 76 5144552 B2  + 1 
  3.6-R4 ApSmSue 1.8e 5044542 A1  + 7 
  3.6-R5 ApCmGmSmSpSuTcTmTpe 1.8e 5044542 A1  + 7 
aCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
bPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
cExperimental support provided by Dr Jannine Bailey and Mr Jeremy Pinyon 
d3-S1R had indistinguishable RAPD profile from 3-S1. 3-S1R is a resistance variant of 3-S1 carrying a blaTEM 
gene that confers resistance to ampicillin 
eIsolates not detected amongst the 100 screened. Ten isolates detected on the 10-2 dilution plates that were 
supplemented with Su. Five were 3.6-R4 and the rest were 3.6-R5 
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In each of the 4 further samples examined, 20 susceptible isolates were analysed using 
the 3 RAPD primers, and in samples 3-3 [Figure 3.10], 3-4 and 3-5, none produced RAPD 
profiles that were the same as 3-S1. However, the 3-S1 RAPD profile was seen again in 
sample 6. The susceptible isolates in sample 6 were also B2 E. coli and they produced the 3-
S1 API20E code [Table 3.4]. Hence, 3-S1 dropped below the detection limit in samples 3-3 to 
3-5, or, it was displaced but reappeared in sample 3-6, almost 2 years after it was last detected 
in 3-2. Alternatively, an indistinguishable strain could have been acquired on 2 occasions.  
 
 
Figure 3.10: RAPD profiles of strains from samples 3-2 and 3-3. The RAPD profiles using primer 1290 on 
isolates of strains 3-S1, 3-S1R, 3-R1, 3.3-S2 and 3.3-R2 from days 141 and 226. The sample numbers are above 
and the strain names are below. The image is of a 1% agarose gel run at 150 V in TBE for 45 minutes.  
 
3.2.1.3.2 3-S1R persists 
Isolates that were resistant to Ap were observed in each of the 4 further samples, and in 
samples 3-4, 3-5 and 3-6, the ApR isolates produced indistinguishable RAPDs and the same 
API20 profile as 3-S1R, and they also belonged to group B2 [Table 3.4]. In 3-3, the ApR 
isolates were also B2 E. coli with the same API20E code as 3-S1R [Table 3.4]. However, 20 
ApR isolates examined with the 3 RAPD primers produced profiles indistinguishable from 
each other but different from the 3-S1R profile [Figure 3.10]. Hence, the ApR isolates from 
sample 3-3 were representatives of a new strain, named 3.3-R2. Further analysis to determine 
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if 3-S1R was present in this sample at a low level was not undertaken. Strain 3-S1R was 
detected in all samples except in 3-3, and thus, was present in subject 3 for at least 652 days.    
 
3.2.1.3.3 Enterobacteriaceae carriage 
K. pneumoniae was detected in 3 samples from subject 3 [Table 3.5] but were not analysed 
further. Other Enterobacteriaceae were also detected [Table A1.5 in Appendix I] and the 
species were identified using the API20E assay [Table A1.5 in Appendix I]. At least 5 isolates 
of each non-E. coli species were frozen and stored at -81°C for future examination. 
 
Table 3.5: The abundance of Enterobacteriaceae in subject 3  
Sample Date Day Abundance CFU/g faecesa 
   E. coli K. pneumoniae 
3-3b, c 26/2/09  226 2.8 x 108 - 
3-4b 23/6/09 343 6.4 x 106 4.0 x 105 
3-5d 4/9/09 416 5.8 x 107 5.0 x 106 
3-6 16/9/10 793 1.0 x 106 - 
aCalculation done based on the number of CFU detected on 10-3 dilution plates of faecal sample 
bData collection was done by Dr Jannine Bailey with support from the author 
cCalculation done based on the number of CFU detected on 10-5 dilution plates of faecal sample 
dCalculation done based on the number of CFU detected on 10-4 dilution plates of faecal sample 
 
3.2.1.4 Subject 11 
Subject 11 provided 4 samples. Samples 11-1 and 11-2 were analysed by Dr Jannine Bailey. 
None of the strains identified in the first sample were detected in the second sample [Table 
A1.10 in Appendix I]. The subject provided two further samples and these were examined 
here. The subject was unavailable between samples 11-3 and 11-4, resulting in a sample gap 
of over 1 year [Table 3.6]. None of the 5 strains that were detected in subject 11 were seen in 
more than 1 sample. The abundance of Enterobacteriaceae is listed in Table A1.11 in 
Appendix I. 
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Table 3.6: Strain typing of E. coli in subject 11 
Sample Day E. coli strains 
Resistance 
phenotype 
% Total 
E. colia 
API20E 
code 
Phylo 
groupb uidA 
RAPD 
type 
11-3 293 11.3-S1 Susceptible 86 5144172 B1 + 3 
  11.3-R3 ApTc 14 5144572 B2 + 4 
11-4 881 11.4-R4 SuTp 100 5144772 D + 5 
aCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
bPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
  
3.2.2 New subjects 
Four new subjects, 14, 21, 22 and 23, were recruited for this study with the aim of increasing 
the number of both persistent and other strains. Subject 14 was a cohabiting partner of subject 
11, and subject 21 and 22 were also cohabiting partners. 
 
3.2.2.1 Strains isolated from subjects 14, 21, 22 and 23 
Each of these 4 new subjects carried a strain that was detected in multiple faecal samples 
[Table 3.7]. In subjects 21 and 22, the 2 strains that were found to persist in each subject, 
21.1-R1 and 22-S1, were both from phylogenetic group A1 whereas in subjects 14 and 23, the 
strains that persisted, 14.2-R2 and 23-S2, were both members of group B2 [Table 3.7]. In 
subjects 21, 22 and 23, these strains were detected in all the samples that were analysed 
whereas in subject 14, strain 14.2-R2 was only detected in 2 of the 5 samples examined. 
Strain 14.2-R2 was found only in samples 14-2 and 14-3, and these samples were 111 days 
apart [Table 3.7]. Further cells from 14-4 were plated out onto MacConkey agar containing 
Ap but ApR colonies were not observed to grow on this medium. Hence, 14.2-R2 was not 
detected in sample 14.4.  
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Table 3.7: Strain typing of E. coli in subjects 14, 21, 22 and 23 
Sample Day E. coli strains 
Resistance 
phenotype 
% Total 
E. colia 
API20E 
code 
Phylo 
groupb uidA 
RAPD 
type 
Subject 14        
 14-1c 1 14.1-R1 ApSmSpSuTcTp 100 5044572 D  + 1 
14-2 50 14.2-S1 Susceptible 20 5144552 B2  + 2 
  14.2-R2 Ap 80 5144552 B2  + 2 
  14.2-R3d Tc 0.9 5044552 A1  + 3 
14-3 161 14.3-S2 Susceptible 20 5044572 A0  + 4 
  14.2-R2 Ap 28 5144552 B2  + 2 
  14.3-R4 Tc 52 5144542 A0  + 5 
14-4 345 14.4-S3 Susceptible 100e 5044552 D  + 6 
  14.4-S4 Susceptible  5044542 A1  + 7 
14-5 749 14.5-S5 Susceptible 100 5144572 B2  + 8 
Subject 21        
21-1 1 21.1-S1 Susceptible 74 1044572 A0  + 1 
  21.1-S2f, g Susceptible 25 1044572 A1  + 2 
  21.1-R1 ApSmSuTc 1 5044552 A1  + 3 
21-2 101 21.2-S3 Susceptible 99 5144552 A1  + 4 
  21.1-R1 ApSmSuTc 1 5044552 A1  + 3 
21-3 252 21.3-S4 Susceptible 60 5144572 D1  + 5 
  21.1-R1 ApSmSuTc 40 5044552 A1  + 3 
21-4 539 21.4-S5h Susceptible 100i 5144112 B2  + 6 
  21.4-S6 Susceptible  5144112 B2  + 7 
  21.4-S7 Susceptible  5144552 A0  + 8 
  21.1-R1d ApSmSuTc 0.9 5044552 A1  + 3 
Subject 22        
22-1 1 22-S1g Susceptible 99 1044572 A1  + 1 
  22.1-S2 Susceptible 1 5144572 B2  + 2 
  22.1-R1d ApCmSmSpSuTcTp 0.7 5144552 B2  + 3 
22-2 101 22-S1g Susceptible 100 1044572 A1  + 1 
22-3 252 22-S1g Susceptible 100 1044572 A1  + 1 
22-4 531 22.4-S3h Susceptible 100e 5144112 B2  + 4 
  22-S1g Susceptible  1044572 A1  + 1 
Subject 23        
23-1 1 23.1-S1 Susceptible 100e 5144552 B2  + 1 
  23-S2 Susceptible  5144552 B2  + 2 
23-2 114 23-S2 Susceptible 100e 5144552 B2  + 2 
  23.2-S3 Susceptible  5044552 A1  + 3 
23-3 207 23-S2 Susceptible 100 5144552 B2  + 2 
23-4 316 23-S2 Susceptible 100 5144552 B2  + 2 
aCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
bPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
cExperimental support for the characterisation of these isolates was provided by Dr Jannine Bailey 
dIsolates not detected amongst the 100 screened. Ten isolates detected on the 10-2 dilution plates that were 
supplemented with Tc 
eTotal susceptible population. Two different susceptible strains distinguished by RAPD analysis of 10 
susceptible isolates. In 14-4, 1/10 isolates was 14.4-S4. In 22-4, 7/10 isolates were 22-S1. In 23-1, 5/10 isolates 
were 23-S2. In 23-2, 9/10 isolates were 23-S2 
f21.1-S2 is morphologically distinct from 21.1-S1. It formed bright red colonies on MacConkey agar and could 
therefore be quantified and differentiated from the other susceptible isolate when 100 isolates were screened 
gStrain 22.1-S2 had indistinguishable RAPD profiles to persistent strain 22-S1 
hNon-lactose fermenting E. coli. Formed white colonies on MacConkey agar 
iTotal susceptible population. Three different susceptible strains distinguished by RAPD analysis of 20 
susceptible isolates. In 21-4, 10/20 were 21.4-S5, 7/20 were 21.4-S6 and 3/20 were 21.4-S7 
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In subject 14, the RAPD profile of strain 14.2-R2 was from 14.2-S1, and both strains 
were from the same phylogenetic group and had the same API20E profile [Table 3.7]. 
However, isolates of 14.2-S1 were only found in sample 14-2. Twenty susceptible isolates 
from samples 14-3 and 14-4 were examined with RAPD PCR but none of the isolates 
produced the RAPD profile of strain 14.2-S1. Hence, strain 14.2-S1 did not persist. 
 
3.2.2.2 Strain sharing 
Subjects 21 and 22 are a cohabitating couple and strain 22-S1 had indistinguishable RAPD 
profile from strain 21.1-S2 [Figure 3.11]. Strain 22-S1 was detected in the 4 samples provided 
by subject 22 [Table 3.7] whereas strain 21.1-S2 was not detected in any of the other samples 
collected from subject 21 [Table 3.7]. Strain 22.4-S3 from subject 22 and strain 21.4-S6 from 
subject 21 also had indistinguishable RAPD profiles but both strains were each detected in the 
last sample. Subject 11 and 14 are also cohabiting partners and strain 14.1-R1 [Table 3.7] was 
indistinguishable from 11.2-R2 but neither strain was detected in multiple faecal samples. 
 
Figure 3.11: RAPD profiles of strains from subject 21 and 22. The RAPD profiles using primer 1252, 1254 
and 1290 on the isolates of strains 21.1-S2, 21.1-R1 and 22-S1 from the first samples of subject 21 and 22. The 
primers used are above and the strain names are below. The image is of a 1% agarose gel run at 150 V in TBE 
for 45 minutes.  
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3.2.2.3 Enterobacteriaceae in subjects 14, 21, 22 and 23 
E. coli was detected in the 4 new subjects throughout the sampling period but K. pneumoniae 
was not detected in subject 23 and was not common in the 3 other subjects [Table 3.8]. Other 
Enterobacteriaceae were not detected. The abundance of E. coli within each subject did 
fluctuate moderately, which was mostly within a 100-fold range between the most and least 
abundant sample [Table 3.8]. Surprisingly, the abundance of E. coli was almost exactly the 
same between samples 14-4 and 14-5, despite a sampling gap of over a year [Table 3.8].  
 
Table 3.8: The abundance of Enterobacteriaceae in subjects 14, 21, 22 and 23 
Sample Date Day Abundance CFU/g Faecesa % Total E. coli 
   E. coli K. pneumoniae 	  
Subject 14     14.2-R2 
14-1b, c, d 25/8/09 1 2.2 x 105 7.0 x 104 - 
14-2b, c 14/10/09 51 4.5 x 105 - 80 
14-3b, w 2/2/10 162 8.3 x 104 - 28 
14-4c 5/8/10 346 1.1 x 106 - - 
14-5c 13/9/11 750 1.6 x 106 - - 
Subject 21     21.1-R1 
21-1 14/1/10 1 2.3 x 106 6.5 x 105 1 
21-2c 24/4/10 101 1.4 x 106 - 1 
21-3c 22/9/10 252 2.2 x 106 - 40 
21-4 6/7/11 539 5.0 x 107 - 0.9 
Subject 22     22-S1 
22-1 14/1/10 1 4.1 x 106 - 99 
22-2 24/4/10 101 1.3 x 107 2.0 x 104 100 
22-3 22/9/10 252 9.7 x 106 - 100 
22-4 28/6/11 531 6.6 x 106 - 70 
Subject 23     23-S2 
23-1c 16/5/11 1 1.8 x 105 - 50 
23-2d 6/9/11 114 1.7 x 106 - 90 
23-3c 8/12/11 207 2.5 x 104 - 100 
23-4 26/3/12 316 3.3 x 105  100 
aCalculation done based on the number of CFU detected on 10-3 dilution plates of faecal sample 
bFaecal sample diluted and plated by Dr Jannine Bailey but enumerated by the author 
cCalculation done based on the number of CFU detected on 10-2 dilution plates of faecal sample 
dCitrobacter freundii and Escherichia hermanii detected 
eCalculation done based on the number of CFU detected on 10-1 dilution plates of faecal sample 
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3.3 Discussion 
 
The focus of the study was to find persistent strains and a total of 13 strains from 9 subjects 
were detected in multiple faecal samples. The isolation and characterisation of 11 of these 
persistent strains were shown above and 2 more [4-R1 and 4-R2] were recovered from subject 
4 whose samples were analysed by Mr Jeremy Pinyon [see Table A1.6 in Appendix I for 
strain profiles, Table A1.7 in Appendix I for abundance of Enterobacteriaceae and Table 3.6 
for persistent strain profiles]. Two other subjects, 5 and 6 were analysed by Dr Jannine Bailey 
and Mr Jeremy Pinyon but these subjects provided only 2 samples before discontinuing with 
the study, and none of their strains were detected in more than 1 faecal sample [see Tables 
A1.8 and A1.9 in Appendix I for details on subjects 5 and 6].  
A persistent strain was defined as a strain that was detected in multiple faecal samples 
for 6 months or longer, and 9 of the 13 strains were considered to be persistent strains [Table 
3.9]. The 4 remaining strains were detected in multiple samples but for less than 6 months. 
Hence, these strains were considered to be short-term persistent strains [below the line in 
Table 3.9].  
 
Table 3.9: Persistent strains 
Strain Resistance phenotype Days persisteda, b, c Phylo group 
1-R1 ApSmSuTcTp >1372 A1 
21.1-R1 ApSmSuTc >539 A1 
22-S1 Susceptible >531 A1 
3-S1 Susceptible >793 B2 
2-S1 Susceptible >745 B2 
3-S1R Ap >652 B2 
2-S2 Susceptible >646 B2 
23-S2 Susceptible >316 B2 
4-R2 ApSmSpSuTcTp >421 D 
14.2-R2 Ap <295 B2 
1-S9 Susceptible <248 B2 
3-R1 ApTc >141 D 
4-R1 ApTc >90 D 
a> denotes shortest duration of days strains could have persisted 
b< denotes duration between first and last samples strains was detected in 
cStrains below the line are short term persistent strains 
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Of the 9 persistent strains, 8 were detected in most samples including the first and last 
samples. Only strain 3-S1R was not detected in the first sample but it was detected in the last 
sample. These 9 strains were tracked for at least a year, and 2 or 3 years in some cases [Table 
3.9]. Hence, these 9 strains are considered to be long-term persistent strains.  
Strain 14.2-R2 was detected only in the second and third faecal samples collected 
from subject 14, and these samples were 111 days apart but the interval between samples 1 
and 4 was 295 days. Hence, 14.2-R2 did not persist for more than 295 days [Table 3.9], 
assuming that it appeared the day after the first sample was collected and disappeared the day 
before the fourth sample was collected. It was considered to be a short-term persistent strain 
because it was tracked only for 111 days. Similarly, 1-S9 was followed for over a 56-day 
period but it did not persist for more than 248 days because this was the interval between the 
samples it was not found in. 
Strain 4-R1, which was only detected in the first 2 samples from subject 4, may have 
persisted for longer in subject 4 prior to the collection of the first sample. Strain 4-R1 could 
have been outcompeted, thus replaced by 4-R2. Dr Jannine Bailey had previously shown that 
3-R1 and 4-R1 had indistinguishable RAPD profiles (20). Thus, they represented isolates of 
the same strain carried by 2 unrelated subjects. Because 3-R1 was also only detected in the 
first and second sample [Table 3.4], it is also possible that in subject 3, 3-S1 and 3-S1R were 
both better adapted to the colonic environment, and hence, replaced 3-R1.   
A total of 73 strains were detected from the 11 subjects [Table 3.10] and only subjects 
5, 6 and 11 did not carry a persistent strain. However, most of the 70 remaining strains cannot 
be considered to be transient strains. This is because of the large duration of days between 
samples, which in some cases was over a year, indicating that some of these strains could 
have been short-term persistent strains. Because transient strains could not be unambiguously 
defined, they were considered to be ‘others’. This is discussed further in Chapter 5.  
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Seven possible phylogenetic genotypes can be detected using the Clermont E. coli 
phylogenetic group PCRs [A0, A1, B1, B22, B23, D1 and D2] (48) but B22 and D2 strains were 
not detected in this study [Table 3.10]. Hence, the B23 and D1 strains were referred to as B2 
and D respectively. Groups A1, B2 and D were almost equally common whereas B1 was rare 
[Table 3.10]. Some studies found commensal isolates to be predominantly made up of groups 
A and B2 (48, 183, 207, 209, 254, 303, 323). Other studies found groups B2 and D (91, 131), 
some found groups A and D (167, 191), and in another study, B1 and D were the most 
common (252). Hence, phylogenetic group membership of commensal isolates appears to be 
quite variable.  
 
Table 3.10: Summary of strains isolated in this work 
  No of strains [%] 
Total           73 
Phylogenetic Group A0 9    [12] 
 A1 23  [32] 
 B1 1    [1  ] 
 B2 21  [29] 
 D 19  [26] 
Antibiotic resistant  34  [47] 
Antibiotic susceptible  39  [53] 
 
It has been claimed that K. pneumoniae has been found frequently in the faeces of 
humans (38) with up to 40% of individuals thought to carry K. pneumonia and other 
Klebsiella species. K. pneumoniae were detected in 8 of the 11 subjects, and this is consistent 
with it being a common in the human faecal flora. RAPD profiling of the K. pneumoniae in 
subject 1 revealed that a single strain persisted through the course of the study. A search of 
the literature revealed no previous studies that observed persistent K. pneumoniae strains. 
Therefore, this is the first report of a K. pneumoniae strain persisting in the human 
gastrointestinal tract. Based on the API20E data, subject 2 could have also carried a persistent 
K. pneumoniae strain but RAPD analysis is required to confirm this.  
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An earlier study, prior to molecular analysis, on resident commensal E. coli found 
isolates with the resistance phenotype SmR SuR TcR in 15 samples collected from an 
individual over a 2-month period (108). A more recent study found that antibiotic treatment 
resulted in the replacement of susceptible E. coli with resistant E. coli that persisted for 6 
months after treatment had ceased before being replaced by other susceptible persistent 
bacteria (182). In this study, none of the subjects had consumed any antibiotics for at least 6 
months prior to the commencement of faecal sampling yet 7 of the 13 persistent strains were 
resistant to at least 1 antibiotic, and 4 of these were long-term persistent strains [Table 3.9]. 
Hence, this study is also the first report that provides evidence of multiply antibiotic resistant 
strains persisting in the absence of any obvious antibiotic selection. See below for a complete 
list of the strains discussed in this chapter [Table 3.11].   
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Table 3.11: Strains recovered from the 11 subjects who provided multiple faecal samples 
Strain Resistance phenotype Phylo  group  Strain Resistance phenotype 
Phylo  
group  
1-R1 ApSmSuTcTp A1  5.1-R1 ApSmSu B2 
1.2-S1 Susceptible A1  5.2-S1 Susceptible D 
1.2-S2 Susceptible A1  5.2-R2 ApCmSmSuTcTp D 
1.2-S3 Susceptible A1  6.1-S1 Susceptible D 
1.2-S4 Susceptible D 6.2-S2 Susceptible D 
1.2-S5 Susceptible A1  6.2-R1 SuTp D 
1.2-R2 Tc A1  11.1-R1 ApTp B2 
1.2-R3 SuTcTp A1  11.2-R2 ApSmSpSuTcTp D 
1.3-S6  Susceptible A1  11.3-S1 Susceptible B1  
1.3-S7 Susceptible A1  11.3-R3 ApTc B2  
1.4-S8 Susceptible A0  11.4-R4 SuTp D 
1.4-R4 SuTcTp A1  14.1-R1 ApSmSpSuTcTp D  
1-S9 Susceptible B2 14.2-S1a Susceptible B2 
1.9-R6 ApCmSmSpSuTcTp B2 14.2-R2 Ap B2 
1.9-R7 ApTc A1  14.2-R3 Tc A1  
1.10-R8 SuTcTp B2  14.3-S2 Susceptible A0  
2-S1 Susceptible B2  14.3-R4 Tc A0  
2.1-R1 Ap B2  14.4-S3 Susceptible D  
2-S2 Susceptible B2  14.4-S4 Susceptible A1  
2.2-R2 Tc A1  14.5-S5 Susceptible B2  
2.3-R4 SuTcTp D 21.1-R1 ApSmSuTc A1 
2.3-R5b SmSuTcTp D 21.1-S1 Susceptible A0  
2.6-S3 Susceptible A0  21.1-S2 Susceptible A1  
3-S1 Susceptible B2 21.2-S3 Susceptible A1  
3-R1 ApTc D 21.3-S4 Susceptible D  
3-S1Rc Ap B2  21.4-S5 Susceptible B2 
3.3-S2 Susceptible B2 21.4-S6 Susceptible B2 
3.3-R2 Ap B2 21.4-S7 Susceptible A0  
3.5-S3 Susceptible A0  22-S1 Susceptible A1  
3.5-R3 SmSpTp A0  22.1-S2 Susceptible B2  
3.6-R5d ApCmGmSmSpSuTcTmTp A1  22.1-R1 ApCmSmSpSuTcTp B2 
4-R1 ApTc D  22.4-S3 Susceptible B2 
4-R2 ApSmSpSuTcTp D  23.1-S1 Susceptible B2  
4.2-S1 Susceptible A1  23.2-S3 Susceptible A1  
4.2-R3e Tc D  23-S2 Susceptible B2 
4.3-R2af Ap D     
4.4-R2bg ApSmSuTc D    
4.5-S2 Susceptible A0     
aSusceptible variant of persistent strain 14.2-R2   
bHas SmR SuR TpR variant named 2.3-R3    
cApR variant of 3-S1      
dHas ApR SmR SuR variant named 3.6-R4 
eTcR variant of 4-R1 
fApR variant of 4-R2 
gApR SmR SuR TcR variant of 4-R2 
 
  
 
 
 
 
 
 
 
 
 
CHAPTER FOUR 
 
Virulence factors in commensal E. coli  
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4.1 Introduction 
E. coli strains are often characterised for their VF and VAG content by PCR (91, 132, 191). 
However, due to the large number of VFs and VAGs and the multifactorial nature of 
virulence, determining which are most useful in the differentiating strain collections is 
difficult. Commensal studies often examine around 20 VFs (72, 91, 191, 204, 254) but their 
findings are not readily comparable because some analyse different sets of VFs. Moreover, 
VFs like type 1 fimbriae and the E. coli common pilus have been found in most E. coli (13, 
240) and are thus not very informative in studying the relationship between commensal 
strains and E. coli that cause infections. One approach (128) has used the presence of at least 
2 out of 5 VFs [iutA, papC, draA, sfaDE and kpsMT II] in a strain to describe it as having a 
higher virulence potential or operationally ExPEC (132, 190, 191, 254). This definition was 
developed to allow the rapid assessment of a strain’s virulence potential, where operationally 
ExPEC or ‘ExPEC’ strains were found to be more likely to cause extraintestinal infections.  
In Chapter 3, 73 strains were recovered from 11 subjects. From a concurrent study 
where 22 subjects each provided a single faecal sample for analysis (20), 19 additional strains  
were identified and these were incorporated into this study. Hence, 92 strains were examined 
in this chapter. The aim of this chapter was to characterise these 92 strains for the presence of 
19 VFs, and to investigate correlations between VF and ‘ExPEC’ distribution among the 5 
phylogenetic groups [A0, A1, B1, B2 and D] identified. The characteristics of these 19 
additional strains are listed in Table A1.12 of Appendix I.  
 
4.2 Screening procedure 
To determine the VF profiles, the 92 strains were screened by PCR using 19 previously 
published pairs of VF primers [Table 4.1]. Three multiplex PCRs from a published study 
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(203) have been designed to detect 11 genes [Table 4.1], and the primer pairs to detect 4 of 
the 5 genes that are used in the ‘ExPEC’ definition of strains [iutA, sfaDE, papC and draA] 
are contained within these 3 multiplexes. The fifth ‘ExPEC’ gene primer pair, group II 
capsule [kpsMT II], was detected using a simplex PCR reaction [Table 4.1]. 
 
Table 4.1: VF PCRs used in this study 
VF  VF PCRa PCR ‘ExPEC’ marker 
Reference 
  Simplex Multiplexb   
S fimbriae sfaDE - 1 + (203)c 
P fimbriae papC - 1 + `` 
Dr adhesin draA [afa] - 1 + `` 
Type 1 fimbriae fimA + 1 - `` 
Aerobactin iutA - 2 + (203)c 
K1 capsuled neuB - 2 - `` 
K5 capsuled kfiC - 2 - `` 
Hemolysin hlyA - 2 - `` 
P fimbriae adhesin papGI - 3 - (203)c 
 papGII - 3 - `` 
 papGIII - 3 - `` 
Group II capsule kpsMT II + NA + (125) 
Colibactin clbB + 4 - (133) 
Brain invasin ibeA + 4 - (125) 
E. coli common pilus ecpA + NA - (240) 
Yersiniabactin uptake fyuA + NA - (125) 
Salmochelin uptake iroN + NA - (124) 
Iron-responsive element ireA + NA - (250) 
FepG/D homolog fepCCFT073 + NA - (320) 
aPrimer sequences are listed in Table A2.8 in Appendix II 
bMultiplexes 4 was created through the course of this analysis 
cMultiplex reference. Reference for each primer is in Table A2.8 in Appendix II 
dGroup II capsule subtypes 
 
Other genes that were screened for by simplex PCR reactions included the clbB, ecpA 
and ibeA genes. The clbB gene is located within a genomic island that encodes the colibactin 
toxin, which has been demonstrated to induce DNA double-strand breaks in mammalian cells 
that can lead to cell death (201). The ibeA gene has been shown to be important in the 
invasion of brain microvascular endothelial cells (115), thus, is important in neonatal 
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meningitis. The E. coli common pilus [ecpA] has been claimed to be in all E. coli, and is a VF 
because it has been shown to be important in epithelial cellular adherence (240).  
As positive controls were not available at the beginning of this work, control strains 
were identified during the course of the analysis by sequencing the first amplicon of the 
expected size detected. The isolates that produced the correct amplicons were then used as the 
positive controls in all subsequent PCR assays. There were no controls for draA or papGI 
because they were not detected in any isolates [see Section 4.4]. 
To reduce the chances of a band not appearing due to amplification failure or other 
issues, 2 isolates of each strain were screened for their VF profiles. In instances where a faint 
amplicon was observed or in the case of persistent strains, where an expected band was not 
observed, the PCR was repeated as a simplex. This occurred infrequently except for the fimA 
PCR in multiplex 1 [see Section 4.3.1].  
 
4.2.1 Reproducibility 
In Chapter 3, the isolates of persistent strains from multiple samples were found to be 
indistinguishable from one another based on the E. coli phylogenetic group assignment, 
resistance gene analysis, the API20E assay and RAPD PCR. The uniformity of the VF 
profiles of persistent strain isolates from multiple time points was used as further 
confirmation that the isolates screened did represent a persistent strain [Figure 4.1]. This 
additionally served to confirm the reproducibility of the VF PCRs [Figure 4.1]. For example, 
the isolates of persistent strains 3-S1 and 3-R1 from the first and second samples collected 
from subject 3 displayed the same VF profile [Figure 4.1], confirming the validity of these 
results. 
The 3 multiplex PCRs used in the screening of all strains were reliable except for the 
fimA primers, which occasionally produced faint [Figure 4.2] or no bands, and this is 
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discussed further in Section 4.3.1. The simplex PCRs were also found to be reliable and due 
to this, attempts were made to incorporate some of the simplex PCRs into new multiplexes, in 
order to expedite the screening process. 
 
 
Figure 4.1: Reproducibility of the PCR assay. An image showing the VF profiles using multiplex 2 [M2] of 2 
isolates each of strains 3-S1 and 3-R1 from days 1 and 141. M represents the 100 bp ladder. Numbers 1 and 2 
represent the two isolates of each strain. The dot represents the primer dimer. The image is of a 1% agarose gel 
run at 150 V in TBE for 45 minutes.  
  
 
 
Figure 4.2: The 3 multiplex PCRs. An image showing the VF profile of two isolates of strain 1.10-R8 using 
multiplexes 1, 2 and 3 [M1, M2 and M3]. M represents the 100 bp ladder. Numbers 1 and 2 represent the two 
isolates of 1.10-R8. draA and papGI have no bands because there were no positive controls. The dot represents 
the primer dimer. The image is of a 1% agarose gel run at 150 V in TBE for 45 minutes. Strain 1.10-R8 carried 
the fimA, papC, papGII, iutA and group II capsule K5 genes. Strain is ‘ExPEC’. See Table 4.13 for full profile.  
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4.2.2 New multiplexes 
To speed up the screening process, attempts were made to incorporate the ecpA primers (240) 
into a multiplex with the primers of the ‘ExPEC’ marker, kpsMT II (125). NetPrimer [Premier 
Biosoft International] was used to analyse all primers for hairpin loops, dimer and cross-
dimer formation before a positive control was selected for thermocycling on a PCR gradient 
to detect any non-specific bands. The control strain, 1-R1, did not produce non-specific bands 
at annealing temperatures above 59°C [Figure 4.3].  
To establish if this multiplex was reliable, 14 strains known to contain ecpA and 
kpsMT II from simplex PCR analysis, were assayed using 60°C as the annealing temperature. 
Because ecpA was not found in 3 of these 14 strains and kpsMT II was not detected in 2 other 
strains, this multiplex was considered to be unreliable. Hence, the ecpA and kpsMT II PCRs 
remained as simplex reactions.  
 
Figure 4.3: PCR gradient of ecpA and kpsMT II multiplex. DNA from 1-R1 was used. Lanes 1 to 8 were 
cycled under the following annealing temperatures: 1. 50.0°C, 2. 51.0°C, 3. 53.9°C, 4. 55.5°C, 5. 59.1°C, 6. 
62.0°C, 7. 63.8°C, 8. 65.0°C. The dot represents primer dimer. The image is of a 1% agarose gel run at 150 V in 
TBE for 45 minutes. 
 
The primers for ibeA and clbB were combined into a multiplex with a 60°C annealing 
temperature, and 10 strains known to carry ibeA or clbB from simplex analysis were tested. 
The expected amplicons were observed in all strains. To evaluate the performance of this 
multiplex on isolates that could contain both genes, the DNA from 2.1-R1 [clbB+] and 2-S1 
CHAPTER 4    Virulence factors in commensal E. coli 109	  
[ibeA+] was combined and the multiplex repeated. Both expected amplicons were produced 
without non-specific bands. Hence, this attempt at multiplexing the clbB and ibeA primers 
was considered to be a success and this multiplex was used routinely on the remaining strains. 
 
4.3 Genes found in most E. coli 
Type 1 fimbriae (13) and the E. coli common pilus (240) have been reported to be very 
common in E. coli. Therefore, in addition to phylogenetic grouping, API20E, lactose 
fermentation and the presence of uidA [see Chapter 3], the fimA and ecpA genes can be used 
as E. coli specific markers. To examine how common these genes were, the 92 strains were 
screened for the fim and ecpA genes.  
 
4.3.1 Detection of genes for type 1 fimbriae 
Only 61 of the 92 strains examined [66%] using multiplex 1 produced an amplicon consistent 
with the expected size of the fimA product. This product was often faint [Figure 4.2 and 4.4] 
or absent. The low intensity of the product in multiplex 1 was reproducible because all 
isolates of 3-S1 and 3-S1R produced faint fimA amplicons [Figure 4.4]. This issue was also 
isolate specific because the fimA product was not detected among the 10 isolates from four 
time points of persistent strain 21.1-R1. Previous studies have found the fim genes in in more 
than 95% of isolates (91, 130, 190, 209, 323). Hence, the fimA PCR was repeated with the 
same primers but as a simplex reaction to determine if there was a problem with multiplex 1.  
The simplex reaction revealed that 26 of the 31 strains that were classified as fimA- 
using multiplex 1 produced the expected fimA amplicon. The occurrence of 26 false negatives 
in 92 strains is a 28% failure rate, confirming that there is a problem with usage of the fimA 
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primers in multiplex 1. Consequently the fimA PCR should be removed from the multiplex 
and performed as a simplex reaction in future analysis.  
 
Figure 4.4: fimA detection PCR in multiplex 1[M1]. An image showing the VF profiles of 2 isolates each of 
strains 3-S1 and 3-R1 from days 1 and 141. The image also shows the VF profiles of two isolates of strain 3-
S1R, a resistance variant of 3-S1 that appeared on day 141. M represents the 100 bp ladder. Numbers 1 and 2 
represent the two isolates of each strain. The dot represents the primer dimer. The image is of a 1% agarose gel 
run at 150 V in TBE for 45 minutes.  
 
Because it was possible that fimA was not detected in the 5 remaining strains [1.3-S7, 
1.9-R6, 1-R1, 1.4-S8 and 1.4-R4] due to primer mismatches, 2 isolates from each of these 5 
strains were examined using another published primer pair that targets the fimH gene (125), 
which also lies within the type 1 fimbriae operon. In 2 of these 5 strains, 1.3-S7 [A1] and 1.9-
R6 [B2], the fimH gene was detected. Hence, it is likely that the priming sites for the fimA 
primers are sufficiently different that PCR amplification failed or alternatively, fimA could be 
missing from the operon. In the 3 remaining strains [1-R1 [A1], 1.4-S8 [A0] and 1.4-R4 [A1]], 
neither fimA nor fimH were detected, and it is possible that the type 1 fimbriae operon is 
absent. Due to the usage of 2 different primer pairs that target different genes in the type 1 
fimbriae operon, fim is used to represent both fimA and fimH.  
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The 3 fim negative strains belonged to either group A0 or A1. One of the A1 strains, 1-
R1, was a persistent strain and isolates of this strain from the first sample were screened for 
further genes within the fim operon in Professor James R. Johnson’s laboratory [University of 
Minnesota] and none were detected confirming that the fim operon is absent [Johnson, 
unpublished observations]. Hence, the fim genes were detected in 97% of strains [Table 4.2]. 
The fim genes were detected more frequently than uidA [Table 4.2]. Hence, fim is a better E. 
coli detection marker than uidA so long as it is performed as a simplex reaction. 
 
Table 4.2: Prevalence of fim, ecpA and uidA genes 
Phylo 
groupa 
Total no. 
of strains 
Prevalenceb 
  fimc ecpA uidA 
     
     
A0d 12 11 [1] 
 
5   [7] 
 
8   [4] 
A1 25 23 [2] 
 
22 [3] 
 
24 [1] 
B1 5 5 
 
4   [1] 
 
4   [1] 
B2 27 27 
 
27 
 
27 
D 23 23 
 
23 
 
22 [1] 
     
Total 
Percentage 
92 89 
97 
81 
88 
85 
92 
aGroup assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
bNumbers in brackets represents strains where gene was not detected 
cCombination of fimA and fimH PCR screening data 
dThe fim, ecpA and uidA genes could not be detected in A0 strain 1.4-S8. 
 
4.3.2 Detection of ecpA  
The E. coli common pilus has been reported to be common in E. coli and mutant commensal 
isolates lacking the ecpA gene were shown to have a significant reduction in their capacity to 
adhere to cultured epithelial cells (240). Published primers that target the ecpA gene (240), 
located within the common pilus operon, were used to determine if this operon was present. 
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Because ecpA is reported to be carried by most E. coli (240), screening was repeated on the 
isolates that did not produce an amplicon, and the ecpA product was not observed in only 11 
strains. Hence, ecpA was detected in 88% of the strains [Table 4.2]. Only A0, A1 and B1 
strains did not produce an ecpA amplicon [Table 4.2]. The numbers in brackets in Table 4.2 
represent the number of strains in which fim, ecpA or uidA genes were not detected. 
 
4.3.3 Strain 1.4-S8 
The ecpA, fim and the uidA genes were detected in most E. coli [Table 4.2] but these 3 genes 
were not detected in the A0 strain 1.4-S8. The phylogenetic group, fim, ecpA and uidA PCRs 
did not produce a result, indicating that this strain might not be an E. coli but the API20E 
assay [Table 3.1 in Chapter 3] identified it as an E. coli. Hence, 1.4-S8 had the metabolic 
profile of an E. coli isolate but was lacking the genes that are commonly found in the species. 
This strain could be a member of one of the cryptic E. coli clades, which are isolates that are 
thought to be members of the Escherichia genus but are genetically divergent from E. coli yet 
retain E. coli metabolic properties (50). However, this was not investigated further.  
 
4.4 ‘ExPEC’ and other VFs 
The 92 strains were examined for the 5 ‘ExPEC’ markers [iutA, kpsMT II, papC, draA and 
sfaDE] and only isolates that contained at least 2 of these 5 genes were considered to be 
‘ExPEC’. The presence of other VFs, which are not universally present in E. coli, were also 
investigated. The complete VF profiles of all strains are listed at the end of this chapter. 
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4.4.1 Phylogenetic group association of ‘ExPEC’ VF 
The 5 ‘ExPEC’ markers were not found in 28 of the 92 strains, and most of these strains were 
from phylogenetic groups A0 and A1 [Table 4.3]. However, the draA gene was not detected in 
any of the strains [Table 4.3]. Forty-six strains [50%] carried the kpsMT II gene [Table 4.3], 
indicating that they are likely to have a capsule. The aerobactin uptake receptor [iutA] was 
found in 48% of strains [Table 4.3], making iutA and kpsMT II the most commonly detected 
VFs in this collection. The sfaDE genes were only detected in 5 strains making sfa amongst 
the least common VFs found in this collection [Table 4.3].  
 
Table 4.3: Prevalence of ‘ExPEC’ VF in commensal E. coli 
Phylo  
group 
#Strains Prevalence [%] 
 
  ‘ExPEC’ 
  iutA kpsMT II papC sfaDE draA None  
A0 
 
12 6  [50] 1  [8] 1   [8] 0 0 5   [42] 1   [8] 
A1 
 
25a 7  [28] 7  [28] 4   [16] 0 0 16 [64] 7   [28] 
B1 
 
5b 2  [40] 0 0 0 0 3   [60] 0 
B2 
 
27c 14 [52] 23 [85] 19 [70] 5  [19] 0 0 21 [78] 
D 23d 15 [65] 15 [65] 3   [13] 0 0 4   [17] 14 [61] 
         
Total 92 44 [48] 46 [50] 27 [29] 5  [5] 0 28 [30] 43 [47] 
a3.6-R5 [A1] is a resistance variant of 3.6-R4. Both counted as a single strain 
b19.1-R1a [B1] is a resistance variant of 19.1-R1. Both counted as a single strain 
c13.1-R2 [B2] is an ‘ExPEC’ resistance variant of 13.1-R3. Both counted as a single strain 
d2.3-R3 [D] is an ‘ExPEC’ resistance variant of 2.3-R5. Both counted as a single strain 
 
The B1 strains had the fewest VFs [Table 4.3], with iutA detected in only 2 strains 
[15.1-S1 and 19.1-R1]. Strain 19.1-R1 had a resistance variant [19.1-R1a] and the variant had 
an identical virulence profile to strain 19.1-R1. 
More VFs were detected in the A0 strains than the B1 strains [Table 4.3]. The iutA, 
kpsMT II or papC genes were found in the A0 strains, and the aerobactin receptor [50%] was 
the most common VF among these 12 strains [Table 4.3]. 
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Among the A1 strains, iutA and kpsMT II were the most common VFs because almost 
a third of the strains carried these genes [Table 4.3]. An equal proportion of strains had iutA 
or kpsMT II, and both of these genes were detected together in 5 of those 7 strains [Table 4.4]. 
Sixteen of the 25 A1 strains carried none of the 5 ‘ExPEC’ genes and this was almost the 
same proportion as B1 strains that did not contain a VF.   
All of the B2 strains had at least 1 of the 4 ‘ExPEC’ VFs [Table 4.3]. The group II 
capsule gene was the most common VF in this group [85% of B2 strains], and the B2 strains 
had the highest proportion of the kpsMT II gene in comparison to the other phylogenetic 
groups [Table 4.3]. The papC gene was in 70% of B2 strains, and this gene, like kpsMT II, 
was in more B2 strains than strains from the other phylogenetic groups [Table 4.3]. Three out 
of the four genes [iutA, kpsMT II and papC] were detected in at least 50% of the B2 strains 
[Table 4.3], and 7 of the 27 B2 strains carried these 3 genes together [Table 4.4].  
More D strains than strains from the other phylogenetic groups carried the iutA gene 
[Table 4.3]. The iutA and kpsMT II genes were both found in 15 of the 23 D strains but they 
were only found together in 11 of those strains [Table 4.4].  
The most common ‘ExPEC’ VF combination was iutA and kpsMT II, followed by the 
iutA, papC and kpsMT II combination, and the papC and kpsMT II combination [Table 4.4]. 
Because iutA, kpsMT II and papC were the most abundant genes in this collection [Table 4.3], 
at least 2 of these three genes were present in every ‘ExPEC’ combination. The presence of 
sfaDE did not make any difference in ‘ExPEC’ assignment because the strains that carried 
sfaDE also contained 2 of the other ‘ExPEC’ markers [Table 4.4]. The B2 group had the most 
‘ExPEC’ strains followed by D whereas A0 had the least with 1 out of 12 strains being 
‘ExPEC’ and B1 had none [Table 4.3 and Table 4.4]. A total of 36 of the 44 ‘ExPEC’ strains 
[82%] were from either groups B2 or D and this is consistent with previous reports that these 
2 groups have more VFs than strains from groups A or B1 (46).  
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Table 4.4: ‘ExPEC’ VF combinations and their abundance 
Phylo group ‘ExPEC’ VF combinations Abundance [%] 
A0    [1] iutA   papC 1 
A1    [7] iutA               kpsMT II 3 
 iutA   papC   kpsMT II  2 
          papC    kpsMT II 1 
 iutA  papC 1 
B1  [0] - - 
B2 [22] iutA               kpsMT II 3 
 iutA  papC    kpsMT II 7 
 iutA               kpsMT II   sfaDE 1 
 iutA  papC                      sfaDE 2 
         papC      kpsMT II  sfaDE 2 
         papC      kpsMT II 7 
D  [14] iutA                kpsMT II 11 
 iutA  papC 3 
All groups iutA, kpsMT II  17 
 iutA, kpsMT II, sfaDE 1 
 iutA, kpsMT II, papC  9 
 iutA, papC, sfaDE 2 
 iutA, papC 5 
 papC, kpsMT II, sfaDE 2 
 papC, kpsMT II 8 
 Total 44 
 
4.4.1.1 Capsule types 
More than half of the strains [27 out of 46 strains] that contained the group II capsule ATP-
binding cassette transporter gene [kpsMT II] also carried the capsule antigen specific genes, 
neuB [K1] or kfiC [K5] [Table 4.5]. Most were K1 because neuB was detected in 20 of the 46 
strains [Table 4.5], and K1 has been reported to be more common than K5 among commensal 
isolates (204, 206, 207). The neuB or kfiC genes were not detected in 10 of the 15 group D 
strains [Table 4.5]. Thus, these strains could not be allocated to types K1 or K5. There are 
many group II capsule antigen types and at least 8 have been well-characterised (307).  These 
non-K1 or K5 strains are likely to contain 1 of the other capsule antigen specific genes. Data 
on the abundance of other group II capsule types among commensal isolates could not be 
found. Hence, it is not known how common the other K antigenic types are. 
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Table 4.5: The prevalence of kpsMT II [K1 and K5] and papC [GI, GII and GIII] 
Phylo group Group II capsule [%]a  P fimbriae [%]b  
 kpsMT II K1 K5 Not K1 papC  papG  Not 
    or K5  I II III known 
A0 1  0 0 1  [100] 1  0 0 0 1  [100] 
A1 7  5   [71] 0 2  [29] 4 0  3   [75] 0 1  [25] 
B1 0 0 0 0 0 0 0 0 0 
B2 23  14 [61] 3  [13] 6  [26] 19 0 15  [79] 2 [11] 2  [11] 
D 15  1   [7] 4  [27] 10[67]  3 0 2    [67] 0 1  [33] 
          
Total 46  20 [43] 7  [15] 19[41] 27 0 20  [74] 2 [7] 5  [19] 
aPrevelance [%] of subtype as a proportion of strains with kpsMT II 
bPrevalence [%] of papG alleles as a proportion of strains with papC 
 
4.4.1.2 The papG alleles  
 The papG gene encodes the adhesin molecule responsible for the adhesion specificity of P 
fimbriae to epithelial cell receptors, and it has three variants which are alleles I, II and III 
(120). A papG allele was always detected in a strain carrying papC but 5 strains contained 
papC without one of the 3 papG alleles [Table 4.5]. The papGI allele was not detected but 
papGII was found in 20 of the 27 strains that carried papC [Table 4.5]. The papGIII allele 
was not common and was seen in only 2 B2 strains [Table 4.6].  
 
4.4.2 Association of clbB, hlyA, ibeA and sfaDE with B2 
Two further VFs were included in the analysis, and these were colibactin [clbB], a toxin that 
induces megalocytosis in mammalian cells (201), and the brain microvascular endothelial cell 
invasin ibe10 (115), also known as ibeA (72). The hemolysin [hlyA] primers were part of 
multiplex 2 [Table 4.1] and hemolysin is a toxin that causes red blood cell lysis (65). All 
strains were examined for the presence of these genes but they were only found in the B2 
strains [Table 4.6].  
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Table 4.6: Occurrence of clbB, hlyA, ibeA and sfaDE in B2 strains 
Strain Resistance phenotype Other VF ‘ExPEC’ VFa ‘ExPEC’ status 
3.3-S2 Susceptible - P - 
1.9-R6 ApCmSpSmSuTcTp - A, K + 
22.1-R1 ApCmSmSpSuTcTp - A, K [K1], P [GII] + 
1.10-R8 SuTcTp - A, K [K1], P [GII] + 
21.4-S5 Susceptible - A, K [K1], P [GII] + 
21.4-S6 Susceptible - A, K [K1], P [GII] + 
22.4-S3 Susceptible - A, K [K1], P [GII] + 
10.1-R1 ApSmSuTcTp - A, K [K5], P [GII] + 
11.3-R3 ApTc ibeA A, K [K1], P [GII]  + 
14.5-S5 Susceptible ibeA A, K [K1] + 
2-S1 Susceptible ibeA A, K [K5] + 
3.3-R2 Ap ibeA K [K1] - 
11.1-R1 ApTp ibeA A - 
5.1-R1 ApSmSu ibeA K - 
1-S9 Susceptible ibeA K - 
2-S2 Susceptible clbB K [K1], P [GII] + 
3-S1 Susceptible clbB K [K1], P [GII] + 
3-S1R Ap clbB K [K1], P [GII] + 
14.2-R2 Ap clbB K [K1], P [GII] + 
14.2-S1 Susceptible clbB K [K1], P [GII] + 
23-S2 Susceptible clbB K [K1], P [GII] + 
19.1-R2 ApSmSpSuTcTp clbB A, K [K5], S + 
16.1-S2 Susceptible clbB K, P [GII] + 
22.1-S2 Susceptible  hlyA K, P [GIII], S + 
13.1-R2b ApSuTc hlyA A, P [GII], S + 
23.1-S1 Susceptible hlyA, clbB A, P, S + 
2.1-R1 Ap hlyA, clbB K, P [GIII], S + 
aA refers to iutA, K for kpsMT II and [K1] and [K5], P for  papC, and alleles [GII] and [GIII], and S for sfaDE 
bStrain 13.1-R2a [B2] was an ‘ExPEC’ resistance variant of 13.1-R2. Both counted as a single strain 
 
The clbB and ibeA genes were more common than the ‘ExPEC’ VF, sfaDE, which 
was only found in 5 B2 strains [Table 4.6]. Eight of the 27 B2 strains did not carry 1 of the 4 
genes [Table 4.6]. Ten strains contained clbB [37%], 7 [26%] carried ibeA, 4 [15%] carried 
hlyA and 5 [19%] had sfaDE. The sfaDE, clbB and hlyA genes were detected together in 2 
strains but the 4 genes were not found together in any of the strains [Table 4.6]. The 2 strains 
that carried sfaDE, hlyA and clbB together however differed in their carriage of aerobactin 
and group II capsule [Table 4.6]. Of the 27 strains that carried at least of one these 4 genes, 22 
were designated as ‘ExPEC’ [Table 4.6]. 
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4.5 Siderophore receptors  
Four siderophore expression systems are found in E. coli, and these are aerobactin [iut], 
yersiniabactin [fyu], salmochelin [iro] and enterobactin [fep] (87). Each siderophore has an 
associated receptor that takes up the siderophore complexed to iron [II], thus providing the 
cell with iron. The fifth siderophore receptor is the iron-responsive element [ireA], and it has 
no known siderophore but the protein encoded by ireA was reported to contribute 
significantly to urovirulence in a mouse model (250). Though enterobactin is claimed to be 
very common in E. coli (87), PCRs to detect its uptake receptor, fepA, or any other genes 
within the enterobactin genetic cluster have not been performed in other studies. Hence, the 
presence of enterobactin was not investigated in this study. To examine the siderophore 
uptake receptor profiles of the 92 strains, published primers were used to detect genes 
encoding 4 different siderophore receptors, ireA, iroN, iutA and fyuA [Table 4.1].  
 
4.5.1 Receptor abundance according to phylogenetic group 
The prevalence data of the aerobactin receptor [iutA] is included in this section because it is a 
siderophore receptor. The fyuA receptor was the most abundant in this collection [Table 4.7], 
and it was detected in 53 of the 92 strains whereas iroN was found in the fewest strains [15 
strains] [Table 4.7]. The ireA gene was almost as uncommon as iroN, and it was found in 16 
strains. The siderophore receptor distribution was similar to the distribution of the other VFs 
because there were more receptors in phylogenetic groups B2 and D in contrast to A0, A1 and 
B1. Several of the group A0, A1 and B1 strains did not carry any of the 4 siderophore 
receptors [Table 4.7]. 
 
 
 
 
 
CHAPTER 4    Virulence factors in commensal E. coli 119	  
Table 4.7: Siderophore receptor profile of commensal E. coli 
Phylo group #Strains Siderophore receptors [%] None 
  fyuA ireA iroN iutA  
A0 12 5   [42] 1   [8] 1   [8] 6   [50] 5   [42] 
       
A1 25a 12 [48] 2   [8] 0 7   [28] 11 [44] 
       
B1 5b 0 1   [20] 0 2   [40] 3   [60] 
       
B2 27c 25 [93] 10 [37] 9   [33] 14 [52] 1   [4] 
       
D 23d 11 [48] 2   [9] 5   [22] 15 [65] 2   [9]  
       
Total 92 53 [58] 16 [17] 15 [16] 44 [48] 22 [24] 
a3.6-R5 [A1] is a resistance variant of 3.6-R4. Both counted as a single strain 
b19.1-R1a [B1] is a resistance variant of 19.1-R1. Both counted as a single strain 
c13.1-R2 [B2] is an ‘ExPEC’ resistance variant of 13.1-R3. Both counted as a single strain 
d2.3-R3 [D] is an ‘ExPEC’ resistance variant of 2.3-R5. Both counted as a single strain 
 
 The fyuA gene was almost equally common in groups A0, A1 and D, and it was 
observed in almost all of the group B2 strains but it was not detected in any of the B1 strains 
[Table 4.7]. In a study using the same primers, fyuA has been detected in 7 out of 33 B1 
strains but that study also found that 115 out of a 120 B2 strains contained fyuA (91).  
Only the ireA and iutA genes were found among the 5 B1 strains [Table 4.7]. The iroN 
gene was also not detected in A1 strains but it was found in a single A0 strain [Table 4.7]. Five 
out of 52 group A strains have been found to carry iroN but that study did not differentiate 
between A1 and A0 strains (91). The complete VF profiles of all strains are listed at the end of 
this chapter. 
 
4.5.2 Iron [II] uptake 
In order to determine if siderophores were functional, a previously described qualitative 
siderophore expression assay was conducted (261). In this assay, strains were grown 
overnight at 37°C on iron [II]-limited medium with a coloured indicator that was blue in the 
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presence of iron [II] and yellow when iron [II] was chelated or absent from the media [Figure 
4.5].  
 
 
Figure 4.5: Siderophore detection assay. Assay was conducted on persistent strain 3-S1. The yellow regions 
are iron [II]-depleted regions where iron [II] has been chelated by siderophores expressed by 3-S1 and 
subsequently taken up by the cells. The blue regions still contain iron [II].  
 
All of strains where at least 1 of the 4 siderophore receptors were detected [70 strains] 
grew on this medium. There was no noticeable difference between the number of siderophore 
receptors a strain carried to growth patterns on the iron [II]-limited medium. All A0, A1 and 
B1 strains where none of the 4 receptors was detected [19 in total, see Table 4.7] were unable 
to grow on the iron [II]-limited medium [see Figure 4.6 for examples]. Their inability to grow 
on this medium suggests that they lack any siderophore uptake receptors, including 
enterobactin but this was not examined further.  
The B2 strain, 3.3-S2, and the 2 group D strains, 1.2-S4 and 6.2-S2, that did not 
contain any of the 4 receptors were able to grow on this medium. Strains 1.2-S4 and 6.2-S2 
carried the ‘fepC’ gene [see Section 4.6.2] and the carriage of this gene or another iron uptake 
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system, like enterobactin, could have allowed these strains to grow on this medium but this 
was not investigated further. 
 
 
Figure 4.6: Siderophore detection assay conducted on several of strains. The black boxes highlight strains 
that failed to grow on the media. Strain in top left box is 1.2-S1. Strains in bottom right box are 1.2-S2, 1.2-S3, 
1.2-S5 and 1.2-R2, and the strain in the bottom left box is 1.4-R4. These 6 strains are from group A1. 
 
4.5.3 Putative iron uptake receptor ‘fepC’ from CFT073 
A previous study on the uropathogenic strain CFT073 claimed that there was a potential PAI 
involved in iron uptake, and one of the genes within the PAI, fepCCFT073, was a homolog of 
the fepC gene (95), which is found in the enterobactin gene cluster. The fepC gene encodes 
FepC, a ferric enterobactin transport ATP binding protein that drives the transport of the iron-
enterobactin complex from the periplasm into the cytoplasm by regulating FepD and FepG, 
the cytoplasmic transmembrane protein channels (236). However, a protein BLAST 
alignment between FepC from E. coli strain IHE3034 [GenBank Accession no. NC_017628], 
whose corresponding gene, fepC, is present in all available E. coli genomes, and FepCCFT073 
[Accession no. NC_004431] found no significant identity between the two proteins. 
Moreover, FepCCFT073 showed significant identity only to the FepD and FepG proteins 
encoded by the enterobactin gene cluster. FepCCFT073 shared 35% identity with FepD and 34% 
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identity to FepG. Both FepG and FepD are cytoplasmic transmembrane transporter proteins 
involved in the uptake of enterobactin complexed with iron [II] into the cell (236). Thus, the 
fepCCFT073 gene could encode a transmembrane iron transporter protein. The fepCCFT073 gene 
was renamed putative iron uptake transporter [piu] and its prevalence was examined [Table 
4.8] using the primers described in Table 4.1.  
 
Table 4.8: The prevalence of piu in commensal E. coli 
Phylo group Number of strains piu Nonea 
A0 12 0 5 
    
A1 25b 2   [8] 11 
    
B1 5c 0 3 
    
B2 27d 17 [63] 1 
    
D 23e 19 [83] 0 
    
Total 92 38 [41] 20 
aStrains do not carry fyuA, iutA, iroN, ireA and piu 
b3.6-R5 [A1] is a resistance variant of 3.6-R4. Both counted as a single strain 
c19.1-R1a [B1] is a resistance variant of 19.1-R1. Both counted as a single strain 
d13.1-R2 [B2] is an ‘ExPEC’ resistance variant of 13.1-R3. Both counted as a single strain 
e2.3-R3 [D] is an ‘ExPEC’ resistance variant of 2.3-R5. Both counted as a single strain 
 
 The piu gene was not detected in any A0 or B1 strains but was found in more than half 
of the B2 strains and more than three quarters of group D strains [Table 4.8]. Though this 
gene was more common than iroN and ireA [Table 4.7], its distribution was similar to that of 
iroN and ireA, because piu was more common in group B2 and D strains than A0, A1 or B1 
strains [Table 4.8]. Comparisons to other studies could not be made because prevalence data 
from diarrheagenic E. coli isolates only was found. 
 None of the 11 A1 or the single B2 [3.3-S2] strain that did not contain one of the 4 
other siderophore receptors carried piu, but it was detected in the 2 group D strains, 1.2-S4 
and 6.2-S2. The carriage of this gene could account for their growth on the iron [II]-limited 
medium.  
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4.6 Resistance variants  
Strains 3.6-R5, 19.1-R1, 13.1-R2 and 2.3-R5 each had a resistance variant and these variants 
carried the same VFs as the parent strain. However, the variants of strain 4-R2, 4.3-R2a and 
4.4-R2b, did not contain the kfiC [K5] gene unlike 4-R2 [Table 4.9]. Both variants could have 
lost the kfiC gene from the capsule operon or, they could have a different K antigen gene. 
Hence, these variants might be variants of each other that were detected in the third and fourth 
samples of subject 4 instead of being 4-R2 variants. 
 
Table 4.9: Strain 4-R2 and variants 
Strain Resistance phenotype VFs 
4.3-R2a Ap fimA, ecpA, piu, iutA, kpsMT II 
4.4-R2b ApSmSuTc fimA, ecpA, piu, iutA, kpsMT II 
4-R2 ApSmSpSuTcTp fimA, ecpA, piu, iutA, kpsMT II [K5] 
 
4.7 Discussion 
Ninety-two strains that were recovered from 21 individuals were examined for the presence of 
19 genes associated with virulence. A comparison of the VF distribution between commensal 
isolates from previous studies [Table 1.6, Chapter 1] with the strains analysed here revealed 
similar levels of VF abundance [Table 4.10]. Only papGII, neuB [K1], kfiC [K5] and iutA 
were found in slightly more strains whereas the prevalence of all other genes was within the 
ranges of VF distribution of the published studies [Table 4.10]. 
 Type 1 fimbriae genes are often found in more than 90% of isolates [8 out of 14 
studies, Table 4.10] but in 2 other studies that used the same VF multiplex PCRs that were 
used in this work (204, 205), the fimA gene was detected in 49% and 71% of isolates 
respectively. The lower prevalence of fimA in these 2 studies could be due to the failure of 
fimA amplification in the multiplex PCR that was identified in this work [see Section 4.3.1]. 
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Table 4.10: Comparison of VF distribution between strains from this work to other studies 
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NS 24 58 17 - - - 4 4 4 - 42 - 33 - - - 4 - (303) 
NS 41 73 - - 5 - 0 0 - - - - - - - - - - (231) 
106 61 98 18 - - - 11 7 26 - 21 - 30 - - - 5 - (209) 
13 63 81 28 0 18 6 19 0 - - 17 8 35 - 46 - 21 - (203, 206) 
65 67 97 33 - 16 13 7 4 9 58 27 - 40 28 61 - 21 - (130) 
42 67 96 15 - 10 0 9 0 6 24 - - 30 - 34 - 9 - (190) 
NS 69 - 30 - 17 - 16 - - 49 - - 20 26 56 7 16 32 (133) 
71 71 92 30 - 18 8 15 6 15 48 25 - 20 25 55 7 14 - (254) 
85 85 - - - - - 6 - - - - - 41 39 58 - 12 - (18) 
88 88 99 33 - - - 13 - - 70 - - 40 - - - 11 - (323) 
39 120 86 21 - 16 3 12 3 10 37 - - 42 - 45 - 8 - (191) 
22 146 49 10 0 8 0 0 1 - - 2 4 47 - - - 8 - (204) 
70 149 71 32 0 14 11 26 0 - - 27 7 29 - - - 23 - (205) 
168 168 - 11 - - - 4 1 3 - - - 16 - - - 7 - (72) 
NS 204 92 32 14 19 13 7 5 17 59 27 - 30 23 58 19 13 - (165) 
266 266 95 25 - - - 17 5 17 60 28 - 43 35 74 11 17 - (91) 
21 92 97 29 0 22 2 5 0 8 50 43 15 48 16 58 17 4 11 This study 
aNS is not stated 
bPercentage of isolates VF gene detected. The – represents not reported. Highest and lowest % in bold  
 
Five strains that carried papC did not contain one of the 3 papG alleles [Table 4.5], 
and this has been observed in other studies [Table 4.10]. These 5 strains could have an 
additional papG allele or this gene might be absent from the P fimbriae operon. If these 5 
strains do not contain a papG gene, they are unlikely to be able to adhere to epithelial cells 
using P fimbriae because papG is necessary for P fimbriae mediated epithelial cell attachment 
(13, 120). 
The clbB gene was found only in B2 strains [Table 4.6], supporting the findings of 
other studies where clbB was found exclusively amongst B2 E. coli (132, 133). Group B2 E. 
coli are claimed to be the basal taxa of E. coli, and that E. coli from groups D, B1 and A 
emerged from group B2 (46). Because colibactin is reported to be carried on a genomic island 
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(201), group B2 E. coli could have acquired this island after groups D, B1 and A had diverged 
from B2, thus limiting clbB distribution to only B2 isolates. 
PAIs have been shown to contribute to the virulence of strains, and the detection of 
specific VF combinations can indicate that a particular PAI might be present (97). For 
example UPEC strain 536 is reported to contain 6 PAIs (69, 97), and PAI II536 carries the 
hemolysin and P fimbriae genes [Table 4.11]. Both of these VFs are also found together on 2 
different PAIs from UPEC strain J96 [PAI IJ96 and PAI IIJ96] [Table 4.11]. Hence, the 
detection of hlyA and papC in the same strain could indicate that 1 of these 3 PAIs might be 
present. The VF combinations that were carried by 9 of the 27 B2 strains suggest that the 
PAIs from strains J96, CFT073 and 536 could be present in these 9 strains [Table 4.11]. In the 
5 strains carrying sfaDE, the iroN gene was also detected indicating that PAI III536 could be 
present [Table 4.11] but the iroN gene was detected in 10 additional strains without sfaDE 
[Table 4.12 and Table 4.13]. PAI III536 is known to be unstable (174) and S fimbriae could 
have been lost from PAI III536 in these 10 additional strains, or iroN could also be linked to 
other mobile elements. Incomplete fragments of PAI III536 and other PAIs from strain 536 
have been found to be widely distributed across the E. coli species (68) 
 
Table 4.11: PAIs that may be present in 9 of the B2 commensal strains 
Strains Phylo Gp VF / Siderophore Possible PAIsa Reference 
2.1-R1, 22.1-S2 
 
B2 hlyA, papC [GII] PAI II536 
PAI I and PAI IIJ96 (97) 
13.1-R3b,c, 23.1-S1d 
 
B2 hlyA, papC, iutA PAI ICFT073 (32) 
2.1-R1, 19.1-R3, 13.1-R3b, 
22.1-S2, 23.1-S1 B2 sfaDE, iroN PAI III536 (32) 
aPAIs that might be present in the commensal strains. Based on PAIs examined in strains 536, J96 and CFT073 
bStrain 13.1-R2 [B2] is an ‘ExPEC’ resistance variant of 13.1-R3. Both counted as a single strain 
aStrain 13.1-R3 has the papGII allele 
dStrain 23.1-S1 had no detectable papG allele 
  
 The genes encoding yersiniabactin are known to be on a PAI called the high-
pathogenicity island [HPI] (258) or PAI IV536 in UPEC strain 536 (97), and HPI carriage is 
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usually confirmed by the detection of a gene called irp2 (32, 258). Because irp2 was not 
examined, it is not known if the HPI is present in the 54 strains that contained fyuA. The ibeA 
gene is also reported to be on a PAI (32) but the ptnC gene, carried on the same PAI was not 
examined, thus it is not known if the ibeA PAI is present in the 7 B2 strains carrying ibeA. 
Noticeably, some strains like persistent strains 2-S2, 3-S1 and 3-S1R, 14.2-R2 and 23-
S2 displayed identical VF profiles [Table 4.12 and Table 4.13]. Hence, these strains could be 
closely related strains, i.e. they could be members of the same clone, and this is investigated 
further in Chapter 5. 
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Table 4.12: VF profiles of the A0, A1 and B1 strainsa 
Strain Resistance  phenotype 
Phylo  
groupb uidA fimA/H ecpA 
Siderophore  
receptors  ‘ExPEC’ markers 
Growth on 
iron [II]c 
21.1-S1 Susceptible  A0 + + - - - - 
4.5-S2 Susceptible A0 + + - - - - 
12.1-S1 Susceptible A0 - + - - - - 
2.6-S3 Susceptible A0 + + + - - - 
1.4-S8 Susceptible A0 - - - fyuA - + 
14.3-S2 Susceptible A0 + + + - kpsMT II - 
3.5-S3 Susceptible A0 + + - fyuA iutA + 
3.5-R3 SmSpTp A0 + + + fyuA iutA + 
12.1-S2 Susceptible A0 - + - - iutA + 
14.3-R4 Tc A0 + + + iroN iutA + 
15.1-S2 Susceptible A0 - + - fyuA, ireA iutA + 
21.4-S7 Susceptible A0 + + + fyuA iutA, papCd + 
         
1.2-S1 Susceptible A1 + + - - - - 
1.2-S2 Susceptible A1 + + - - - - 
1.2-S3 Susceptible A1 + + + - - - 
1.2-S5 Susceptible A1 + + + - - - 
1.2-R2 Tc A1 + + + - - - 
1.2-R3 SuTcTp A1 + + + - - - 
1.3-S6 Susceptible A1 + + - - - - 
1.3-S7 Susceptible A1 + + + - - - 
1.4-R4 SuTcTp A1 - - + - - - 
1.9-R7 ApTc A1 + + + - - - 
3.6-R5e ApCmGmSmSpSuTcTmTp A1 + + + - - - 
4.2-S1 Susceptible A1 + + + fyuA - + 
17.1-S1 Susceptible A1 + + + fyuA - + 
23.2-S3 Susceptible A1 + + + fyuA, ireA - + 
16.1-S1 Susceptible A1 + + + fyuA, piu - + 
14.4-S4 Susceptible A1 + + + piu, ireA - + 
21.1-R1 ApSmSuTc A1  + + + fyuA kpsMT II + 
2.2-R2 Tc A1 + + + fyuA papC, kpsMT II [K1] + 
14.2-R3 Tc A1 + + + - iutA + 
21.2-S3 Susceptible  A1 + + + fyuA iutA, papC [GII] + 
15.1-S3 Susceptible A1 + + + fyuA iutA, kpsMT II + 
1-R1 ApSmSuTcTp A1 + - + fyuA iutA, kpsMT II [K1] + 
15.1-R1 ApSmSuTp A1 + + + fyuA iutA, kpsMT II [K1] + 
22-S1 Susceptible A1  + + + fyuA iutA, papC [GII], kpsMT II [K1] + 
21.1-S2 Susceptible  A1  + + + fyuA iutA, papC [GII], kpsMT II [K1] + 
         
11.3-S1 Susceptible B1 + + + - - - 
8.1-S1 Susceptible B1 + + + - - - 
12.1-S3 Susceptible B1 - + - - - - 
15.1-S1 Susceptible B1 + + + - iutA + 
19.1-R1f SmSpTp B1 + + + ireA iutA + 
aPersistent strains are highlighted in red 
bGroup assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
cGrowth on iron [II]-limited medium 
dA papG allele was not detected 
eHas ApR SmR SuR variant, 3.6-R4. Variant had identical VF profile 
fHas TpR variant, 19.1-R1a. Variant had identical VF profile 
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Table 4.13: VF profiles of the B2 and D strainsa, b, c 
Strain Resistance phenotype Phylo groupd 
Siderophore 
receptors Other VFs ‘ExPEC’ markers 
3.3-S2 Susceptible B2 - - papCe 
11.1-R1 ApTp B2 fyuA ibeA iutA 
1-S9 Susceptible B2 fyuA ibeA kpsMT II 
5.1-R1 ApSmSu B2 fyuA, piu ibeA kpsMT II 
3.3-R2 Ap B2 fyuA, iroN ibeA kpsMT II [K1] 
1.9-R6 ApCmSpSmSuTcTp B2 fyuA - kpsMT II, iutA 
2-S1 Susceptible B2 fyuA, piu ibeA kpsMT II [K5], iutA 
2.1-R1 Ap B2 fyuA, iroN hlyA, clbB kpsMT II, sfa, papC [GIII]  
22.1-S2 Susceptible  B2 fyuA, piu, iroN hlyA kpsMT II, sfa, papCe  
19.1-R2 ApSmSpSuTcTp B2 fyuA, iroN clbB iutA, sfa, kpsMT II [K5] 
23.1-S1 Susceptible B2 - hlyA, clbB iutA, sfa, papCe 
13.1-R2f ApSuTc B2 fyuA, iroN hlyA iutA, sfa, papC [GII] 
14.5-S5 Susceptible B2 fyuA, piu, iroN ibeA iutA, kpsMT II [K1] 
16.1-S2 Susceptible B2 fyuA, piu, ireA clbB papC [GII], kpsMT II 
14.2-S1 Susceptible B2 fyuA, piu, ireA clbB papC [GII], kpsMT II [K1] 
2-S2 Susceptible B2 fyuA, piu, ireA clbB papC [GII], kpsMT II [K1] 
3-S1 Susceptible B2 fyuA, piu, ireA clbB papC [GII], kpsMT II [K1] 
3-S1R Ap B2 fyuA, piu, ireA clbB papC [GII], kpsMT II [K1] 
14.2-R2 Ap B2 fyuA, piu, ireA clbB papC [GII], kpsMT II [K1] 
23-S2 Susceptible B2 fyuA, piu, ireA clbB papC [GII], kpsMT II [K1] 
10.1-R1 ApSmSuTcTp B2 fyuA, piu, ireA - papC [GII], kpsMT II [K5], iutA 
11.3-R3 ApTc B2 fyuA, iroN ibeA papC [GII], kpsMT II [K1], iutA 
21.4-S5 Susceptible B2 fyuA, piu - papC [GII], kpsMT II [K1], iutA 
21.4-S6 Susceptible B2 fyuA, piu - papC [GII], kpsMT II [K1], iutA 
22.4-S3 Susceptible B2 fyuA, piu - papC [GII], kpsMT II [K1], iutA 
22.1-R1 ApCmSmSpSuTcTp B2 fyuA, piu, iroN, ireA - papC [GII], kpsMT II [K1], iutA 
1.10-R8 SuTcTp B2 fyuA, piu, iroN, ireA - papC [GII], kpsMT II [K1], iutA 
      
13.1-R1 Tc D fyuA - - 
1.2-S4 Susceptible D piu - - 
21.3-S4 Susceptible  D fyuA, piu - - 
6.1-S1 Susceptible D fyuA, piu - - 
11.4-R4 SuTp D piu, iroN - iutA 
5.2-S1 Susceptible D iroN - kpsMT II 
6.2-S2 Susceptible D piu - kpsMT II 
10.1-S1 Susceptible D fyuA, iroN - kpsMT II 
5.2-R2 ApCmSmSuTcTp D fyuA, piu - kpsMT II [K1] 
18.1-R1 ApTc D fyuA, piu - iutA, papCe 
9.1-R1 Su D fyuA, piu - iutA, papC [GII] 
2.3-R5g SmSuTcTp D fyuA, piu, iroN, ireA - iutA, papC [GII] 
14.4-S3 Susceptible D piu - iutA, kpsMT II 
2.3-R4 SuTcTp D iroN - iutA, kpsMT II 
4.2-R3 Tc D fyuA, piu - iutA, kpsMT II 
3-R1 ApTc D fyuA, piu - iutA, kpsMT II 
4-R1 ApTc D fyuA, piu - iutA, kpsMT II 
4.3-R2ah Ap D piu - iutA, kpsMT II 
4.4-R2bh ApSmSuTc D piu - iutA, kpsMT II 
4-R2 ApSmSpSuTcTp D piu - iutA, kpsMT II [K5] 
14.1-R1 ApSmSpSuTcTp D piu - iutA, kpsMT II [K5] 
11.2-R2 ApSmSpSuTcTp D piu - iutA, kpsMT II [K5] 
6.2-R1i SuTp D piu, ireA - iutA, kpsMT II [K5] 
aPersistent strains are highlighted in red 
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bAll strains carried ecpA and fimA/H 
cAll strains grew on the iron [II]-limited medium 
dGroup assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
eA papG allele was not detected 
fHas ApR SuR variant. 13.1-R2a 
gHas SmR SuR TpR variant, 2.3-R3 
hPossible resistance variants of each other and not 4-R2 
iuidA not detected 
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5.1 Introduction 
Commensal E. coli that have been found to persist in infants (204, 205, 208, 217) or young 
children (203, 206) have been examined for their carriage of VF. However, it is believed that 
the microbial consortia of children and infants are different from the microbial flora of adults 
(176). Hence, the properties of persistent commensal strains in adult humans could be 
different. Comparable studies on the characteristics of persistent E. coli in adult humans are 
not common. One study has examined the VF content of persistent strains recovered from 2 
adults (132) that were members of the same household but this study was biased towards the 
detection of the numerically dominant strains in the faeces. That study (132) analysed 5 
isolates from 6 faecal samples per person that were collected over a 3-year period, and some 
of resident strains were identified as members of clones that are usually associated with non-
intestinal infections (132).  
In this study, 11 adults were examined and 13 persistent [Figure 5.1] and 60 other E. 
coli strains were recovered from those adults [see Chapter 3]. These 73 strains and 19 
additional strains from Bailey et al. (20) [see Table A1.12 in Appendix I] were characterised 
by PCR for the presence of 19 VFs [see Chapter 4]. In this chapter, one of the aims was to 
establish if a correlation exists between the VFs examined and the 13 persistent strains. To 
accomplish this, the VF profiles of persistent and other strains were compared to determine if 
there was a difference in VF distribution. Another aim was to determine the STs of the 
persistent strains and a select group of other strains, and this was done by MLST (312). 
  
CHAPTER 5 Properties of persistent E. coli strains 132	  
 
 
 
 
Figure 5.1: Timeline for the detection of each of the 13 persistent strains. The figure shows a 5-year timeline 
for the detection of the 13 persistent strains from the 8 subjects that carried them. The subject numbers are 
shown on the left and the years shown above. The coloured lines above each horizontal arrow show the duration 
that each strain was detected. For strains 2-S1, 3-S1 and 3-S1R, the coloured dotted horizontal lines represent 
periods where these strains were not detected in the faecal samples. The thin dotted vertical lines delineate each 
year and the thick black horizontal arrow represents the sampling duration of each subject. The thick vertical 
green lines represent the samples that were examined in an earlier project (12) whereas the thick vertical black 
lines represent the samples that were collected in this work. The thin vertical lines in subject 1 represent the 
samples that were collected at 1-day intervals. The numbers under the thick and thin solid vertical lines represent 
the month the sample was collected. Subject 3 was overseas for over 1 year between samples 5 and 6, and 
subject 22 received tetracycline treatment for an undisclosed infection between samples 3 and 4.  
 
5.2 Defining strain groups 
The 92 strains that were analysed for their VF content in Chapter 4 were divided into 3 
groups. These were the ‘persistent strains’, ‘others’ and ‘single sample strains’. This was done 
to facilitate comparisons between the persistent group and the 2 remaining groups for 
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phylogenetic group distribution, VF abundance, strain ‘ExPEC’ status and total number of 
siderophore receptors detected.  
 
5.2.1 Persistent strains 
As discussed in Chapter 3, the persistent strains were subdivided into two groups [Table 5.1]. 
The first 9 strains were detected in most samples including the first and last faecal samples 
[Table 5.1]. Of these 9 strains, 3-S1R was the only strain that was not detected in the first 
sample. These 9 strains were considered to be long-term persistent strains because each was 
tracked for at least 6 months [Table 5.1]. The 4 remaining strains were considered to be short-
term persistent strains because they were detected in samples for less than 6 months.  
 
Table 5.1: Persistent strains 
Strain Days persisteda, b Phylo group 
1-R1 >1372 A1 
21.1-R1 >539 A1 
22-S1 >531 A1 
3-S1 >793 B2 
2-S1 >745 B2 
3-S1R >652 B2 
2-S2 >646 B2 
23-S2 >316 B2 
4-R2 >421 D 
14.2-R2 <295 B2 
1-S9 <248 B2 
3-R1 >141 D 
4-R1 >90 D 
a> denotes shortest duration of days strains could have persisted. Strains above line detected in the last sample  
b< denotes duration between first and last samples strains was detected in 
 
5.2.2 Others 
Due to the study design and the focus on finding persistent strains, the 79 remaining strains 
could not classified as ‘transient’ because they were isolated from the first or last faecal 
samples, or the interval between samples was sufficiently long that these strains could have 
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been short-term persistent strains. Of these 79 strains, 36 were not first or last sample strains, 
and these were considered to be ‘others’.  
 
Table 5.2: ‘Others’ E. coli strains 
Strain Phylo group Strain Phylo group 
    
1.4-S8 A0 14.4-S4 A1 
3.5-R3 A0 21.2-S3 A1 
3.5-S3 A0 23.2-S3 A1 
14.3-R4 A0 11.3-S1 B1 
14.3-S2 A0 1.9-R6 B2 
1.2-R2 A1 3.3-S2 B2 
1.2-S1 A1  3.3-R2 B2 
1.2-S2 A1  11.3-R3 B2 
1.2-S3 A1  14.2-S1 B2 
1.2-S5 A1  1.2-S4 D 
1.2-R3 A1  2.3-R4 D 
1.3-S6  A1 2.3-R5a D 
1.3-S7 A1 4.2-R3 D 
1.4-R4 A1 4.3-R2a D 
1.9-R7 A1 4.4-R2b D 
2.2-R2 A1 11.2-R2 D 
4.2-S1 A1 14.4-S3 D 
14.2-R3 A1 21.3-S4 D 
aStrain has a SmR SuR TpR resistance variant, 2.3-R4 
 
5.2.3 Single sample strains 
Forty-three of the 92 strains collected were from either first or last samples, or from hosts 
where only a single faecal sample was analysed (20) [see Chapter 4]. These 43 strains formed 
the single sample strain group [Table 5.3]. This group also contained a mixture of strains 
could have been short-term persistent strains or transient strains.  
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Table 5.3: Single sample E. coli strains 
Strain Phylo group Strain Phylo group Strain Phylo group 
2.6-S3 A0 1.10-R8 B2 5.2-S1 D 
4.5-S2 A0 2.1-R1 B2 5.2-R2 D 
12.1-S1 A0 5.1-R1 B2 6.1-S1 D 
12.1-S2 A0 10.1-R1 B2 6.2-S2 D 
15.1-S2 A0 11.1-R1 B2 6.2-R1 D 
21.1-S1 A0 13.1-R2c B2 9.1-R1 D 
21.4-S7 A0 14.5-S5 B2 10.1-S1 D 
3.6-R5a A1 16.1-S2 B2 11.4-R4 D 
15.1-S3 A1 19.1-R2 B2 13.1-R1 D 
15.1-R1 A1 21.4-S5 B2 14.1-R1 D 
16.1-S1 A1 21.4-S6 B2 18.1-R1 D 
17.1-S1 A1 22.1-S2 B2   
21.1-S2 A1 22.1-R1 B2   
8.1-S1 B1 22.4-S3 B2   
12.1-S3 B1 23.1-S1 B2   
15.1-S1 B1     
19.1-R1b B1     
aStrain has a ApR SmR SuR resistance variant, 3.6-R4 
bStrain has a TpR resistance variant, 19.1-R1a 
cStrain has a ApR SuR resistance variant, 13.1-R2a 
 
5.3 Comparisons between the strain groups 
The prevalence of each trait [phylogenetic group membership, VFs, strain ‘ExPEC’ status and 
total number of siderophore receptors detected] was calculated as a proportion of the total 
number of strains within each of the 3 groups. The relative abundances of each trait was then 
compared and contrasted between the 3 strain groups.  
 
5.3.1 Comparison of phylogenetic group profiles 
Only A1, B2 and D strains were consistently found in the 5 groups whereas A0 abd B1 strains 
were present only in 2 of the 3 groups [Table 5.4]. Most of the persistent strains were B2 
[Table 5.6], and this is similar to the findings made by Nowrouzian (206, 207). The majority 
of the ‘single sample’ strains were also from the B2 phylogroup [Table 5.4]. 
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Table 5.4: A comparison of strain phylogenetic group profiles  
Phylo 
Group 
Persistent Others Single sample 
A0 - 5 7 
A1 3 16 6 
B1 - 1 4 
B2 7 5 15 
D 3 9 11 
    
Total 13 36 43 
 
5.3.2 A comparison of ‘ExPEC’ status 
The operational definition of ‘ExPEC’ entailed the presence of at least 2 of 5 specific VFs 
[draA, kpsMT II, sfaDE, papC and iutA] in a strain (128, 249). Using this definition, more 
persistent strains were considered to be ‘ExPEC’ than any of the strains from the 2 remaining 
groups [Figure 5.2].  
 
Figure 5.2: The relative abundance of ‘ExPEC’ strains among the 3 groups. P represents the persistent 
strain group, O for others, and SS for single sample strains.  
 
Persistent strains were almost 3 times as likely to be ‘ExPEC’ than the ‘others’ [Figure 
5.2]. However, B2 strains usually contain more VF than strains from other phylogenetic 
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groups (72, 91, 189, 206, 227, 254, 323). Thus, the ‘others’ strains are biased because they 
contain more A1 strains [Table 5.4].  
 
5.3.3 Comparison of siderophore receptors 
All persistent strains carried at least one receptor whereas several of the ‘others’ and ‘single 
sample’ strains had none [Figure 5.3] but this analysis did not include enterobactin. None of 
the persistent strains carried more than 2 receptors but a few strains from the ‘others’ and 
‘single sample’ groups did [Figure 5.3].  
 
 
Figure 5.3: The total number of siderophore receptors detected in the 3 groups. The number of 
siderophores detected per strain is shown at the bottom and the colours representing each group are shown 
above.  
 
5.3.4 Comparison of VF profiles 
A comparison of all the VFs detected in this study revealed that the group II capsule [kpsMT 
II] and yersiniabactin receptor [fyuA] genes were more abundant in the persistent strain group 
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than the other groups [Figure 5.4]. All of the persistent strains carried kpsMT II but it was 
found in 33% of the ‘others’. Hence, capsule and yersiniabactin could be an important 
property of persistence. 
 
Figure 5.4: The relative abundance of VF in the 3 strain groups. The VFs are listed at the bottom and the 
colours that represent each group are shown above. 
 
The yersiniabactin receptor was carried by 12 of the 13 persistent strains and it is the 
second most common trait among the persistent strains [Figure 5.4]. Yersiniabactin was more 
than twice as likely to be seen in persistent strains than in ‘others’ strains.  
The aerobactin siderophore receptor [iutA] was found in similar proportions in the 3 
groups [Figure 5.4]. The ireA receptor was the least common siderophore receptor in this 
collection as only 17% of strains carried this gene [Chapter 4, Table 4.8]. However, it was 
mostly found among the persistent strains [Figure 5.4]. Among the strains that persisted, ireA 
was always detected alongside clbB, and hence, the strains containing both clbB and ireA 
could be members of the same clone. This is examined further in the next section.   
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5.4 Sequence types 
MLST analysis was another approach that was used to compare commensal strains to 
published data on the STs of E. coli that can cause infections outside the colon. Due to the 
significant cost associated with MLST, the Achtman MLST scheme (312) was used to 
determine the STs of all persistent strains and a random selection of 15  ‘others’ strains.  
The 7 genes utilised by this MLST scheme (312) are adenylate kinase [adk], fumarate 
hydratase [fumC], gyrase [gyrB], isocitrate dehydrogenase [icd], malate dehydrogenase [mdh], 
adenylosuccinate synthetase [purA] and recombinase A [recA]. The sequences of these genes 
were analysed using the online MLST database [http://mlst.ucc.ie/mlst/dbs/Ecoli/]. The 
complete VF and ST profile of all strains is listed in Table A1.13 in Appendix I. 
 
5.4.1 ST profiles of persistent strains 
Of the 13 persistent strains, 12 belonged to clones associated with non-intestinal infections 
whereas only one strain, 1-S9, was a novel ST [Table 5.5]. Five of the 7 B2 persistent strains 
were ST95 and this was the most common lineage within the persistent group [Table 5.5]. 
These 5 strains carried the same VFs, including clbB and ireA [see Section 5.4.3.2 for the 
CC95 VF profiles], thus explaining the prevalence of both these VFs among the persistent 
strains. In the second sample collected from subject 3, a persistent ApR variant of 3-S1, 3-S1R 
was detected, and it was also a ST95 member [Table 5.5]. Hence, this was further evidence 
that 3-S1 and 3-S1R are closely related strains.  
A further B2 strain was assigned to ST131, another well-known clone that causes 
extraintestinal infections [Table 5.5]. The remaining B2 strain, 1-S9, had a novel combination 
of alleles, and hence, it was assigned a new ST, ST3164. It was the only persistent strain that 
was not part of a clone associated with ExPEC infections.  
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Table 5.5: Sequence types of persistent strains 
Strain Days  
persisteda, b 
Phylo  
group 
   Locus    ST 
   adk icd purA recA fumC gyrB mdh  
1-R1 >1372 A1 10 8 8 2 11 4 8 10 
21.1-R1 >539 A1 10 8 8 2 11 4 8 10 
22-S1 >531 A1 10 8 8 2 11 4 8 10 
3-S1 >793 B2 37 37 11 26 38 19 17 95 
2-S1 >745 B2 53 13 28 29 40 47 36 131 
3-S1R >652 B2 37 37 11 26 38 19 17 95 
2-S2 >646 B2 37 37 11 26 38 19 17 95 
23-S2 >316 B2 37 37 11 26 38 19 17 95 
4-R2 >421 D 21 6 5 4 35 27 5 69 
14.2-R2 <295 B2 37 37 11 26 38 19 17 95 
1-S9 <248 B2 40 14 94 10 253 87 17 3164 
3-R1 >141 D 35 25 5 73 37 29 4 405 
4-R1 >90 D 35 25 5 73 37 29 4 405  
aStrains that persisted for less than 6 months appear beneath the line 
b> denotes the shortest duration of days the strains could have persisted for 
 
The 3 group A1 strains were ST10, consistent with previous findings that most A1 
strains are from CC10 (92, 312). Strains 21.1-R1 and 22-S1 were isolated from cohabitating 
individuals but these strains carried different VFs and had different antibiotic resistance 
profiles [Table A1.13 in Appendix I].  
Among the 3 group D strains, one was ST69 [4-R2] but the 2 other strains, 3-R1 and 
4-R1, were both ST405 [Table 5.7]. Both the ST405 strains produced indistinguishable 
RAPD, VF and antibiotic resistance profiles [see Chapters 3 and 4]. CC405 isolates have also 
been found in UTI (89, 90, 231) but they are not found as often as ST131, ST69 or ST95 [see 
Chapter 1]. 
 
5.4.2 ST profiles of ‘others’ strains 
Fifteen of the 36 ‘others’ strains were randomly selected and examined by MLST [Table 5.6], 
and 6 of the 15 strains examined were members of novel lineages. One of the 2 A0 strains, 
14.3-R4 contained a novel combination of alleles, and it was assigned the ST number 3182 
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[Table 5.6]. ST3182 was found to differ from ST10 by the icd, gyrB and the mdh alleles but it 
was not considered to be from CC10 as Wirth and colleagues have proposed that only SLVs 
and DLVs of an ST are members of the same clone (312). The second A0 strain was not novel 
but ST1136 is not known to be associated with extraintestinal infections.  
Five of the 6 A1 strains were CC10 members [Table 5.6]. Strain 1.3-S6 and 14.2-R3 
were ST48 [Table 5.6], an adk SLV of CC10. Strain 1.2-R2 carried a novel combination of 
the 7 alleles and was assigned a new ST number, 3179, and it was an icd and gyrB DLV of 
CC10 [Table 5.6]. A further group A1 strain, 4.2-S1 also contained a novel combination of the 
7 alleles and was assigned a new ST, ST3282 [Table 5.6]. However, the clonal complex that 
ST3282 belonged to could not be established. Hence, 5 of the 6 group A1 strains were 
members of CC10, supporting previous findings that most group A1 strains belong to CC10 
(92, 312). An examination of the 518 bp icd sequence used for ST assignment from 4.2-S1 
revealed 1 SNP. This SNP was still present when the PCR was repeated on the same isolate 
and the amplicon was sequenced using the opposite primer. Hence, the icd sequence of 4.2-S1 
had one mismatch to icd allele 30. Strain 1.2-S4 also contained a confirmed SNP but it was in 
the fumC allele. These new alleles were submitted to the MLST database for new allele 
assignment but none were provided.  
Four B2 strains were assayed [Table 5.6] and 2 belonged to known CCs, 131 and 538. 
Strain 11.3-R3 was ST131 [Table 5.6] but the VF profile of 11.3-R3 was different from 2-S1, 
the persistent ST131 strain. The VF profiles of these CC131 strains are examined further in 
Section 5.4.3.3. Strain 3.3-R2 was a new adk SLV of CC538, and hence, it was assigned a 
new ST number, 3500 [Table 5.6]. One study has found 3 CC538 isolates among 92 Spanish 
ESBL-producing ExPEC isolates (218) but 3.3-S2 was susceptible to cefotaxime and 
ceftazidime. 
 
 
CHAPTER 5 Properties of persistent E. coli strains 142	  
Table 5.6: STs of a randomly selected group of ‘others’ strains 
Strain Phylo 
group 
   Locus    ST CC 
  adk icd purA recA fumC gyrB mdh   
14.3-R4 A0 10 10 8 2 11 41 7 3182 - 
3.5-R3 A0 6 1 48 7 212 4 9 1136 - 
23.2-S3 A1 10 8 8 2 11 4 8 10 10 
2.2-R2 A1 10 8 8 2 11 4 8 10 10 
1.2-R2 A1 10 1 8 2 11 27 8 3179a 10 
1.3-S6  A1 6 8 8 2 11 4 8 48b 10 
14.2-R3 A1 6 8 8 2 11 4 8 48b 10 
4.2-S1 A1 6 30c 18 2 196 4 8 3282 - 
3.3-S2 B2 6 26 7 7 23 3 9 129 - 
3.3-R2 B2 40 13 28 30 40 19 36 3500d 538 
11.3-R3 B2 53 13 28 29 40 47 36 131 131 
1.9-R6 B2 14 200 7 10 14 47 17 3180 - 
1.2-S4 D  18 6 5 4 3e 17 5 1158 31 
2.3-R5f D 20 43 32 2 45 41 5 117 - 
21.3-S4 D 4 25 5 19 26 3 5 3183g 38 
aCC10 icd and gyrB DLV 
bCC10 adk SLV 
cSequence has one SNP. One mismatch to icd allele 30 
dCC538 adk SLV  
eSequence has one SNP. One mismatch to fumC allele 3 
fStrain has a SmR SuR TpR resistance variant, 2.3-R4 
gCC38 gyrB SLV 
 
Among the group D strains examined, strain 21.3-S4 contained novel combinations of 
alleles, and was assigned the ST number 3183 [Table 5.6]. However, 21.3-S4 was determined 
to be a gyrB SLV of CC38 [Table 5.6]. CC38 strains have been found in UTI and most CC38 
strains have several VFs (59, 90). However, 21.3-S4 carried only the fyuA gene [see Table 
A1.13 in Appendix I]. Strain 2.3-R5 was an ST117 isolate [Table 5.8], and ST117 is a known 
antibiotic resistant clone that causes avian infections (173). Among human infections, only 2 
ST117 isolates were detected among 300 UTI isolates (89), and thus, it is not likely to be a 
very common cause of extraintestinal disease in humans. Hence, persistent strains were more 
likely to be members of clones associated with human non-intestinal infections than the other 
strains examined.  
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5.4.3 PCRs for CCs 69, 95 and 131 
Due to the clinical significance of CC69, CC95 and CC131, published PCRs are available to 
detect these 3 clones (27, 49, 129). To establish how common these 3 CCs were in this 
collection, the 92 strains were screened with the CC131 (49), CC95 (27) and CC69 (129) 
PCRs. Strains that produced the expected products had the preliminary ST assignment 
confirmed by MLST.  
 
5.4.3.1 CC69 PCR screening 
CC69 is part of the E. coli phylogenetic group D (285). Hence, of the 92 strains, only the 23 
group D strains were screened using the CC69 PCR (129). Six of the 23 strains, including 
persistent strain 4-R2 produced the expected amplicon. Strains 4.3-R2a, 4.4-R2b, 11.2-R2, 
14.1-R1 and 5.2-S1 were typed with MLST and all were found to be CC69 members [Table 
5.7]. Strain 11.2-R2 shared the same antibiotic resistance phenotype and carried the same VFs 
[Table 5.8] as 4-R2 and 14.1-R1, but it was a novel gyrB SLV of ST69 [Table 5.7]. Strain 
5.2-S1 was ST69 but it differed from the 5 other strains because it was the only antibiotic 
susceptible strain, and it did not carry the kfiC [K5], iutA and piu genes but it did contain the 
iroN gene [Table 5.8].  
 
Table 5.7: CC69 strains that were detected amongst the 23 group D strains 
Strain Resistance 
phenotype 
   Locus    ST 
 adk icd purA recA fumC gyrB mdh  
11.2-R2 [Oa] ApSmSpSuTcTp 21 6 5 4 35 4 5 3181b 
14.1-R1 [SSc] ApSmSpSuTcTp 21 6 5 4 35 27 5 69 
4-R2 [Pd] ApSmSpSuTcTp 21 6 5 4 35 27 5 69 
4.3-R2a [Oa] Ap 21 6 5 4 35 27 5 69 
4.4-R2b [Oa] ApSmSuTc 21 6 5 4 35 27 5 69 
5.2-S1 [SSc] Susceptible 21 6 5 4 35 27 5 69 
aOthers strain 
bCC69 gyrB SLV  
cSingle sample strain 
dPersistent strain 
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The resistance variants, strains 4.3-R2a and 4.4-R2b were both ST69 [Table 5.7], 
providing further evidence that they are closely related to 4-R2. However, as discussed in 
Chapter 4, both variants did not carry the kfiC [K5] gene [Table 5.8].  
 
Table 5.8: VF profiles of the CC69 strains 
Strain Resistance 
phenotype 
VF profile ST 
   
11.2-R2 ApSmSpSuTcTp fimA, ecpA, piu, iutA, kpsMT II [K5] 3181 
14.1-R1 ApSmSpSuTcTp fimA, ecpA, piu, iutA, kpsMT II [K5] 69 
4-R2 ApSmSpSuTcTp fimA, ecpA, piu, iutA, kpsMT II [K5] 69 
4.3-R2a Ap fimA, ecpA, piu, iutA, kpsMT II  69 
4.4-R2b ApSmSuTc fimA, ecpA, piu, iutA, kpsMT II  69 
5.2-S1  Susceptible fimA, ecpA, kpsMT II, iroN  69 
 
A comparison of the RAPD profiles of these 6 CC69 strains using primer 1290 
revealed that strain 5.2-S1 had a different profile [Figure 5.5] but this could be due to 
variation in gel loading. Strains 4-R1 and 14.1-R1 were indistinguishable and 11.2-R2 
appeared to be very similar [Figure 5.5]. Strains 4.3-R2a and 4.4-R2b looked different to each 
other because 4.3-R2a produced a fewer brighter bands in contrast to 4.4-R2b.  
 
 
Figure 5.5: RAPD profiles of the CC69 strains. An image that shows the amplicons from the 6 CC69 strains 
that were amplified using RAPD primer 1290. The names of CC69 strains are shown above. The image is of a 
1% agarose gel run at 150 V in TBE for 45 minutes.  
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  Some group D strains, like 2.3-R5, which was shown to be a ST117 [Table 5.6], also 
produced an amplicon of the expected size [Figure 5.6]. However, the intensity of the product 
was weaker than the bands produced by the ST69 strains, like 4.4-R2b [Figure 5.6]. Non-D 
strains were also observed to produce the expected band however the intensity of the bands in 
these strains were much fainter than those produced by group D strains [Figure 5.6].  
The forward primer of the CC69 specific PCR relies on a terminal nucleotide [3`-
nucleotide] that anneals to a SNP in the fumC allele of CC69 isolates (129). Because this gene 
is a core gene within the E. coli species (312), 3`-end of the primer could undergo terminal 
degradation resulting in the amplification of the fumC gene carried by non-CC69 isolates. 
Non-specific amplification could also arise from a low annealing temperature. According to 
Johnson and co-workers (129), the annealing temperature of the reaction was 60°C, and the 
same annealing temperature was used here. To determine if the lack of fumCCC69 specificity 
was due to a low annealing temperature, the PCR was repeated at 63°C and only the 6 CC69 
strains produced bands. Hence, non-specific amplification produced the bands in the other 
group D strains. 
 
Figure 5.6: Amplicons from the rapid ST69 detection PCR. An image showing the amplicons from 8 strains 
screened using duplicate isolates for 6 strains. Strains were from phylogenetic groups A1, B2 and D. The strain 
names of the group D isolates are listed above. M represents the 100 bp ladder. The dot represents primer dimer. 
The arrow indicates the location of the expected band. The image is of a 1% agarose gel run at 150 V in TBE for 
45 minutes.  
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5.4.3.2 CC95 PCR screening 
A previous study (27) that used a subtractive DNA pathoarray on 23 ST95 strains and 16 
other strains found a unique open reading frame in ST95 isolates that was named the ‘specific 
for virulent subgroup’ [svg] gene. Primers have been designed to detect svg (27), and only the 
27 B2 strains in this work were screened for the presence of svg because ST95 isolates are 
members of the B2 phylogenetic group (27). Eight strains, including the 5 ST95 persistent 
strains, produced the expected band, and when the 3 additional strains were analysed further 
using MLST, all were CC95 [Table 5.9]. Hence, the PCR primers were found to be very 
reliable because non-specific products were not observed.  
 Of the 3 further CC95 strains detected, 2 were ST95 but 1 was a new gyrB SLV and it 
was assigned the ST number 3201 [Table 5.9]. Interestingly, strains 22.1-R1 and 1.10-S8 
were multiply antibiotic resistant, and CC95 is not usually associated with resistance to 
antibiotics (85).  
 
Table 5.9: CC95 strains detected amongst the 27 B2 strains 
Strain Resistance 
phenotype 
   Locus    ST 
 adk icd purA recA fumC gyrB mdh  
2-S2 [Pa] Susceptible 37 37 11 26 38 19 17 95 
3-S1 [Pa] Susceptible 37 37 11 26 38 19 17 95 
3-S1R [Pa] Ap 37 37 11 26 38 19 17 95 
14.2-R2 [Pa] Ap 37 37 11 26 38 19 17 95 
23-S2 [Pa] Susceptible 37 37 11 26 38 19 17 95 
14.2-S1 [Ob] Susceptible 37 37 11 26 38 19 17 95 
1.10-R8 [SSc] SuTcTp 37 37 11 26 38 19 17 95 
22.1-R1 [SSc] ApCmSpSuTcTp 37 37 11 26 38 4 17 3201d 
aPersistent strain 
bOthers strain 
cSingle sample strain 
dCC95 gyrB SLV 
 
The 5 persistent CC95 strains and 14.2-S1 carried the same VFs [Table 5.10]. Strain 
14.2-S1 is a susceptible variant of persistent strain 14.2-R2 but 14.2-S1 was not detected in 
multiple samples, hence, was not persistent. A similar occurrence was seen in subject 3 where 
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a ST95 strain, 3-S1 and its ApR variant, 3-S1R, were detected [Table 5.9]. However, both 
strains were observed to persist in subject 3. 
 
Table 5.10: VF profiles of the CC95 strains 
Strain Resistance 
phenotype 
VF profile ST 
   
2-S2  Susceptible fimA, ecpA, fyuA, piu, ireA, papC [GII], kpsMT II [K1], clbB  95 
3-S1  Susceptible fimA, ecpA, fyuA, piu, ireA, papC [GII], kpsMT II [K1], clbB  95 
3-S1R  Ap fimA, ecpA, fyuA, piu, ireA, papC [GII], kpsMT II [K1], clbB  95 
14.2-R2 Ap fimA, ecpA, fyuA, piu, ireA, papC [GII], kpsMT II [K1], clbB  95 
23-S2  Susceptible fimA, ecpA, fyuA, piu, ireA, papC [GII], kpsMT II [K1], clbB  95 
14.2-S1 Susceptible fimA, ecpA, fyuA, piu, ireA, papC [GII], kpsMT II [K1], clbB 95 
1.10-R8 SuTcTp fimA, ecpA, fyuA, piu, ireA, papC [GII], kpsMT II [K1], iroN, 
iutA 
95 
22.1-R1 ApCmSpSuTcTp fimA, ecpA, fyuA, piu, ireA, papC [GII], kpsMT II [K1], iroN, 
iutA 
3201 
 
Strains 22.1-R1 and 1.10-S8 carried the same VFs but unlike the 6 other CC95 strains, 
they did not carry the clbB gene but both contained the iutA and iroN siderophore receptor 
genes instead [Table 5.10]. The clbB, iroN and iutA genes are found on genomic islands (68, 
201, 260), hence, the variation in VF profiles between these CC95 isolates might be due to the 
gain or loss of these islands.  
The clbB gene was detected in 10 of the 27 B2 strains [see Table 4.6, Chapter 4] and 
of these, 6 were ST95 [Table 5.10]. The 4 remaining strains that carried clbB did not produce 
a svg amplicon. One of these 4 strains, 23.1-S1 had its ST determined to identify if it was a 
CC95 member that lacked svg, but it was found to be a ST73 [see Table A1.13 in Appendix 
I]. Hence, clbB was not uniquely associated with CC95, and thus, it could not be used as a 
good marker for CC95 detection.  
 
5.4.3.3 CC131 PCR screening  
Isolates from CC131 are known to be members of group B2 (246). Thus, only the 27 B2 
strains were screened for the presence of CC131 using the CC131 pabB allele-specific PCR 
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(246). The 27 B2 strains produced the expected product, including the CC95 strains. Ten A1 
and 10 D strains were screened to determine if the presence of the predicted product in all of 
the B2 strains was a result of non-specific pabB amplification. The expected product was also 
observed in the A1 and D strains [Figure 5.7].  
The pabB gene is a core E. coli gene because it is one of the 8 genes utilised by the 
Institute Pasteur MLST scheme (119), and both forward and reverse primers that target the 
CC131 pabB allele contain terminal nucleotides [3` nucleotide] that anneal to SNPs that are 
present only in the CC131 pabB allele (49). The degradation of the 3`-end of the primers or a 
low annealing temperature can result in non-CC131 specific pabB gene amplification. The 
PCR was initially done at the recommended annealing temperature of 60°C but after it was 
repeated at 67°C, pabB amplification still occurred in non-B2 isolates. Hence, usage of this 
PCR was discontinued due to its unreliability.  
   
 
Figure 5.7: The CC131 detection PCR. An image showing the amplicons of the duplicate isolates screening of 
9 strains from phylogenetic groups A1, B2 and D. Persistent strain 2-S1 [ST131] was used as a positive control. 
M represents the 100 bp ladder. The images if of a 1.0% agarose gel run in 0.5X TBE at 150 V for 45 minutes. 
 
CHAPTER 5 Properties of persistent E. coli strains 149	  
Besides persistent strain 2-S1, the other ST131 strain detected, 11.3-R3, was found 
due to it being randomly chosen for MLST analysis from the ‘others’ strain group [Table 5.6]. 
Both ST131 strains contained ibeA [Table 5.11] and this gene was only detected in 7 B2 
strains [see Table 4.6, Chapter 4]. However, persistent strain 1-S9 [ST3164, CC not known] 
and ‘others’ strain 3.3-R2 [CC538] also carried ibeA [see Table A1.13 in Appendix I]. Hence, 
ibeA could not be used to identify other putative CC131 members. None of the 92 strains 
were resistant to third generation cephalosporins, which is frequently associated with CC131 
members (246, 314). Hence, the resistance phenotype of the strains could also not be used to 
identify putative CC131 isolates.  
 
Table 5.11: VF profiles of the CC131 strains 
Strain Resistance 
phenotype 
VF profile ST 
   
2-S1  Susceptible fimA, ecpA, fyuA, ibeA, iutA, kpsMT II [K5], piu 131 
11.3-R3  ApTc fimA, ecpA, fyuA, ibeA, iutA, kpsMT II [K1], papC [GII], iroN 131 
 
5.5 Discussion 
Of the 13 persistent strains, 5 were ST95, 2 were ST405, 1 ST131 and 1 ST69 [Table 5.5], 
and isolates belonging to these STs are frequently recovered from extraintestinal infections 
[see Table 1.4, Chapter 1]. In contrast, of a random selection of 15 ‘others’ strains, only 3 of 
them, CC538, ST131 and ST117 [Table 5.5], were members of CCs found in ExPEC 
infections. Hence, persistent strains are much more likely to be the same clones as those 
usually found in non-intestinal human infections. This indicates that the persistent strains 
could cause infections, and they are more likely to do so than other commensal strains. Three 
of the 13 persistent, 5 of the ‘others’ were members of CC10 [Tables 5.5 and 5.6]. However, 
the persistent A1 strains carried more VFs than the ‘others’ A1 strains [Table 5.12], and this 
suggests that only the group A1 strains that carry VFs can persist in the human colon.  
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Table 5.12: VF profiles of the CC10 strains 
Strain Resistance 
phenotype 
fim ecpA VF profile ST 
Persistent      
21.1-R1 ApSmSuTc + + fyuA, kpsMT II  10 
1-R1 ApSmSuTcTp - + fyuA, iutA, kpsMT II [K1] 10 
22-S1 Susceptible + + fyuA, iutA, kpsMT II [K1], papC [GII] 10 
Others     
1.2-R2 Tc + +   10 
1.3-S6 Susceptible + -  48 
14.2-R2 SuTcTp + + iutA 48 
23.2-S3 Susceptible + + fyuA, ireA 10 
2.2-R2 Tc + +  fyuA, papC, kpsMT II [K1] 10 
 
All persistent strains contained the kpsMT II gene but this was in contrast to the 
‘others’ strains, only a quarter of which contained a capsule [Figure 5.4]. Similarly, the genes 
involved in the expression of yersiniabactin, P fimbriae and aerobactin were more abundant in 
the persistent strains than the ‘others’ strains [Figure 5.4]. This suggests that these VFs could 
play a role in persistence. Interestingly, Nowrouzian also found P fimbriae and aerobactin to 
be more common among the persistent strains from infants and children (203-205, 208), and 
proposed that these VFs could be important for persistence. Some VFs like hemolysin, ibeA 
and S fimbriae were rare throughout the collection indicating that these VFs may not have a 
role to play in intestinal colonisation. Hemolysin and ibeA could be required only for 
infections, thus making them ‘genuine’ VFs.  
Subject 3 spent 1 year travelling abroad and overseas travel did not displace strains 3-
S1 and 3-S1R [Figure 5.1]. Hence, persistent strains can persist despite extended overseas 
travel. In subject 22, persistent strain 22-S1 was susceptible to tetracycline but subject 22 
completed a course of tetracycline antibiotics, and antibiotic treatment did not displace 22-S1 
[Figure 5.1]. This finding is contradictory to the findings of a previous study (182), where the 
subject who provided faecal samples also consumed a course of antibiotics after the fourth 
sample and this resulted in the replacement of the 2 susceptible persistent strains by a 
persistent strain that was resistant to multiple antibiotics. In this study, strain 22-S1 could 
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have been able to persist despite the presence of antibiotics because there could be host-
specific properties that protect susceptible strains from being affected by antibiotic exposure. 
Alternatively, subject 22 could have been recolonised by 22-S1 from another reservoir 
containing isolates of 22-S1. Of the 8 CC95 strains, 4 were resistant to antibiotics and 2, 22.1-
R1 and 1.10-R8, were resistant to multiple antibiotics [Table 5.10]. This is the first report of 
CC95 isolates displaying a multiply antibiotic resistance phenotype. As CC95 is usually 
associated with neonatal meningitis (187, 188), the emergence of resistant CC95 strains could 
complicate the treatment of neonatal meningitis infections, which already result in significant 
morbidity and mortality (85). 
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Resistance genes and their contexts 
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6.1 Introduction 
Several resistance genes can encode resistance to the same antibiotic, like sul1, sul2 and sul3 
which confer sulphonamide resistance (226, 274). However, the sul3 gene (226) is rarely seen 
among SuR E. coli isolates (102). To account for SuR, sul1 and sul2 are routinely screened for 
because they are the common Su resistance determinants (102), and many strains can carry 
both genes (93, 102, 315). Thus, it is important to screen for both genes. 
Antibiotic susceptible bacteria usually acquire resistance determinants from resistant 
bacteria through the horizontal transfer of resistance genes associated with plasmids (224, 
281). MGEs such as transposons and insertion sequences can move resistance genes onto 
plasmids (281), thus ensuring the dissemination of resistance genes. Gene cassette are MGEs 
that often encode resistance genes and they are carried by class 1 and 2 integrons (101). Both 
classes of integrons can acquire, exchange and more importantly accumulate resistance 
cassettes, forming cassette arrays that confer a multiply antibiotic resistant phenotype (101).  
Resistance genes can also be found in several contexts. For example, the ampicillin 
resistance determinant, blaTEM, is found in transposons Tn1, Tn2, or Tn3, or on fragments of 
these transposons linked to IS26 (19). Another example is sul2 next to the CR2 mobile 
element (224) or linked to a fragment of transposon Tn5393 carrying the streptomycin 
resistance genes, strA and strB (319). This sul2-strAB resistance cluster can be found on its 
own on plasmids like RSF1010 (319) or linked to blaTEM and 3 IS26 elements, forming the 
composite transposon Tn6029 [see Figure 1.6 in Chapter 1] (39). Transposon Tn6029 and a 
variant, Tn6029B [Tn6029B has an 85 bp deletion relative to Tn6029] have been detected in 
Salmonella enterica (39) and Tn6029B has been detected in commensal E. coli (19). 
Identifying the context of resistance genes can provide insight into their mobilisation and how 
resistance in commensal E. coli might be related to resistance in clinical isolates, thus 
contributing to the broader understanding of the epidemiology of resistance genes.   
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In Chapter 3, 34 of the 73 strains recovered were resistant to one or more antibiotics. 
Eight of the 19 additional strains examined in Chapter 4 were resistant, making 42 strains 
resistant to at least one antibiotic. Isolates of 4 of these 42 strains were from the same sample, 
the same phylogenetic group, produced indistinguishable RAPD and API20E profiles but had 
a different resistance phenotype, making them possible resistance variants. These possible 
resistance variants were not considered in Chapters 3, 4 and 5 but are included here, making a 
total of 46 resistant strains. The resistance genes in 18 of these resistant strains had been 
previously reported (12, 20), and they formed Resistance Collection 1 [RC1] [Table 6.1].  
In this chapter, the resistance genes of the 28 remaining strains [Resistance Collection 
2 or RC2] were characterised using the methodology employed on RC1. The contexts of some 
of the resistance genes identified were also determined for strains from both RC1 and RC2. 
 
Table 6.1: Resistance Collection 1 gene profilesa 
Strain Resistance phenotype 
Phylo 
Gp sul strAB blaTEM tetA intI Gene cassettes  merA CC
b 
1-R1 ApSmSuTcTp A1 1, 2 + + A 1 dfrA7  21 10 
1.2-R2 Tc A1 - - - A - - - 10 
1.2-R3 SuTcTp A1 2 +c - A - dfrA14d  - 10 
1.4-R4 SuTcTp A1 1 - - A 1 dfrA7  21 - 
19.1-R1ae Tp B1 - - - - 2 dfrA1-sat2- aadA1f  - - 
19.1-R1e SmSpTp B1 - - - - 2 dfrA1-sat2- aadA1 - - 
2.1-R1 Ap B2 - - + - - - - - 
5.1-R1 ApSmSu B2 2 + + - - - - - 
11.1-R1 ApTp B2 - - + - - - - - 
13.1-R2g ApSu B2 2 - + - - - - - 
13.1-R2ag ApSuTc B2 2 - + B - - - - 
19.1-R3 ApSmSpSuTcTp B2 1, 2 + + B 1 dfrA1-aadA1 21 - 
3-R1 ApTch D - - + B - - - 405 
4-R1 ApTch D - - + B - - - 405 
4-R2 ApSmSpSuTcTp D 1, 2 + + A - dfrA17-aadA5 - 69 
9.1-R1 Su D 2 - - - - - - - 
13.1-R1 Tc D - - - B - - - - 
18.1-R1 ApTc D - - + B - - - - 
aPersistent strains are highlighted in pink colour 
bSee Chapter 5 for ST numbers 
cstrA interrupted by dfrA14 
ddfrA14 not in class 1 integron 
eResistance variants. Strains have indistinguishable RAPD and API20E profiles 
fIS3411-like insertion interrupts aadA1 (20) 
gResistance variants. Strains have indistinguishable RAPD and API20E profiles 
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6.2 Resistance in collection 2 
All strains were screened for the genes listed in Table 6.2. Controls were available for all 
genes except tetA[E]. Strains were tested in duplicate, where possible, to reduce the chances 
of a band not appearing due to amplification failure or other experimental issues. The DNA 
from the susceptible strains [36 strains] was pooled into groups of 5 and screened for the 
presence of the resistance genes and none were detected. The mercuric ion resistance gene, 
merA, is discussed in Section 6.2.1.4 and class 1 and 2 integrons are discussed in Section 
6.2.2. Resistance to Tp is conferred by many different genes carried in class 1 integrons (274). 
Thus, Tp resistance genes were not screened for directly. Resistance to Sp was also not 
accounted for directly, and Sp and Tp resistance genes are discussed in Section 6.2.2.4 
 
Table 6.2: PCRs used to detect resistance genes and integrons 
Gene Confers resistance to Primersa Product size [bp] 
blaTEM Ampicillin [Ap] RH605/RH606 860 
blaSHV `` RH1005/RH1006 861 
catA1 Chloramphenicol [Cm] RH513/RH514 595 
catA2 `` Cat2b-F/Cat2b-R 573 
cmlA1 `` RH330/RH331 115 
sul1 Sulfamethoxazole [Su] HS549/HS550 1103 
sul2 `` Sul2-F/Sul2-R 405 
sul3 `` Sul3-F/Sul3-R 790 
strA Streptomycin [Sm] StrA-F/StrA-R 548 
strB Streptomycin [Sp] StrB-F/StrB-R 509 
tetA[A]b Tetracycline [Tc] TetA-F/TetA-R 210 
tetA[G]b `` TetG-F/TetG-R 468 
tetA[E]b `` TetE-F/TetE-R 278 
tetA[B]c `` TetB-F/TetB-R 659 
tetA[C]c `` TetC-F/TetC-R 418 
tetA[D]c `` TetD-F/TetD-R 787 
aacC2 and aacC3 
aacC4 
Gentamicin [Gm] and 
Tobramycin [Tm] 
aac2-F/aac2-R 
RH554/RH555 
680 
605 
merA Mercuric ions RH671/RH672 variabled 
intI1 Class 1 integron HS463a/HS464 473 
intI2 Class 2 integron HS501/HS502  788 
Gene cassettes Class 1 integron L1/R1 variable 
Gene cassettes Class 2 integron Hep74/Hep51 variable 
aSee Table A2.2 in Appendix II for primer sequences 
b and c Primers used in a multiplex 
dmerA from Tn21 is 1201 bp, merA from Tn1696 is 1189 bp 
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6.2.1 Resistance gene profiles 
The 28 RC2 strains and the resistance genes they carry are listed in Table 6.3. Persistent 
strains are highlighted in pink.  
 
Table 6.3: Resistance genes in Resistance Collection 2a 
Strain Resistance phenotype Phylo Gp sul strAB blaTEM tetA Others  merA CC
b 
3.5-R3 SmSpTp A0 - - - - - - 1136c 
14.3-R4 Tc A0 - - - A - - 3182c 
1.9-R7 ApTc A1 - - + A - - - 
2.2-R2 Tc A1 - - - A - - 10 
3.6-R4d ApSmSu A1 2 + + - - - - 
3.6-R5d ApCmGmSmSpSuTcTpTm A1 1, 2 + + A aacC2/3, catA1 - - 
14.2-R3 SuTcTp A1 2 - - A - - 10 
15.1-R1 ApSmSuTp A1 1, 2 + + - - - - 
21.1-R1 ApSmSuTc A1 2 + + A - 21 10 
1.9-R6 ApCmSmSpSuTcTp B2 1, 2 + + A - - 3180c 
1.10-R8 SuTcTp B2 1 - - B - 21 95 
3-S1R Ap B2 - - + - - - 95 
3.3-R2 Ap B2 - - + - - - 538 
10.1-R1 ApSmSuTcTp B2 2 + + B - - - 
11.3-R3 ApTc B2 - - + A - - 131 
14.2-R2 Ap B2 - - + - - - 95 
22.1-R1 ApCmSmSpSuTcTp B2 3 - + B cmlA1 21 95 
2.3-R4 SuTcTp D 1 - - C - - - 
2.3-R3e SmSuTp D 1, 2 + - - - - - 
2.3-R5e SmSuTcTp D 1, 2 + - B - - 117 
4.2-R3f Tc D - - - B - - - 
4.3-R2ag Ap D - - + - - - 69 
4.4-R2bg ApSmSuTc D 2 + + A - - 69 
5.2-R2 ApCmSmSuTcTp D 2 + + D catA1 - - 
6.2-R1 SuTp D 2 +h - - - - - 
11.2-R2 ApSmSpSuTcTp D 1, 2 + + A - - 69 
11.4-R4 SuTp D 1 - - - - - - 
14.1-R1 ApSmSpSuTcTp D 1, 2 + + A - - 69 
aPersistent strains are highlighted in pink colour 
bSee Chapter 5 for ST numbers 
cST number. CC assignment not available 
d and e Strains have identical RAPD and API20E profiles 
fResistance variant of persistent strain 4-R1. Strains have indistinguishable RAPD and API20E profiles 
gPossible variants of 4-R2. Strains have indistinguishable RAPD and API20E profiles 
hstrA interrupted by dfrA14 
  
The strains were screened for the presence of the tetA[A, B, C, D, G and E] genes and only 
the 18 TcR strains produced amplicons of an expected size. Only 1 strain had tetA[C] and 1 
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had tetA[D] [Table 6.3]. The tetA[A] gene was the most common [11 strains], followed by 
tetA[B] [5 strains] [Table 6.3]. This was in contrast to RC1 where almost an equal proportion 
of strains had tetA[B] [6 strains] and tetA[A] [5 strains] but neither tetA[C] or [D] were 
detected [Table 6.1]. The tetA[E] and [G] genes were not detected in either collection, and no 
strain carried more than one tet gene. Thus, Tc resistance was accounted for in all TcR strains 
from RC1 and RC2.  
In the third sample from subject 2 [see Chapter 3], strain 2.3-R5 [SmR SuR TcR TpR] 
made up 89% of the isolates analysed, and it carried a tetA[B] gene. The single isolate of a 
resistance variant, 2.3-R3 [SmR SuR TpR] did not have a tet resistance determinant, explaining 
the difference in phenotype. It is not known how the tetA[B] gene was lost from 2.3-R3. 
Amplicons corresponding to the blaTEM control band were seen only in the 17 ApR 
strains in RC2. No strain contained blaSHV. The 11 ApR strains from RC1 also all carried the 
blaTEM gene [Table 6.1], and the ApR phenotype was accounted for in all strains. The blaTEM 
linkage analysis is described in Section 6.3. 
Three sul genes were detected, and they were only found in the 18 SuR strains. The 
sul2 gene was the most common [14] followed by the sul1 gene [10] [Table 6.3]. The sul1 
and sul2 genes were found together in 7 of the 18 strains. In RC1, 8 strains carried sul2 
whereas only 4 carried sul1 [4], and they were together in 3 strains [Table 6.1]. Resistance to 
Su was accounted for in all strains, and 10 of the 25 SuR strains from RC1 and RC2 had sul1 
and sul2 together. The sul3 gene was detected in only 1 RC2 strain [22.1-R1] but was not 
found amongst the strains in RC1. The context of this sul3 gene is examined further in 
Section 6.2. 
Resistance to the aminoglycoside Sm is associated with the strA and strB genes and 13 
of the 14 SmR strains from RC2 had these genes [Table 6.3]. Surprisingly, the Sm susceptible 
strain 6.2-R1 [SuR TpR] produced strA and strB amplicons but the strA amplicon was 
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approximately 600 bp larger than the strA control amplicon [548 bp] [Figure 6.1]. This had 
previously been observed in another SmS strain, 1.2-R2 [SuR TcR TpR] from RC1. The strA 
amplicons from 1 isolate of each strain were sequenced. This revealed that a 568 bp dfrA14 
gene cassette had interrupted the strA gene, accounting for the Tp resistance in these strains 
[Tables 6.1 and 6.3]. In both strains, the dfrA14 gene was inserted in precisely the same spot. 
Though the strB gene was intact, the interruption of strA resulted in a susceptibility to Sm. 
The context of this dfrA14 gene cassette in a secondary site is discussed further in Chapter 7. 
One SmR strain did not have strA or strB amplicons but it was also SpR, and this is discussed 
in Section 6.2.2.4  
 
 
Figure 6.1: The strA PCR amplicons. An image showing [a] a map of the strA PCR and [b] the strA amplicons 
from strains 1.2-R2 and 6.2-R1 alongside the amplicon from a strA control strain. In [a], the horizontal arrow 
represents the orientation and extent of strA, and the PCR primers and amplicon is shown above by the thick 
bounded line. In [b], M represents the 100 bp ladder and the positions of the 500 bp, 1 and 1.2 kb bands are 
indicated on the left. Strain names are listed above. The image is of a 1.0% agarose gel run at 150 V in TBE for 
45 minutes.  
 
6.2.1.1 Linkage of sul2 to strAB 
The sul2 gene is often found linked to strAB, and this resistance cluster is known to be 
broadly disseminated (319). To determine if sul2 was linked to strAB, the 18 RC1 and RC2 
strains carrying sul2 and strAB were examined using linkage PCRs [Figure 6.2]  
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Figure 6.2: Schematic of sul2 linked to the strA and strB genes. The horizontal arrows show the orientation 
and extent of the genes. The PCR primers and their amplicons are shown above by the thick bounded line. 
Primers and amplicon sizes are in Table A2.3 in Appendix II. 
 
The strA to strB PCR confirmed that strAB was linked in 16 of the 18 strains carrying 
those genes, and, the sul2 gene was linked to strB in 14 of them [Table 6.4]. Hence, the sul2-
strAB cluster represented the most frequent means of distribution for the sul2 and strAB 
genes. The sul2 gene was also linked to the strB gene in the 2 strains [1.2-R3 and 6.2-R1] 
with a dfrA14 gene cassette in the strA gene, thus creating a different resistance cluster [see 
Chapter 7].  
 
Table 6.4: The incidence of sul2 linked to strAB 
Strain Resistance phenotype Phylo Gp sul2 strAB sul2-strAB 
1-R1 ApSmSuTcTp A1 + + + 
1.2-R3 SuTcTp A1 + +b + 
3.6-R4a ApSmSu A1 + + + 
3.6-R5a ApSmSpSuTcTpCmGmTm A1 + + + 
15.1-R1 ApSmSuTp A1 + - - 
21.1-R1 ApSmSuTc A1 + + + 
1.9-R6 ApCmSmSpSuTcTp B2 + + + 
5.1-R1 ApSmSu B2 + -c -c 
10.1-R1 ApSmSuTcTp B2 + + + 
19.1-R3 ApSmSpSuTcTp B2 + + + 
2.3-R3d SmSuTp D + + - 
2.3-R5d SmSuTcTp D + + - 
4-R2 ApSmSpSuTcTp D + + + 
4.4-R2be ApSmSuTc D + + + 
5.2-R2 ApCmSmSuTcTp D + + + 
6.2-R1 SuTp D + +b + 
11.2-R2 ApSmSpSuTcTp D + + + 
14.1-R1 ApSmSpSuTcTp D + + + 
a Resistance variants. Strains have identical RAPD and API20E profiles 
bstrA interrupted by dfrA14 
cTn2 found in between strA and strB [Pinyon and Hall, unpublished observations] 
dResistance variants. Strains have identical RAPD and API20E profiles 
ePossible variant of 4-R2. Strains have identical RAPD and API20E profiles 
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6.2.1.2 Chloramphenicol resistance 
None of the RC1 strains were resistant to Cm. However, 3 RC2 strains exhibited high levels 
of Cm resistance and grew on media supplemented with 25 µg/ml of Cm. Using the CDS disc 
diffusion assay, these 3 CmR strains produced a 0 mm zone of inhibition in the presence of a 
30 µg Cm disc. They were screened for 3 CmR genes, catA1, catA2 and cmlA1, and 3.6-R5 
and 5.2-R2 contained the catA1 gene [Table 6.3] whereas a cmlA1 cassette was detected in 
strain 22.1-R1. A further RC2 strain, 1.9-R6, displayed a low level of Cm resistance and 
produced an inhibition zone with an annular radius of 3.5 mm whereas Cm susceptible strains 
produced a inhibition zones with a 9 mm radius with a 30 µg Cm disc. Strain 1.9-R6 grew 
only on media supplemented with 15 µg/ml of Cm. None of the 3 CmR genes assayed for 
were detected in 1.9-R6 and this was not investigated further. Therefore, Cm resistance was 
accounted for in 3 of 4 CmR strains.  
 
6.2.1.3 Gentamicin and tobramycin resistance 
Strain 3.6-R5 was the only strain resistant to Gm and Tm. It was susceptible to the 
aminoglycosides kanamycin, amikacin and neomycin but exhibited low level netilmicin 
resistance because it produced a zone of inhibition with a 5 mm radius in the presence of a 30 
µg disc of netilmicin whereas susceptible strains produced zones that were between 8 to 9 
mm. The carriage of the aacC2 or aacC3 genes are known to be associated with resistance to 
Gm and Tm, and to low levels of netilmicin resistance (271). Strain 3.6-R5 produced an 
amplicon of the expected size for the PCR detecting both aacC2 and aacC3, which are 97% 
identical, but sequencing was not done to determine which of these 2 genes strain 3.6-R5 
carried. Hence, resistance to Gm and Tm in 3.6-R5 was attributed to either aacC2 or aacC3.  
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6.2.1.4 Mercuric ion resistance 
Mercuric-ion resistance regions carried by transposons are frequently associated with class 1 
integrons (220). The merA PCR [Table 6.2] was used to determine if a mercuric-ion resistance 
operon was present. The merA amplicon was digested using RsaI alongside the merA 
amplicons from Tn21, Tn1696, Tn501 and pDU1358 to identify the type of mer module 
carried. 
The merA gene of Tn21 was detected in 3 resistant strains from RC2. Two of these 
strains [1.10-R8 and 22.1-R1] also contained a class 1 integron [see Section 6.2]. Therefore, it 
is possible that the class 1 integrons in these strains were carried by a Tn21-like transposon 
[see Figure 1.9 in Chapter 1]. Notably, strains 1.10-R8 and 22.1-R1 were both resistant to 
multiple antibiotics and belonged to CC95 [see Table 5.11 in Chapter 5 for ST profiles]. An 
amplicon was also observed in susceptible strain 21.1-S1, and the merA from 21.1-S1 
belonged to Tn1696 [Table 6.5]. 
 
Table 6.5: Strains carrying the merA gene and its typea 
Strain Phylo Gp Resistance phenotype intI1 merA 
21.1-S1 A0 Susceptible - 1696 
21.1-R1 A1 ApSmSuTc - 21 
1.10-R8b B2 SuTcTp + 21 
22.1-R1b B2 ApCmSmSpSuTcTp + 21 
aAntibiotic susceptible strain highlighted in green 
bStrains is a CC95 member 
 
6.2.2 Class 1 and class 2 integrons  
To determine if integrons belonging to classes 1 and 2 were present, PCRs to detect the 
integrase genes of 1 [intI1] and 2 [intI2] were performed. Their gene cassettes were detected 
by performing class 1 and 2 gene cassette specific PCRs [Table 6.2, and Figure 6.3 and 6.4]. 
The sul1 gene which is usually found in a class 1 integron (224), was also considered. Where 
gene cassette PCRs produced amplicons, the identity of the cassette[s] was established by 
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sequencing the L1-R1 amplicon [class 1 integron] of 1 isolate per strain. Sequencing was also 
used to establish the class 2 integron cassette identities.   
 
6.2.2.1 Class 2 integrons 
Two strains [3.5-R3 and 10.1-R1] from RC2 had an intI2 gene [Table 6.6]. The cassette 
amplicon from 10.1-R1 was approximately 1.3 kb in size and this corresponded to the size of 
the dfrA1-sat2 cassette array [Table 6.6]. The amplicon produced by 3.5-R3 was 
approximately 2.2 kb, similar to the cassettes in Tn7 [Table 6.6], which is a 14 kb transposon 
that contains 5 transposition genes that are involved in its mobilisation, and a class 2 integron 
[Figure 6.3] with the dfrA1, sat2 and aadA1 cassettes (57, 100). 
 
 
Figure 6.3: Map of class 2 integron in Tn7. The horizontal arrows show the orientation and extent of the 
genes. The PCR primers are shown above and the gene names below. The thick red line represents the 5`-CS and 
the thick orange line for the 3`-CS. The variable region carries the gene cassettes. The solid boxes indicate the 
locations of gene cassettes. The thick coloured vertical lines represent the attC sites of each cassette. Primer 
sequences are listed in Table A2.2 in Appendix II.  
 
Table 6.6: Sizes of common class 2 integron gene cassette arrays 
Cassette array Hep74-Hep51 size [bp] GenBank accession No. 
dfrA1-sat2-aadA1a 2194 JQ805124 
dfrA1-sat2 1297 FJ785527 
sat2-aadA1 1626 X15995 
estX-sat2-aadA1 2469 AB161461 
aTn7 class 2 integron cassette array 
 
Partial sequencing of the cassette amplicons from 10.1-R1 revealed the presence of 2 
cassettes. The 885 bp sequence showed 100% identity to the two cassettes of GenBank 
accession number FJ785527. From the 1.3 kb amplicon size [Figure 6.4] and the sequencing 
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result, 10.1-R1 was considered to carry the dfrA1-sat2 cassette array [Table 6.7]. In 3.5-R3, 
the cassette array was completely sequenced and the 2095 bp sequenced showed 100% 
identity to the 3 cassettes of GenBank accession number JQ805124, and hence were identified 
as dfrA1-sat2-aadA1 [Table 6.7], as found in Tn7 [Figure 6.3b] (237). The presence of dfrA1 
[TpR] and aadA1 [SmR and SpR] accounted for the resistance phenotype of strain 3.5-R3. 
 
6.2.2.2 Class 1 integrons 
A class 1 integron usually contains a 5`-CS [intI1], a variable region and a 3`-CS [sul1] 
[Figure 6.4] but a complete 5`-CS and 3`-CS are not always both present (221, 224).  
 
 
Figure 6.4: Map of class 1 integron. The horizontal arrows show the orientation and extent of the genes. The 
PCR primers are shown above and the gene names below. The thick red line represents the 5`-CS and the thick 
orange line for the 3`-CS. The variable region carries the gene cassettes. The open boxes indicate the locations of 
gene cassettes. The thick coloured vertical lines represent the attC sites of each cassette. Primer sequences are 
listed in Table A2.2 in Appendix II.  
 
Of all resistant strains in RC2, only 8 strains carried intI1 but only 6 of these strains also 
carried sul1 [Table 6.7]. Hence, an intact 5`-CS and 3`-CS [sul1] was found in only 6 strains 
that contained a class 1 integron. The sul1 gene, as discussed earlier, was detected in 10 
strains but in 4 of these strains, an intI1 amplicon was not observed [Table 6.7]. Strain 4-R2 
from RC1 also had a class 1 integron without an intI1 amplicon. Thus, neither sul1 nor intI1 
could be used alone to reliably detect class 1 integrons. A sul3 gene was detected in 22.1-R1, 
and the association of sul3 instead of sul1 with intI1 has been previously demonstrated (283). 
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This is discussed further in Section 6.2.2.3. Hence, class 1 integrons were more common than 
class 2 integrons in both RC1 and RC2. 
 
Table 6.7: Strains carrying class 1 and 2 integrons from RC2 
Strain Resistance phenotype Phylo Gp intI Gene cassettes  sul1 sul3 
Class 2 integron      
3.5-R3 SmSpTp A0 2 dfrA1-sat2-aadA1 - - 
10.1-R1 ApSmSuTcTp B2 2 dfrA1-sat2 - - 
       
Class 1 integron [5`-CS+]      
3.6-R5 ApSmSuSpTcTpCmGmTm A1 1 dfrA17-aadA5 + - 
15.1-R1 ApSmSuTp A1 1 dfrA5 + - 
1.10-R8 SuTcTp B2 1 dfrA5 + - 
2.3-R3a SmSuTp D 1 dfrA5 +  - 
2.3-R5a SmSuTcTp D 1 dfrA5 + - 
11.4-R4 SuTp D 1 dfrA5 + - 
       
Class 1 integron [5`-CS-]      
1.9-R6 ApCmSmSpSuTcTp B2 - dfrA17-aadA5 +  - 
2.3-R4 SuTcTp D - dfrA5 + - 
11.2-R2b ApSmSpSuTcTp D - dfrA17-aadA5  + - 
14.1-R1b ApSmSpSuTcTp D - dfrA17-aadA5 + - 
       
Class 1 integron [3`-CS-]      
22.1-R1 ApCmSmSpSuTcTp B2 1 dfrA12/aadA/cmlA1  - + 
5.2-R2 ApCmSmSuTcTp D 1 dfrA1-sat2 - - 
aResistance variants. Strains have identical RAPD and API20E profiles 
bStrains belong to CC69 
 
Only strains that contained either intI1 or sul1 produced L1-R1 amplicons but 22.1-R1 
did not [Table 6.7]. In the 6 strains that carried both intI1 and sul1, complete sequencing of 
the cassette amplicons from an isolate of each strain identified their gene cassettes [Table 
6.7]. Five strains, 15.1-R1, 1.10-R8, 2.3-R3, 2.3-R5 and 11.4-R4, each carried the dfrA5 [TpR] 
cassette, but the sixth strain, 3.6-R5, had 2 gene cassettes, which was dfrA17 [TpR] and aadA5 
[SpR and SmR].  
Cassette amplification products were detected in the 4 strains that carried sul1 but not 
intI1. Despite the absence of intI1, successful gene cassette detection using primers L1 and 
R1 indicated that a portion of the 5`-CS, which includes the annealing site of primer L1, was 
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still present in these strains. Strain 2.3-R4 had sul1 and the dfrA5 cassette but did not have an 
intI1 gene. The absence of intI1 was not investigated further. The 3 remaining strains 
produced a 1.6 kb cassette amplicon indistinguishable from that of persistent CC69 strain, 4-
R2 [RC1] [Figure 6.5]. Two of these strains, 11.2-R2 and 14.1-R1, also belonged to CC69 
whereas the third, 1.9-R6, was a B2 strain. Complete sequencing of the L1-R1 PCR products 
from an isolate of each strain revealed that they contained the dfrA17-aadA5 gene cassette 
pair [Table 6.7], like 4-R2 [Table 6.1].  
 
 
Figure 6.5: CC69 gene cassette amplicons. Gel image of the amplicons produced by an L1-R1 PCR on strains 
with a class 1 integron. An image showing the gene cassette content of strains 1.9-R6, 14.1-R1, 11.2-R2, 4-R2, 
two isolates of 11.4-R4 and 1-R1. Strains 4-R2, 11.2-R2 and 14.1-R1 belong to CC69. The identities of the 
cassettes are listed on the side. M represents the 100 bp ladder. The dot represents the primer dimer. The image 
is of a 1.0% agarose gel run at 150 V in TBE for 45 minutes.  
 
In strain 5.2-R2, sul1 was not detected and SuR was accounted for by the presence of 
sul2 [Table 6.3]. However, the dfrA1 and sat2 gene cassettes were detected in 5.2-R2 [Table 
6.7]. Hence, 5.2-R2 retained a fragment of the 3`-CS large enough for the annealing of R1. 
 
6.2.2.3 Class 1 integron with sul3 
The 3`-CS, which includes sul1, was absent from 22.1-R1 because the cassette amplification 
failed to produce an amplicon. The sul3 gene has been previously shown to be present in a 
region downstream of the cassettes that is structurally different from the 3`-CS [sul1] (283) 
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[Figure 6.6]. In one study (283), isolates carrying a class 1 integron with a 3`-CS [sul3] were 
found to have the dfrA12 [TpR], cmlA1 [CmR], aadA1 and aadA2 [SmR and SpR] gene 
cassettes [Figure 6.6]. Strain 22.1-R1 could include this arrangement because it was resistant 
to Cm and a cmlA1 gene cassette accounted for this [see Section 6.2.1.2]. Furthermore, strain 
22.1-R1 was also resistant to Sp and Tp. A PCR for the dfrA12 gene cassette and one that 
detects both aadA1 and aadA2 were performed. Amplicons of the expected size were 
produced, confirming that these cassettes were present [Table 6.7]. A PCR from intI1 to 
aadA2 [L1 to RH531] produced an amplicon of the predicted size, 1.7 kb, confirming that the 
first 3 cassettes were in in the order shown in Figure 6.6. The identity of the aadA cassettes 
present and the precise configuration of the remaining cassettes was not investigated. 
 
 
Figure 6.6: Class 1 integron with 3`-CS [sul3]. A map of a class 1 integron with a 3`-CS [sul3] from plasmid 
pEC355. The horizontal arrows show the orientation and extent of the genes. The PCR primers are shown above 
and the thick black bounded line indicate the linkage amplicon. The gene names are below, the thick red line 
represents the 5`-CS and the thick orange line for the 3`-CS [sul3]. The open boxes indicate the locations of gene 
cassettes. The green box represents the dfrA12 gene cassette, the red box represents aadA2, the blue box for 
cmlA1 and the orange box for aadA1. Figure is not to scale and adapted from Sunde et al. (283). Sequence 
available under GenBank Accession Number FM244708. Primer details are listed in Table A2.4 in Appendix II. 
 
6.2.2.4 An overview of trimethoprim and spectinomycin resistance 
Six RC2 strains were resistant to the aminoglycosides Sp and Sp, and an aadA gene cassette 
conferring these resistances was detected in these strains [Table 6.7]. The aadA5 cassette was 
the most common [4 of 6 strains] [Table 6.7] but aadA1 was more common in RC1 [3 of 4 
strains] [Table 6.1]. Four RC2 and 2 RC1 strains carried an aadA cassette and strAB [SmR], 
highlighting the importance of screening strains for more than just gene cassettes.   
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Of the 15 Tp resistant RC2 strains, 14 carried a dfr gene cassette [Table 6.7], 
accounting for the TpR phenotype. In 6.2-R1, TpR was due to a dfrA14 gene cassette in a 
secondary site, as discussed above. Resistance to Tp in strains 14.2-R3 [RC2] and 11.1-R1 
[RC1] remains unaccounted for. All RC2 data is is summarized below [Table 6.8]. 
 
Table 6.8: Resistance genes in Resistance Collection 2a 
Strain Resistance phenotype Phylo Gp sul strAB blaTEM tetA intI Gene cassettes Other CCb 
3.5-R3 SmSpTp A0 - - - - 2 dfrA1-sat2-aadA1 - 1136c 
14.3-R4 Tc A0 - - - A - - - 3182c 
1.9-R7 ApTc A1 - - + A - - - - 
2.2-R2 Tc A1 - - - A - - - 10 
3.6-R4d ApSmSu A1 2 + + - - - - - 
3.6-R5d ApCmGmSmSpSuTcTpTm A1 1, 2 + + A 1 dfrA17-aadA5 catA1, aacC2/3 - 
14.2-R3 SuTcTpe A1 2 - - A - - - 10 
15.1-R1 ApSmSuTp A1 1, 2 + + - 1 dfrA5  - - 
21.1-R1 ApSmSuTc A1 2 + + A - - merA21 10 
1.9-R6 ApCmfSmSpSuTcTp B2 1, 2 + + A - dfrA17-aadA5 - 3180c 
1.10-R8 SuTcTp B2 1 - - B 1 dfrA5 merA21 95 
3-S1R Ap B2 - - + - - - - 95 
3.3-R2 Ap B2 - - + - - - - 538 
10.1-R1 ApSmSuTcTp B2 2 + + B 2 dfrA1-sat2 - - 
11.3-R3 ApTc B2 - - + A - - - 131 
14.2-R2 Ap B2 - - + - - - - 95 
22.1-R1 ApCmSmSpSuTcTp B2 3 - + B 1 dfrA12-orfF-aadA;cmlA1g merA21 95 
2.3-R4 SuTcTp D 1 - - C - dfrA5 - - 
2.3-R3h SmSuTp D 1, 2 + - - 1 dfrA5 - - 
2.3-R5h SmSuTcTp D 1, 2 + - B 1 dfrA5 - 117 
4.2-R3i Tc D - - - B - - - - 
4.3-R2aj Ap D - - + - - - - 69 
4.4-R2bj ApSmSuTc D 2 + + A - - - 69 
5.2-R2 ApCmSmSuTcTp D 2 + + D 1 dfrA1-sat2 catA1 - 
6.2-R1 SuTp D 2 +k - - - dfrA14l - - 
11.2-R2 ApSmSpSuTcTp D 1, 2 + + A - dfrA17-aadA5  - 69 
11.4-R4 SuTp D 1 - - - 1 dfrA5 - - 
14.1-R1 ApSmSpSuTcTp D 1, 2 + + A - dfrA17-aadA5 - 69 
aPersistent strains are highlighted in pink colour 
bSee Chapter 5 for ST numbers 
cST number. CC assignment not available 
dResistance variants. Strains have identical RAPD and API20E profiles 
eTp resistance unaccounted for  
fCm resistance unaccounted for 
gLinkage of gene cassettes not determined 
hResistance variants. Strains have identical RAPD and API20E profiles 
iResistance variant of persistent strain 4-R1. Strains have indistinguishable RAPD and API20E profiles 
jPossible variants of 4-R2. Strains have indistinguishable RAPD and API20E profiles 
kstrA interrupted by dfrA14 
ldfrA14 not in class 1 integron 
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6.3 Context of blaTEM 
The blaTEM gene is found in the closely-related transponsons Tn1, Tn2 or Tn3 (223). 
Fragments carrying the blaTEM gene and the IR bounding the end of the transposon can be 
found linked to IS26. Because this fragment is of variable size and can be derived from Tn1, 
Tn2 or Tn3, the portion of the blaTEM segment linked to IS26 was called TnA. The carriage of 
blaTEM by either Tn1, Tn2 or Tn3 for the ApR strains in this collection was examined 
previously (19). Linkage to IS26 was examined as part of this work. Potentially, IS26 can be 
found linked to TnA, in 2 configurations upstream of blaTEM [Figure 6.7a and b] and 2 
configurations downstream of blaTEM [Figure 6.7c and d]. PCRs that could detect blaTEM 
linked to IS26, shown in Figure 6.7, were performed on the 28 RC1 and RC2 strains carrying 
blaTEM. The amplicons were sequenced to determine the length of TnA present from the IR of 
blaTEM to the boundary of IS26 [Figure 6.7a and b], thus establishing the location of the IS26-
TnA junction. 
 
 
Figure 6.7: Linkage of IS26 to blaTEM. Schematics of IS26 linked to blaTEM in the upstream configuration 
shown in [a] and [b], and linked to blaTEM in the downstream configuration shown in [c] and [d]. IS26 is shown 
in 2 orientations relative to the blaTEM gene and on both sides of the gene. The horizontal arrows show the 
orientation and extent of the genes [blaTEM and the IS26 transposase genes]. The thick horizontal line represents 
TnA [the region derived from Tn1, Tn2 or Tn3], with a vertical line representing the inverted repeat [IR] and 
slashes indicating segments of variable lengths. The IS26 element is shown as a box. The PCR primers used to 
distinguish the orientations, and their amplicons are shown above by the bounded line. Primer details are in 
Table A2.5 in Appendix II. 
 
IS26 was found linked to blaTEM in 12 strains, and in 11 strains, IS26 was upstream of 
blaTEM as shown in Figure 6.7a [A in Table 6.9] whereas only 1 had the IS26 in the opposite 
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orientation [shown in Figure 6.7b, B in Table 6.9]. Except in 1-R1 where Tn6029B was 
known to be present (12, 19), none of the strains produced amplicons indicating that an IS26 
element was present downstream of blaTEM. The CC69 strains [4-R2, 4.3-R2a, 4.4-R2b, 11.2-
R2 and 14.1-R1] had the same IS26-TnA junction [Table 6.9]. Surprisingly, an IS26 element 
was in precisely the same spot in the B2 strain 1.9-R6 as in the CC69 strains [Table 6.9], and 
1.9-R6 had the same integron configuration as 4-R2, 11.2-R2 and 14.1-R1 [Table 6.7].  
 
Table 6.9: IS26 linkage to the blaTEM gene  
Strains Resistance Phenotype Amplicon size TnA Lengthc [bp] 
  A [kb]a B [kb]b  
4-R2 ApSmSpSuTcTp 1.4 - 1243 
4.3-R2ad Ap 1.4 - 1243 
4.4-R2bd ApSmSuTc 1.4 - 1243 
11.2-R2 ApSmSpSuTcTp 1.4 - 1243 
14.1-R1 ApSmSpSuTcTp 1.4 - 1243 
1.9-R6 ApCmSmSpSuTcTp 1.4 - 1243 
5.2-R2  ApCmSmSuTcTp 1.5 - 1436 
18.1-R1 ApTc - 1.3 1583 
1-R1 ApSmSuTcTp 1.6 - 1444 
1.9-R7  ApTc 1.4 - 1155  
15.1-R1e ApSmSuTp 1.6 - 1453 
21.1-R1e ApSmSuTc 2.0 - 1856f 
aOrientation shown in Figure 6.7a 
bOrientation shown in Figure 6.7b 
cThe length is from the blaTEM IR to the edge of IS26 
dPossible resistance variants of 4-R2. Strains have indistinguishable RAPD and API20E profiles 
eStrain positive for Tn2 (19) 
f99 bp of unknown sequence separate the Tn2 segment from IS26 
  
 These sequences were compared with publicly available sequences in GenBank [last 
search 26th January, 2013] and only 2 junctions had been seen elsewhere. The sequence from 
18.1-R1 matched GenBank accession number FJ744121 while the junction in 1-R1 matched 
Tn6029B in GenBank, accession number AL513383. The 4 remaining junctions were novel, 
and these were probably the result of IS26 deleting different sized portions of the original 
TnA segment. 
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6.4 Discussion 
The resistance genes that accounted for the resistance phenotypes of the 28 RC2 and 18 RC1 
strains were identified except for the genes that conferred resistance to Tp in 14.2-R3 [Table 
6.8] and 11.1-R1 [Table 6.1]. Resistance to Tp could be attributed to a non-cassette Tp 
resistance gene like dfrA8 or dfrA9 (6), or it could be due to a new TpR gene and future work 
will aim to identify the relevant gene.  
 Resistance to chloramphenicol, tobramycin and gentamicin was rare, and none of the 
strains were resistant to third generation cephalosporins. In this work, only 1 strain was GmR 
and in other studies isolates were largely gentamicin susceptible with less than 1% of GmR 
isolates detected (143, 144, 152, 159, 267). However, a study on 269 Dutch faecal isolates 
found 27% of the isolates to be GmR (35) and of 53 Chinese isolates, 32% were GmR (152). 
In the present study, 4 strains were resistant to chlormaphenicol and CmR was rare and in less 
than 5% of isolates in some studies (144, 159), 10% in another study (143) but in more than 
40% of isolates in 2 further studies (35, 152). Resistance to third generation cephalosporins 
has been found in about 10% of other commensal E. coli isolates (143), in less than 2% of 
isolates (144, 168) or not detected at all (269). The distribution of the resistance genes 
conferring GmR, TmR and CmR, and ESBL-production genes appears to be quite variable. 
This variation could be influenced by difference in antibiotic usage policies around the world. 
Data on prevalence of tobramycin resistant commensal E. coli was not found. 
In this work, Tc resistance was the most common antibiotic phenotype observed and 
29 RC1 and RC2 strains were TcR but only tetA[A] [16 strains] and tetA[B] [11 strains] were 
the predominant TcR genes. The tetA[C] and [D] genes were rare, and tetA[E] was not found. 
Previous studies that examined commensal ioslates have found TcR in approximately 20% 
(143) to 40% of isolates (73, 275) but data on the genes that conferred TcR in those studies 
was not found. The tetA[A] gene can be found in several contexts, and this includes Tn1721 
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(257) but it is usually seen as a fragment of Tn1721 (228, 304). A portion of Tn1721 
containing the tetA[A] gene has been found linked to the sul2-strAB cluster on the 8.4 kb 
plasmid, pSS4 [GenBank accession number AF534183]. The sul2-strAB cluster was detected 
in 15 out of the 18 strains that were examined in this work that carried sul2 and strAB [Table 
6.4] and 9 of these 15 strains contained tetA[A] [Table 6.1, 6.4 and 6.8]. Hence, these 9 
strains could contain a plasmid like pSS4. The tetA[B] gene is often found in Tn10 (44), and 
the prevalence of tetA[B] suggests that Tn10 might be carried by these strains.  
Class 1 integrons [16 strains] were more common than class 2 integrons [4 strains] 
[Table 6.1 and 6.8], and they also were variable in structure. Gene cassettes were detected in 
each of the 16 class 1 integrons, though 7 of the 16 strains did not contain either intI1 or sul1. 
The sul3 gene has been recently identified (226) and it is not very common in E. coli. The 
identification of sul3 in this work represents the first report of its detection in an Australian 
commensal strain. Another analysis of the region that contains the sul3 gene (60) had found 
two IS26 elements flanking the class 1 integron that contains sul3, as shown in Figure 6.6. 
Thus, that class 1 integron (60) could be part of a possible IS26-compound transposon. In the 
present study, the strain that carried the sul3 gene, 22.1-R1, also contained a merA21 gene 
[Table 6.8]. Other isolates have been shown to carry the merA gene downstream of sul3 (60) 
but they type of merA, i.e. the merA from Tn21, Tn1696 etc. was not described.  
Besides 22.1-R1, a merA gene from Tn21 was found in 1.10-R8, and this strain also 
carried a class 1 integron [Table 6.8]. A class 1 integron with the aadA1 gene cassette [see 
Figure 1.9 in Chapter 1] can be found in Tn21 (163). Hence, 1.10-R8 could contain Tn21 but 
with a dfrA5 gene cassette instead. Both 1.10-R8 and 22.1-R1 are members of the usually 
antibiotic susceptible clone CC95 [see Chapter 5], and the carriage of this integron highlights 
the acquisition of possible resistance islands by a known globally distributed virulent CC. 
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7.1 Introduction 
In Chapter 6, it was shown that in strains 1.2-R3 and 6.2-R1, a dfrA14 gene cassette was 
found inserted into strA, and the interrupted strA gene was flanked by sul2 and strB. The 1.2 
kb sequence of the interrupted strA gene from these 2 strains was identical to the strA region 
carried in pSTOJO1 [Figure 7.1] whose size was estimated through restriction mapping to be 
6.8 kb (214). Plasmid pSTOJO1 was recovered in 2001 from a uropathogenic E. coli strain 
that was isolated in Nigeria [Table 7.1]. However, only 3839 bp of pSTOJO1 that contained 
the sul2-strAB resistance cluster [Figure 7.1], with strA interrupted by a dfrA14 gene cassette 
was sequenced (214). Small plasmids carrying sul2 with a dfrA14 cassette in strA that confer 
resistance to both Su and Tp have been detected around the world [Table 7.1] but none have 
been completely sequenced. 
 
 
Figure 7.1: pSTOJO1. Map of the available sequence of pSTOJO1. The horizontal arrows show the extent and 
orientation of the genes annotated in GenBank entry AJ313522. The dfrA14 cassette is shown as green box. The 
red region represents the sul2-strAB cluster.  
 
 
Table 7.1: Bacteria harbouring SuRTpR plasmids with dfrA14 in the strA gene 
aserovar Typhimurium DT104 
Plasmid 
 
Organism Year 
isolated 
Source Source 
type 
Location Evidence Accession 
 
Ref 
pSTOJO1 E. coli 2001 Human Clinical Nigeria dfrA14 in strA  
6.8 kb SuR TpR plasmid 
3.9 kb sequenced 
AJ313522 (214) 
pUK1329 E. coli 1995 Human  Clinical Scotland dfrA14 in strA 
681 bp sequenced 
Z50805 (322) 
- E. coli 2001 Cattle, pig 
chicken 
Commensal Kenya dfrA14 in strA 
1214 bp sequenced 
AJ884725 (141) 
- S. entericaa  2002- 
2004 
Human Clinical Spain dfrA14 in strA 
1020 bp sequence 
AM711128 (245) 
- S. entericaa 2004 Human  Clinical Scotland dfrA14 in 6.8 kb plasmid 
No sequence 
- (55) 
- E. coli 2005- 
2008 
Cattle, pig 
chicken 
Diseased Lithuania dfrA14 in strA 
 
- (268) 
- S. entericaa  2002 Human  Clinical England 6.8 kb SuR TpR plasmid 
 
- (290) 
- E. coli 2001 Rat Commensal Kenya Strains SuR TpR carrying 
6.8 kb plasmid  
- (86) 
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The aim of this chapter was to characterise the plasmid that carried this resistance 
region, and to establish its relationship to pSTOJO1 and other closely related plasmids.  
 
7.2 Characterisation of pCERC1 
Plasmid DNA was isolated from 1.2-R3 and 6.2-R1 and transformed into E. coli DH5α. 
Transformants were selected with Su or Tp. Plasmids approximately 7 kb in size conferring 
SuR and TpR were recovered from both strains. These plasmids exhibited the same pattern of 
fragments after digestion with either EcoRV or PstI [Figure 7.2]. Thus, these plasmids were 
considered to be the same and were designated pCERC1 [commensal E. coli resistance 
collection].  
 
Figure 7.2: Digestion of pCERC1. An EcoRV and PstI restriction digest of plasmids recovered from 1.2-R3 
and 6.2-R1. M represents the 1 kb ladder. The sizes of the relevant bands are listed on the side. The strains from 
which the plasmids were recovered from are listed above. The image is of a 1.0% agarose gel run at 150 V in 
TBE for 45 minutes.  
 
7.2.1 pCERC1 sequence 
Plasmid pCERC1 recovered from strain 1.2-R3 was sequenced and the sequence is available 
in GenBank under the accession number JN012467. It was 6790 bp long and identity to 
pSTOJO1 extended into the segments flanking both sides of the resistance cluster and 
included all available sequence of pSTOJO1 [Figure 7.3a]. Therefore, it is likely that 
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pSTOJO1 and pCERC1 are identical.  
The 3.8 kb resistance cluster of pCERC1 carried a fragment of Tn5393 that contained 
the strAB genes and the IR downstream of strAB, which abuts part of the small mobile 
element CR2 [Figure 7.3a]. The CR2 piece contains the ter [T] end of CR2 and a short orf 
corresponding to the truncated rcr2 gene, named Δrcr2. The sul2 gene is next to the Tn5393 
fragment and upstream of strAB [Figure 7.3a]. This configuration of resistance genes linked 
to Δrcr2, without dfrA14 has been seen in other plasmids like the IncQ plasmid RSF1010 
(319), highlighting the broad mobility of this region.  
 
Figure 7.3: pCERC1 and p9123. Map of [a] pCERC1 and [b] p9123. The horizontal arrows show the extent 
and orientation of known genes and open reading frames [2-6]. The dfrA14 cassette is shown as green box with a 
vertical line representing the attC site. The dotted lines show the dfrA14 insertion site in strA. The segment 
derived from the ter end CR2 is shown as a blue line, labelled T at the ter end, and the red line represents the 
region derived from Tn5393, including the interrupted strA [ΔstrA], strB and the terminal inverted repeat of 
Tn5393 that is represented by the red vertical line. The line below shows the region matching the resistance 
region in RSF1010 and other plasmids carrying the sul2 and strAB genes. The dotted line below pCERC1 
indicates the available sequence [3.8 kb] from pSTOJO1. Sequence of p9213 is available under the GenBank 
Accession Number AY360321. 
 
Comparison of the sequence of pCERC1 to other available sequences in GenBank 
[last search 27th January, 2013] revealed the closest match to be plasmid p9123, an SmR SuR 
plasmid recovered before 2003 from a clinical E. coli isolate in the UK (75). Plasmid p9123 
[Figure 7.3b] does not carry the dfrA14 cassette but it is 99.99% identical [3 differences in 
6222 bp] to the remainder of pCERC1, and hence, is the precursor of pCERC1. The strA gene 
in p9123 is uninterrupted and all bases surrounding the cassette in pCERC1 are present 
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[Figure 7.3b], confirming that the cassette was integrated into a plasmid identical to p9123. 
Plasmid p9123 was reported to have 6 potential open reading frames [orfs] in addition to the 
resistance genes (75). However, orf1 corresponds to Δrcr2 and it was renamed in Figure 7.3b. 
The 5 other orfs could not be identified because nucleotide and protein BLAST searches 
produced no significant matches.  
Primers were designed to span pCERC1 [Figure 7.4] and the plasmid recovered from 
6.2-R1 was mapped using these primers. All products obtained were indistinguishable from 
the amplicons produced by pCERC1, thus providing further confirmation that the SuRTpR 
plasmid in 6.2-R1 was indeed pCERC1.  
 
 
 
Figure 7.4: Schematic representation of primers used to map plasmid pCERC1. Primer positions are shown 
above and are indicated by the dotted lines. The predicted amplicons are the thin horizontal lines bound by thin 
vertical lines, next the primer names, and the dotted lines indicate the primer positions. Other features are as in 
Figures 7.2. Primer sequences are listed in Table A2.6 in Appendix II. 
 
7.2.2 Resistance gene expression 
A BLAST search of the sequence upstream of the sul2 start codon revealed that 96 base pairs 
preceding the start codon was always found linked to sul2 [shown in blue in Figure 7.5a]. 
However, a possible promoter that is able to direct the transcription of sul2 was not found in 
this upstream segment. An inspection of the plasmid backbone between orf6 and the fragment 
derived from sul2 identified 2 potential promoter regions, which contained -10 and -35 
signals that were 17 and 18 bp apart respectively [Figure 7.5a]. One of these 2 promoters is 
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likely to direct the expression of the sul2 gene. A sul2 ribosome-binding site [RBS] however 
was not found. 
 
Figure 7.5: Resistance gene promoters. The possible promoter regions for [a] sul2 and [b] ΔstrA, and [c] the 
translational coupling of dfrA14 to Δ strA. The nucleotide positions relative to where pCERC1 was opened are 
shown on the left. The gene names and the single letter amino acid codes are shown below. The stop codon is 
represented by  and underlined in blue in [c]. All promoter signals are boxed. The red and black boxes in [a] 
differentiate the 2 potential sul2 promoters [-10 and -35 signals]. The -35 and -10 spacing for the red boxed 
promoters are 18 bp while the black boxed promoters are 17 bp apart, and in [b]. they are 16 bp apart. The thick 
underline in [b] denotes the RBS. The * symbol represents the last base of pCERC1 [position 6790]. The red 
region represents the piece derived from Tn5393, the green region represents the dfrA14 gene cassette and the 
blue region represents the sul2 fragment. The consensus sequence for the -35 signal is 5`-TTGACA-3`, the -10 
signal is 5`-TATAAT-3` and for the RBS is 5`-AGGAGG-3`. 
 
While strB alone has been shown to confer SmR (47), it is translationally coupled to 
strA and the inability of pCERC1 to confer SmR suggests that the dfrA14 insertion has 
prevented strB expression. The potential promoter provided by the sul2-Tn5393 junction 
could direct transcription of strAB and translation is likely to be initiated at the RBS detected 
in front of strAΔ [Figure 7.5b]. However, dfrA14 seems to be translationally coupled to strAΔ 
[Figure 7.5c], and because a RBS was not found between the dfrA14 stop codon and the ΔstrA 
start codon, strB was not expressed. The possible promoter upstream of sul2 [Figure 7.5a] 
could also direct the ΔstrA and dfrA14 expression but more experiments are required to 
ascertain this.  
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7.2.3 Identifying pCERC1 replication region 
None of the orfs in pCERC1 encode a replication initiation protein. To identify which portion 
of the 3.5 kb outside the resistance region was required for plasmid replication, deletions were 
constructed. Plasmid pCERC1 was digested with DraI and NaeI, and the fragments were 
ligated and transformed into E. coli DH5α. Transformants were selected with Su, and a 3343 
bp SuR plasmid, designated pRMH963 [Figure 7.6b], was recovered. This confined the 
replication functions to a 1.7 kb region. Plasmid pRMH963 was digested with SacI and 
EcoRV, ligated and transformed. Transformants selected Su yielded a 2199 bp SuR plasmid, 
designated pRMH964 [Figure 7.6b]. This further confined the replication functions to a 1.1 
kb region that included orf6. Plasmid pRMH963 was also digested with NheI and SacI. After 
the NheI site was end-filled using T4 DNA polymerase, it was ligated to the SacI site and 
transformed into E. coli DH5α. However, transformants were not recovered, indicating that 
the 61 bp between the EcoRV and NheI sites are necessary for the replication of pCERC1. 
 
 
Figure 7.6: pCERC1 and derivatives. Map of [a] pCERC1 and [b] pRMH963 and pRMH964. The map shows 
the structure of pCERC1 and its deletion derivatives pRMH963 and pRMH964. Features are as seen in Figure 
6.5a. The initiation RNA genes are labelled RNA I [antisense RNA involved in the regulation of initiation] and 
RNA II [plasmid replication primer]. The black box labelled cer represents the dimer resolution site. Restriction 
enzyme cleavage sites shown just now are S, SacI; D, DraI; Na, NaeI; N, NheI; and E, EcoRV. 
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BLAST searches with this 1.1 kb piece identified a region that was 77% identical to a 
819 bp fragment of plasmid ColE1 [accession number J01566] that contained RNA I, RNA II 
and the origin of replication [Figure 7.7a]. Plasmid ColE1 does not require a plasmid initiator 
protein but uses the host’s DNA polymerase I to initiate replication (278). The RNA II 
molecule is transcribed by RNA polymerase and hybridizes to the DNA, after which a portion 
of it is removed by RNAse H to provide a free 3`-end for replication initiation by DNA 
polymerase I (278). In ColE1, this initiation point is usually 555 bp downstream from the start 
of RNA II and it is defined as the origin of replication [ori]. RNA I is a 108 bp long antisense 
molecule that is entirely complementary to the 5`-end of RNA II and functions as a control 
for plasmid replication (278). The binding of RNA I to RNA II prevents the RNA II-DNA 
hybrid from forming, thus preventing the initiation of replication.  
 
 
Figure 7.7: Replication region of ColE1 and pCERC1. Schematic representation of the replication region of 
[a] ColE1 and [b] pCERC1. The horizontal arrows show the extent and orientation of the RNAs and genes. The 
thick red line indicates a region of 77% identity shared by ColE1 and pCERC1. Shown above are the -10 and -35 
signals for the RNAs with the number in () indicating the number of bases between the -10 and -35 signals, and 
the EcoRV and NheI sites. The dotted line indicates the extent and orientation of orf6. 
 
A promoter sequence for RNA I and RNA II were not described for ColE1 but an 
inspection of the 638 bp sequence of pCERC1 related to ColE1 revealed a promoter region 
with an 18 bp spacing near the end of this region [Figure 7.7b]. Putative RNA sequences 
associated with this promoter that were 105 to 115 bp long [corresponding to the size of RNA 
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I] were chosen and analysed using the RNAfold program (114). RNAfold predicted that a 
structure with the least free energy, - 44.50 kcal/mol, was a 106 bp long RNA sequence that 
formed a secondary structure containing 3 stems-loop domains [I, II and III] [see Figure A1.2 
in Appendix I]. This tri-domain stem-loop structure closely resembled the previously 
described ColE1 secondary structure of RNA I (62) [see Figure A1.2 in Appendix I], 
suggesting that this sequence was RNA I. At the 3`- end of the putative RNA I sequence, 
another promoter, facing in the opposite direction to the first promoter, was found [Figure 
7.7b]. This second promoter could initiate the transcription of a gene that began precisely 
where the RNA I sequence terminated. Hence, the RNA I was the antisense complement of 
the first 106 bp of a sequence likely to be RNA II. In ColE1, the ori region is composed of 5 
adenosine residues and this segment is surrounded by a guanine and cytosine rich region 
(291). In pCERC1, this site was found 520 bp downstream from the start of the putative RNA 
II gene [Figure 7.7b], and hence, is likely to be the pCERC1 ori. The organisation of RNAs I 
and II, and the ori in pCERC1 is the same as the region in ColE1 that controls plasmid 
replication (104). Hence, it very likely that the replication of pCERC1 is controlled by an 
antisense RNA mechanism.  
In ColE1, the length of the RNA II transcript extends well beyond the ori because the 
region downstream of the ori is required for the appropriate RNA II secondary structure to 
form, permitting RNase H recognition at the ori (62). Hence, it is possible that the NheI 
digestion of pCERC1 removed enough of the 3`- end of RNA II, preventing the appropriate 
secondary structure from forming, thus, preventing the replication of pCERC1. 
 
7.2.4 Role of the cer site 
A cer site [Figure 7.6a], believed to increase plasmid stability by allowing multimer 
resolution by the E. coli XerCXerD site-specific recombination system (282), was previously 
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identified between the orf3 and orf4 in pRF-1 (104), a plasmid that is closely related to 
pCERC1. However, when cells containing pCERC1 or plasmids pRMH964 or pRMH965, the 
latter two lack the cer site, were grown without antibiotic selection for 250 generations, no 
loss of plasmid was detected. This suggests that these plasmids are very stably maintained in 
the absence of the cer site, possibly due to a high plasmid copy number (104). Hence, dimer 
resolution at the cer site does not appear to significantly contribute to the stability of 
pCERC1.  
 
7.3 Plasmids related to pCERC1 
Table 7.2: Sequenced plasmids related to pCERC1 
Plasmid Isolate Sourcea Location Accession Reference 
 Organism Year     
SuTpR       
pCERC1 E. coli 2008 Human Australia JN012467 This study 
SmSuR       
p9123b E. coli <2003c Human England AY360321 (75) 
pSS046_spA S. sonnei 1950s Human China CP000641 (318) 
pSFxv_3 S. flexneri 2002 Human China CP001386 (321) 
p62 E. coli <1980d Human Hong Kong FN822747 (58) 
pETEC_6 E. coli <1999e Human USA CP000798 - 
pMG828-5 E. coli <2006c Human Taiwan DQ995355 - 
pVI678b E. coli <2006c Red deerf Norway EF090911 - 
pQ1-1 E. coli <2010c Sea water China HM371192 - 
SmR       
pE2348-2g E. coli 1969 Human England FM180570 (117) 
p6148g E. coli 1969 Human England EU580136 (103) 
SuR       
pRF-1 S. entericah <2001c Unknown Japan AB076707 (104) 
SmSuTcR       
pSS4 S. sonnei 2000 Human South Korea AF534183 - 
pKKTET7 S. sonnei 1998 Human South Korea AF497970 - 
aHuman isolates are clinical except for pCERC1 
bSequence contains 3 SNPs relative to other plasmids in the group 
cDate of isolation not provided 
dThe earliest mention of the strain was in 1980 
eThe earliest mention of the strain was in 1999 
fCervus elaphus [wild-living] 
gBoth isolated from E. coli ETEC strain E2348/69. A +1 frameshift mutation has inactivated the sul2 gene 
hserovar Choleraesuis  
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Bioinfomatic analysis was used to identify plasmids related to pCERC1 with sequences 
available in GenBank, and 13 plasmids with a backbone closely related to pCERC1 were 
found [last search 27th January, 2013] [Table 7.2]. 
Plasmid p9123 was the first of several identical plasmids to be found in E. coli, 
Shigella and Salmonella. These plasmids have been circulating in the environment since the 
1950’s and have been recovered in many different countries [Table 7.2]. A variant form of 
p9123, named both pE2348-2 and p6148, that fails to confer SuR due to a premature stop 
codon in the sul2 gene was recovered from a 1969 enteropathogenic E. coli isolate (103, 104). 
Two further variants were also found [Table 7.2 and Figure 7.8]. In one, the strA and strB 
genes are missing, and the CR2 element is complete [Figure 7.8b]. This form of the resistance 
region is predicted to be the precursor of the more complex strA-strB configuration (319). 
 
 
Figure 7.8: The p9123 plasmid family. In [a] maps show the structure of sequenced plasmids p9123 and 
derivatives with additional resistance genes. Features are as seen in Figure 6.5a, with only the genes in the 
resistance segment marked, and the region derived from Tn5393 is shown in a thick red line. The thick blue lines 
denote the remnant CR2 region while the dfrA14 cassette is a green line and the tet region derived from Tn1721 
is represented by a brown line. [b] Shows pRF-1 and its relationship to p9123. CR2 is a blue box with the ori [O] 
and ter [T] ends marked. Dashed lines indicate the region that is replaced by a part of Tn5393 in p9123.  
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7.3.1 Plasmid pSS4 
The final variant type is pSS4 [Figure 7.8a] that includes a fourth resistance gene, the tetA[A] 
tetracycline resistance determinant and it’s repressor gene [tetR]. A closer inspection of pSS4 
revealed that a piece from Tn1721 carrying tetA[A] abuts IR5393 [Figure 7.9] and a part of the 
CR2 remnant has been lost, forming CR2Δ2. The boundary at the CR2Δ2 end has been 
formed by recombination between a very short region of identity [8/9 bases or 11/14 bases] 
near the end of the tetA[A] gene and within CR2 [Figure 7.10].  
 
 
Figure 7.9: The IR5393 junction of plasmids pSS4 and p9123. The figure shows the IR5393 junction in plasmids 
p9123 and pSS4, and the portion of Tn1721 carrying the tetA[A] and tetR genes. The arrows indicate the extent 
and orientation of genes. The thick red line indicates the region derived from Tn5393, the thick vertical red line 
is the IR of Tn5393, the orange is the region derived from Tn1721 and the blue box indicates Δrcr2 and Δ2rcr2. 
 
The 3`- end of the tetA[A] from Tn1721 and a region of CR2 had recombined and 
formed the tetA-Δ2rcr2 junction in pSS4. The event led to the replacement of the last 6 
codons of tetA[A], and the 6 amino acids are replaced by 6 alternate amino acids encoded by 
the CR2-derived segment [Figure 7.10]. This configuration suggests that this region in pSS4 
evolved by the transposition of Tn5393 into Tn1721 upstream of tetR and this structure was 
resolved by a recombination event that removed a part of Tn1721 and Δrcr2, forming Δ2rcr2. 
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Figure 7.10: The tetA[A]-CR2 boundary in pSS4. The nucleotides in the crossover are bold and boxed. The 
stop codon of the tetA[A] gene is underlined. The sequence of pSS4 [GenBank accession number AF534183] 
has been aligned with Tn1721 and CR2 [GenBank accession numbers X61367 and JN247441]. 
 
7.3.2 Detecting plasmids related to pCERC1 
To determine whether any of the plasmids identified by bioinformatic analysis [Table 7.1] 
were present in the commensal E. coli collection, isolates containing sul2 with strAB, or with 
strAB and tetA[A] or with only sul2 were screened for the presence of a resistance segment 
flanked by the sequence found in the pCERC1 backbone using primers RH963 and RH964 
[Figure 7.11]. Without the dfrA14 cassette insertion, primers RH963 and RH964 produce a 
3.6 kb amplicon. If the tetA[A] configuration of pSS4 was present, this PCR would have 
produced a 5.9 kb amplicon, which exceeds the upper limit of PCR amplification using Taq 
Polymerase. Therefore, to reliably detect larger resistance clusters, shorter PCRs from RH963 
to strA-R and RH964 to strB-F were also performed [Figure 7.10].  
 
Figure 7.11: Location of the primers used to detect plasmids related to pCERC1/p9123. Features are as 
seen in Figure 7.5a. Primer names are shown above and the vertical lines indicate their location within the 
plasmid. Primer sequences are listed in Table A2.6 in Appendix II. 
 
  Two strains, 3.6-R4 [ApR SmR SuR] and 10.1-R1 [ApR SmR SuR TcR TpR] yielded 
amplicons of 3.6 kb, consistent with the presence of a sul2-strAB resistance region without a 
dfrA14 cassette. Plasmids 6.2 kb in size, conferring SuR and SmR were recovered from both 
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strains. An EcoRV or PstI digest of these plasmids showed their restriction patterns to be 
indistinguishable from each other and they matched the predicted p9123 restriction pattern 
[Figure 7.12]. One fragment was also smaller than the fragment obtained from pCERC1, 
consistent with the absence of the dfrA14 cassette [Figure 7.12]. The plasmids recovered from 
3.6-R4 and 10.1-R1 were considered to be the same and were designated pCERC2.  
 
Figure 7.12: EcoRV and PstI digestions of pCERC1 and pCERC2. Plasmids pCERC2 from strain 3.6-R4 
and pCERC1 from 1.2-R3 were digested. Plasmid names are above and enzyme names are below. M represents 
the 1 kb molecular weight marker. Sizes of the relevant bands from the molecular marker are indicated on the 
side. The image is of a 1.0% agarose gel run at 150 V in TBE for 45 minutes. 
 
Four primer pairs spanning the whole of pCERC1/pCERC2 [Figure 7.4] were used to 
map pCERC2 from 3.6-R4 and 10.1-R1. Products of the predicted size were obtained for all 
PCRs, confirming these plasmids were likely to be identical or nearly identical to p9123.  
 
7.3.3 Plasmid NTP168 
The E. coli plasmid sizing strain 39R861 was previously shown to have a strA product that 
was 600 bp larger than expected [Yau and Hall, unpublished observations]. This strain was 
known to carry a 4.6 MDa plasmid [approximately 6.9 kb] (289), named NTP168 (300). 
Plasmid DNA from strain 39R861 was transformed into E. coli DH5α and transformants were 
selected on Su or Tp, and a 7 kb plasmid conferring resistance to Su and Tp was recovered. 
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This plasmid was digested using EcoRV or PstI and the digestion patterns were 
indistinguishable from the digestion profiles of pCERC1. The strA PCR was performed on 
this plasmid and sequencing revealed that NTP168 had a dfrA14 cassette inserted in precisely 
the same position as in pCERC1. Plasmid NTP168 was analysed using the 4 pCERC1 
mapping primer pairs and amplicons that were indistinguishable from the amplicons produced 
by pCERC1 were obtained. Thus, it is likely that NTP168 is identical or very closely related 
to pCERC1. Strain 39R861 was constructed in 1986 in the UK (289) showing that pCERC1 
has been present globally for at least 27 years.   
 
7.4 Discussion  
This is the first report of a small plasmid that belongs to the p9123 family of plasmids that 
carries a dfrA14 insertion in strA to be completely sequenced. Plasmids carrying dfrA14 
inserted into strA have been detected several times [Table 7.2]. However, this is also the first 
report of a plasmid carrying dfrA14 in strA to be detected in a human commensal isolate. 
Because NTP168 was shown to be the same as pCERC1, pCERC1 has been present in the 
environment since at least the 1980s. The earliest detection of pCERC2 was in China in the 
1950s [Table 7.2]. This shows that these plasmids have been circulating in the environment 
for a long time. The detection of pCERC1 and its relatives in isolates recovered from Europe 
and Africa [Table 7.1], China and the USA [Table 7.2], and now Australia highlight the 
globalisation of these plasmids, and hence the sul2-strAB cluster.  
Bioinformatic analysis identified a 764 bp fragment of pCERC1 that showed 77% 
identity to the replication origin of ColE1 [red segment in Figure 7.7]. Though a small portion 
of pCERC1 RNA II and most of RNA I was outside this segment, the high identity of this 
region suggested that it is crucial for replication control. RNA I and II both can fold into tri-
domain stem-loop structures, and the term ‘kissing’ is used to describe the interaction 
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between these two structures (278). The ‘kissing’ interaction prevents the initiation of 
replication (278) but variation of the RNA I sequence can affect incompatibility because it 
would not be able to act in trans and ‘kiss’ a RNA II molecule of another ColE1-like plasmid 
carried by the same host (62). Hence, variation in the RNA I could allow plasmids like 
pCERC1 and ColE1 to be stably maintained in the same host. However, plasmid 
incompatibility experiments will need to be performed to confirm this.  
The subjects from whom pCERC1 and pCERC2 were recovered did not consume 
antibiotics for at least 6 months prior to sampling and no significant loss of pCERC1 was 
observed after over 250 generations of growth in the absence of antibiotic selection [see 
Section 7.2.4]. Hence, it appears that these plasmids are stably maintained without any 
antibiotic selection. It has been claimed that small plasmids with the sul2-strAB cluster can 
confer a fitness advantage to hosts (75), thus providing a possible explanation for their 
retention in an antibiotic free environment. However, this finding could not be reproduced in 
another study (103), and further studies are needed to clarify this point.  
The sul2-strAB cluster is carried chromosomally (162), on small (319) and large (70, 
324) plasmids, and plasmids carrying this cluster have been detected in many species, 
including E. coli (75), K. pneumonia (70, 324) and Salmonella enterica serovar Typhimurium 
(319). This cluster can be found linked to other resistance genes like blaTEM in transposons 
such as Tn6029 [see Figure 1.6 in Chapter 1] (39). The sul2-strAB cluster with dfrA14 
inserted in precisely the same position as in pCERC1 has also been found recently on a 53 kb 
IncN plasmid, pRSB206, isolated in Germany (74). The original insertion of dfrA14 into strA 
would have been mediated by an IntI integrase, possibly IntI1. However, due to the broad 
mobility of plasmids like pCERC1 and hence sul2-dfrA14-strB, homologous recombination 
could further propagate this cluster.   
The sul2-strAB region was detected in 14 of the 18 strains that carried sul2 and the 
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strAB genes [Table 7.3], and in 4 cases the cluster was carried by pCERC1 or pCERC2 [Table 
7.3]. The broader context of sul2-strAB in 1-R1, Tn6029B, was previously identified (12, 19). 
Hence, future work would entail mapping the broader context of this cluster in the 9 
remaining strains, and to investigate the context of sul2 and strAB in the 4 strains where these 
genes were not linked [Table 7.3]. 
 
Table 7.3: Summary of sul2 to strAB linkage 
Strain Resistance Phenotype Phylo Gp sul2 strAB sul2-strAB pCERC Other 
1-R1 ApSmSuTcTp A1 + + + - Tn6029Ba 
1.2-R3 SuTcTp A1 + +b + 1 - 
3.6-R4c ApSmSu A1 + + + 2 - 
3.6-R5c ApSmSpSuTcTpCmGmTm A1 + + + - - 
15.1-R1 ApSmSuTp A1 + - - - - 
21.1-R1 ApSmSuTc A1 + + + - - 
1.9-R6 ApCmSmSpSuTcTp B2 + + + - - 
5.1-R1 ApSmSu B2 + -d -d - - 
10.1-R1 ApSmSuTcTp B2 + + + 2 - 
19.1-R3 ApSmSpSuTcTp B2 + + + - - 
2.3-R3 SmSuTp D + + - - - 
2.3-R5 SmSuTcTp D + + - - - 
5.2-R2 ApCmSmSuTcTp D + + + - - 
6.2-R1 SuTp D + +b + 1 - 
9.1-R1 Su D + - - - sul2-CR2e 
4-R2f ApSmSpSuTcTp D + + + - - 
4.4-R2bf ApSmSuTc D + + + - - 
11.2-R2f ApSmSpSuTcTp D + + + - - 
14.1-R1f ApSmSpSuTcTp D + + + - - 
aShown previously (12, 19) 
bstrA interrupted by dfrA14 
cStrains have identical RAPD and API20E profiles 
dTn2 found in between strA and strB [Pinyon and Hall, unpublished observations] 
eBailey and Hall, unpublished observations 
fCC69 strains 
 
 
  
 
 
 
 
 
 
 
 
 
 
CHAPTER EIGHT 
 
Characterisation of a resistance island  
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8.1 Introduction 
In Chapter 6, three resistant CC69 strains [4-R2, 11.2-R2 and 14.1-R1] were found to contain 
the same resistance genes and gene cassettes without a complete 5`-CS [Table 8.1], and very 
closely related RAPD patterns [Figure 5.5, Chapter 5]. They also carried the sul2-strAB 
cluster and had the same length of TnA present [Table 8.1]. A previous study on a ST69 
isolate identified a 23 kb resistance island [see Figure 1.10 in Chapter 1] in the genome (151).  
The aim of this chapter was to characterise the context of the resistance genes in these 
CC69 strains to establish their relationship to the island carried on UMN026. Because the B2 
strain 1.9-R6 was found to have identical characteristics to 4-R2, 11.2-R2 and 14.1-R1 [Table 
8.1], it was included in the analysis. The 2 possible CC69 resistant variants from subject 4, 
4.3-R2a and 4.4-R2b, that did not carry a class 1 integron, were also examined. 
 
Table 8.1: Characteristics of the resistant CC69 strains and B2 strain 1.9-R6 
Strain R Phenotype CC sul2-strAB blaTEM 
TnA 
lengtha tetA intI1 sul1 
Gene 
cassettes 
4-R2 ApSmSpSuTcTp 69 + + 1243 A - + dfrA17-aadA5 
11.2-R2 ApSmSpSuTcTp 69 + + 1243 A - + dfrA17-aadA5 
14.1-R1 ApSmSpSuTcTp 69 + + 1243 A - + dfrA17-aadA5 
1.9-R6b ApSmSpSuTcTp - + + 1243 A - + dfrA17-aadA5 
4.3-R2a Ap 69 - + 1243 - - - - 
4.4-R2b ApSmSuTc 69 + + 1243 A - + - 
a The length is from the blaTEM IR to the edge of IS26 
bStrain belongs to phylogenetic group B2 and has low level CmR but CmR determinant not identified 
 
8.2 Island characterisation 
The context of the resistance genes in these 6 strains was characterised using internal primer 
pairs to detect genes and linkage primers that are listed below [Table 8.2]. A single isolate of 
each strain was analysed. An isolate of 4-R2 was chosen as a representative when sequencing 
reactions were performed.  
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Table 8.2: Linkage primers used to map the island 
Location Gene Primersa 
5`-CS intI1 HS463a, HS464 
  L1 
  L2 
  L3 
3`-CS sul1 HS549, HS550 
  R1 
IS26  RH1270 
  RH882 
IS6100  DB-T1, IS6100-Rv2 
  RH115 
IS1  RH621 
Tn2 blaTEM RH605, RH606 
Macrolide resistance cluster mphR RH970, RH966 
 mxr mxr-R 
 mphA mphA-F, mphA-R 
UMN026 backbone leuX tRNA RH957 
UMN026 genomic island intB RH968 
aSee Table A2.7 in Appendix II for primer sequences. Primer pairs used for internal PCRs 
 
8.2.1 Class 1 integron structure 
In strain 4-R2, an intI1 amplicon was not produced because an IS26 element had been found 
to be linked to the 5`-CS [Pinyon and Hall, unpublished observations] [Figure 8.1a]. Because 
11.2-R2, 14.1-R1 and 1.9-R6 also did not produce an intI1 amplicon, a PCR with a primer in 
the 3`-end of the 5`-CS [primer L3] and one in IS26 [primer RH1270] was performed in the 
same orientation as was found in strain 4-R2 [Figure 8.1a]. An amplicon of approximately 1.4 
kb, as in 4-R2, was observed in the 3 strains [Figure 8.1b]. To determine the exact position of 
the junction between IS26 and the 5`-CS, the amplicon from 4-R2 was completely sequenced, 
and 881 bp of the 1352 bp 5`-CS was present. This 881 bp sequence matched precisely to a 
segment from a sequenced plasmid, pKF3-140 (324) that was recovered from a clinical K. 
pneumoniae isolate [GenBank accession number FJ876827]. The class 1 integron on this 
plasmid also contained the same gene cassettes as 4-R2. 
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Figure 8.1: Mapping the 5`-CS in the commensal strains. The figure shows [a] the map of the IS26 insertion 
in the 5`-CS of 4-R2 and [b] an image of the corresponding PCR linkage products. The dotted horizontal line 
represents the chromosomal backbone. The horizontal arrows show the extent and orientation of the genes. The 
thick red line represents the 881 bp of the 5`-CS and contains intI1Δ. The open green boxes are gene cassttes and 
the solid green boxes are the attC sites. The thick orange line is the 3`-CS. Primer names and orientations are 
next to the predicted amplicon, which is the horizontal line bounded by the vertical line. The dotted vertical lines 
indicate the primer positions. The gel image shows the RH1270 to L3 PCR linkage products for two isolates 
each of strains 4-R2, 11.2-R2, 14.1-R1 and 1.9-R6. M represents the 1 kb ladder and relevant sizes are shown on 
the side. Image [b] is of a 1.0% agarose gel run at 150 V in TBE for 45 minutes.  
 
To determine if the rest of the 5`-CS was on the other side of the IS26 element, primer 
L3 was linked to the intI1 reverse primer, HS464 [Figure 8.1a] with an increased extension 
time of 3 minutes [usual extension time is 1 minute] but products were not observed. Thus, 
the remainder of the 5`-CS is not on the other side of the IS26 element. 
To determine if the gene cassettes and the 3`-CS in these strains is next to the 5`-CS in 
the usual configuration of a class 1 integron, primer L1 in the 5`-CS was linked to sul1 
[primer HS550] [Figure 8.2a], and an amplicon approximately 2.9 kb in size was observed 
[Figure 8.2b]. A HindIII digest of these amplicons produced the digestion pattern, predicted 
based on accession number U12388, [Figure 8.2c] of bands approximately 1.8 kb, 0.9 kb and 
0.2 kb in size. Thus, the 3`-CS is linked to the 5`-CS in the usual configuration of a class 1 
integron. 
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Figure 8.2: Mapping the 3`-CS of the CC69 strains and 1.9-R6. The figure shows [a] the predicted 5`-CS to 
3`-CS linkage, [b] the corresponding linkage amplicon and [c] a HindIII digest of the linkage PCR product. 
Features are as seen in Figure 8.1a and b. H indicates the HindIII sites. The * symbol represents a non-specific 
band in [b] that was present in [c]. The dot indicates the position of primer dimer. Image [b] is of a 1.0% agarose 
gel run at 150 V in TBE for 45 minutes. 
 
8.2.2 Analysis of the UMN026 resistance island 
The sequenced multiply antibiotic resistant CC69 representative, E. coli strain UMN026, was 
reported to include a 23 kb resistance island located within its chromosome (151). Some of 
the elements reported to be carried by this island were misannotated, and these were the cat, 
dhfrVII and aadA genes, and one of the transposase gene fragements was not identified (151). 
To facilitate comparisons to the 6 Australian strains examined here, the sequence of this 
resistance island [GenBank accession number CU928163] was reanalysed in more detail and 
its structure is shown below [Figure 8.3]. 
 The dhfrVII and aadA genes were identified as the dfrA17 and aadA5 gene cassettes 
respectively [Figure 8.3] by a comparison to GenBank entry AF220757, which is of a class 1 
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integron that carries these cassettes. A comparison to GenBank entry V00622, which is Tn9, 
identified the cat gene as catA1 [CmR] [Figure 8.4], and the unidentified transposase fragment 
was found to be a remnant of 3`-end of IS6100, and hence, it was annotated as ΔIS6100 
[Figure 8.3]. 
 
 
Figure 8.3: Map of the resistance island carried by UMN026. The thick black line represents the 
chromosomal backbone. The horizontal arrows show the extent and orientation of the genes. The black flags 
indicate 8 bp direct repeats [DR] duplicated during transposition while the red flags indicate 8 bp inverted 
repeats [IR]. Insertion sequences are shown as open boxes with their numbers inside except ΔIS6100, which is a 
partial copy and shown above the navy blue box it represents. Vertical bars are IRs and the lower case letters 
indicate the type of IRs. The vertical green boxes represent the attC sites of the gene cassettes. The thick red line 
represents the region derived from Tn21, the thick orange line represents the 3`-CS derived from a class 1 
integron and the thick blue line represents the region derived from Tn2. Sequence available at GenBank 
[accession number CU928163] 
 
  The sequence flanking the island carried 8 bp DR [5`-AAAAAAGT-3`] at the outer 
junctions of the 2 flanking IS1 elements [black flags in Figure 8.3], and these 2 flanking 
regions are together in 21 of completed E. coli genomes in GenBank [last search 14th of April, 
2013]. The catA1 gene is bounded by IS1 elements in a structure resembling Tn9 [GenBank 
accession number V00622] [Figure 8.3]. An alignment of this segment with Tn9 revealed that 
the junction formed between the first IS1 element and the piece carrying catA1 is 122 bp 
shorter than in Tn9. The second IS1 element [IS1Δ in Figure 8.3] is 48 bp shorter than usual 
768 bp, and has been truncated by the IS26 element next to it. The location of Tn9-like 
transposon next to the tnpA21 closely resembles Tn2670 (222) but in Tn2670, the catA1 gene 
is next to the IRtnp21, which is not in UMN026, and it is not interrupted by an IS26 element or 
an IS1Δ like in UMN026 [Figure 8.3] 
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The 5`-CS is intact but only 72 bp of the 3`-CS was next to the 2 gene cassettes 
[Figure 8.3]. The remaining 1.5 kb of the 3`-CS, including sul1, was found 2.3 kb away but in 
the opposite orientation and next to an IS26 [Figure 8.3]. The 2.3 kb region between the two 
3`-CS segments carried an IS26, a chromate resistance gene [chrA] and the IRchrA. Eight bp IR 
[red flags in Figure 8.3] were found on the left boundaries of the 2 IS26 elements [5`-
TTTAAGCG-3` next to the IS26 that is next chrA and the other, 5`-CGCTTAAA-3`, next to 
the IS26 that is next to sul1]. Thus, the segment between these 2 IS26 elements that contains 
the sul1 and chrA genes appears to have been inverted, and if this inversion is reversed, a 
segment of the 3`-CS interrupted by an IS26 is formed. 
The 319 bp remnant of IS6100, ΔIS6100 is located adjacent to an IS26 element 
[Figure 8.3]. A macrolide inactivation cluster [mph] conferring erythromycin resistance (200) 
is present between the ΔIS6100 and a third IS26 element [Figure 8.3]. This IS26 element is 
linked to a blaTEM gene and to the last IS1 element, which formed the right-hand island 
boundary. 
 
8.2.3 Comparison of the UMN026 island to the Australian strains 
There are several differences between the island contained within UMN026 and the one 
carried by the Australian strains. The catA1 gene was not detected in any of the 6 strains 
examined here. Unlike the UMN026 resistance island, strains 4-R2, 11.2-R2, 14.1-R1 and 
1.9-R6 has only part of the 5`-CS and an IS26 element was linked to intI1Δ [Figure 8.1a]. The 
3`-CS is not inverted [Figure 8.2a] and not interrupted by an IS26. The junction between 
blaTEM and IS26 in UMN026 is 286 bp longer than in the Australian strains. The mph cluster 
and chrA were not routinely screened for but they are examined below to establish the 
relationship of the Australian strains to the resistance island in UMN026.  
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8.2.3.1 The mph cluster in the Australian strains 
To determine if the mph cluster is present in the 6 strains, PCR using primers from a previous 
study (230) and others designed as part of this work were used to map this region [Figure 
8.4a]. In all strains except 4.3-R2a, amplicons of the predicted size were obtained with 
primers linking mphA to mphR [Figure 8.4a]. Hence, the macrolide inactivation cluster was 
present in strains 4-R2, 11.2-R2, 14.1-R1 and 1.9-R6. It was also in 4.4-R2a, 1 of the 2 strains 
that did not have the class 1 integron.  
Searches of GenBank for the context of the mph cluster [last search 14th of April, 
2013] revealed that in 24 of the 27 entries, mph is flanked by IS6100 on one side and an IS26 
on the other [Figure 8.4a]. Thus, a PCR linking mxr to IS26 was performed and it produced a 
1.7 kb amplicon, as expected, and an RsaI digest of this amplicon produced 4 bands [0.65 kb, 
0.42 kb, 0.41 kb and 0.25 kb] as predicted from a hypothetical RsaI digest using the 
corresponding sequence from GenBank accession number FJ876827. Also, mphR is linked to 
IS6100 and the expected products [0.42 kb, 0.32 kb and 0.3 kb] were obtained with an RsaI 
digest [Figure 8.4b]. A PCR linking mphR to IS26, as seen in UMN026 [Figure 8.4c] and in 
the opposite orientation [to primer RH882] did not produce amplicons. Hence, the mph cluster 
in 4-R2, 11.2-R2, 14.1-R1, 1.9-R6 and 4.4-R2b is in the FJ876827 [Figure 8.4a], the 
configuration that was commonly found in GenBank [Figure 8.4a] and not in the UMN026 
[Figure 8.4c] configuration.  
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Figure 8.4: Mapping the macrolide inactivation gene cluster. The figure shows [a] a map of the context of the 
macrolide inactivation gene cluster, [b] RsaI digest of PCR using primers RH966 to RH115 and [c] the map of 
the mph region in UMN026. Features are as seen in Figure 8.3. The primer names and orientations are next to 
the predicted amplicon, which is the thick horizontal line bounded by vertical lines. The dotted lines indicate the 
primer positions. Sequence for the context of the mph cluster is available under GenBank accession number 
FJ876827. Image [b] is of a 1.0% agarose gel run at 150 V in TBE for 45 minutes. 
  
 An internal PCR of IS6100 produced an amplicon of the expected size, 300 bp, in all 
strains except 4.3-R2b [Table 8.3]. These primers would not have produced a product in 
UMN026 due to the truncation of IS6100 [Figure 8.3]. Hence, an intact IS6100 was present in 
these strains.   
 
Table 8.3: Summary of linkage data from the CC69 strains and 1.9-R6 
Strain R Phenotype Linkage PCRs IS6100 
  IS26 -intI1Δ 
5`-CS - 
3`-CS 
mph 
cluster 
mphA -  
IS26 
mphR - 
IS6100 
 
4-R2 ApSmSpSuTcTp + + + + + + 
11.2-R2 ApSmSpSuTcTp + + + + + + 
14.1-R1 ApSmSpSuTcTp + + + + + + 
1.9-R6a ApSmSpSuTcTp + + + + + + 
4.3-R2a Ap - - - - - - 
4.4-R2b ApSmSuTc - - + + + + 
aStrain belongs to phylogenetic group B2 and has low level CmR 
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Of the 27 GenBank entries, the mph cluster was next to chrA and to the 3`-CS of the 
class 1 integron in 16 entries [last search 14th of April, 2013], in the context shown in Figure 
8.5a. This linkage was examined to assess if the 3`-CS and chrA was next to IS6100 and the 
mph cluster. Amplicons consistent the expected sizes from entry FJ876827 were obtained for 
both reactions for strains 4-R2, 11.2-R 2, 14.1-R1 and 1.9-R6 [Figure 8.5b]. The 4.1 kb 
amplicon from HS549 to IS6100-Rv2 was digested using RsaI and 1.5 kb, 0.9 kb, 0.67 kb, 
0.55 kb and 0.5 kb fragments were observed [Figure 8.5c], while bands of the expected size 
[1.5 kb, 0.9 kb, 0.92 kb, 0.67 kb, 0.55 kb, 0.4 kb and 0.3 kb] were also produced when the 
HS549 to RH966 amplicon was digested with RsaI. As the fragments were obtained for the 
digests of both amplicons [HS549 to RH966 and HS549 to IS6100-Rv2], the chrA gene is 
most likely to be present between the 3`-CS and IS6100.  
 
Figure 8.5: Linkage of the 3`-CS to the macrolide inactivation cluster. The figure shows [a] a map of the 
linkage between the 3`-CS, IS6100 and mph, [b] the PCR products obtained from amplification using primer pair 
HS549 and IS6100-Rv2, and primer pair HS549 and RH966, and [c] fragments of a RsaI digest on the 
amplification products obtained with primer pair HS549 and IS6100-Rv2. Features are as seen in Figures 8.2, 
8.2, 8.3 and 8.4. The asterisks indicated non-specific PCR amplification products. Sequence for the context of 
the 3`-CS – chrA - mph linkage is available under GenBank accession number FJ876827. Image [b] and [c] are 
of a 1.0% agarose gel run at 150 V in TBE for 45 minutes. 
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Hence, the 3`-CS in 4-R2, 11.2-R2, 14.1-R1 and 1.9-R6 is next to chrA, IS6100 and 
mph [Figure 8.5a], and this is the same as the context seen in 16 GenBank entries where the 
greater context of the mph cluster has been examined.  
 
8.2.4 The context of blaTEM 
In UMN026 to the right of the mph cluster is an IS26 element, which is linked to blaTEM 
[Figure 8.3]. The blaTEM gene in the Australian CC69 strains and in 1.9-R6 is preceded by an 
IS26 element [Table 8.1] but the length of TnA present was 286 bp shorter than in UMN026 
[see Section 8.2.3.1]. To determine if these genes are linked in the Australian strains, a PCR 
from blaTEM to mphA was performed [Figure 8.6], and none of the strains produced an 
amplicon. Thus, the mph cluster is not next to blaTEM in the Australian strains. 
 
 
Figure 8.6: Linkage of blaTEM to mph and IS1. The figure shows the primers used to link the blaTEM gene to 
mphA, and to the IS1 element that forms the terminal end boundary of the resistance island in UMN026. 
Features are as seen in Figures 8.3, 8.4 and 8.5. 
 
To investigate if blaTEM was linked to IS1 as in UMN026 [Figure 8.3], a PCR from 
blaTEM to IS1 was performed [Figure 8.6] and a 1.3 kb amplicon, 0.2 kb shorter than expected 
in UMN026 was observed in all strains except 1.9-R6. The amplicon from 4-R2 was 
completely sequenced to determine the precise position of IS1 but 80 bp of the sequence 
obtained matched to IS1 and the rest to a random chromosomal segment found in all available 
E. coli sequences in GenBank. Hence, the RH605 primer had non-specifically amplified a 
chromosomal segment that is to IS1 but only in the CC69 strains, and, blaTEM is not next to an 
IS1, as it is in UMN026.  
CHAPTER 8   Characterisation of a resistance island 	   200	  
8.2.5 Position of the resistance island 
The resistance island in UMN026 is flanked by 2 IS1 elements [Figure 8.3] and it was 
reported to be located in a larger, 105 kb genomic island that also contains the type 1 fimbriae 
operon (151). To determine if the resistance island in the Australian strains was in the 
UMN026 position, primers in the leuX tRNA gene in the backbone of UMN026 and in the 
intB gene, which is reported to be located next to the left boundary of the larger genomic 
island (151), were designed but the PCRs linking these primers to RH617 in the first IS1 
element [Figure 8.7a] did not produce amplicons in any of the strains. Hence, an IS1 element 
is not present next to the intB gene. However, the leuX and intB genes were linked to IS26 
[Figure 8.7b] in the 6 commensal strains. The products were approximately 2.2 kb in size 
from 4-R2, 4.3-R2a, 4.4-R2b, 11.2-R2 and 14.1-R1 but approximately 4.2 kb in 1.9-R6 
[Figure 8.7c].  
 
Figure 8.7: Linkage of leuX tRNA to IS26. The figure shows [a] a map of the linkage from leuX tRNA to IS26 
and [b] a gel image of the PCR products obtained from the amplification of primer RH957 to primer RH617. 
Features are as seen in Figures 8.3. The vertical arrow indicates the position of the resistance island [RI] in 
UMN026. Image [c] is of a 1.0% agarose gel run at 150 V in TBE for 45 minutes. 
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The products from 4-R2 and 1.9-R6 were partially sequenced using primer RH617 to 
determine the precise location of the IS26, and it was found to be in same position in both 
strains but this was 391 bp further downstream of the position of the resistance island in 
UMN026 [indicated by arrow in Figure 8.7b]. Hence, the UMN026 resistance island position 
is intact in the Australian strains. In 1.9-R6, the partial sequence also matched to an IS2, a 
1331 bp insertion sequence but this only accounted for approximately half of the extra 2 kb 
observed in the 1.9-R6 PCR product. Another IS could be present but this was not 
investigated further.   
Thus, the contexts of the resistance genes in the CC69 strains and in 1.9-R6 are 
closely related to each other. However, the configuration of the resistance island is not the 
same as the island carried by UMN026. Further work is required to elucidate how these pieces 
are joined together to form the resistance island carried by the Australian strains.  
 
8.3 Discussion 
The findings made here show that the structure of the resistance island in the Australian 
strains is not the same as in UMN026. Because IS26 has been shown to mediate deletions of 
the 5`-CS (185), it is likely that the IS26 element next to intI1Δ has deleted the rest of the 5`-
CS in the Australian strains. The 3`-CS in UMN026 has been inverted and reversing this 
inversion leads to the 3`-CS being interrupted by an IS26, but the Australian strains have an 
intact 3`-CS [Figure 8.8].  
In 4.4-R2b, the class 1 integron was not detected [Figure 8.8] but because the presence 
of chrA was not examined, it may still be next to the IS6100. IS6100 has been reported to 
delete the 3`-CS (221), and in 4.4-R2a, IS6100 could have deleted the class 1 integron. Strain 
4.4-R2a still contains the sul2-strAB cluster and tetA, and these are also found in 4-R2, 11.2-
R2, 14.1-R1 and 1.9-R6 [Figure 8.8]. Hence, these resistance genes could be on the resistance 
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island but to the right hand side of the mph cluster. In 4.3-R2b, only the blaTEM gene and an 
IS26 are present [Figure 8.8] and the rest of the island could have been deleted by the IS26 
element.  
 
 
Figure 8.8: Resistance gene context in the Australian CC69 strains and 1.9-R6. The map shows the 
established context of the resistance genes carried by [a] 4-R2, 11.2-R2, 14.2-R1 and 1.9-R6, [b] 4.4-R2b and [c] 
4.3-R2a. Strain 4.3-R2a contained only the blaTEM gene linked to an IS26 element. Features are as seen in 
Figures 8.1 to 8.7.  
 
The junction formed between the linkage of intI1Δ to IS26 was identical to that in a 
sequenced F plasmid, pKF3-140 that was recovered from a clinical K. pneumoniae strain 
(324), and further investigation of the sequence of pKF3-140 identified a 19 kb resistance 
island [Figure 8.9]. The pKF3-140 resistance island contains the same gene cassettes, and a 
3`-CS next to chrA and the mph cluster like in the Australian strains. The island in pKF3-140 
also contains the sul2-strAB cluster and tetA[A] [Figure 8.9], genes that were not carried by 
UMN026 but are in the Australian strains. Hence, a pKF3-140-like plasmid may be in all 6 
strains. Future work will aim to recover plasmids from the 6 strains examined here by 
performing transformation or conjugation experiments, and to complete the mapping of this 
resistance island.  
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Figure 8.9: Plasmid pKF3-140 resistance island. The figure shows the pFK3-140 resistance island and all 
features are as seen in Figure 8.1 to 8.8. The sequence for pKF3-140 is available under accession number 
FJ876827. 
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9.1 Overview 
Studies that examine the virulence properties of commensal E. coli usually do not examine 
antibiotic resistance gene carriage and vice versa. However, in this thesis, both aspects were 
addressed. A collection of 92 well-characterized commensal strains including 42 resistant and 
50 susceptible strains, and containing 13 persistent strains, was assembled. The persistent 
strains had many properties that are usually associated with E. coli that cause extraintestinal 
disease. Because the ability to persist in the colon for long periods is a clear measure of 
success as a commensal, this provides strong support for the hypothesis that virulence outside 
the colon is simply a consequence of successful commensalism (203, 206).  
Additionally, many strains in the collection were antibiotic resistant, and the resistance 
genes they carried, and in some cases, their contexts, were identified. Human commensal E. 
coli are an important reservoir for resistance genes (20, 71, 159, 160, 168, 175), and, 
importantly, multiply resistant strains that persisted in the absence of antibiotic selection were 
found. The colon is a potential location for resistance gene exchange between co-resident 
strains, and the acquisition of resistance genes by persistent strains is likely because they have 
more opportunities than transient strains. The accumulation of resistance genes in persistent 
strains may explain the emergence of resistance to multiple antibiotics in UTI and other 
infections. 
This carefully characterized commensal E. coli collection can form the basis of future 
studies such as the identification of pathogenicity islands and plasmids. Though persistent 
strains were found, the design of the sampling protocol did not allow transient strains to be 
unambiguously identified. Hence, future work should collect faecal samples at closer intervals 
to detect transient strains whose properties can be compared to and contrasted with the 
persistent strains.  
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9.2 Persistent strains resemble ExPEC isolates 
E. coli primarily inhabit the colonic niche of humans and warm-blooded animals as 
commensals (11, 105, 139, 178, 256, 288), and the ability to survive in this environment for 
an extended period of time is a good indicator of success for adaptation to this niche. All of 
the persistent strains identified in this study contained 2 or more VFs, and 9 of the 13 
persistent strains belonged to ST131, ST95, ST69 or ST405, the clones that represent up to 
50% of the isolates recovered from UTI and other extraintestinal infections (4, 59, 89, 90, 
146, 231). Hence, the clones that can persist in the colon for long periods of time, reflecting 
successful commensalism, are the same clones that make up a substantial portion of infections 
outside the colon. Other studies have observed CC69 (172), CC131 (149) and CC95 (188) 
strains in the faeces of healthy adults. However, none of these studies examined persistence as 
only single faecal samples were collected from the subjects.  
 Three of the 13 persistent strains were ST10 but it is difficult to draw the same 
correlation between persistence and the ability to cause infections because studies of group A 
E. coli (92, 312) have found that most belong to CC10. Many of the group A strains analysed 
in this work were members of CC10, supporting that finding. However, the 3 persistent ST10 
strains were different from most of the other CC10 strains from the present collection because 
they contained more VFs. Published analyses of group A commensal strains have found many 
of the isolates carry only a few or no VFs (72, 227), or PAIs (161), whereas group A isolates 
recovered from infections contained more VFs than faecal isolates (26, 28). Hence, the 3 
persistent ST10 strains could represent a sub-lineage, which has acquired the ability to reside 
in the colon for a long time, and potentially can cause extraintestinal infections.  
Some of the similarities between the persistent strains that were identified in this work 
to strains that cause UTI had been observed in previous studies of strains that had persisted in 
colon for 3 weeks or more in infants (204, 205, 208) or for 3 months or more in schoolgirls 
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(203). The resident strains from those studies (203-205, 208) were found to more frequently 
contain the genes encoding P fimbriae, capsule, aerobactin, hemolysin or colibactin than 
transient strains, and the authors suggested that the ability to persist was associated with the 
carriage of these VFs. The persistent strains were later shown to be predominantly from 
phylogenetic groups B2 and D whereas the transient strains were mostly from A and B1 (206, 
207), indicating that the resident strains were more likely to be from the two phylogenetic 
groups more frequently associated with infections. The clonality of these strains was assessed 
using only RAPDs, and it would be interesting to determine if they belong to the STs that are 
often found in UTI (59, 89, 90, 146, 231).  
A further study identified and examined a small number of persistent strains that were 
collected from a family of 5, all of whom were sampled intermittently over 3 years (132). 
Only a total of 14 strains were found because a limited number of isolates were analysed. Six 
of these were detected in multiple samples from a single subject or in multiple household 
members, and two of these 6 persistent strains were ST95 and another strain was ST73. 
However, in contrast to the findings presented here, an ST95 and an ST69 were found among 
the 8 strains that were detected in only one faecal sample. Indistinguishable isolates of a ST95 
strain that had caused a UTI in one household member were also detected in the faeces of that 
person and 3 other family members (132). Thus, this ability of a strain to be shared by 
different individuals who come into contact is a second property that can be viewed as an 
indicator of successful commensalism. The original strain typing (132) indicated that 4 
household members carried the same ST73 strain over 2 years. However, SNP analysis of 8 
sequenced ST73 isolates [one representative isolate sequenced from each faecal sample], 
revealed that each isolate differed by a few SNPs (238). This was interpreted as indicative of 
repeated acquisition of related ST73 strains, and highlights the difficulty in determining that 
strains are identical. Hence, it will be important to compare the genomes of isolates from 
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different time points of the persistent strains found in the current study in order to confirm 
that they are indeed persistent. 
It is has been established that the faecal strain that causes a UTI originates from the 
commensal flora of the patient (130, 190, 248, 317), and in cases of neonatal meningitis, 
when transmission of the strain appears to occur directly from the faeces of the mother to the 
child (255). However, which commensal E. coli are most likely to do this is less well 
understood. Based on their findings, Nowrouzian and co-workers proposed that virulence in 
E. coli might be “a coincidental product of adaptation to the colonic niche” (203, 206). The 
findings described in this thesis support this hypothesis. Hence, persistent commensal E. coli 
might be the subset of commensal strains that are most likely to cause infections. This theory 
potentially draws together 2 other theories (310) that have been proposed to explain why only 
some commensal strains seem to cause extraintestinal infections. The prevalence theory 
stipulates that an infection is caused by a commensal strain with the most opportunity, i.e. the 
dominant or numerically superior strain (310). However, persistence is also a means of 
presenting a strain with enhanced opportunity. In the present study, the persistent strains 
fluctuated between 100% of the E. coli to less than 1%, and this could be an explanation for 
the UTI causing strain not being the dominant strain or not detected in every faecal sample 
from patients (130, 190). The special pathogenicity theory posits that an infection is caused 
by a strain possessing the necessary VFs (310). However, because virulence is considered to 
be a multifactorial process (11, 142, 298), the ‘necessary’ VFs cannot be unambiguously 
identified. Nonetheless, the persistent strains were more likely to carry VFs than the other 
strains examined in this study and those by Nowrouzian and associates (203-205, 208). 
Therefore, the hypothesis that successful/persistent commensal E. coli can cause non-
intestinal infections incorporates both the prevalence and special pathogenicity theories into 
one that is more inclusive. On the other hand, whether VFs are commensal adaptation factors 
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or simply properties that are associated with successful commensal strains remains to be 
established.  
 
9.2.1 Other comparisons between commensal and ExPEC strains 
A few studies (5, 148) have used different approaches to compare commensal strains with 
those isolated from infections to determine if there are additional properties that might be 
shared between these strains. One group (148) examined commensal B2 and B2 strains from 
infections, and both groups were found to be similar genetically and did not differ 
significantly in murine lethality. Based on their findings, the authors concluded that virulence 
was a by-product of commensalism. However, B2 E. coli represent only a subset of 
commensal E. coli, and consequently the data simply shows that similar strains are found in 
both groups. Moreover, it is has been established that most E. coli causing infections originate 
from the commensal flora of the patient (130, 190, 248, 317). 
Another factor that could lead to successful commensalism is predation resistance. E. 
coli are the prey of colonic protozoan species (284) and those that can resist predation would 
survive longer. Resistance to grazing by the amoeba Dictyostelium discoideum was observed 
in 15 out 21 strains recovered from infections but in only 5 out 10 commensal strains (5). The 
31 strains used in the study had previously been examined for lethality in mice and 
Caenorhabditis elegans (66) and the carriage of 11 VFs, and the 5 commensal strains that 
resisted predation appeared to have more in common with the strains from infections than 
with the 5 remaining commensal strains. The authors concluded that their findings supported 
the hypothesis that evolution of virulence factors occurs in the colon, i.e. virulence is 
coincidental, because they were of the view that the capacity to resist grazing by protozoa 
could manifest itself as virulence in a human host (5). In the future, repeating some of the 
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experiments discussed above, particularly the protozoan predation assay on the collection of 
strains assembled here would further enhance our understanding of successful commensalism. 
 
9.2.2 VF or intestinal colonization factors? 
As a corollary to the hypothesis that virulence is a by-product of successful commensalism, it 
is possible that VFs could have evolved as factors that promote survival in the colon, and this 
has also been proposed elsewhere (5, 67, 148, 204, 205, 207). However, there is little direct 
evidence to support this claim. 
The role fimbriae can play in the colonization of the human colon by E. coli strains 
has been examined (9, 52, 313). P fimbriae (313) and S fimbriae (9) have been shown to 
enhance the attachment of E. coli to human colonic epithelial cells. The same was shown for 
type 1 fimbriae (9) and in other studies (91, 130, 190, 209, 323) and in the current study, most 
E. coli contained a fim gene indicating that type 1 fimbriae play an important role in the 
colonization of the intestine. However, the fim genes were not detected in one of the persistent 
strains, and this strain also did not carry any of the other fimbrial genes assayed for. This calls 
into question what trait this E. coli strain is using to attach itself to the epithelial layer. The 
purified K1 capsule from a commensal isolate was found to strongly adhere to the mucus 
collected from the colon of mice (52), and, the capsule layer has been reported to protect the 
cell from the harsh colonic environment (118). The water-soluble iron [II] concentration in 
the faeces of healthy adults is reported to be around 25 µM (166) but E. coli require up to 100 
µM iron [II] for survival (37). Hence, the expression siderophores to sequester iron should be 
necessary for survival in the colon. However, some of the strains in the present study did not 
contain any of the 4 siderophore receptors and were unable to grow on iron-limited medium.  
To establish if PAIs might have a role to play in intestinal colonization, UPEC strain 
536 and mutants that each had 1 of 7 different PAIs or all 7 PAIs deleted, where each was 
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found to colonize the guts of mice over a period of 7 days (67). However, 536 outcompeted 
some of the mutants when a gut colonization assay was conducted using 2 strains. The 
deletion of certain PAIs were found to be advantageous for growth in urine, suggesting that 
the colon not the urinary tract provided the selective pressure needed for the maintenance of 
PAIs (67). However, it was not clear which PAIs mattered the most.  
Some VFs, like toxins, may not have a role to play in intestinal colonization and could 
be genuine virulence determinants. This could explain the scarcity of hemolysin among the 
commensal strains examined here and in other commensal E. coli collections (72, 190, 191, 
203, 209, 303). Colibactin, which is also a toxin, was common among strains that are long-
term colonizers of the colon of infants (208). It has been proposed that colibactin expressed 
by commensal strains could slow the renewal of the colonic epithelium by blocking the cell 
cycle, thus prolonging colonization of the epithelial layer (111).  
 Future studies should examine the role ‘virulence factors’ play in strain persistence. 
Mouse colonization experiments using persistent strains with mutants that lack VFs, and 
transient strains, could provide some of the evidence needed to establish if VFs evolved as 
colonization factors. There could also be certain properties that are unique to successful 
commensal E. coli but are not required to cause non-intestinal infections.  
 
9.3 The commensal reservoir of resistant strains 
In the USA, E. coli are reported to be the most prominent antibiotic resistant enteric species 
that causes infections (179). It is thought that resistant bacteria are emerging in other niches 
(61), such as the colons of humans and food-producing animals, and moving into the clinical 
setting. Several studies have proposed that the human colon is an important reservoir for 
antibiotic resistant Gram-negative bacteria (20, 71, 159, 160, 168, 175), and in this work, 
close to half of the E. coli strains were resistant to at least one antibiotic and most of these 
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were multiply antibiotic resistant. Hence, this study provides more evidence that the colon is a 
large reservoir for resistant E. coli.  
In the strains where the context of the resistance genes were examined, many of the 
genes were contained in the same or closely related structures indicating that horizontal gene 
transfer is the main culprit behind the spread of resistance genes. As the colon has also been 
shown to be a reservoir for strains that could cause infections, in this work and by others (130, 
132, 190), the acquisition of resistance genes by non-intestinal disease causing strains from 
resistant co-resident strains could explain the increase in antibiotic resistant E. coli infections. 
The accumulation of resistance genes by successful commensals could explain the emergence 
of highly resistant clones like CC131 and CC69.   
 
9.3.1 The threat posed by resistant E. coli that can persist  
The colon is a reservoir for resistant strains but strains that can persist in the absence of 
selection are likely to represent a greater threat than others. Eight of the 13 persistent strains 
identified in this work were resistant to at least one antibiotic and three were multiply 
antibiotic resistant. The persistent strains were often the majority of the isolates examined in a 
sample, and the average abundance of each strain was around 106 CFU/g of faeces. A healthy 
adult male defecates approximately 200g per day (241, 276), and this amounts to roughly 200 
billion resistant E. coli cells shed daily. Thus, in a year, a person like the subject who carried 
the persistent CC69 strain can shed approximately 1011 CFU of resistant isolates. If 10% of 
the human population carried resistant strains that were present in the colon for an extended 
period of time, the total amount of resistant strains that are continuously being released into 
the environment is enormous, if not astronomical. The carriage of resistant strains that are 
successful intestinal colonizers provides strong evidence that the colon is one of the most 
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important reservoirs for resistant strains, and the depth of this reservoir might be greater than 
previously thought.  
 
9.3.2 Emergence of resistant CC95 strains 
In cases of neonatal meningitis, it appears that the transmission of the strain that causes the 
infection occurs directly from the faeces of the mother to the infant during childbirth (255), 
and many of these strains have been shown to belong to CC95 (187, 188). Resistance to 
antibiotics has not been reported for this clone and resistance to front-line antibiotics is not 
considered to be a serious problem in the treatment of meningitis infections caused by E. coli 
(85). However, multiply antibiotic resistant CC95 strains were found in the present study. 
Hence, members of this clone appear to be slowly acquiring resistance genes and this is a 
worrying trend because neonatal meningitis already results in high morbidity and mortality 
(85). The acquisition of multiple resistance determinants by CC95 could make an already 
invasive pathogen resistant to treatment, thus resulting in an increased rate of mortality. 
 
9.3.3 How are these strains becoming resistant? 
The resistance genes in E. coli are also found in other Gram-negative bacteria, including 
pathogens like K. pneumoniae, Acinetobacter baumanii and Salmonella spp. (164), and 
resistance plasmids, some of which can carry many resistance genes (42), are the main culprit 
behind the spread of antibiotic resistance genes. Resistant strains are commonly found in the 
food supply (173, 215), and they could be sharing their resistance plasmids with human 
commensal strains when they meet in the colon.  
One of the persistent strains examined here contained Tn6029, which contains the 
sul2-strAB cluster and the blaTEM gene [see Figure 1.6 in Chapter 1], and this transposon has 
been found on plasmids from commensal E. coli in Nigeria (145) and a French ST405 isolate 
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[GenBank accession number FQ482074], and on plasmids from Japanese (213), Australian 
(299) and German (195) enteropathogenic E. coli. It was also found on the chromosome of 
the E. coli O104:H4 strain that caused an outbreak of hemolytic-uremic syndrome in 
Germany in 2011 (7). Thus, Tn6029 is broadly disseminated around the world and its 
movement is most likely to have been mediated by 1 or more plasmids.  
Small plasmids like pCERC1, which have been found in food producing animals (141, 
268), could be acquired by successful commensal strains, thus contributing to the retention of 
resistance genes in the colon. A plasmid that is nearly identical to pCERC1 but did not have a 
dfrA14 gene cassette in strA was detected in China in the 1950s (318). In the subsequent 60 
years, plasmids from the same family have been detected all over the world (55, 58, 75, 86, 
103, 104, 117, 141, 214, 245, 268, 290, 321, 322) in E. coli from a variety of niches, 
including infections. Hence, these resistant plasmids can persist in the environment and it is 
only a matter of time before a persistent strain acquires this plasmid.  
Plasmid pKF3-140 was recovered from a Chinese clinical K. pneumoniae strain and it 
contains a large multiply antibiotic resistance region (324). It appears that this plasmid or a 
close relative could be in the Australian CC69 strains. If this resistance region on pKF3-140 is 
transferred onto the chromosome of the Australian CC69 strains, it could form a large 
genomic island similar to the one seen in the American CC69 strain, UMN026 (151), thus 
strengthening the association between resistance and successful commensalism. 
The findings made here provide additional evidence that some of the reservoirs of 
resistance genes are interconnected and that resistance plasmids appear to have unimpeded 
mobility between these reservoirs. This level of connectivity is troubling because it would 
lead to the acquisition of resistance plasmids by persistent E. coli. Some resistance plasmids 
have been reported to be common in both human commensal E. coli, and those that cause 
non-intestinal infections (64, 80, 136). These plasmids might also be prevalent among the 
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resistant strains examined here. Hence, future analysis should aim to investigate if the 
commensal strains from the present study contain resistance plasmids, and to determine how 
closely related these plasmids are to each other and to other plasmids.   
 
9.4 Concluding remarks 
Insights into the properties of commensal E. coli strains have been presented in this thesis. 
The fact that almost all of the persistent strains, unlike the other strains, were members of the 
clones that are found frequently in infections strongly supports the hypothesis that 
extraintestinal virulence is a by-product of successful intestinal colonization. The carriage of 
antibiotic resistance genes by persistent strains is troubling because if successful commensals 
are the source of UTI and other infections, the accumulation of resistance genes in these 
strains will result in severe clinical outcomes. A limitation of this study was that the 
identification of transient strains was not conclusive. Hence, future analysis should address 
this by collecting samples at much closer intervals to identify genuine transient strains to act 
as a comparator group. The sequencing of representative strains from this collection would 
provide further information on the properties of persistent and transient commensal E. coli, 
broadening our understanding of how E. coli can behave as a commensal most of the time but 
occasionally cause disease.  
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Table A1.1: Strain typing of E. coli in subject 1 
Sample Day E. coli strains 
Resistance 
phenotypea 
% Total 
E. colib 
API20E 
code 
Phylo 
groupc uidA 
RAPD 
typed 
1-1 1 1-R1 ApSmSuTcTp 100 1044552 A1 + 1 
1-2 29 1.2-S1 Susceptible 74e 5104572  A1 + 2 
  1.2-S2 Susceptible  5104572 A1 + 3 
  1.2-S3 Susceptible  5004552 A1 + 4 
  1.2-S4 Susceptible  5104552 D + 5 
  1.2-S5 Susceptible  1004552 A1 + 6 
  1.2-R2 Tc 23 5004552 A1 + 7 
  1.2-R3 SuTcTp 2 5004572 A1 + 8 
  1-R1 ApSmSuTcTp 1 1044552 A1  + 1 
1-3 99 1.3-S6  Susceptible 80f 1104572 A1  + 9 
  1.3-S7 Susceptible  5004552 A1  + 10 
  1-R1 ApSmSuTcTp 20 1044552 A1  + 1 
1-4 164 1.4-S8 Susceptible 1 5154572 A0  - 11 
  1.4-R4 SuTcTp 3 1044552 A1  - 12 
  1-R1 ApSmSuTcTp 96 1044552 A1  + 1 
aIsolates resistant to ampicillin [Ap], chloramphenicol [Cm], streptomycin [Sm], sulfamethoxazole [Su], 
tetracycline [Tc] and trimethoprim [Tp] 
bCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
cPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D1 [+ - -] 
dRAPD type is a combination of RAPD data collected with primers 1252, 1254 and 1290 
eTotal susceptible population. Five susceptible strains distinguished by RAPD analysis of 10 susceptible isolates 
f Total susceptible population. Two susceptible strains distinguished by RAPD analysis of 10 susceptible isolates 
 
Table A1.2. Abundance of Enterobacteriaceae in subject 1 
 
Sample Date Day Abundance c.f.u./g faecesa 
   E. coli K. pneumoniae 
1-1b 10/3/08 1 4.8 x 106 6.7 x 107 
1-2b 7/4/08 29 2.9 x 106 3.8 x 106 
1-3b 16/6/08 99 1.8 x 106 2.1 x 107 
1-4b 20/8/08 164 1.9 x 107 1.0 x 108 
1-5 14/1/09 311 9.7 x 106 6.9 x 107 
1-6 10/3/09 366 1.0 x 107 6.9 x 106 
1-7c 11/3/09 367 5.7 x 106 7.5 x 104 
1-8c 12/3/09 368 5.0 x 105 4.5 x 106 
1-9c 24/6/09 472 2.5 x 105 3.1 x 106 
1-10d 12/12/11 1372 1.5 x 105 1.7 x 107 
aCalculation done based on the number of c.f.u. detected on 10-3 dilution plates of faecal sample 
bData collected during Honours Project (12) 
cK.pneumoniae calculated from 10-2 dilution plates due to low abundance 
dE. coli abundance was calculated from the 10-2 dilution on the MacConkey Agar plate supplemented with 
tetracycline. This was because E. coli was rare in this sample. No E. coli was detected on the MacConkey Agar 
plate without antibiotics  
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Figure A1.1: RAPD profiles of strains from subject 1. The RAPD profiles of strains using primer 1290. The 
strain names are above each image while the isolation day is listed below. The image is of a 1.0% agarose gel 
run in TBE. The figure is taken from the author’s honours thesis (12). 
 
Table A1.3: Strain typing of E. coli in subject 2 
Sample Days E. coli strains 
Resistance 
phenotype 
% Total 
E. colia 
API20E 
code 
Phylo 
groupb uidA 
RAPD 
type 
2-1 1 2-S1c Susceptible 98 5144532 B2 + 1 
  2.1-R1 Ap 2 5144572 B2 + 2 
2-2 99 2-S1c Susceptible 1.4f 5144532 B2 + 1 
  2-S2 Susceptible 15 5144512 B2 + 3 
  2.2-R2 Tc 85 5044512 A1 + 4 
aCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
bPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D1 [+ - -] 
cNon-lactose fermenting E. coli. Forms while colonies on MacConkey agar 
f3 white colonies detected amongst 208 E. coli colonies on 10-2 dilution plate. No further white colonies found  
 
Table A1.4: Strain typing of E. coli in subject 3 
Sample Days E. coli strains 
Resistance 
phenotype 
% Total 
E. colia 
API20E 
code 
Phylo 
groupb uidA 
RAPD 
type 
3-1 1 3-S1 Susceptible 58 5144552 B2 + 1 
  3-R1 ApTc 39 5144552 D + 2 
3-2 141 3-S1 Susceptible 77 5144552	   B2 + 1 
  3-S1Rc Ap 23  5144552	   B2 + 1 
  3-R1 ApTc 1.0d 5144552	   D + 2 
aCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
bPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
d3-S1R RAPD profile indistinguishable from 3-S1. An ApR resistance variant of 3-S1  
dIsolates not detected amongst the 100 screened. Eight isolates detected on the 10-2 Tc dilution plates  
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Table A1.5. Abundance of Enterobacteriaceae in subject 3 
Sample Date Day Abundance c.f.u./g faecesa Other Enterobacteriaceae	  
   E. coli K. pneumoniae 	  
3-1 16/7/08 1 2.0 x 107 - E. cloacae, Enterobacter aerogenes, Citrobacter freundii	  
3-2 3/12/08 141 4.0 x 108 5.0 x 105 -	  
aCalculation done based on the number of CFU detected on 10-3 dilution plates of faecal sample 
 
Table A1.6: Strain Typing of E. coli in subject 4 
Sample Days E. coli strains 
Resistance 
phenotype 
% Total 
E. colia 
API20E 
Code 
Phylo 
groupb uidA 
RAPD 
type 
4-1 1 4-R1 ApTc 96 5144552 D + 1 
  4-R2 ApSmSpSuTcTp 4 5044572 D + 2 
4-2 90 4.2-S1 Susceptible 8 1144552 A1  + 3 
  4.2-R3c Tc 56 5144552 D + 1 
  4-R1c ApTc 11 5144552 D + 1 
  4-R2 ApSmSpSuTcTp 25 5044572 D + 2 
4-3 211 4.3-R2ad Ap 1 5044572 D + 2 
  4-R2d ApSmSpSuTcTp 99 5044572 D + 2 
4-4 289 4.4-R2bd ApSmSuTc 4 5044572 D + 2 
  4-R2d ApSmSpSuTcTp 96 5044572 D + 2 
4-5 421f 4.5-S2 Susceptible 44 1144532 A0  + 4 
  4-R2 ApSmSpSuTcTp 36 5044572 D + 2 
aCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
bPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
cResistance variants of the same strain 
dResistance variants of the same strain 
f100 were screened. Twenty were determined to be Citrobacter freundii after the original faecal sample was 
discarded 
 
Table A1.7: Abundance of Enterobacteriaceae in subject 4 
Sample Date Day Abundance c.f.u./g faecesa Other Enterobacteriaceae	  
   E. coli K. pneumoniae 	  
4-1 6/8/08 1 3.5 x 106 - - 
4-2 3/11/08 90 7.5 x 106 - - 
4-3 4/3/09 211 4.5 x 106 - -	  
4-4b 21/5/09 289 1.3 x 106 - -	  
4-5b 30/9/09 421 5.0 x 106 1.9 x 105 C. freundii	  
aCalculation done based on the number of c.f.u. detected on 10-3 dilution plates of faecal sample 
bK.pneumoniae calculated from 10-2 dilution plates due to low abundance 
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Table A1.8: Strain typing of E. coli in subjects 5 and 6 
Sample Days E. coli strains 
Resistance 
phenotype 
% Total 
E. colia 
API20E 
code 
Phylo 
groupb uidA 
RAPD 
type 
5-1 1 5.1-R1 ApSmSu 100 5144552 B2 + 1 
5-2 106 5.2-S1 Susceptible 18 5044552 D + 2 
  5.2-R2c ApCmSmSuTcTp 82 1044552 D + 3 
         
6-1 1 6.1-S1 Susceptible 100 5144572 D + 1 
6-2 113 6.2-S2 Susceptible 100 5044572 D + 2 
  6.2-R1d SuTp 0.9 5044552 D - 3 
aCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
bPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
cNon-lactose fermenting E. coli. Forms while colonies on MacConkey agar 
dIsolates not detected amongst the 100 screened. Six isolates detected on the 10-3 Su dilution plate  
 
Table A1.9: Abundance of Enterobacteriaceae in subjects 5 and 6  
Sample Date Day Abundance c.f.u./g faecesa Other Enterobacteriaceae	  
   E. coli K. pneumoniae 	  
5-1 12/8/08 1 4.8 x 107 - - 
5-2b 25/11/08 106 2.4 x 106 - - 
      
6-1 20/8/08 1 1.5 x 107	   - - 
6-2b 10/12/08 113 3.0 x 107 - - 
aCalculation done based on the number of c.f.u. detected on 10-3 dilution plates of faecal sample 
bCalculation done based on the number of c.f.u. detected on 10-2 dilution plates of faecal sample 
 
Table A1.10: Strain typing of E. coli in subject 11 
Sample Days E. coli strains 
Resistance 
phenotype 
% Total 
E. colia 
API20E 
code 
Phylo 
groupb uidA 
RAPD 
type 
11-1 1 11.1-R1 ApTp 100 5144532 B2 + 1 
11-2 181 11.2-R2 ApSmSpSuTcTp 100 5044572 D + 2 
aCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
bPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
 
Table A1.11: Abundance of Enterobacteriaceae in subject 11  
Sample Date Day Abundance c.f.u./g faecesa Other Enterobacteriaceae	  
   E. coli K. pneumoniae 	  
11-1b 16/4/09 1 9.0 x 104 - C. freundii 
11-2c 13/10/09 181 6.0 x 104 1.1 x 104 - 
11-3 2/2/10 293 1.9 x 107 - - 
11-4 13/9/11 881 1.8 x 106 - - 
aCalculation done based on the number of c.f.u. detected on 10-3 dilution plates of faecal sample 
bCalculation done based on the number of c.f.u. detected on 10-2 dilution plates of faecal sample 
cCalculation done based on the number of c.f.u. detected on 10-1 dilution plates of faecal sample 
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  Table A1.12: Characteristics of the 19 additional strains taken from Bailey et al., (20) 
Subject E. coli strains 
Resistance 
phenotype 
% Total 
E. colia 
API20E 
code 
Phylo 
groupb uidA 
RAPD 
type 
8 8.1-S1 Susceptible 100 5144572 B1 + 9 
9 9.1-R1 Su 100 5044572 D + 10 
10 10.1-S1 Susceptible 100 5144572 D + 11 
 10.1-R1 ApSmSuTcTp 0.7c 5144532 B2 + 12 
12 12.1-S1 Susceptible 60d 1044552 A0 - 14 
 12.1-S2 Susceptible 30d 1044552 A0 - 15 
 12.1-S3 Susceptible 10d 1044552 B1 - 16 
13 13.1-R1 Tc 6 5044552 D + 17 
 13.1-R2e ApSuTc 93 5144513 B2 + 18 
 13.1-R2ae ApSu 1 5144513 B2 + 18 
15 15.1-S1 Susceptible 1f 5144572 B1 + 21 
 15.1-S2 Susceptible 6f 1044552 A0 - 22 
 15.1-S3 Susceptible 7f 5044542 A1 + 23 
 15.1-R1 ApSmSuTp 86 1044472g A1 + 24 
16 16.1-S1 Susceptible 70 5144572 A1 + 25 
 16.1-S2 Susceptible 30 5544552 B2 + 26 
17 17.1-S1 Susceptible 100 5044552 A1 + 27 
18 18.1-R1 ApTc 100 5044572 D + 28 
19 19.1-R1h SmSpTp 14 1144572 B1 + 29 
 19.1-R1ah Tp 1 1144572 B1 + 29 
 19.1-R2 ApSmSpSuTcTp 85 5144552 B2 + 30 
aCalculation made based on 100 isolates per sample screened for their antibiotic resistance phenotype 
bPhylogenetic group based on all possible combinations of the presence and absence of 3 genetic markers [chuA, 
yjaA, TspE4.C2]. Assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
cIsolates not detected amongst the 100 screened. Seven isolates detected on the 10-3 Su dilution plate 
dTen susceptible isolates screened using RAPDs and  6 were 12.1-S1, 3 were 12.1-S2 and 1 was 12.1-S3 
eResistance variants of each other 
fFourteen susceptible isolates screened using RAPDs and  1 was 15.1-S1, 6 were 15.1-S2 and 7 were 15.1-S3 
gThis API code did not yield an identification; nearest codes were 1044572 and 1044412, and both were codes 
produced and E. coli identification (20) 
hResistance variants of each other. In 19.1-R1a, the aadA1 cassette is interrupted by the insertion of IS629 (20) 
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  Table A1.13: VF and ST characteristics of the 92 strains 
Strain Resistance  phenotype 
Phylo  
groupa fyuA 
Other 
siderophore  
receptors  
Other 
VAGs ecpA fim ‘ExPEC’ markers 
‘ExPEC’  
statusb ST CC 
Persistent           
1-R1 ApSmSuTcTp A1 + - - + - iutA, kpsMT II [K1] + 10 10 
21.1-R1 ApSmSuTc A1 + - - + + kpsMT II - 10 10 
22-S1 Susceptible A1 + - - + + iutA, papC [GII], kpsMT II [K1] + 10 10 
            
1-S9 Susceptible B2 + - ibeA + + kpsMT II - 3164 NA 
2-S1 Susceptible B2 + piu ibeA + + iutA, kpsMT II [K5] + 131 131 
2-S2 Susceptible B2 + piu, ireA clbB + + papC [GII], kpsMT II [K1] + 95 95 
3-S1 Susceptible B2 + piu, ireA clbB + + papC [GII], kpsMT II [K1] + 95 95 
3-S1R Ap B2 + piu, ireA clbB + + papC [GII], kpsMT II [K1] + 95 95 
14.2-R2 Ap B2 + piu, ireA clbB + + papC [GII], kpsMT II [K1] + 95 95 
23-S2 Susceptible B2 + piu, ireA clbB + + papC [GII], kpsMT II [K1] + 95 95 
            
3-R1 ApTc D + piu - + + iutA, kpsMT II + 405 405 
4-R1 ApTc D + piu - + + iutA, kpsMT II + 405 405 
4-R2 ApSmSpSuTcTp D - piu - + + iutA, kpsMT II [K5] + 69 69 
            
Other           
1.4-S8 Susceptible A0 + - - - - - - - - 
14.3-S2 Susceptible A0 - - - + + kpsMT II - - - 
3.5-S3 Susceptible A0 + - - - + iutA - - - 
3.5-R3 SmSpTp A0 + - - + + iutA - 1136 NA 
14.3-R4 Tc A0 - iroN - + + iutA - 3182 NA 
            
1.2-S1 Susceptible A1 - - - - + - - - - 
1.2-S2 Susceptible A1 - - - - + - - - - 
1.2-S3 Susceptible A1 - - - + + - - - - 
1.2-S5 Susceptible A1 - - - + + - - - - 
1.2-R2 Tc A1 - - - + + - - - - 
1.3-S7 Susceptible A1 - - - + + - - - - 
1.4-R4 SuTcTp A1 - - - + - - - - - 
1.9-R7 ApTc A1 - - - + + - - - - 
14.4-S4 Susceptible A1 - piu, ireA - + + - - - - 
4.2-S1 Susceptible A1 + - - + + - - 3282 NA 
1.2-R3 SuTcTp A1 - - - + + - - 3179 10 
23.2-S3 Susceptible A1 + ireA - + + - - 10 10 
1.3-S6 Susceptible A1 - - - - + - - 48 10 
14.2-R3 Tc A1 - - - + + iutA - 48 10 
21.2-S3 Susceptible  A1 + - - + + iutA, papC [GII] + - - 
2.2-R2 Tc A1 + - - + + papCc, kpsMT II [K1] + 10 10 
            
11.3-S1 Susceptible B1 - - - + + - - - - 
            
3.3-S2 Susceptible B2 - - - + + papCc - 129 NA 
3.3-R2 Ap B2 + iroN ibeA + + kpsMT II [K1] - 3500 538 
1.9-R6 ApCmSpSmSuTcTp B2 + - - + + iutA, kpsMT II + 3180 NA 
14.2-S1 Susceptible B2 + piu, ireA clbB + + papC [GII], kpsMT II [K1] + 95 95 
11.3-R3 ApTc B2 + iroN ibeA + + iutA, papC [GII], kpsMT II[K1] + 131 131 
            
1.2-S4 Susceptible D - piu - + + - - 1158 31 
21.3-S4 Susceptible  D + piu - + + - - 3183 38 
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Strain Resistance  phenotype 
Phylo  
groupa fyuA 
Other 
siderophore  
receptors  
Other 
VAGs ecpA fim ‘ExPEC’ markers 
‘ExPEC’  
statusb ST CC 
4.2-R3 Tc D + piu - + + iutA, kpsMT II + - - 
4.3-R2ad Ap D - piu - + + iutA, kpsMT II + 69 69 
2.3-R5e SmSuTcTp D + piu, iroN, ireA - + + iutA, papC [GII] + 117 NA 
2.3-R4 SuTcTp D - iroN - + + iutA, kpsMT II + - - 
14.4-S3 Susceptible D - piu - + + iutA, kpsMT II + - - 
4.4-R2bd ApSmSuTc D - piu - + + iutA, kpsMT II + 69 69 
11.2-R2 ApSmSpSuTcTp D - piu - + + iutA, kpsMT II [K5] + 3181 69 
            
Single sample           
21.1-S1 Susceptible  A0 - - - - + - - - - 
12.1-S1 Susceptible A0 - - - - + - - - - 
2.6-S3 Susceptible A0 - - - + + - - - - 
4.5-S2 Susceptible A0 - - - - + - - - - 
12.1-S2 Susceptible A0 - - - - + iutA - - - 
15.1-S2 Susceptible A0 + ireA - - + iutA - - - 
21.4-S7 Susceptible A0 + - - + + iutA, papCc + - - 
           
3.6-R5f ApCmGmSmSpSuTcTmTp A1 - - - + + - - - - 
17.1-S1 Susceptible A1 + - - + + - - - - 
16.1-S1 Susceptible A1 + piu - + + - - - - 
15.1-S3 Susceptible A1 + - - + + iutA, kpsMT II + - - 
15.1-R1 ApSmSuTp A1 + - - + + iutA, kpsMT II [K1] + - - 
21.1-S2 Susceptible  A1  + - - + + iutA, papC [GII], kpsMT II [K1] + - - 
            
8.1-S1 Susceptible B1 - - - + + - - - - 
12.1-S3 Susceptible B1 - - - - + - - - - 
15.1-S1 Susceptible B1 - - - + + iutA - - - 
19.1-R1g SmSpTp B1 - ireA - + + iutA - - - 
            
5.1-R1 ApSmSu B2 + piu ibeA + + kpsMT II - - - 
11.1-R1 ApTp B2  + - ibeA + + iutA - - - 
22.1-S2 Susceptible  B2 + piu, iroN hlyA + + sfa, papC [GIII], kpsMT II + - - 
2.1-R1 Ap B2 + iroN hlyA, clbB + + sfa, papC [GIII], kpsMT II + - - 
23.1-S1 Susceptible B2 - - hlyA, clbB + + sfa, papCc, iutA + 73 73 
16.1-S2 Susceptible B2 + piu, ireA clbB + + papC [GII], kpsMT II + - - 
13.1-R2h ApSuTc B2 + iroN hlyA + + iutA, sfa, papC [GII] + - - 
19.1-R2 ApSmSpSuTcTp B2 + iroN clbB + + iutA, sfa, kpsMT II [K5] + - - 
10.1-R1 ApSmSuTcTp B2 + piu, ireA - + + iutA, papC [GII], kpsMT II [K5] + - - 
14.5-S5 Susceptible B2 + piu, iroN ibeA + + iutA, kpsMT II [K1] + - - 
21.4-S5 Susceptible B2 + piu - + + iutA, papC [GII], kpsMT II [K1] + - - 
21.4-S6 Susceptible B2 + piu - + + iutA, papC [GII], kpsMT II [K1] + - - 
22.4-S3 Susceptible B2 + piu - + + iutA, papC [GII], kpsMT II [K1] + - - 
1.10-R8 SuTcTp B2 + piu, iroN, ireA - + + iutA, papC [GII], kpsMT II [K1] + 95 95 
22.1-R1 ApCmSmSpSuTcTp B2 + piu, iroN, ireA - + + iutA, papC [GII], kpsMT II [K1] + 3201 95 
            
13.1-R1 Tc D + - - + + - - - - 
6.1-S1 Susceptible D + piu - + + - - - - 
11.4-R4 SuTp D - piu, iroN - + + iutA - - - 
10.1-S1 Susceptible D + iroN - + + kpsMT II - - - 
6.2-S2 Susceptible D - piu - + + kpsMT II - - - 
5.2-S1 Susceptible D - iroN - + + kpsMT II - 69 69 
5.2-R2 ApCmSmSuTcTp D + piu - + + kpsMT II [K1] - - - 
6.2-R1 SuTp D - piu, ireA - + + iutA, kpsMT II [K5] + - - 
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Strain Resistance  phenotype 
Phylo  
groupa fyuA 
Other 
siderophore  
receptors  
Other 
VAGs ecpA fim ‘ExPEC’ markers 
‘ExPEC’  
statusb ST CC 
14.1-R1 ApSmSpSuTcTp D - piu - + + iutA, kpsMT II [K5] + 69 69 
18.1-R1 ApTc D + piu - + + iutA, papCc + - - 
9.1-R1 Su D + piu - + + iutA, papC [GII] + - - 
aGroup assignments are A0 [- - -], A1 [- + -], B1 [- - +], B2 [+ + +] and D [+ - -] 
bStrains that have any 2 of sfa, kpsMT II, iutA and papC are considered ‘ExPEC’ 
cA papG allele was not detected 
dResistance variants of each other and not 4-R2 
eHas SmR SuR TpR variant, 2.3-R3 
fHas ApR SmR SuR variant, 3.6-R4 
gHas TpR variant, 19.1-R1a 
hHas ApR SuR variant. 13.1-R2a 
 
 
 
Figure A1.2: pCERC1 and ColE1 RNA I. The figure shows the RNAfold images of the secondary structures 
formed by [a] RNA I from pCERC1 and [b] RNA I from ColE1, which closely resembles the ColE1 RNA I 
secondary structure shown in Davison, 1984 (62). The 3 domains are indicated by the numerals I, II and III.  
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Table A2.1 Characteristics of primers used to type strains. 
Gene Primer Sequence [5`→3`] Amplicon  size [bp] 
Annealing  
temp [°C] Source 
uidA uidAF CATTACGGCAAAGTGTGGGTCAAT 658 58 (302) 
 uidAR TCAGCGTAAGGGTAATGCGAGGTA    
      
Phylogenetic groups     
chuAa ChuA1 GACGAACCAACGGTCAGGAT 279 59 (48) 
 ChuA2 TGCCGCCAGTACCAAAGACA    
TspE4.C2a TspE4C2.1 GAGTAATGTCGGGGCATTCA 152 59 (48) 
 TspE4C2.2 CGCGCCAACAAAGTATTACG    
yjaAa YjaA1 TGAAGTGTCAGGAGACGCTG 211 59 (48) 
 YjaA2 ATGGAGAATGCGTTCCTCAAC    
      
RAPD      
 1252 GCGGAAATAG variable variable (219) 
 1254 CCGCAGCCAA variable variable (219) 
 1290 GTGGATGCGA variable variable (219) 
aReaction performed as a multiplex 
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Table A2.2 Characteristics of primers used to identify resistance genes and integrons.  
Gene Confers R to Primer Sequence [5`→3`] Amplicon  size [bp] 
Annealing  
temp [°C] Source 
blaTEM Ampicillin RH605 TTTCGTGTCGCCCTTATTCC 860 60 Hall Laba 
  RH606 CCGGCTCCAGATTTATCAGC    
blaSHV Ampicillin RH1005 ATGCGTTATATTCGCCTGTG 861 60 (16) 
  RH1006 TTAGCGTTGCCAGTGCTC    
catA1 Chloramphenicol RH513 GTACTGTTGTAATTCATTAAGCAT 595 60 Hall Laba 
  RH514 TCCCAATGGCATCGTAAAGAACA    
catA2 Chloramphenicol Cat2b-F CCGGATTGACCTGAATACCT 573 60 (233) 
  Cat2b-R TCACATACTGCATGATGAAC    
cmlA1 Chloramphenicol RH330 CACCAATCATGACCAAG 115 60 Hall Laba 
  RH331 GGCATCACTCGGCATGGACATG    
sul1 Sulfamethoxazole HS549 ACTAAGCTTGCCCCTTCCGC 1103 60 (280) 
  HS550 CTAGGCATGATCTAACCCTCG    
sul2 Sulfamethoxazole Sul2-F GGCAGATGTGATCGACCTCG 405 60 (153) 
  Sul2-R ATGCCGGGATCAAGGACAAG    
sul3 Sulfamethoxazole Sul3-F GAGCAAGATTTTTGGAATCG 790 60 (226) 
  Sul3-R AACTAACCTAGGGCTTTGGA    
strA Streptomycin StrA-F CTTGGTGATAACGGCAATTC 548 60 (88) 
  StrA-R CCAATCGCAGATAGAAGGC    
strB Streptomycin StrB-F ATCGTCAAGGGATTGAAACC 509 60 (88) 
  StrB-R GGATCGTAGAACATATTGGC    
tetA[A]b Tetracycline TetA-F GCTACATCCTGCTTGCCTTC 210 60 (198) 
  TetA-R CATAGATCGCCGTGAAGAGG    
tetA[G]b Tetracycline TetG-F GCTCGGTGGTATCTCTGCTC 468 60 (198) 
  TetG-R AGCAACAGAATCGGGAACAC    
tetA[E]b Tetracycline TetE-F AAACCACATCCTCCATACGC 278 60 (198) 
  TetE-R AAATAGGCCACAACCGTCAG    
tetA[B]c Tetracycline TetB-F TTGGTTAGGGGCAAGTTTTG 659 60 (198) 
  TetB-R GTAATGGGCCAATAACACCG    
tetA[C]c Tetracycline TetC-F CTTGAGAGCCTTCAACCCAG 418 60 (198) 
  TetC-R ATGGTCGTCATCTACCTGCC    
tetA[D]c Tetracycline TetD-F AAACCATTACGGCATTCTGC 787 60 (198) 
  TetD-R GACCGGATACACCATCCATC    
aacC2 and Gentamicin and Aac2-F GGCAATAACGGAGGCAATTCGA 680 60 (84) 
aacC3 Tobramycin Aac2-R CTCGATGGCGACCGAGCTTCA    
aacC4  RH554 TCGGTCAGCTTCTCAACCTT 605 60 Hall Laba 
  RH555 ACCGACTGGACCTTCCTTCT    
merA Mercuric ions RH671 GTCAGGTAGGGGAACAACTG Variabled 60 Hall Laba 
  RH672 GTGTGCCGTCCAAGATCATG    
       
Integrons       
intI1 Class 1 integron HS463a CTGGATTTCGATCACGGCACG 473 60 (280) 
  HS464 ACATGCGTGTAAATCATCCGTCG    
intI2 Class 2 integron HS501 CACGGATATGCGACAAAAAGGT 788 60 (181) 
  HS502 GTAGCAAACGAGTGACGAAATG    
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Gene cassettes      
5`-CS  Class 1 integron L1 GGCATCCAAGCAGCAAGC variable 65 (155) 
3`-CS  R1 AAGCAGACTTGACCTGAT   (156) 
5`-CS  Class 2 integron Hep74 CGGGATCCCGGACGGCATGCACGATTTGTA variable 
60 (306) 
3`-CS  Hep51 GATGCCATCGCAAGTACGAG    
aDesigned and used routinely in the Hall Laboratory  
b and b Primers used in a multiplex 
cmerA from Tn21 is 1201 bp, merA from Tn1696 is 1189 bp 
 
Table A2.3 Characteristics of primers used to map the sul2-strAB region.  
Gene Primer Sequence [5`→3`] Amplicon  size [bp] 
Annealing  
temp [°C] 
strAB StrA-F CTTGGTGATAACGGCAATTC 1191 60 
 StrB-R GGATCGTAGAACATATTGGC   
     
sul2 to Sul2-F GGCAGATGTGATCGACCTCG 2181 60 
strB StrB-R GGATCGTAGAACATATTGGC   
 
Table A2.4 Characteristics of primers used to map the class 1 integron containing a sul3 
gene.  
Gene  Primer Sequence [5`→3`] Amplicon  size [bp] 
Annealing  
temp [°C] 
Source 
aadA1 and  RH522 GTGGATGGCGGCCTGAAGCCA 517 60 Hall Labb 
aadA2a RH531 GGCAGCGACATCCTTCGGCGC    
dfrA12c dfrXII-F GGTGSGCAGAAGATTTTTCGC 308 60 (197) 
 dfrXII-R TGGGAAGAAGGCGTCACCCTC    
intI1 L1 GGCATCCAAGCAGCAAGC variabled 60 (155) 
aadA2 RH531 GGCAGCGACATCCTTCGGCGC   Hall Labb 
aConfers resistance to streptomycin and spectinomycin 
bDesigned and used routinely in the Hall Laboratory  
cConfers resistance to trimethoprim 
dSeveral gene cassette configurations have been identified (60) 
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Table A2.5 Characteristics of primers used to examine the blaTEM-IS26 linkage.  
Linkage  Primer Sequence [5`→3`] Amplicon  size [bp] 
Annealing  
temp [°C] 
Source 
IS26 to RH1270 ACCTTTGATGGTGGCGTAAG variable 60 Hall Labb 
blaTEMa RH606 CCGGCTCCAGATTTATCAGC    
blaTEM to RH605 TTTCGTGTCGCCCTTATTCC 985 60 Hall Labb 
IR2a temR ACGCTCAGTGGAACGAAAAC   (23) 
IS26 to RH882 GATGCGTGCACTACGCAAAG variable 60 Hall Labb 
blaTEMc RH606 CCGGCTCCAGATTTATCAGC    
blaTEM to RH605 TTTCGTGTCGCCCTTATTCC variable 60 Hall Labb 
IS26d RH882 GATGCGTGCACTACGCAAAG    
blaTEM to RH605 TTTCGTGTCGCCCTTATTCC variable 60 Hall Labb 
IS26e RH1270 ACCTTTGATGGTGGCGTAAG    
aConfiguration shown in Figure 6.7a in Chapter 6 
bDesigned and used routinely in the Hall Laboratory  
cConfiguration shown in Figure 6.7b in Chapter 6 
dConfiguration shown in Figure 6.7c in Chapter 6 
eConfiguration shown in Figure 6.7d in Chapter 6 
 
Table A2.6 Characteristics of primers used to map and sequence pCERC1/pCERC2a.  
Linkage  Primer Sequence [5`→3`] Amplicon  size [bp] 
Annealing  
temp [°C] 
Source 
   pCERC1 pCERC2   
Mapping       
sul2 to Sul2-F GGCAGATGTGATCGACCTCG 2748 2181 60 (153) 
strB StrB-R GGATCGTAGAACATATTGGC    (88) 
strB to StrB-F ATCGTCAAGGGATTGAAACC 2690 2690 60 (88) 
orf3 RH962 GCTCATACGTCACTTTCATCC    This studyb 
       
orf1 to RH961 CCCGTCAAAACCACACCGTC 1496 1496 60 This studyb 
orf4 RH953 CCCCATGCCATCTGAATATG    This studyb 
       
orf4 to RH965 GCTGCGTATCAGTCGAATCC 1764 1764 60 This studyb 
sul2 Sul2-R ATGCCGGGATCAAGGACAAG    (153) 
       
Detection of pCERC      
RNA II to  RH963 CAGAGCAAGAGATTACGATT 4179 3611 60 This studyb 
orf1 RH964 CGACACCCGATAACTGTCCC    This studyb 
RNA II to RH963 CAGAGCAAGAGATTACGATT 2562 1994 60 This studyb 
strA StrA-R CCAATCGCAGATAGAAGGC    (88) 
strB to StrB-F ATCGTCAAGGGATTGAAACC 1484 1484 60 (88) 
orf1 RH964 CGACACCCGATAACTGTCCC    This studyb 
aConfiguration shown in Figure 7.4 in Chapter 7 
bRH primers were used to primer walk and sequence pCERC1. All RH primers here were designed as part of this 
study using pCERC1 [GenBank accession number JN012467] as a template 
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Table A2.7 Characteristics of primers used to map the resistance region in the ST69 strains.  
Linkage  Primer Sequence [5`→3`] 
Amplicon  
size [bp] 
Annealing  
temp [°C] 
Source 
5`-CS L2 GACGATGCGTGGAGACC 297 60 (154) 
 L3 CTTGCTGCTTGGATGCC   (170) 
5`-CS to L3 CTTGCTGCTTGGATGCC 1467 60 (170) 
IS26 RH1270 ACCTTTGATGGTGGCGTAAG   Hall Laba 
5`-CS L3 CTTGCTGCTTGGATGCC variable 60 (170) 
 
HS464 
ACATGCGTGTAAATCATCCGTC
G 
 
 
(280) 
5`-CS to L1 GGCATCCAAGCAGCAAGC 2897 60 (155) 
3`-CS HS550 CTAGGCATGATCTAACCCTCG   (280) 
      
mphA to mphA-F AACTGTACGCACTTGC 1484 60 (230) 
mxr mxr-R CACCGTGTTTCAATCGACAGC    
mphR RH966 CAAGTCCGATGACGAGGTACT 681 60 Hall Laba 
 RH970 TTGTAAGCCGTAGACCTGAG    
mphA to mphA-F AACTGTACGCACTTGC 2807 60 (230) 
mphR RH970 TTGTAAGCCGTAGACCTGAG   Hall Laba 
mxr to mxr-R CACCGTGTTTCAATCGACAGC 1729 60 (230) 
IS26 RH882 GATGCGTGCACTACGCAAAG   Hall Laba 
IS6100 to RH115 TGGATGAAACCTACGTCA 1599 60 Hall Laba 
mphR RH966 CAAGTCCGATGACGAGGTACT    
IS6100 DB-T1 TGCCACGCTCAATACCGAC 300 60 (157) 
 IS6100-Rv2 AATGGTGGTTGAGCATGCC    
3`-CS to HS549 ACTAAGCTTGCCCCTTCCGC 5159 60 (280) 
mphR RH966 CAAGTCCGATGACGAGGTACT   Hall Laba 
3`-CS to HS549 ACTAAGCTTGCCCCTTCCGC 4082 60 (280) 
IS6100 IS6100-Rv2 AATGGTGGTTGAGCATGCC   (157) 
      
leuX tRNA RH957 GCGAAATCGGTAGACGCAGTTG variable 60 Hall Laba 
to IS26 RH617 TTGAATGGGTTCATGTGCAG    
intB to  RH968 GCAGTACCGTTATGAGGGAA variable 60 Hall Laba 
IS26 RH617 TTGAATGGGTTCATGTGCAG    
aDesigned and used routinely in the Hall Laboratory  
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Table A2.8 Characteristics of VF primers.  
Gene Primer Sequence [5`→3`] Amplicon size  [bp] 
Annealing 
temp [°C] Source 
Multiplex 1a     
papCb Pap1 GACGGCTGTACTGCAGGGTGTGGCG 328 65 (147) 
 Pap2 ATATCCTTTCTGCAGGGATGCAATA    
sfaDEb Sfa1 CTCCGGAGAACTGGGTGCATCTTAC 410 65 (147) 
 Sfa2 CGGAGGAGTAATTACAAACCTGGCA    
draAb Dr-321f GCCAACTGACGGACGCAGCAC 229 65 (203) 
 Dr-550r CCCCAGCTCCCGACATCGTTTTT    
fimA type1-331f CGACGCATCTTCCTCATTCTTCT 721 65 (203) 
 type1-1052r ATTGGTTCCGTTATTCAGGGTTGTT    
Multiplex 2 a     
iutAb Aer-851f GGCTGGACATCATGGGAACTGG 301 65 (122) 
 Aer-1152r CGTCGGGAACGGGTAGAATCG    
hlyA hly1 AACAAGGATAAGCACTGTTCTGGCT 1177 65 (316) 
 hly2 ACCATATAAGCGGTCATTCCCGTCA    
neuB [K1] K1-1011f CTACCCCTTTTGACGAAGAC 493 65 (203) 
 K1-1504r ACACACCTGACCCCAATAC    
kfiC [K5] K5-1756f GCCACCAACTGTCGCAAAA 809 65 (203) 
 K5-2564r TGTCGCCCAAACAAAAAGATT    
Multiplex 3a     
papGI j96-193f TCGTGCTCAGGTCCGGAATTT 461 65 (121) 
 j96-653r TGGCATCCCCCAACATTATCG    
papGII ia2-383f GGGATGAGCGGGCCTTTGAT 196 65 (121) 
 ia2-572r CGGGCCCCCAAGTAACTCG    
papGIII prs-198f GGCCTGCAATGGATTTACCTGG 258 65 (121) 
 prs-455r CCACCAAATGACCATGCCAGAC    
Additional VF     
kpsMT IIb kpsII f GCGCATTTGCTGATACTGTTG 272 60 (125) 
 kpsII r CATCCAGACGATAAGCATGAGCA    
fimH FimH f TGCAGAACGGATAAGCCGTGG 508 60 (125) 
 FimH r GCAGTCACCTGCCCTCCGGTA    
ecpA G84 CGCGGATCCATGAAAAAAAAGGTTCTGGC 587 60 (240) 
 G85 CGCGAATTCTAACTGGTCCAGGTCGCGTCG    
clbB clbBr CCATTTCCCGTTTGAGCACAC 578 60 (133) 
 clbBf GATTTGGATACTGGCGATAACCG    
ibeA ibe10-f AGGCAGGTGTGCGCCGCGTAC 170 60 (125) 
 ibe10-r TGGTGCTCCGGCAAACCATGC    
fyuA FyuA f TGATTAACCCCGCGACGGGAA 880 60 (125) 
 FyuA r CGCAGTAGGCACGATGTTGTA    
fepCCFT073 fepC-F TACCTGGATAATGCTGTCGG 347 60 (320) 
 fepC-R ATGGTGTTGATGGGGCTGGC    
ireA IRE-F GATGACTCAGCCACGGGTAA 254 60 (45) 
 IRE-R CCAGGACTCACCTCACGAAT    
iroN IRONEC-F AAGTCAAAGCAGGGGTTGCCCG 665 60 (124) 
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 IRONEC-R GACGCCGACATTAAGACGCAG    
aThe 3 multiplexes were taken from previous study (203) 
b‘ExPEC’ markers 
 
Table A2.9 Characteristics of MLSTa and clone specific primers.  
Gene Primer Sequence [5`→3`] Amplicon size  [bp] 
Annealing 
temp [°C] Source 
MLST primer pairs     
adk adkF ATTCTGCTTGGCGCTCCGGG 583 54 (312) 
 adkR CCGTCAACTTTCGCGTATTT    
 adkF1 TCATCATCTGCACTTTCCGC    
 adkR1 CCAGATCAGCGCGAACTTCA    
fumC fumCR1 TCCCGGCAGATAAGCTGTGG 806 54 (312) 
 fumCF TCACAGGTCGCCAGCGCTTC    
 fumCR GTACGCAGCGAAAAAGATTC    
gyrB gyrBF TCGGCGACACGGATGACGGC 911 60 (312) 
 gyrBR1 GTCCATGTAGGCGTTCAGGG    
 gyrBR ATCAGGCCTTCACGCGCATC    
icd icdF ATGGAAAGTAAAGTAGTTGTTCCGGCACA 878 54 (312) 
 icdR GGACGCAGCAGGATCTGTT    
mdh mdhF ATGAAAGTCGCAGTCCTCGGCGCTGCTGGCGG 932 60 (312) 
 mdhR TTAACGAACTCCTGCCCCAGAGCGATATCTTTCTT    
 mdhF1 AGCGCGTTCTGTTCAAATGC    
 mdhR1 CAGGTTCAGAACTCTCTCTGT    
purA purAF1 TCGGTAACGGTGTTGTGCTG 816 54 (312) 
 purAF CGCGCTGATGAAAGAGATGA    
 purAR CATACGGTAAGCCACGCAGA    
recA recAR1 AGCGTGAAGGTAAAACCTGTG 780 58 (312) 
 recAF CGCATTCGCTTTACCCTGACC    
 recAF1 ACCTTTGTAGCTGTACCACG    
 recAR TCGTCGAAATCTACGGACCGGA    
Clone specific PCR primers    
ST131      
pabB O25pabBspe.F TCCAGCAGGTGCTGGATCGT 347 65 (49) 
 O25pabBspe.R GCGAAATTTTTCGCCGTACTGT    
ST69      
fumC CGAf GCTATCTGGCAGACT 175 63 (129) 
 CGAr CGTGCATCGCCGTTGGAAAG    
ST95      
svg svg.1 TCCGGCTGATTACAAACCAAC 434 55 (27) 
 svg.2 CTGCACGAGGTTGTAGTCCTG    
aSecondary primers for each gene end with the numerical suffix, i.e. 1. The secondary primers were used when 
amplification failure occurred with main primers 
 
 
